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Abstract 
Non-proteinacous amino acids are important components of numerous 
biologically active compounds. As a consequence, there is much interest in the 
development of straightforward routes for their synthesis. A novel strategy for the 
synthesis of several classes of non-proteinacous a-amino acids from a variety of a-arnino 
acids is presented in this thesis. 
A general strategy of protecting the a-carboxyl group of serine. threonine, 
aspartic acid and glutamic acid as a cyclic ortho ester (OBO), sufficiently reduces the 
acidity of the a-proton to allow the use of a variety of basic reagents minimizing 
racemization at the a-proton. 
The sidechain hydroxyl group in BodOBO protected senne and threonine is 
oxidized to the corresponding aldehyde and ketone without enolization. Grignard and 
Reformatsky additions produced predorninantly threo-fl-hydroxy-a-amino acids in good 
selectivi ty w i th no racemization. Adaptation of the methodology ont0 the solid phase 
also gave threo-P-hydroxy-a-amino acids albeit with some racemization 
The addition of various electrophiles to the enolate of N-Cbz-a-OBO-y-methyl 
ester glutamic acid gave the 2S,4S stereoisorners with excellent selectivity and good 
yield. Alkylation, acylation, Aldol and Claisen reactions and the electrophilic addition of 
various heteroatoms is described. 
Electrophilic additions to the enolate of N-Cbz-a-OBO-y-rnethyl ester aspartic 
acid gave the more dificult to synthesize 2S,3S stereoisomer with varying degrees of 
stereoselectivity and yields depending on the electrophile. 
The stereochemistry of addition for the enolate chernistry is also explored. 
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Chapter One 
Introduction: The Synthesis of a-Amino Acids 
1.1 General Introduction 
a-Amino acids represent a vast arcay of chiral molecules with considerable 
structural diversity and importance, both as inherently biologically active compounds and 
as constihients of larger biomolecules. a-Amino acids are ubiquitous in nature, where 20 
comrnon "proteinogenic" amino acids are the standard building blocks for the peptides 
and proteins that form the structural bais of life. However, over a thousand of the so- 
called "non-proteinogenic" a-amino acids have been isolated from a variety of natural 
~ources.''~ The enonnous interest in a-amino acids can be attributed to two factors: their 
biological activity and their relevance to chernical asymmetric synthesis. 
Many non-proteinaceous amino acids (defined as "those amino acids which are 
not found in protein main chahs either for lack of a specific transfer RNA and codon 
triplet, or because they do not arise from protein amino acids by post-translational 
modifications")' or compounds containing them have been found to possess biological 
activity. These range from antimicrobial effects to antiepileptic activity to 
irnmunosuppressive action. The interest in synthetic routes to these unusual amino acids 
exists because many are diffkult to isolate andlor purify in significant quantities. 
Consequently, the development of spthetic methods for the practical synthesis of these 
unusual arnino acids allows for the development of structure-activity relationship studies 
(SAR) in order to identify compounds with optimal therapeutic properties. 
Non-proteinogenic amino acids have also k e n  used extensively as probes of 
biochemical rnechanisms. By incorporating amino acids that are confonnationaily 
restrïcted, isotopically labeled or chernically modified into peptides or proteins, insight 
may be gained into the mechanism of enzymatic action or binding properties of the 
enzyme. Rationally designed inhibitors may then be developed. Isotopically labeled 
substrates can also be used to study biosynthetic pathways in order to elucidate the 
mechanistic details and various steps involved in those pathways. Recent advances in 
protein engineering use a codon that codes for a transfer RNA containing an unusual 
amino acid, thus allowing the incorporation of unusual amino acids directly into large 
proteins." 
The other factor goveming the increased interest in arnino acids is the remarkable 
gro wth in as ymrnetric organic s ynthesis. Amino acids, as compounds natu rd1 y 
incorporating both chirality and functionality, have been intrinsically involved in the 
development of as yrnmetrïc s ynthesis as both substrates and targets? The proteinogenic 
amino acids provide a cheap source of starting materials usually available in both 
enantiomenc foms. and can be used as chiral auxiliaries,6 reagents7 and substrates.' 
The research presented in this thesis has concentrated on expanding the synthetic 
use of the 2,6,7-trioxabicyclo[2.2.2]0ctane protecting group for the a-carboxylate group 
in arnino acids that was pioneered earlier in this laboratory9 The use of this group in the 
synthesis of unusual amino acids will be described. 
The volume of Iiterature relevant to arnino acid synthesis is immense and a 
comprehensive review is beyond the scope of this thesis. However, a comparatively brief 
review of classical routes for the synthesis of both racernic and optically active amino 
acids will be presented including a number of selected routes that have proven to be of 
greatest importance and general utility in leading to enantiomerically pure amino acids. 
Methods that are specific to classes of amino acids will be discussed in the relevant 
chapter- For a more detailed review of methods for the stereoselective synthesis of a- 
amino acids, readers are referred to the excellent reviews by Williarn~'~ and Duthaler." 
1.2 Chernical Synthesis of Racemic a-Amino Acids 
Prior to the 1970's, the most widely used procedures for the synthesis of a-amino 
acids led to racemic compounds. Many of these routes were based on classical syntheses 
and could be categorïzed into three groups: addition of the arnino or carboxy function to 
the side Chain, alkylation of glycine derivatives and other methods. 
1.2.1 Addition of the Amino or Carboxy Function to the Side Chain. 
Racemic a-amino acids can be synthesized by the a-amination of a synthon 
containing a carboxyl group or conversely, by the a-carboxylation of an amine 
containing synthon. The first reported synthesis of an a-amino acid, in 1850 by the 
S trecker s ynthesis is an example of this method (Scheme 1.1). '' 
Scheme 1.1 




RCHo ~2 AOH KCN Y&CN .k.iW ~2 IiTI\C02H 
The Strecker synthesis is widely used in industry where the racemic arnino acid is 
N-acylated and subsequently enzymatically resolved to give the desired optically pure 
product,13 as in the case of L-a-methyldopa" The Bücherer-Bergs synthesis is a 
modification of the Strecker synthesis proceeding through a hydantoin intermediate? 
In the Gabriel synthesis, ammonia is replaced with potassium phthalidde 1.1 as 
the aminating reagent, generally resulting in fewer side reactions (Scheme 1 .2).12 
Scheme 1.2 
O 
R + G N K  - @( acid/alkali acid or or R 
XAC02Et 
cogt hydrazine/acid5 CO,Et Hz 
O O 
Racemic syntheses are still cornmonly used even though the literature on 
stereospecific syntheses over the past decade has grown immensely. A recent procedure 
describes the amination of 2-bromocarboxylic esters 13 with trichloroacetamide 1.2 
(Scheme 1.3) giving the free amino acid in 40-908 yield.I6 
Scheme 1.3 






1.2.2 A l w t i o n  of Glycine Derivatives. 
The strategy of adding the side chain of an amino acid to a glycine equivalent was 
first reported by Sorensen in 1903" and since then a number of varied templates have 
been used. N-Acylaminornalonates 1.4 provide a versatile route (Scheme 1 -4) where 
generation of the enolate and addition of an allcyl halide is followed by decarboxylation 




S imilar methodology emplo ys glycine Schiff bases (or a-isoc yanoacetates) whic h 
are alkylated to a number of mono- and di-alkylated amino acids obtained in 50-90% 
yield from the benzylidene derivative of glycine ethyl ester 1.5 (Scheme 1 S)." 
Scheme 1.5 
1) LDA or KOBu R ' alkaline 
2) R'X hydrolysis R' P~CH=N"CO~E~ rn PhCH= &C02Et - 
H2 
1.2.3 Other Synrhetic Routes to Racemic a-Amino Acids 
Numerous specific methods exist for the synthesis of racernic arnino acids as a 
survey of the literature, especially pre-1970's, indicates. Included amongst these is the 
classic Cunius rearrangement and the many modifications employed to synthesize a large 
number of both proteinogenic and non-proteinogenic a-arnino acids." 
1.3 Synthesis of O p t i d y  Active a-Amino Acids 
Optically active a-amino acids were initially obtained by the resolution of 
.J 
racemic mixtures, either by crystallization of diastereomeric salts, through derivatization 
and separation of diastereomers or through enzymatic methods. Amino acids have aiso 
played a pivotal role in the field of stereoselective synthesis, either as targets or reagents 
(for some reviews of early developments in asymmetric synthesis and the importance of 
amino acids as targets and reagents see Kagan and Fiaud," Apsimon and Séguin,lg 
Halpern," Mosher and Hamison2' and Bosnich and Fryzuky. A number of elegant 
approaches for the asymrnetric synthesis of various a-amino acids in their optically pure 
forms have k e n  developed and are summarized below. 
1.3.1 Enanfioselective Introduction of the a-Hydrogen 
The principal transformations leading to a-amino acids 1.6 by the 
enantioselective introduction of the a-hydmgen are shown in Scheme 1.6." The chiral a- 
carbon of 1.6 is generated either by hydrogenation of 1.7 or via 1,4-addition of 
nucleophiles (via 1.8). protonation of enolates 1.8, hydration of a-amino-ketenes 1.9 or 
by reductive amination of a-keto acids 1.10. 
Scheme 1.6 
1.8 1.9 
1.3.1.1 Asymemk Hydroge~tion of a;gDidehydro Amino Acids 
The utility of this method in the generation of optically active a-amino acids is 
twofold; the ease of synthesis of the appropnately functionaiized starting material via 
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classical techniques (Scheme 1.7) and the numerous methods available for the 
enantioselective hydrogenation of dehydroarniw acids. 
A number of methods exist for the generation of E- and 2-olefins, including 
variations of the Wittig and Horner-Wadsworth-Ernrnons reactions. Among the most 
versatile is the reaction of phosphonates 1.11 with various aldehydes to afford Cbz or 
Boc protected deh ydroamino acids 1.12 with a preterence for 2-isomers (Scheme 1.7)? 
Heck coupling of aryl iodides or bromides to 1.13 gives a-amido acrylates 1.14, 
providing an alternative route to various aryl functionalized Z isomers. rhreo-BHydroxy- 
a-arnino acids 1.15 cm be dehydrated into the E-isomer 1.16 providing complementarity 
to the above methods. 
Scheme 1.7 
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The enantioselective hydrogenation of dehydroarnino acids 1.7 is generally 
catalyzed by a chirally modified Wilkinson catalyst 1.17, and is such an efficient process 
for the preparation of chiral amino acids that it is also used industrially (Scheme 1.8). 
Higher activity is usually observed for cationic R h 0  complexes and over 1 0  chiral bis- 
phosphines have k e n  prepared, the most fiequenily used being DIPAMP ( (Ra) -  1,2- 
ethanedi y lbis[(o-methoxyphen y1)pheny lphospne]) 1 . 1  with enantioselectivities 
typically in the range of 80% to >99%. For example. both 1.19 and 1.20 were generated 
in 902 ee? P-Hydroxy-a-amino acids have also been synthesized using this 
method~logy.~ Numerous reviews cover this topic in more detail? 
As an alternative to chiral hydrogenation catalysts, reduction of the a$- 
unsaturated amino acid can also be controlled by chiral auxiliaries or asymmetric centers 
in the sidechain. This technique has been used extensively toward the synthesis of 
substituted glutamic acids and will be covered in more detail in Chapter Four. 
Scheme 1.8 mT [Rh(L*)COOpC C02H L*: Chiral Diphosphine 
1 .17/H2 Q', COD: 1.5-Cyctoactadiene 
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1.3.1.2 Reductive Amination of a-Ketoacids 
The reductive amination of a-ketoacids is a known biosynthetic step and the 
corresponding enzymes have been used comprehensively in the spthesis of a-amino 
acids. Phen y t alanine dehydrogenase from Badius  sphaericus has k e n  used to 
investigate the amination of various ammatic a-ketoacids with varying degrees of 
s ~ c c e s s . ~  The same principle has been used in the synthesis of a number of ysubstituted 
glutamic acids but will be discussed in M e r  detail in chapter four. 
1.3.1.3 Asymmetnc Protonation of Enolates 
The protonation of enolates generated from Schiff's bases occurs with moderate 
optical purity and is dependent on the structures of the Schiff base, the lithium base and 
temperature. For example, the imine 1.21 was deprotonated with lithium 
diisopropylamide &DA) and quenched with (Ra)-dipivaloyl-tartaric acid 1.22 to give 
predominantly the L-configuration of amino acid esters 1.23 (Scheme 1 .9)29 
Scheme 1.9 
R = Me, bPr, Ph 
1 -22 
31 HCI 
R = Me (65% ee) 
R = CPr (54% ee) 
1 .AS Enantioselective Introduction of the a-Amino Function 
Numerous groups have addressed the difficulties of the chiral synthesis of a- 
amino acids through the concept of enantioselectively introducing the a-amino 
fùnctionality. Two approaches rnay be taken; nucleophilic amination based on SN2 
displacement or direct electrophilic amination of enolates both of which rely on 
previously existing chirality to give the desired selectivity. 
1.3.2.1 M e o p h i l i c  Amination 
The diastereoselective synîhesis of Fhydroxy-a-amino acids €rom epoxides is 
particularly amenable to nucleophilic amination (Scheme 1.10). The Sharpless 
epoxidation provides a convenient route to both stereoisomers of the epoxides 1.24 and 
1.25 which are subsequently protected as the carbarnate 1.26 and isomerized to the 
oxazolidinones 1.27 followed by straightforward deprotection to the p-hydroxy-a-amino 
acids generally in good yields and with high ~iiastereoselectivity.~~ Minor contamination 
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Another route to p-hydroxy-a-arnino acids via epoxy allylic alcohols is by 
oxidation to the corresponding acid followed by epoxide opening by arnmonia, primary 
amines and hydrazines which avoid the regioselectivity problems desctibed in Scheme 
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a-Hydroxy-carboxylates are also readily available chiral compounds and lend 
themselves to N-nucleophilic substitution (Scheme 1.12). The reactions are generally 
clean although racemization difficulties have been encountered. Direct substitution by N- 
nucleophiles has k e n  achieved with sodium azide," amines:2 phthalimidef3 and imides3) 
under Mitsunobu conditions. Conversion of the alcohol to the triflate and subsequent 
direct displacement with di-N-Boc-imide has proven to be especially effective3' and has 
advantages over the Mitsunobu method, which requires harsh conditions for the 
unmasking of the nitrogen functionality. 
Scheme 1.12 
One of the best methods for the generation of a-amino acids by nucleophilic 
amination has been developed by Evans et al? The use of N-acyloxazolidinones 18M to 
generate a-bromides followed by SN2 displacement to the azide gives the desired 
precursor in high diastereoselectivity (usuaily 9 0 %  de) (Scheme 1.13). Altering the 
stereochemistry of the N-acyloxazolidinones 18m cm generate both enantiomers of 1.6. 
Furthemore, P-substituted-a-amino acids have been synthesized by first incorporating 
the desired &substituenf5 onto Evans' chiral oxazolidinone 1 3  or by diastereoselective 
cuprate addition to a$-unsaturated-N-acyloxazoiidinones 1.34) followed by a- 
brornination. The chiraiity of the B-carbon appears to have little effect on the 
stereoselectivity of a-bromination." 
Several other systems have been adapted to enantioselectively aminate the a- 
carbon and are based on the use of chiral templates developed for the enantioselective 
addition to glycine enolates and wili be discussed in more detail in Section 1.5.1.1 (vide 
infra). 
Scheme 1.13 
1.3.2.2 Electrophilic Amination of Enolates 
Perhaps the most direct route to a-amino acids is by amination of enolates with 
electrophilic reagents. This has only recently k e n  developed due to the scarcity of 
electrophilic sources of nitrogen that participate in C-N bond forming reactions. One of 
the first reagents used in this application was di-t-butyl azodicarboxylate, which converts 
Li-enolates to a-hydrazido acids.' However, this method suffers from difficulties 
associated with the harsh conditions required for the cleavage of the N-N bond in the 
newly fomed a-hydrazido acids. 
Evans and coworkers have optimized the direct azidation of potassium enolates of 
N-acyloxazolidinones 1.30 with trisyl azide, which occws in both good yield and high 
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stereosele~tivities.~ Numerous examples exist of the synthesis of a-amino acids using 
this methodology including the recent synthesis of a novel phosphotyrosyl mimetic?' and 
p,y-dehydrovaline?'" Evans' chiral N-acyloxazolidinones methodology thus provides 
access to both R- and S-a-amino acid enantiomers. 
1.3.3 Stereoselective Introduction of the Side Chain 
An obvious disconnection in the synthesis of a-amino acids is the stereoselective 
incorporation of the sidechain to a glycine equivalent. A cyclic chiral template usuall y 
induces stereochemical orientation and a revie w of the literature indicat es the majorit y of 
methods describing the asymmetnc synthesis of a-amino acids employ this approach. 
Both nucleophilic and electrophilic additions are used in order to introduce a wide range 
of side chains ont0 the template. Numerous examples of these chiral synthons exist. 
however, only the most important and frequentiy used systems will be discussed. 
2.3.3.1 Glycine a-Anion Equivalents 
The first cyclic template developed, the most versatile and widely used was the 
bis-lactim ether 1.32 developed by Schollkopf et al. of which several reviews have 
appeared." The dimethoxy lactirn ether 1.32 was formed from the diketopiperazine 1.31 
in 70-8096 yields and was subsequently used to generate a-methyl amino acids by 
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This approach was then applied to the synthesis of a-amino acids by forming a 
bis-lactim ether 1.33 from L-ValGly. A number of electrophiles were added, to give 
after hydrolysis, D-amino acid methyl esters in 75-959 ee, with 62-9196 yields for the 
addition and 5249% yields for the hydrolysis to the methyl ester (Scheme 1. 15).39 
Stereocontrol at the Pcarbon is less impressive, with only 22% de when chiral halide 
electrophiles were used? Furthemore, when the Li-enolate of 1.33 was added to 
carbonyl electrophiles, only 10-75 % de was achieved, although exchanging the Iithium 
enolate to a titanium derivative increased the diastereoselectivity to >95% de with >95% 
ee and yields of between 77-93%.41 A major disadvantage of the method. however, is the 
necessity to separate the two amino acid methyl esters that are generated as a result of 
hydrolysis of bis-lactim template. 
Scheme 1.15 
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Williams and coworlcers have examinai electrophilic additions to chiral 
oxazinones 1.34. Generation of the enolate and subsequent alkylation gave the tram 
adduct 1.35 in excellent diastereoselectivity (>99%) and reasonable yields (50-90%) 
(Scheme 1.16 top)? Only disilazanes are successful at deprotonating the oxazinone 1.34 
and the temperature, mode of addition and many other parameters have to be carefully 
controlled. Aldol condensations of the boron enolate of 1.34 with aldehydes produce 
anti-J3-hydroxy adducts 1.36 in 3857% yield with diastereoselectivities of approximately 
5: 1 observed at the carbinol center (Scheme 1.16 bottom)." 
Scheme 1.16 
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The camphor sultam 1.37 introduced by Oppolzer has k e n  used to direct the 
denvatization of glycine enolate equiva lent~ .~  Deprotonation of the imino sultam 
sp thon  1.37 followed by alkylation in the presence of HMPA gives the amino acid 
derivatives 1.38 with high diastereoselectivities (90-98% de) and excellent yields 
(Scheme 1.17). h i n e  hydrolysis under acidic conditions and removal of the auxiliary 
with LiOH fumishes a-amino acid 1.6. 
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Scheme 1.17 
The chiral nickel (II) complex 1.39 reported by Belokon et al.. derived from 
benzyl-proline, O-arninoacetophenone and glycine, is one of the best-studied systems for 
glycine enolate derivatization. Alkyl halides,& aldehydes4' and 1,4-unsaiurated 
carbonyls4' have al1 been added to 139 and enantioselectivities for addition are typically 
in the order of 9 0 %  ee (Scheme 1.18). p-Hydroxy amino acid derivatives are generated 
from aldehydes in good yield and with threo:allo ratios of >20: 1 in most cases, however, 
poor induction of stereochemistry at the B-carbon is achieved with 1,4unsaturated 




A wide variety of alkylating agents have been reacted with the enolate of 1.39 to 
give alkylated a-amino acids in yields of 60-901 and generally >98% ee.' 
Seebach and coworkers have developed the use of irnidazolidinones 1-41 prepared 
from Ala, Met, Val, Phe> Asp and Glu." Deprotonation of the imidazolidinone 
template, reaction with alkyl halides and deprotection gave the amino acid in nearly 
100% ee at the chiral center. 
R = Me, P r ,  Ph, Bn, (CH&SCH3 
CH2C02CH3, (CH2)&02CH3 
1 -41 
The more functional chiral glycine imidazolidinone 1.42 proved to be dificult to 
synthesize and was initially generated in poor yields (40%) from the degradation of 
senne or methionine." Better results were obtained by the recrystallization of the 
mandelate salt of the racemic imidazolidinone prepared directly from glycine (Scheme 
1.19). Both enantiomers c m  be isolated in >98% ee and the cyclic arninals (abbreviated 
BMI for the N-methyl derivatives) acylated to give Bz, Boc, and Cbz-BMI derivatives 
1-42 and 1.43.52 The racemic BMI is isolated in <50% yield from glycine methyl amide 
and upon resolution gives 30% of the S-enantiomer and 22% of the R-enanti~mer!~ 
Scheme 1.19 
Deprotonation of 1.42 allows for reaction with various electrophiles including 
alkyl haiides, nitroolefins, carbonyls and epoxides. Products with one new stereocenter 
(the a-center) gave a single diastereomer whilst secondary halides or nitroolefins give 
reasonable selectivity at the second center (7745% ds)? Aldol reactions typically occur 
in 4165% yields with 63-96% diastereoselectivity in preference of the syn (threo) 
Myers et al. have recently reported the use of a pseudoephedrine derivative 1.44 
as a chiral auxiliary in the synthesis of various allcylated a-amino acids? The 
advantages of this template include ease of preparation, high ee and de's and simplicity 
of hydrolysis off the template. The reported yields ranged between 70-805 for 
intermediate 1.45 and hydrolysis gives the fiee a-amino acids in generally >85% yield, 
however, few reports currently exist utilizing this methodology (Scheme 1.20). 
Scbeme 1.20 
1.44 R=Me, Et. allyi, Bn 1.45 
1 J.3.2 Glycine a-Cation Equivalents 
Many of the cyclic chiral templates described in the previous section can be 
converted to a-cation equivalents simply by the introduction of good leaving groups at 
the a-position. This approach has been used successfully with Schollkopf's bis-lactim 
1.33, Williams' oxazinone 1.34 and Belokon's Ni-complex 1.39. 
The chlorinated derivative of bis-lactim ether 1.33 was converted into aromatic a- 
amino acids by Friedel-Crafts alkylation with yields in the 60% range and 
enantioselectivites generaily >90% ee and occurs with inversion of stereochemistry at the 
a-carbon ." 
The 3-bromo analog of Williams and CO-worker's oxazinone 1.34 has b e n  
extensively studied and has been substitutad efficiently by alkyl thiolates, malonates, 
alkyl Zn-halides and cuprates in both good yield and high enantio~electivity.~ Coupling 
of al1 y lsilanes and si1 y 1 en01 ethers? FriedelCrafts alkylations7' and 
trialkylstannylacetylidesU could also be effected under Lewis-acid catalyzed conditions. 
The relative stereochemistry of the product remains anti and is postulated to proceed 
through iminium species 1.47 after zinc coordination to the bromide 1.46 (Scheme 1.2 1). 
The steric factors controlling addition of the electrophile to 1.34 in Scheme 1.16 exert the 
sarne influence in the case of the incoming nucleophile in scheme 1.21, resulting in 
retention of stereochemistry at the a-carbon. 
Belokon et al. have investigated the reactivity of the brorninated Ni-complex 1.40 
which was generated as a 2: 1 diastereomeric mixture from 1.39. However, nucleophilic 
addition gave the anti adducts with excellent stereocontrol (90-98% ee (S)) and good 
yields (6&9û%)." 
Scheme 1.21 
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1.3.4 Synthesàs fiom a-Amino Acids 
a-Amino acids, with their inherent chirality and functionality, provide an 
excellent source of starting materials for the synthesis of more complex derivatives. 
Countiess examples exist of the synthesis of unusual a-amino acids from other amino 
acid precurs~rs, '~*"~~ but as a whole. general methods for the synthesis of a-amino acids 
can be separated into three groups: formylglycine equivalents, alanine p-anion 
equivalents and alanine &cation equivalents. The basic chiral a-amino acid synthons are 
the alanine p-anion 1.48 and p-cation 1.49 which are generally denved frorn senne, 
cysteine, aspartic acid and to a lesser extent from glutamic acid (Scheme 1.22). 
Formylglycine, although discussed separately, can be considered an alanine B-cation 
equivalent . 
Scheme 1.22 
1.3.4.1 Formyiglycine Equivalents 
The most common formylglycine equivalents are serine aldehydes generally 
derived directly from serine. As an obvious choice for the derivatization to other a- 
amino acids, serine suffers from a few notable deficiencies that must necessarily be 
addressed. Senne is one of the amino acids most prone to racernization and is believed to 
involve a plana. carbanion intemediate produced by the rate-determining removal of the 
a-proton.' This increased rate is due to the hydroxyl gmup which helps stabilue the 
intermediate anion. Furthemore, if the side chain is oxidized to a senne aldehyde, 
enolization results in racemization at the a-center. As such, numerous approaches have 
been undertaken in order to adbss this issue. Two routes may be employed in the 
formation of serine aldehydes; direct oxidation of the side chah to the aldehyde without 
altering the oxidation state of the carboxylic acid group, and reduction of the acid to the 
aldehyde and subsequently oxidizing the side chah to the carboxylic acid in order to 
regenerate the a-amino acid These methods include the use of protecting groups that 
reduce or mask the ability of the a-proton to racernize. 
The most important serine-derived aldehydes designed for the synthesis of a- 
arnino acids are illustrated in Figure l. l. 
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Figure 1.1: Important Serine Aldebyde Equivalents. 
Rapoport first described the conversion of L-serine to D-amino acids in 1984 
using a-suIfonamido acids 1.50 treated with excess organo-Li reagents or Grignard 
reagents? These could be reduced directly to p-hydroxy-a-amino acids, erythro 
configuration with NaB& (7:3 ratio), threo with L-selectride (99: 1) in good yield or to 
the alkyl derivative via thioketal desulfurization or trïethylsilane reduction. Platinum 
catdyzed oxidation and subsequent deprotection gave the desired D-amino acids in very 
good overall yields (Scheme 1.23). However, the conditions used for reduction and 
oxidation limit the functional groups that can be incorporated. A large scale synthesis 
has aiso been developed for the preparation of a-amino ketones 1.54.62 This synthon has 
been applied to the synthesis of various carbacephems6' and calicogorgin A." 
Scheme 123 
Rapoport has also studied the use of the N-(9-phenylfluoren-9-yl) (PhH) 
protecting group for preventing racemization in the serine aldehyde equivalents 1.51 and 
1S2.65 The buky protecting group is proposed to prevent enolization by obstructing 
removal of the a-proton. 
Probably the most versatile serine aldehyde synthon is Garner's aldehyde 1.53. 
Fia t  reported in 1984," with an Orgunic Syntheses preparation appearing in 199 1 ," this 
synthon has been used extensively for the synthesis of various chiral arnino alcohols such 
as sphingosine 156 and a-arnino acids, particularly p,y-unsaturated amino acids such as 
1.57 (Scheme 1.24).' The numerous exarnples of successful reactions include Wittig 
olefinations with unstabilized ylides," a-phosphonocarbo~ylates,~~ Takai olefinations." 
Reformatsky reactions," cuprate additionsn and Grignard reactions." Most of the 
described reactions occur in both good yield and with minimal racernization at the a- 
carbon even under relatively basic conditions. Stereoselectivity at the p-carbon after 
various addition reactions to 1.53 varied between 3:l for vinylmagnesium bromide 
(antixyn) to 98:2 (syn:anti) for the 1,4-addition of ~uprates.".'~ Perfect stereocontrol has 
been obtained with chiral reagents such as allyl-Ti complexes chelated with a di01 ligand 
derived from tartrate." 
Scheme 1.24 
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The main drawback with the Garner aldehyde 1.53 is that an oxidation step is 
required to generate the a-arnino acid d e r  formation of the penultimate fbamino alcohol, 
lirniting the type of side chain functionality that can be presento Racernization has aiso 
been observed during the oxidation to a-amino acids? 
1.3.4.2 Alanine PAnion Equivalents 
The utilization of the side chah of senne as a nucleophilic entity 1.a has been 
accomplished a number of ways with varying degrees of success. Alanine P-anion 
equivalents are outlined in figure 1.2. 
Sasaki et al. generated the p-anion of 1.58 derived from senne, and after reaction 
with various alkyl halides and subsequent desulhirization and reoxidation gave the 
desired alkyl a-amino acids in good yields with ~ 9 8 %  ee? 
Figure 1.2: Selected AlPniw p-Anion Equivaients. 
Two sirnilar phosphonium salts have been developed, the serine derived Wittig 
ylide 1.59 of Itaya et al." and the oxazolidinone Wittig ylide 1.60 of Sibi and 
cow~rkers .~ Of the two, 1.60 appears to be the more versatile and has been used in the 
synthesis of a number of sugar-substituted a-amino acids via a Wittig miction." 
The p-iodozinc alanine derivative 1.61 has been reacted with both acid chlorides 
and aryl iodides in Pd-cataiyzed coupiing reactions to give the desired derivatives in 
moderate yield~.'~ ZnlCu exchange gives the cuprate derivative, which has been reacted 
with a variety of allyl halides to give a number of unsaturated a-arnino a~ids. '~ 
Aspartate, and to a lesser extent glutamate, can be considered as an alanine p- 
anion equivalent since regioselective P-enolate formation is possible when the a-carbon 
is either protected with the buky Phi3 gmup, by deprotonation of the amide or the 
carboxylate. Following enolate formation, reactions are typically perfonned with 
reactive electrophiles and then further derivatized as desired. 1-2-Stereoinduction is 
generally observed in electrophilic additions to aspartic acids and 1,3-induction in the 
case of glutamates. Both aspartic acid (chapter five) and glutamic acid (chapter four) 
will be discussed in more detail in the appropriate section. 
1.3.4.3 Alanine FCation Equivalents 
The generation of an alanine ptation equivalent is realized by the nucIeophilic 
substitution of the serine OH-function after appropriate activation into a good leaving 
group. However, this irnmediately raises concems due to the propensity of senne to 
undergo elimination as illustrated in the case reported in 1963 by Photaki where 
displacement of N-Cbz-O-tosyl-L-senne methyl ester 1.62 (P = Cbz) with the sodium salt 
of thiol trityl led to racemic cysteine (Scheme 1.25)? On closer examination, the S-trityl 
anion was shown to cause the elimination of the tosyl group to give dehydroalanine 1.64, 
followed by subsequent addition of thiol tri@ to the dehydrodanine adduct. 
Despite this tendency of activated serine derivatives to eliminate, a number of 
displacement reactions have been successfÛlly accomplished. For example, both sodium 
benzyl selenoatea and thioacetate' displace the tosylate from O-tosyl, N-Boc or N-Cbz 
senne methyl or  benzyl ester to give the enantiomerically pure product. 
The Cbz-Ser(0Ts)-OBn serine derivative can be converted to the P-iododanine 
compound by Finkelstein reaction with NaI. Viallefont and coworkers have successfuliy 
used organocuprates for displacement reactions with O-tosyl serine 1.62 and iodoalanine 
1.63 with 2-70% formation of dehydroalanine 1.64 (Scheme 1.25).= 
Scheme 1.25 
1.62 X=OTs Nal. 
1.63 X =  l acetone 
P = Boc, Ts 
R = Me, Et, nPr, Mu,  Bu, Ph, vinyl 
Aziridines are another source of fbcation equivalents described by Okawa and 
coworkers. Azindines are generated from serine in much the same manner as used to 
form 1.62 (P = Cbz) except a N-trityl protecting group is used (Scheme 1.26)." 
Scheme 1.26 
Reprotection of the azuidine 1.65 as the Cbz has allowed for various 
derivatizations. Okawa opened 1.65 (P=Cbz) with alcoholsn or thiolsgO in the presence of 
boron trifluoride etherate to give the B-alkoxy or fhhioalkyl-a-arnino acids 1.66 in 57- 
98% yield (Scheme 1.27). 
Scheme 1-27 
Baldwin et have reported opening the p-nitrobenzoyl derivative of 1-65 with 
Wittig ylides to generate a mixture of two new ylides, with the C3 product 1-67 
predominating (Scheme 1.28). The ylide was then M e r  reacted with paraformaldehyde 
or acetaldeh yde to give 4 - m e t h y l e n e - ( 2 g a t e  derivatives 1.68. 
Scheme 1.28 
The most useful method for the synthesis of a-arnino acids based on alanine b- 
cation equivaients is the p-iactone methodology as developed by Vederas and 
coworkemn Serine is cyclized under modified Mitsunobu conditions without 
racernization to give N-protected a-amino-fi-lactones 1.69 in 60-72 % yield (Scheme 
1.29). Ring opening with the desired alkyl-oxygen cleavage is achieved with soft 
nucleophiles such as acetate and imidazole since hard nucleophiles such as amrnonia and 
methoxide cause unwanted acyl-oxygen cleavage? No racemization is observed. 
Scheme 1.29 
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Carbon-carbon bonds are fonned by reaction of the p-lactone 1.69 with 
organocuprates since organolithiums and Grignard reagents lead to carbonyl attack. Di- 
N-protected B-lactones were generaily found to be better substrates than the 
corresponding mono-IV-protected B-lactones with yields in the range 70-80%, however, 
the deprotected synthons also suffer from increased racemization (10-144 compared with 
4% for mono-N-protected de ri vat ive^).^^ 
Threonine and other homologs c a n o t  be transfomed into p-lactones 1.70 under 
Mitsunobu conditions although cyclization is successful using phenylsulfonarnide or 2- 
nitrophenylsulfenyl amides with p-bromophenylsulfonyl chlonde in pyridine. 
Unfortunately, the range of nucleophiles that add successfulIy to 1.70 is limiteci since 
organometallic reagents add to the carbonyl. Those that do add, do so with inversion at 
the Bcarbon (Scheme 1 .30).95 
Scheme 130 
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1.4 Description of Thesis 
As evident in the methodologies described above, amino acid synthesis is a 
challenging endeavor due to the chirality and hinctionality present in this class of 
molecules. Moreover, a number of criteria should be met by new synthetic routes. The 
products should be optically active and both enantiomers should be available with other 
stereocenters in the molecule generated with good stereoselectivity. Several different 
classes of amino acids should be accessible from a comrnon stable intermediate which is 
in tum easily obtainable on a large scale from inexpensive starting materiais. Finally, it 
should be possible to generate the deprotected arnino acid under conditions mild enough 
not to cause racemization or decomposition of sensitive functionalities. 
The generd methods discussed above each have advantages and shortcomings, 
addressing some but not al1 of the optimal yet demanding cnteria. Most of the chiral 
glycine enolate templates require fairly strong hydrolytic conditions to generate free 
amino acids and suffer from a lack of precise control specifically at the fkarbon since 
both the a- and p-centers are fonned simultaneously. Synthesis via nucleophilic 
displacement of activated senne derivatives is limited in the type of nucleophiles that 
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may be employed, while the oxidation step required with the use of serinal equivalents 
limits the functionalities that may be present. 
Our approach to the synthesis of non-proteinogenic &amino acids was based on 
the elaboration of the current pool of derivatizable a-arnino acids using senne, threonine 
and both aspartic and glutamic acid. Earlier work in our laboratory had show promise in 
protecting the carboxylic acid as a base stable cyclic ortho ester which concurrently 
masked the acidity of the a-proton by preventing enolate formation and thereby anion 
formation at the arenter .  The generation of intermediates particularly susceptible to 
racemization and the use of strongly basic reaction conditions is possible since the acidity 
of the a-proton is no longer an issue. We also sunnised the steric bulk of the ortho ester 
would induce stereoselectivity in either nucleophilic or electrophilic additions to the 
OB0 ester protected amino acid. 
1.4.1 Ortho Esters 
Ortho esters have been used as acid protecting groups for many years and an 
extensive review of their preparation and use appeared in 1974." Essentially inen under 
neutral or alkaline conditions, ortho esters are readily hydrolyzed in very rnild acidic 
environments and are one of the few protecting groups that protect the carbonyl against 
nucleophilic attack by hydroxide or other strong nucleophiles such as Grignard reagents. 
We selected the 2,6,7-trioxabicyclo[2.2.2]0ctane ortho ester 1.71 as the carboxyl 
protecting group since cyclic ortho esters are considerably more stable than the acyclic 
analogs* and a simple route to these ortho esters was available. 
1 .If 1 .m 
The 2,6,7-trioxabicyclo[2.2.2]0ctane protecting group has been used to mask the 
carboxyl group in several syntheses," most recentiy in the synthesis of laurencin?' a 
member of the polyether toxins. Wipf et al. have recently introduced the 2,7.8- 
trioxabicyclo[3.2. lloctane (AB0 esters) 1.72 as a structurally similar alternative to the 
OB0 esters whose functionality may be incorporated as a desired backbone once 
deprotection occurs.* 
General use of 2,6,7-trioxabicyclo[2.2.2]octane began after 1982 when Corey and 
Raju reported the facile preparation of 4-methyl-2,6,7-trioxabicycl0[2.2.2]octane ortho 
ester (OB0 ester, 1.71) from the boron trifluoride etherate cataiyzed remangement of the 
corresponding 3-methyl-3-hydroxymethyloxetane ester 1.73.1m Prior to this. ortho esters 
had been obtained by the acid catalyzed esterification of the carboxylic acid with 2- 
substihited-2-hydroxymethyl-1,3-propanediols.101 Most (acyclic) ortho esters are too 
thermodynamically unstable relative to their hydrolysis products to allow this method to 
be used? This increased stability makes the bicyclic ortho esters chromatographically 
stable compared to their acyclic counterparts.lm Corey's procedure relies on the Lewis 
acid catalyzed opening of the oxetane ester by carbonyl participation to form the 6- 
rnembered zwittenon 1.75 (Scheme 1.3 1). Rearrangement generates the ortho ester 1.71. 
with the ring angle strain of the oxetane providing the overdl thermodynarnic dnving 
force. '00 
Several methods for the removal of the ortho ester protecting group have k e n  
reported in the literanire and may be categorized into two procedures. In the first, acid 
hydrolysis is employed to ring-open the ortho ester followed by base hydrolysis to 
generate the acid ( & S O m H  then 1N NaOWMeQH,*a DME:H20, pH 3 with NaSO, 
then LiOH,m cataiytic pyridinium PTSA in MeOWH20 then LiOHIm). The other 
procedure employs tramesterification of the ring-opened octho ester, usually to a methyl 
ester (with NaOMelMeOH or K&OmeOH) followed by base hydrolysis of the methyl 
ester to give the deprotected acid? 
1 A.2 N-Amine Protection 
In developing a strategy for the synthesis of unusual amino acids from amino acid 
denved O B 0  ester synthons, we decided to use the benzyloxycarbonyl (carbobenzyloxy 
or Cbz) and ten-butyloxycarbonyl (Boc) protecting groups. 
The Cbz group was first introduced into peptide chemistry in 1932'03 and has 
many advantages over other amino protecting groups. Unlike the fluorenyl-9- 
ylmethoxycarbonyl (Fmoc) group, the Cbz group is stable to basic reagents, and can be 
removed by catalytic hydrogenolysis or strong acid hydrolysis. The Cbz group is 
probabl y the most popular of the N-protecting group and as such, its continued use allows 
for the cornparison of results to previous methods of synthesis. 
The Boc group, introduced in 1957 (for a review of Boc and other protecting 
groups see car pin^),'^ has been used extensively in peptide synthesis for amine 
* protect i~n. '~ The Boc group is not hydrolyzed under basic conditions and is inert to 
man y nucleophilic reagents. Removal is accomplished w i th trif luoroacetic acid 
providing a complementary deprotection procedure to that of the ortho ester which is also 
removed with acid. 
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Chapter Two 
Synthesis of Boc Protected &Hydroxy-a-Amino Acids 
2.1 Introduction 
p-Hydroxy-a-amino acids are of immense interest due to either their direct 
biological action or as structural components of compounds with biological activities 
(Figure 2.1).'.' For example, D-do-threonine is found in antibiotics such as the 
katanosins 2.1,3 while &hydroxyleucine is found in the leucinostatins 2.2 and the 
katanosins 2.1. B-Hydroxytyrosine is present in antibiotics such as vancomycin 2.3' 
(widely used to treat deep seated Gram negative bacterial infections), the orienticins 2A6 
and chloroorienticins 2.5,' risocetins 2.@ and chloramphenicol2.~ and a number of other 
cyclic peptides (avoparcin, teicoplanin, actapanin, parvocidin, actinodin, and 
chloropolysp~rin).~ The catecholamine class of neurotransrnitters (adrenaline 2.8 and 
norepinephrine 2.9) incorporate a ~hydroxytyrosine moiety whereas epinephrine 2.10 
contains P-hydroxyphenylalanine. p-Hydroxyproline and fbhydroxyaspartic acid have 
been isolated from empedopeptin1° and p-hydroxyaspartic acid is also believed to play a 
role in hemeostasis proteins." 8-Hydroxyglutamine has been identified in antibiotics 
such as neopep tin.12 (4R)-4-(E)-2-Butenyl-4J-dimethyl-L-threonine 2.1 1, probabl y the 
most well known f3-hydroxy-a-amino acid, is a crucial constituent of cyclosporin A, a 
potent irnmunosuppressive drug." b-Hydroxy-a-arnino acids are also important 
intermediates in the synthesis of other compounds, for exarnple, many p-Iactams (with 
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Figure 2.1: p-Hydroxys-Amino Acids in Various Biological Compounds. 
2.1.1 Synthesis of SHydroxy-a-Amino Acids: General Routes 
Many of the general methods described in chapter one are capable of synthesizing 
P-hydroxy-a-amino acids and other recent methods include Sharpless AE,'." Sharpless 
AD,I6 electrophilic amination" and hydro~ylat ion.~~ stereoseiective hydrolysis of 
azindine carboxylate esters,I9 aldol condensationsm from oxazolidinone intermediates2' 
and numerous other metho&.= A bnef overview of the synthesis of f3-hydroxy-a-amino 
acids complementing that in chapter one will be described. 
2.1.2 Synthesis of Racernic PHydroxy- a-Amino Acids 
Racernic f!-hydroxy-a-amino acids have traàitionally been synthesized by the 
addition of glycine enolates to aldehydes and ketones. Numerous examples of this 
methodology exists and are typified by the report of Ozaki et al? in which a- 
isocyanoacetamide 2.12 is reacted with aldehydes in the presence of KOH. forming the 
truns-oxazoline4-~arboxafnides 2.13 (Scheme 2.1). Recrystallization followed by acid 
h ydrol y sis gave pure threo- p h  ydrox y amino acids in excellent yields. 
Shanzer et al. have reported a route to synthesize both threo and erythro isomers 
from glycine? Reaction of the N&-bis(aimethylsily1)glycine trimethylsilyl ester 2.14 
with aldehydes or ketones gave pure eryrhro diastereomer, attributable to induction by 
the bulky disilylated arnino group (Scheme 2.2) The threo isomers were obtained from 
addition of the enolate of Cbz-Gly ethyl ester 2-15 to various carbonyl denvatives and 
subsequent cyclization to the 2-oxazolidone 2.16 intemediate followed by acid 
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2. 1.3 Synthesis of Optically Active PHydroxy- a-Amino Acidr 
2.1.3.1 Enzylll~ltic Synthesis of /%Hydrom-a-Amino Acids 
Various groups have tried to use the intrinsic chirospecificity of enzymes to 
synthesize fi-hydroxy-a-arnino acids with varying degrees of success. Saeed and Young 
first repocted the use of serine hydroxymethyltransferase (EC 2.1.2.1) in 1992 using the 
enzyme to couple glycine with various aldehyde~.~ However, the products were 
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typically generated in both poor yield and threo:eryîhro selectivity and required 
prolonged reaction times limiting the use of this method. 
Wong and coworkers have used L-threonine aldolase (EC 4.1.2.5) to synthesize 
various substituted f3-hydroxy-a-amino acids? Yields and seiectivity are dependent on 
the aldehyde and Vary significantly with threo:erythro selectivities of <1:99 and 71:29 
reported for acetaldehyde and benzaldehyde respectively. 
2.1.3.2 Enantioselective Reductions 
Catalytic asymmetric synthesis of f3-hydroxy-a-amino acids has been 
accomplished by both the dynamic kinetic resolution of reduced carbonyls and the 
asymmetric hydrogenation of dehydro-a-amino acids. 
Noyori and coworkers used a ruthenium-BINAP chiral catalyst in a dynamic 
kinetic resolution in which racemic keto ester 2.17 was selectively reduced (Scheme 
2.3):' The stereomutation of the ester and selectivity of the catalyst are both rapid 
enough that 100% conversion to a single enantiomer occurs, avoiding the 50% loss 
normally associated with enzyrnatic resolutions. A number of substrates gave quantative 
conversion with the product amino acid esters having 93-98% ee and 94:6 to 99: 1 syrt 
selectivity . 
Genêt et al. reported a similar methodology using various rhodium and ruthenium 
catalyzed hydrogenations with a wide variety of ligands." The best results were achieved 
not only with BINAP-Ru as reported by Noyon but also with CHIRAPHOS@-RU giving 
the syn product preferentially (97:3) with 85-99% ee. This methodology has k e n  used 
b y Genêt et al. in the s ynthesis of pchloro-3-hydrox ytyro~ine ,~  3-hydrox y I ysineM and 
MeBmt 2.11.3' 
Scheme 2.3 
syn - major product 
Ito and coworkers have reported the enantioselective synthesis of eryrhro- and 
threo-fhh ydrox y-a-arnino acids by as ymmetric h ydrogenation of (2)- and (E)-f3-ox y-a- 
acetamidoacrylates 2.18/2.19 with (S,S)-2,2"-bis[(R)- 1 -(dialkyIphosphophh)ethyl]- 1,l' - 
biferrocene (TRAP)-rhodium complexes 2.20 (Scheme 2.4).'2 Yields are generally >90% 
with 88-97% ee. 
Scheme 2.4 
R = Me, Et* Pr. 
CHflMe, Pr 
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2.19 R = Me, Et, Bu, Ph 
2.1.3.3 Electrophilic%Nucfeophilic Aminotion 
Evans' methodology (Scheme 1.13) is capable of producing both 2S.3RnR.3S 
(syn or rhreo) and 2S,3S/2R,3R (anti or erythro) diastereomers. Addition of the enolate 
of 2.21 to acetaldehyde gives a 9 5 5  selectivity of the syn diastereomer although 10% 
epimenzation occurs at the a-center upon azide displacement (Scheme 2.5).33 This 
methodology has been used to synthesize numerous p-hydroxy-a-amino acids including 
MeBmt 2.11Y 
Scheme 2.5 
R = Me, Ph 67%. 95:s 
L-allet hreonine 
38% overall yield from 2.21 (R=Me) 
Electrophilic amination has been used to synthesize D-allo-threonine from chiral 
3-hydroxybutanoate 2.22 protected as a dioxanone 2.23 in 42% yield from the dioxanone 
and with 99% diastereoselectivity (Scheme 2.6) using di-tert-butyl azodicarboxylate 
@BAD) as the aminating agent? 
Seebach and coworken have used a similar methodology in the synthesis of 
trifluorothreonine in both excellent yield and diastereoselectivity using 4.4.4-uifluoro-3- 
hydroxybutanoate instead of 2.22.'' 
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Scheme 2.6 
Epoxides are obvious intermediates in the synthesis of B-hydroxy-a-amino acids 
since nucleophilic opening of the epoxide installs the desired p-hydroxy functionality. 
Furthemore, Sharpless epoxidation generally provides a convenient route to the desired 
epoxide chirality. in fact, many of the epoxide-derived methods described in section 
1.3.2.1 are capable of the synthesis of p-hydroxy-a-arnino acids. 
Genêt and coworkers have used the Sharpless epoxidation of crotyl alcohol 2.24 
to establish the epoxide in the desired confoxmation for the synthesis of L-allu- 
threonine? Oxidation to the acid 2.25 followed by ring opening with arnmonia gives L- 
allo-threonine in 29% overail yieid (Scheme 2.7). However, the amination takes 10 days 
limiting the applicability of the method. 
Scheme 2.7 
Sharpless , O iab +#*..qCOpH O .L+ 'O'J  CH^ 
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2.24 2.25 
Goodman has used a cyclic sulfate 2.26 (an epoxide equivalent) derived from 
benzyl crotonate to synthesize allo-threonines and B-hydroxyvaiine in both g w d  yield 
and >99% ee (Scheme 2.8).37 
Scheme 2.8 
2-(Arylthi0)-2-nitrooxiranes 2.27 have been used as intermediates towards the 
synthesis of various B-hydroxy-a-arnino acids." Either diastereomer can be accessed in 
the case of P-alkyl-8-hydroxy-a-amino acids while only anti-p-aryl-p-hydroxy-a-amino 
acids may be synthesized (Scheme 2.9). Various aldehydes were condensed with the 
dianion of (4-methy1phenylthio)nitromethane to give the alkenes 2.27 in 5244% yield 
(Sc heme 2.9). Subsequent deprotection, epoxidation and reprotection gave epoxides 2.28 
in 40-55% yield over three steps. Syn epoxidation occurs with tBuOOLi with 12: 1 
selectivity whereas anti epoxidation with Ph300K gives 15: 1 selectivity. Ring opening 
of the epoxide with aqueous ammonia and trapping with benzyl chloroformate gave the 
desired protected p-alkyl-f3-hydrox y thioester derivatives in 55-68 % yield. Treatment 
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2.1.3.4 Synthesis fiom Glycine Enolates 
Most of the methods of synthesizing a-amino acids via glycine enolates as 
discussed in chapter one (section 1.3.3) can be used to synthesize f3-hydroxy-a-amino 
acids. The majority of glycine enolate equivalents tend to produce the syn or  threo 
stereochernistry upon addition to aldehydes with no oppominity of producing the other 
diastereomer. The stereochernistry at the a-center is usually well defined in these 
electrophilic additions of aldehydes to glycine anion equivalents, whereas variable 
selectivity occurs at the p-carbon, in this instance the p-hydroxy functionality. 
In general, Schollkopf s bis-lactim ether 1.33 (Scheme 1.15). the Ni(@ glycine 
Schiff base 1.39 of Belekon et al. (Scheme 1.18) and Seebach's oxazolidinone 1.42 
(Scheme 1-19) al1 add to aldehydes and ketones to give the threo diastereomer. Williams' 
glycine boron enolate equivalent derived from oxazinone 1.34 (Scheme 1.16) gives 
predorninantly the eryrhro isorner. 
Williams' oxazinone 1.34 h a  been used as a boron enolate to add to acetaldehyde 
to give the protected L-alfo-threonine derivative 2.30 in 85: 15 diastereoselectivity and 
57% yield (Scheme 2. IO)." 
Scheme 2.10 
Schollkopf et al. have synthesized the protected denvatives of Dfhreo-p- 
phenylserine with 86% ee and 4% de and D-threo-p-benzylserine with 89% ee and 66% 
de from the lithium enolate of the bis-lactim ether 133. The titanium enolates generally 
gave much better diastereoselectivities upon condensation with a number of aromatic 
aldehydes to give the desired adducts in 65-8396 yield (Scheme 2.1 l)." Deprotection by 
acid hydrolysis gave the methyl esters in 4666% yields, significantly lower than yields 
obtained for the aliphatic B-hydroxy-a-amino acids indicating the relative instability of 
the aromatic compounds. The bis-lactim ether 1.33 enolate has also been reacted with 
acetone to give the P-duwthyl-P-hydroxy adduct in 98% yield and after deprotection 




Me Me R 
HO 
1.33 
R = H, -Me. CCN, 4-Br, 4-NO2, 2-OCH2Ph 
R H2 '"'co~H 
Seebach's oxazolidinone enolate 1.42 has k e n  reacted with aromatic aldehydes 
to give the threo adduct 
the hydroxyl in 77-85% 
with concomitant transfer of the N-benzoyl protecting group to 
yield and 88-96% diastereoselectivity (Scheme 2.12):' Only 
hydrolysis of the L-threo-B-phenylserine derivative was reported, giving the €tee amino 
acid in 54% yield and 92:8 threo:erythro ratio with an overall yield of 4646 from the 
imidazolidinone template 1.42. 
Scheme 2.12 
Another imidazolidinone-bound enolate 2.31, described by Craddick et al., has 
been shown to undergo aldol condensations with aliphatic and aromatic aldehydes in 
good yield (62-841) and high stereocontrol(93-95% de) (Scheme 2.1 3)'3 
Scheme 2.13 
Belokon et al. have successfully used the chiral nickel (II) complex 1.39 in the 
synthesis of threo-P-hydroxy-a-arnino acids usually with diastereoselectivities >30: 1 and 
yields of 55-87% (Scheme 2.14)." 
Unlike the glycine enolaîes described above, Evans' methodology provides access 
to boih syn and anti diastereomers. &Phenylserine was synthesized in 50% overall yield 
with >98% de in the stereocenter forming reactions (Scheme 2. lS)." 
Scheme 2.14 
Scheme 2.15 
2.1.3.5 Synthesis fiom #-Amino Acids 
Clearly, the most straightforward method for the synthesis of p-hydroxy-a-amino 
acids is the derivatization of senne and threonine. In particuiar, the serine aldehyde 
equivalents 1.50-1.53 described in section 1.3.4.1 are capable of producing 2S,3R/2R,3S 
(syn or threo) and 2S93S/2R,3R (anti or erythro) diastereomers. 
Rapopon's serinal equivalent 1.50 has been reacted with various organometallic 
reagents to give ketone 2.32 which is diastereoselectively reduced with L-Selectride to 
give the syn alcohol in ratios of 99: 1 to 9: 1 depending on the alkyl group or  to the anti 
product with LiBfi in 6: 1 selectivities (Scheme 2.16)? Oxidation and deprotection to 
the amino acid was not reported. 
Scheme 2.16 
L-Selectridû OH 1 
0 0 9:1t099A 
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1.50 2.32 LiBH, OH 6:1 HO-R 
R = CH,  CH=Cb, 
Nucleophilic additions4' to Garner's aidehyde 1.53 introduces the f3-hydroxy 
motif in the correct position with good selectivity although the method suffers from the 
limitation that an oxidation step is required to generate the a-carboxylate necessitating a 
tedious protec tion/oxidation/deprotec tion scheme. 
Joullié and coworkers have demonstrated good to high selectivity in the Grignard 
addition of various nucleophiles to Garner's aldehyde 1.53. Generally the erythro 
diastereomer predominated (9:l to 15: 1) dthough in the case of PhMgBr the threo 
diastereomer was generated in excess (8:l) (Scherne 2.17).* Deprotection gave the 
amino alcohol2.33 in 10-22% yield. The two-step oxidation to the protected b-hydroxy- 
a-amino acids proved to be difficult, proceeding in 5-22% yield under a number of 
conditions and demonstrating one of the shortcomings of Garner's aldehyde. 
Scheme 2.17 
HO 
This laboratory previously reported the synthesis of B-hydroxy-a-amino acids 
using senne protected as an ortho estePg The use of the OB0 ester as an a-carboxylate 
protecting group is an attempt to address the tendency of serinais to racemize for the 
reasons discussed in Sections 1.3.4.1 and 1.4. Fmoc-L-serine 2.34 was converted to the 
oxetane ester 2.35 by Nfl-dicyclohexylcarbodiimide (DCC) and dimethylamino-pyridine 
(DMAP) mediated esterification with 3-methyl-3-(hydroxymethyi)oxetane (Scheme 
2.18). Rearrangement to the OB0 ester 2.36 and oxidation to the aldehyde 2.37 followed 
by Grignard addition gave protected p-hydroxy-a-amino acids in both good yield and 
excellent diastereoselectivity with a threo:erythro ratio of 94:6 @=Me). The erythro 
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2.2 Resuits and Disudon 
2.2.1 Preparution of Bac-Ser(aLd)OBO ester 
in an effort to expand the scope of the OB0 ester methodology previously 
reported (Scheme 2. 18),49 we investigated expanding the various nitrogen protecting 
groups to inciude the Boc group. We were patticularly interesteci in the synthesis of j3- 
hydroxy-a-arnino acids for the eventual incoporation and synthesis of analogs of the 
aureobasidin class of antihingal agents? 
We initially attempted to overcome the dificulties associated with the 
esterification of oxetane dcohol with DCC and DMAP. Although the yields for the 
esterif ication were excellent (80-85%), the reaction required an excess of oxetane alcohol 
and chromatography on silica to obtain a pure produd9 Trace amounts of the diimide or 
urea aiso affected the yields of the BSsEt2O catalyzed rearrangement of the oxetane ester 
to the OB0 ester. W e  found that the desired oxetane ester is much more conveniently 
prepared by esterification of the N-protected senne carboxylate by the corresponding 
oxetane tosylate 2.38 or bromide 2.39. The oxetane bromide 2.39 cm be prepared in a 
number of ways from the 3-methyl-3-(hydroxymethyl)oxetane with 
brominehnphenylphosphine," carbon tetrabromideltri-phenylphosphine5* or by 
displacement of the corresponding tosylate 2.38 with sodium bromide in acetone 
(Scheme 2.19). The oxetane bromide 2.39 may be distilled from these reactions but 
slowly decomposes upon standing. The tosylate 2.38 was prepared using standard 
conditions and then poured into a slurry of icdcold water at which point the tosylate 
precipitated out and was isolated as a stable crystalline material in 90-95% yield after 
filtration and drying under vacuum over PzO5. 
Scheme 2.19 
NaBr, acetone 
The best yields for the estenfication reaction were obtained using the cesiurn salt 
of Boc-L-serine 2.40 or Boc-L-threonine 2.41 with the oxetane bromide 2.39 (85-90%) 
(Scheme 2.20). However, the prefemd method is esterification with the oxetane tosylate 
2.38 in DMF in the presence of sodium iodide (10 mol%) as distillation and storage of 
the sensitive oxetane bromide 2.39 is avoided. In these latter conditions the Boc serine 
derivative 2e42 wwas obtained in 6696 yield and the Boc threonine derivative 2-43 in 73% 
yield as oils which crystallized upon standing. The formation of the ortho ester 2.44 and 
2.45 from the oxetane esters 2.42 and 2e43 was performed in CH2Clz with a catalytic 
arnount of BF3*Et20 (2-5 mol%). The more acid sensitive Boc derivative 2.44, in 
cornparison to the Fmoc and Cbz denvatives, is obtained in 66% yield after 
chrornatography with similar yields obtained for the threonine derivative 2.45. Oxidation 
under Swem conditions gave the aldehyde 2-46 and ketone 2e47 in 90-95s yields. 
Reduction with NaBb, deprotection and HPLC analysis of the derivatized amino acid 
(vide infa)  indicated no loss of optical activity during the conversion to the aldehyde 
2.46 or ketone 2.47. 
Scheme 2.20 
DMF, Nal 
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The aldehyde was also generated using the Dess-Martin periodinaneS3 2.48, 
synthesized by a siight modification of the method described by Ireland." Aithough 
Schreiber and coworkers described acceleration of the Dess-Martin oxidation when 
performed in the presence of water," it was imperative that the reaction be executed 
under anhydrous conditions due to the sensitivity of the ortho ester to acid hydrolysis. 
Results initially varied considerably from batch to batch of the periodinane 2.48, with 
sorne batches fading to give the desired aldehyde 2.46 although oxidation of benzyl 
alcohol proceeded successiùlly. We detemiined that residuai acetic acid, from the 
acetylation reaction to give the periodinane 2.48, was opening the ring of the ortho ester 
and hence a complex mixture of products. Washing of 2.4û with large volumes of 
anhydrous diethyl ether under Nz in a Schlenk tube gave 2.48 with consistent punty for 
the synthesis of aldehyde 2.46. An advantage of this method of oxidizing the alcohol is 
that the reaction is performed at raom temperature, although the synthesis of 2.48 
requires carefiil attention to prevent any contaminating acetic acid which hyàrolyzes the 
O B 0  ester. 
Both Boc-Ser-OB0 ester 2.44 and Boc-Thr-OB0 ester 2-45 have been stored for 
over one year at room temperature with the slow loss of opticd activity, primarïly due to 
O B 0  ester ring opening. Aldehyde 2.46 tends to rapidly lose its optical activity due to 
racemization even when stored at -20°C. 
2.2.2 Addition of Various Grignard Reagents to Boc-Serfa1d)OBO ester 2.46 and Boc- 
Thr(ket)OBO ester 2.47. 
In order to investigate the suitability of Boc protected amino acids to the 
conditions required for the synthesis of O B 0  ester protected p-hydroxy-a-amino acids, 
we first examined the Grignard addition of methylmagnesium halides to Boc- 
Ser(ald)OBO ester 2.46 since the products would correspond to threonine and affo- 
threonine. Standards are available for d l  four diastereomers (L- and D-threonine and L- 
and D-allo-threonine or 2S,3R; 2R,3S; 2S,3S; îR,3R respectively) and therefore the 
stereoselectivity and extent of racemization could be monitored. 
A variety of conditions, based on earlier experience, were examined (Table 2.1):' 
Typically, the Grignard reagent (3 equivalents) was added quickly to a sotution of the 
ddehyde 2.46 at the appropriate temperature (Scherne 2.2 1). Reaction times generally 
varied from 0.5-2 hours and the progress of the reaction monitored by TLC. The reaction 
mixture was quenching by pouring into cold 3% -1 after a TLC indicated no further 
progression in the reaction. The yields for al1 reactions in Table 2.1 are reported for the 
two step procedure fiom Boc-Set-OB0 ester 2-44 (Swem oxidation then Grignard 
reaction) since the cade ddehyde was generally used without M e r  purification. 
2S,3 R = major diastemorner 
2.49 R = CH3 
2.50 R = Et 
2.51 R = vinyl 
2.52 R = Ph 
As summarized in Table 2.1, the type of Grignard reagent, solvent and 
temperature were examined in an attempt to optirnize the addition. Little difference in 
yield was obtained with various halide counter ions and thus MeMgBr was used as the 
reagent of choice due to its commercial availability. Temperature and solvent played a 
more important role in determining both yield and diastereomenc ratios. Increased 
temperatures resulted in lower yields due to the formation of complex mixtures of by- 
products that were not isolated. The moderate increased reactivity of the Grignard 
reaction in toluene at O°C (entry 5) is an anomaly, although not without precedent? This 
enhanced reactivity through the use of a non-polar and noncwrdinating solvent has been 
previously described? However, when the addition was performed in toluene at -78"C, 
the increased reactivity experienced at O°C was not observed although the 
srereoselectivity was increased. The reaction failed to proceed to completion even with 
extended reaction times (entry 10) for al1 solvents at -78°C. 
The major by-product of the additions was unreacted Boc-Ser(a1d)OBO ester 
2.46. One of the most fkequent side reactions encountered with Grignard reagents is 
enolization.' Formation of the enolate of the ddehyde 2.46Jketone 2.47 would compete 
with the addition reaction and upon work-up produce the aldehyde, albeit racemic. In 
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order to investigate this as a possible side reaction, once the reaction appeared to have 
reached completion, it was quenched and the remaining aldehyde reduced with NaB& 
since the aldehyde is lcnown to racernize dunng exposure to silica gel. The specific 
rotation of the Boc-Ser-OB0 ester 2.44 (-40.2) generated by reduction was found to be 
close to the specific rotation of pure 2A4 (-41.8) indicating minimal enolization of the 
unreacted aldehyde occurs during Grignard addition. This consequently eliminated 
enolization as a possible side reaction preventing reaction of the aldehyde. 
Table 2.1: Addition of MeMgX to BocSer(ald)OBO ester 2m46. 
Entry Reagenta Solvent (OC j Yield (%lb thretxerythro e g  
1 MeMgCl THF O 30 - - 
2 MeMgBr THF O 42 7O:3Oe - 
5 MeMgBr toluene O 55 71 :29' - 
6 MeMgBr THF -78 60 (75) 79:2 1 96 
10 MeMgBr toluene -78 51 (85) 82: 18 98 
' 3 Equivalents of Grignard reagent added. 
b Yield for 2 steps (fiom 2.44). Value in parenthesis represents yield based on recovered 
starting material. 
Ratio determined by HPLC analysis unless otherwise stated. 
d Minimal CH2Clz was used to dissolve the aldchyde. 
Ratio determined by 'H-NMR. 
Having optimized the addition of MeMgBr our attention turned to the addition of 
other Grignard reagents to Boc-Ser(a1d)OBO ester 2.46 (Scheme 2.2 1, Table 2.2). In al1 
cases the addition caused little racemization with the deprotected amino acids dl 
possessing 297% ee. Diastereoselectivity of the crude product ranged from 84:16 to 
88: 12 threo:erythro and yields from 40-6695. Purification by flash chromatography and 
subsequent deprotection and HPLC analysis of the ion-exchange purified amino acid 
showed a siight increase in diastereoselectivity. In fact, although the Rf for both 
diastereomers were typically sirnilar, diastereomeric enrichment seemed to be occuning 
after flash chromatography although the values detennined by 'H-NMR integration are 
subject to experimental error. Steric bulk of the Grignard reagent does not appear to play 
much of a role in stereoselectivity since similar thre0:erytht-o ratios are obtained for al1 
reagen ts. 
Table 2.2: Additions of RMgBr to Boc-Ser(ald)OBO ester 2.46. 
protected aa deprotected aa 9% 
% ds ratio (s,R:s,S)~ ds ratio % overall 
Entry RMgBr Roduct yielda crude (s$:s,S)C eec yield 
1 Et 2.50 49 84: 1 6 87: 13 98 24 
2 vin y 1 2.51 40 87: 13 89: 1 1 97 16 
3 Ph 2.52 66 88: 12 90: 10 98 40 
a Yield reported for 2 steps (from 2.44). 
Ratio determined by 'H-NMR 
Ratio determined by HPLC analysis 
Addition of MeMgBr to Boc-Throcet)-OB0 ester 2.47 gave protected p- 
hydroxyvaline 2.57 (Scheme 2.22, Table 2.3). The reaction proceeded in good yield 
(7246, over two steps) but, as with the additions to the aldehyde 2.46, TU3 analysis 
indicated remaining ketone 2.47. The recovered ketone 2.47, which was stable on silica, 
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retained its optical activity indicating enoiization with the a-hydrogen was not 
responsible for preventing complete reaction of the ketone, althougb the enolization of 
the methyl ketone cannot be disregardeci. However, a sirnilar observation of incornpiete 
reaction of Grignard reagent with 2.46 suggests some other phenornena is preventing 
complete reaction of the ketone. 
Scheme 2-22 
2S13R = major diastereomer 
2-57 R = CH3 
2.58 R = Et 
Excellent stereoselectivity of nucleophilic addition was observed with the bulkier 
EtMgBr (98:2 threo:erythro) Grignard reagent when reacted with 2-47. The 
stereochernistry of the adduct 2.58 was assigned through spectroscopic cornparison to 
literature values49 and is consistent with the direction of attack observed with the senne 
aidehyde 2-46. This model is discussed in further detail in section 2.2.5. Yields for the 
addition of both MeMgBr and EtMgBr were generally good; however, the longer reaction 
times necessary for optimal yields in the case of EtMgBr resulted in the formation of by- 
product 2-61 in less than 5% yield. This occurs as a result of cornpetitive attack of the 
Grignard reagent on the carbamate and has ken  previously reported to take place with 
bulky Grignard reagen ts and prolonged reaction time~.'~ Although the carbamate most 
likely exists as the magnesium enolate, slow equilibrium to the carbonyl and subsequent 
attack of EtMgBr is the probable mechanism of formation. 
Table 23: Addition of RMgBr to Boc-Thr(lcet)OBO ester 2.47. 
protected aa deprotected aa % 
96 ds ratio (S&:S,S)~ ds ratio % overall 
Entry R.MgBr Product yielda crude (S&:S,S)c eec yield 
I Me 2.57 72 - - 99 38 
2 Et 22% 65 98:2 99: 1 99 37 
a Yield reported for 2 steps (fiom 2.45). 
Ratio determined by 'H-NMR 
Ratio determined by HPLC analysis 
2.2.3 Deprotecrion of FDiaIkyl- and PHydroxry- a-Amino Acids 
A necessary part of any synthetic route is the straighdonvard removal of 
protecting groups. However, this is the stage at which numerous methods fail for 
different reasons. Once the various B-hydroxy-a-amino acids had been synthesized. 
deprotection was required in order to assess both diastereomeric and enantiomeric punty. 
2.2.3.1 Boc Removal 
The Boc protecting group was easily removed with wet trifluoroacetic acid (TFA) 
in CH2C12 under standard conditions and was typically complete in less than 30 minutes 
(Scheme 2.23)? 
2.2.3.2 Ortho Ester Cleavage 
Concomitant cleavage of the ortho ester occumd dunng Boc cleavage with 
exposure to wet TFA giving the 2-methyl-2-hydroxymethyl-1.3-propanediol ester (mphd) 
derivative 2.62. 
Several multi-step methods have been reported in the literanire for removing 
bicyclic ortho esters (Section 1.4.1). One employs acid hydrolysis to initially open the 
ortho ester and base hydrolysis to generate the acid or transesterification of the ring 
opened ortho ester to a methyl ester followed by base hydrolysis of the methyl ester to 
give the acid with yields normally ~ 6 0 % . ~ '  Removai of the mphd ester by the methods 
described above was found to be unsuccessiÙl.62 However, alkali carbonates have been 
show to be more efficient at ester hydrolysis than  bicarbonate^^^ and the combination of 
Cs2C03 in MeOH:H20 was highiy effective in cleaving the ringspened rnhpd ester 2-62 
to the acid 2.53. 
Scheme 2.23 
The optirnized one-pot procedure consists of concurrent cleavage of the Boc 
protecting group and the OB0 ester to the rnhpd ester 2.62 with TFA. Mer evaporation 
to dryness, the residue was dissolved in methanol to which a solution of 10% C s K 0 3  was 
added in an amount to ensure at least 5 equivalents of base was added. 
2.2.3.3 Punication Met- 
Once the arnino acid was deprotected, ion-exchange chromatography was used to 
purify the product from the salts of the cleavage reaction. Cation purification was 
generally used for the Cs2C03 based cleavages and volatile bases (5% Et3N in H D  or 0.5 
N N W H )  employed for elution, allowing for the isolation of the free amino acid. The 
solution from the C s a 3  cleavage was acidified before loading ont0 the resin. Most 
often, contamination resulted from incomplete hydrolysis of the rnhpd ester 2.62. Anion 
exchange chrornatography effectively removed the rnhpd ester during column loading 
and washing, and elution with either 0.5 N acetic or formic acid allowed the free amino 
acid to be isolated. Anion exchange chromatography was most often used during 
purification of the p-diallcyl-p-hydroxy amino acids in order to rninimize exposure of the 
dehydration sensitive p-dialkyl-p-hydroxy moiety to basic conditions. Although strong 
anion exchange resins incorporate a basic, polymer supported tetra alkylammonium 
hydroxide, no racemization has been observed in previous reports from this laboratory." 
Cnide yields after ionexchange chromatography varied from 40-8 1 %, however, 
generally in the 50% range. 
Many of the synthesized amino acids were difficult to recrystallize although 
spectroscopie techniques indicated high purity after ionexchange chromatography. 
Diastereomeric ratios could be determined by 'H-NMR and both diastereomeric and 
enantiomeric ratios assigned after derivatization and HPLC analysis (Section 2.2.4). 
Good agreement was found between the two methods. 
2.2.4 Determination of Enantiomeric Purity by HPLC Anolysis 
Due to the propensity of seruials to racemize via enolization, evaluation of the 
enantiomeric purity of the product amino acids was essential in establishing the Boc- 
Ser(a1d)OBO ester 2.46 as a practical alternative to other serinal based synthetic methods. 
A number of techniques are cornmonly used to determine enantiomeric purity, al1 of 
which rely upon the formation of a diastereomeric complex and subsequent quantitation 
by spectroscopie or chromatographic methods. However, previous experience within this 
laboratory has shown the method of Brückner et aï.' to be particularly powerful in 
resol ving a-amino acid diastereomers ."' 
This method relies upon the derivatization of arnino acids with O-phthalaldehyde 
2.63 and N-isobutyryl-L-cysteine 2.64 (Scheme 2.24) and their separation on a reverse 
phase column with detection at 338 nm. The procedure is very rapid (less than 5 
minutes) and most importantly is very general. 
Scheme 2.24 
The sample is prepared by dissolving crude cleaved product in borate buffer and 
mixing with O-phthalaldehyde 2.63 and N-isobutyryl-L-cysteine 2.64. M e r  5 minutes, 
25p.L was injected ont0 a reverse phase column and eluted under a gradient of 30 mM 
sodium acetate buffer (pH 6.5) and MeOH. Retention times of the derivatized amino 
acids 2.53-2.56 and 2.59-2.60 compareci favourably to identical previously synthesized 
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amino acids- The extent of racemization caused by oxidation of Boc-Ser-OB0 ester 
2.44 to the aldehyde 2.46 was detennined by comparing deprotected reduced aldehyde to 
a sample of deprotected Boc-Ser-OB0 ester starting material. Enantiomeric purities of 
>97% ee were routinely assessed for the reduced deprotected aldehyde. 
HPLC analysis conditions were generally established independently for each 
amino acid. in general, the threo and erythro diastereomers were well resolved but the L- 
and D-enan tiomers presented more of a challenge. Racemic D,L-N-i-Buc ys teine w as 
used to establish conditions for the separation of the amino acid D,L enantiomers. 
2.2.5 Stereoselectivity of Carbonyl Additions to Boc-Ser(a1d)OBO ester 2.46 and Boc- 
Thr(ket)OBO ester 2.47. 
The nucleophilic carbonyl addition reactions described (vide supra) show 
surprising diastereoselectivity for an acyclic system. Diastereoselectivity ranged from 
79:21 to 99: 1 (threo:erythro) for the addition of various Grignard reagents to both Boc- 
Ser(ald)OBO ester 2.46 and Boc-ThrO<et)OBO ester 2.47 at -78°C. These results 
compare favourably to those reported by Beauiieu et al? in which addition of MeMgBr 
to Garner's Cbz-protected aldehyde 1.53 gave a 1:l mixture of diastereomers although 
better diastereoselectivities have been observed with other nucleophiles (>go% ee).67 
The stereochemical outcome observed in the carbonyl additions to Boc- 
Ser(ald)OBO ester 2.46 and Boc-Thr(ket)OBO ester 2.47 is consistent with both a 
chelation (Figure 2.2A) and nonchelation (Figure 2.2B) controlled Felkin-An h attack on 
the aldehyde from the face opposite to the OB0 ester group (re face attack - see Figure 







Figure 2.2: Felkin-Anh Mode1 Predicting n Face Attack on the Side Chain 
Carbonyl of 2.46 and 2.47 A) Chelation, B) Non-Chelation models. 
The diastereoselectivities observed for the addition of Grignard reagents to Boc 
protected OB0 denvatives are in most cases comparable to those achieved upon 
nucleophilic addition to Fmoc and Cbz protected OB0 de ri vat ive^?^.^' However, the 
addition of MeMgBr to Boc-Ser(a1d)OBO ester 2.46 gave an 85: 15 threo:erythro ratio 
whereas addition to the Fmoc and Cbz e q u i v a l e n t ~ ~ ~  resulted in 96:4 and 97:3 ratios 
respectively. This might be attributed to the stenc attributes of the Fmoc and Cbz groups 
compared to Boc, an observation alluded to by the apparently more accessible carbarnate 
in the case of 2-47 due to the absence of formation of side-products 2-61 in the Fmoc and 
Cbz derivatives. 
The synthetic strategy described provides a route to various Boc protected threo- 
P-dialkyl- and p-alkyl-$-hydroxy-a-arnino acids from the Boc-Ser(a1d)-OB0 ester 2.46 
and Boc-Thr(ket)-OB0 ester 2.47 synthons. Overall yieids ranged from 1640% and al1 
products had >96% ee. Diastereomeric purities ranged from 70:30 to 99: 1 threo:erythro; 
with ratios generally increasing with steric bulk and reduced reaction ternperatures. 
The overall yields and diastereoselectivity of Grignard additions to Boc- 
Ser(a1d)OBO ester 2.46 and Boc-Thr(ket)OBO ester 2.47 generaily correspond to those 
achieved for the analogous Fmoc and Cbz protected derivatives. In most cases, the 
diastereoselectivities are comparable to previously published methods (Section 2.1.3) but 
the method does not require harsh oxidation or deprotection steps. A variety of 
sidechains have been readily introduced and deprotection to the free amino acid is easily 
achieved. 
2.4.1 General Methods. 
Most reagents were purchased fiom the Aldrich Chemicai Company. Boc-Ser 
and Boc-Thr were purchased fiom Advanced ChemTech. CH2Clz was distilled from 
Ca&; toluene, THF and Et20 frorn Nalbenzophenone. Reâctions were carried out under 
Nz or A .  in glassware dried ovemight at l2O0C or fiame dried before use. 
NMR spectra were recorded in CDCll (referenced to TMS at 0.00 ppm for 'H. to 
CDCI, at 77.00 ppm for I3c) or D20 (referenced to 2,2,3,3-dr3-(trimethy1silyl)propionic 
acid, sodium sait at 0.00 ppm for both 'H and 13c) on a Baker AC-200, AM-250. AM- 
300, Avance 300 or Avance 500 spectrometer. CDClp used for NMR sarnples containing 
an ortho ester was prefiltered through basic alumina to remove traces of acid. IR spectra 
were recorded on a Bomem MB-100 FT-IR spectrophotometer. Optical rotations were 
measured on a Perkin-Elmer 241 digital polarimeter. Melting points were determined on 
a Mel-Temp apparatus in an open capillary tube and are uncorrected. Low resolution 
mass spectral analysis were performed on a VG Quattro II triple quadrupole mass 
spectrometer (Micromass, UK) equipped with an electrospray source interfaced with an 
Hewlett-Packard HPLC running 5050 H20MeCN (0.1 % formic acid) at a flow rate of 
30 @min at the University of Waterloo. Elernental analyses were performed by MHW 
Laboratones, Pheonix, Arizona TLC was canied out on Merck aluminurn backed silica 
gel 60 Fm with visualization by W, ninhydrin solution (2% in EtOH), or 12. 
HPLC analyses were performed using a Waters 600E System Controller with 
Waters 600 Multisolvent Delivery System, Mode1 481 or 486 Variable Wavelength 
UVNis Detector, and Waters 745 Data Module. 
2.4.2 2-Me~yl-%(toIuenesulConyloxgmetbyl)oxc Omtane tosyiate, 23. 
Tosyl chloride (57.20 g, 0.3 mol) was dissolved in dry pyridine (400 mL) under argon. 3- 
Methyl-3-(hydroxymethyl)oxetane (20.4 g, 0.2 mol) was added slowly and stirred for 1.5 
hours. A slurry of cold water (200 mL) and cnisbed ice ( m g )  was vigourously stirred 
and the oxetane tosylate mixture slowly poured in then allowed to stir for an additional 
20 minutes. The white precipitate was then collected on Whamian filter paper # 1 and 
washed with cold H20. The product was dned under vacuum over P2O5 to obtain the 
white powder of oxetane tosylate (49.1 1 g, 924). 
mp 49.5-5 1 OC. TLC (3:2, HexEtOAc) Rt = 0.42; 'H NMR (CDC13, 250 MHz) 6 7.8 1 (d, 
2H, J = 8.2Hz, ArH), 7.37 (d, 2H, J = 8.2&, ArH), 4.44-4.3 1 (m, 4H, CHzO), 4.1 1 (s, SH, 
S03C&), 2-46 (s, 3H, Ar-CHd, 1.31 (s, 3H, CCH3); I3c NMR (CDC13, 63 MHz) 5 145.1 
(M-SOJ), 132.8 (AcCH3), 129.9, 127.9 (A-H), 78.9 (oxetane w), 74.2 (oxetane 
S 0 3 m ) ,  39.3 (oxetane -3), 21.6 (oxetane WH3), 20.6 (ArCArCH3). HRMS @AB) calcd 
for (M + K+) C12HioO& 256.0769, found 256.0774. Anal. Calcd for CI2HI6O4S: C, 
56.23; H, 6.29. Found: C, 56.33; H, 6.44. 
2.4.3 2-Methyl-2-(bromomethyl)oxetane, oxetane bromide, 239. 
Procedure A : 3-Methyl-3-(hydroxymethy1)oxetane (50.0 mL, 0.50 mol) and carbon 
tetrabromide (182.9 g, 0.55 mol) were dissolved in CH2C12 (500 mL) and cooled to O°C 
under argon. Triphenylphosphine (157.8 g, 0.60 mol) was added in portions. The 
reaction was warmed to room temperature and stirred for a further 20 minutes under 
argon. The CH2C12 was removed in vacuo and Et20 (500 mL) was added to the mixture. 
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The crude product was fiitered through Celite to remove some of the by-product P h 9 0 .  
The filtrate was then concentrated to a viscous liquid and hexane (500 mL) was added. 
The mixture was filtered once more through Celite to remove most of the by-product 
Ph3P0. The filtrate was concentrated to obtain a viscous yellow oil. The crude product 
was distilled under vacuum with a fractionation column. Oxetane bromide 2.39 was 
collected as a viscous liquid in 95-99% (8 1 .O g) yield. 
bp 62-64"C/lO mm Hg; 'H NMR (CDC13, 250 MHz)  6 4.464.38 (d+d, 4H, J = 6.3Hz, 
CHzO), 3.65 (s, 2H, C&Br), 1.44 (s, 3H CCH3); 13c NMR (CDC13, 63 MHz) 6 80.5 
CH20), 41.3 cH2Br), 40.5 (CCH3), 22.3 (Cm3). IR (neat) 2960, 1453, 1233; ESI-MS 
(M + H+) 157.21, 159.22; Anal. Calcd for C5H9Br0 : C, 36.39; H, 5.50. Found : C, 
36.50; H, 5.70. 
Procedure B: To a stirred solution of oxetane alcohol (20.4 g, 0.20 mole), 
triphenylphosphine (63.0 g, 0.24 mole), and pyridine (39 ml, 0.48 mole) in 200 ml 
CH2Q was slowly added a solution of bromine (10.2 mL, 0.2 mol) in 50 mL of CHzClz 
at 0°C. The mixture was stirred at room temperature for one hour. The solvent was 
rernoved under reduced pressure. To the residue was added Et20 (400 mL) and the 
mixture then filtered through Celite and the filtrate evaporated in vacuo. Hexanes (200 
mL) was then used to rinse the remaining solids. The final filtrate was concentrated and 
distilled to give the product 2.39 (22.7 g, 69%). 
Procedure C: 2-Methyl-2-(toluenesulfony1oxymethyl)oxee 2.38 (25.0 g, 97.53 
mmol) and NaBr (50.18 g, 0.49 mol, 5.0 equiv) were suspended in dry acetone (250 rnL) 
under dry nitrogen and refiuxed for 30 hours. The solution was first filtered and 
decolonzing charcoal was added. The solution was filtered and the acetone was 
evaporated in vacuo to give a colorless thick oil (14.8 g, 92%) which was used without 
further purification. 
2.4.4 (2-MethyC2-oxetanyI)methyl (ZS)-2-[(te~-b~toxy~bonyl)amino]-3-hydroxy- 
propanoate, Boc-Ser oxetane ester, 2.42. 
Boc-L-Ser ZAO (5.0 g, 0.024 mol) and Cs2C03 (4.69 g, 0.014 mol. 0.6 eq) were 
combined and dissolved in &O (50 mL). The water was then removed in vacuo and the 
resulting oil lyophilized for 12 hours to give a white foam. To this foam was added 
oxetane tosylate 2.38 (6.46 g, 0.025 mol) and Nd (0.72 g, 4.8 mmol, 0.2 eq) which was 
then taken up in DMF (250 mL) and allowed to stir under Ar for 48 hours. The DMF 
was then removed in vacuo and the resulting solid dissolved in EtOAc (300 mL) and H20 
(100 mL) and extracted with 10% NaHC03 (2 x 50 d), saturated NaCl (1 x 50 rnL) and 
dned over MgSQ. The solvent was removed under reduced pressure to yield a yellow 
oil which was purificd by flash chromatography (1: 1, Et0Ac:Hex) to yield the ester 2.42 
in 66% yield (4.32 g) as a paie oil. 
[ a ~ * ~ ~ ~ ~ =  - 15.4 (c=1.02, EtOAc); TU3 (1 : 1, Et0Ac:Hex) Rf = 0.33; 'H NMR (CDC13, 
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250 MHz)  6 5.47 (br ci, lH, J = S.OH& NH), 4.47 (d, LH, I = 6.1Hz, &CHH), 4.43 (d, 
1 H, J = 6. lHz, B-CHH), 4.354.27 (m, 4H, 2 oxetane CH&)), 4.07-3.57 (m, 3H, a-CH, 
C02CH2), 3.01 (br s, lH, OH), 1.36 (s, 9H, (CH3)3C), 1.24, (s, 3H, oxetane CCH3); 13c 
NMR (CDClp, 63 MHz) G 17 1 .O (C=O), 155.6 (CONH), 80.1 ((C&)3C) , 79.8 (oxetane 
CH20), 68.8 ( C O ~ H ~ ) ,  663.1 ($-=), 55.8 (a-CH), 39.3 (oxetane cCH3), 28.2 - 
(GH3)3C), 20.7 (oxetane CcH3); IR (neat) 3386, 2970, 1746, 17 13, 1509, 1367, 1 163, 
1060; HRMS (FAB) calculated for (M + H+) Cl3H2m6 290.1604, found 290.1594. 
Anal. calcd for C13Ha06: C, 53.78; H, 8.33; N, 4.83. Found: C, 53.97; H, 8.62; N, 
5.06. 
2AS (2-Methyl-2.oxetanyl)methyl-(2SJR)-t[(?e~-buto~~bnyI)~o]-3- 
hydroxybutanoate, Boc-Thr oxetane ester, 2.43. 
Boc-L-Thr 2.41 (5.0 g, 0.023 mol) and Cs2C03 (4.65 g, 0.014 mol, 0.6 eq) were 
combined and dissolved in H20 (50 mL). The water was then removed in vacuo and the 
resulting oil was lyophilized for 12 hours to give a white foam. To this foam was added 
oxetane tosylate 2.38 (6.41 g, 0.024 mol) and Nd (0.71 g, 4.7 mmol, 0.2 eq) which was 
then taken up in DMF (250 rnL) and allowed to stir under Ar for 48 hours. The DMF 
was then removed in vacuo and the resuIting sofid dissolved in EtOAc (300 mL) and 
H20 ( 100 mL) and extracted with 10% NaHC03 (2 x 50 mi,), saturated NaCl ( 1 x 50 
mL) and dried over MgS04. The solvent was removed under reduced pressure to yield a 
yellow oil which was purified by flash chromatography (1: 1, Et0Ac:Hex) to yield the 
ester 2*43 as a white solid in 73% yield (4.32g). 
mp 69-7 1 O C ;  [a]2057s = -24.5 (c = 1.04, EtOAc ); TLC (1: 1, Et0Ac:Hex) Rf = 0.2 1; 'H 
N l 4 . R  (-13, 250 MHz) 6 5.40 (br d, 1 H, J = 9.2W NH), 4.54 (d, 2H, J = 6.1 Hz, 
oxetane C m ) ,  4.50 (d, 2H, J d . 1  Hz, oxetane C m ) ,  4.44 (d, 1 H, J = 6.1 Hz, 
CozCHH), 4.42 (d, 1H, J =  6.1Hz, C02CHN), 4.40-4-35 (m, lH, p-CH), 4.30 (br d, lH, I 
= 9.2Hz, a-CH), 2.60 (br s, lH, OH), 1.36 (s, 9H, (CH&C), 1.27, (s, 3H, oxetane CC&), 
1.21 (d, 3H, J = 6.3& p-CH3); 13c NMR (CDC13, 63 MHz)  G 171.6 (C=O), 155.8 
GQNH), 80.1 ((CH3)Q 79.5 (oxetane GHzO), 68.6 (COKH*), 68.0 @-CH), 59.0 (a- 
* 
CH), 39.7 (oxetane -&), 28.3 (cH3)3C), 20.8 (oxetane CCH3), 20.0 ($-CH3); IR (cast - 
in CH2C12) 3386, 2975, 1694, 15 15, 1367, 1 164, 1055; HRMS (FAB) calculated for (M + 
8.31; N, 4.62. Found: C, 55.74; H, 8.51; N, 4.68. 
2.4.6 (1s)-1-[la-(tert-Butoxy~~~bon y1)-(lS)-1-amin0-2-hydr0xyethy1]4-methyl- 
2,6,7-trioxabicyclo[2.2.2]0ctane, Boc-Laer-OB0 ester, 2.44. 
Boc-Ser oxetane ester 2.42 (5.0 g, 0.0183 mol) was dissolved in dry CH2C12 (250 mL) 
and cooled to O°C under Ar. BF3- EtzO (0.1 1 mL, 0.93 mmol) was diluted in CHIC12 (5.0 
mL) and added to the reaction flask. The reaction was allowed to warm to room 
temperature and checked by TLC. After 18 hours, Et3N (0.51 mL, 3.66 rnmol) was added 
and the reaction stirred for an additional 30 minutes before being concentrated to a thick 
oil. The crude product was redissolved in EtOAc (200 mL) and washed with 3% -1 
(2 x 100 mL), 10% NaHC03 (100 mL), saturated NaCl (100 mL), dried (MgS04), and 
evaporated to dryness. The residue was purified by flash chromatography (silica gel, 4: 1 
CH2C12:EtOAc) to give a light yellow oil(3.35 g) in 67% yieid. 
= -4 1.8 (c = 1.00, EtOAc); TLC (4: 1 CH2C12:EtOAc) Rr = 0.47; 'H NMR (CDC13, 
250 MHz) 6 5.05 (d, 1 H, J = 7.7Hz, NH), 3.90 (s, 6H, OB0 ester CH20), 3.85-3.62 (m, 
3H, a-CH. $-Cf&), 2.65 (br s, lH, OH), 1.42 (s, 9H, (C&)3C), 0.79 (s, 3H, OB0 ester 
CCff3); 13c NMR (CDCl3, 63 MHz) 6 155.6 (CONH), 108.1 (OB0 ester - 0 )  79.3 
((CH3)3Q, 72.6 (OB0 ester CH@), 67.0 @-CH2), 62.9 (a-_CH), 40.2 (OB0 ester 
CCH3), 27.9 ((CH3)3C), 1 3.9 (OB0 ester Cm3);  IR (neat) 3386,2975, 1694, 15 15, 1 367, - 
1 164, 1055. Anal. calcd for Ci3bN06: C, 53.78; H, 8.33; N, 4.83. Found: C, 54.02; H, 
8.61; N, 5.02. 
2.4.7 l-[N~ett-Butoxycarbonyl-(1S~)-1-~012-hydn,xypropyI 1-4-methyl-2,6,7- 
trioxabicyclo [2.2.2]octane, Boc-L-Thr-OB0 ester, 2.45. 
Boc-L-Thr oxetane ester 2-43 (4.18 g, 13.7 rnmol) was dissolved in dry CH2C12 (250 mL) 
and cooled to O OC under Ar. BF3- EtzO (0.08 mL, 0.69 mmol) was diluted in CH2Ch 
(2.0 mL) and added to the reaction flask. The reaction was allowed to wam to room 
temperature and was checked by TLC. After 24 hours, Et3N (0.38 rnL, 2.76 mrnol) was 
added and the reaction was stimd for an additional 30 minutes before being concentrated 
to a thick oil. The cmde product was redissolved in EtOAc (200 mL) and washed with 
(MgS04), and evaporated to dryness. The product was purifieci by flash chromatograph y 
(4: 1, C&C12:EtOAc) to give a white solid (2.84 g) in 68% yield. 
mp 128- 129°C; [a]20ss = - 15.2 (c = 1 .CM, CH2C12); TU= (4: 1, CH2CI2:EtOAc) Rf = 0.39; 
'H NMR (CDC13, 250 MHz) 6 5.06 (br d, lH, J = 10.4Hz, NH), 4.3 1 (br q, 1 H, J = 
6.4Hz, B-CH), 3.89 (s, 6H, OB0 ester CH20), 3.63 (d, lH, J = 10.4Hz, a-CH), 2.88, (br 
S. I H, OH), 1.42 (s, 9H, (CH&C), 1 .O6, (d, 3H, J = 6.4H.2, P-CH3). 0.79 (s, 3H, OB0 
ester CCH3); I3c C (CDCb, 63 MHz) 6 156.3 (CONH). 108.8 (OB0 ester Ç-O), 79.2 
((CH3)3ç), 72.6 (OB0 ester cm), 65.3 (B-_CH), 57.1 (a-CH), 30.5 (OB0 ester WH3), 
28.3 cH&C), 18.9 @-CH3), 14.3 (OB0 ester CÇH3); IR (cast from CH2C12) 3386,2975, 
1715, 1506, 1365, 1169, 1049; HRMS (FAB) calculated for (M + EI+) CIJ&NO6 
304.1761, found 304.1732; Anal. calcd for C1&5N06: C, 55.43; H, 8.30; N, 4.61. 
Found: C, 55.63; H, 8.56; N, 4.92. 
2.4.8 1-[N~ert-Butoxy~~1rbonyl-(lS)-1-amin012-0xoethyl]-4-methy1-2,6,7- 
trioxabicyclo [2.2.2]octane, Boc-L-Ser(a1d) OB0 ester, 2.46. 
Boc-Ser OB0 ester 2.44 (1.12 g, 3.87 mmoi) was dissolved in freshly distillai CH2C12 
(15 mL) under Ar and cooled to -78OC in flask 1. Oxalyl chloride (0.54 mL. 6.19 mrnol, 
1.60 equiv) was added to CH2C12 (120 mL) in a separate round bottom fiask (flask 2) 
under Ar, and cooled to -78OC. Dry DMSO (0.91 mL, 12.8 mrnol, 3.30 equiv) was added 
to the oxalyl chloride solution (flask 2) and the mixture was stirred at -78OC for 15 
minutes. The akohol solution was transferred slowly by cannula to flask 2 over a period 
of 15 minutes and then rinsed with CH2C12 (5 mL). The resulting cloudy, white mixture 
was stimd for 1.5 hours at -78OC. DIPEA (3.35 m .  19.4 rnrnol, 5.0 equiv) was added 
and the solution stirred for 30 minutes at -7g°C and 10 minutes at O°C. Ice-cold CHzClz 
(100 mL) was added and the solution was washed with ice-cold 3% N W l ( 2  x 80 mL), 
saturated NaCl (1 x 80 mL), dried (MgSOd), and evaporated to dryness to yield a light 
coloured foam ( 1. log) in 99% yield. 
[ ~ ] ~ O s 7 8 =  -44.8 (c = 1.02, CHXl2); TU3 (1 : 1, Et0Ac:Hex) Rf = 0.58; 'H NMR ( m l i ,  
250 MHz)  6 9.64 (s, 1H, CHO), 5.07 (br d, lH, J =  7.8H.2, NH), 4.48 (d, lH, J =  7.8Hz, 
a-CH), 3.91 (s, 6H, OB0 ester CH20), 1.41 (s, 9H, (CH3)3C), 0.79 (s, 3H, OB0 ester 
CCH3); 13c NMR (Cml3, 63 MHz) 6 195.7 (CHO), 155.6 EONI-I), 107.3 (OB0 ester 
C-O), 80.1 ((CH3)3C), 72.8 (OB0 ester CHzO), 63.3 (a---, 30.9 (OB0 ester CCH3), 
28.2 ((CH3)3C), 14.3 (OB0 ester CcH3); IR (cast from CH2C12) 3374, 2973, 1716, 1506, 
1166, 1046; HRMS (FAB) calculated for (M + HC) c13HUN06 288.1447, found 
288.1425. Anal. calcd for C13H21N06: C, 53.78; H, 8.33; N, 4.83. Found: C, 53.98; H, 
8.56; N, 4.89. 
2.4.9 1-[NJerf-Butoxyarbonyl-(lS)-l-amino-2~xopropyl]4-methy1-2,6,7- 
trioxabicyclo [2*2.2J0~tPw, Bor-L-Thr(ket)OBO ester, 2.47. 
Boc-Thr OB0 ester 2.45 (0.90 g, 2.97 mmol) was dissolved in fieshly distilled CH2C12 
(15 mL) under Ar and cooled to -7g°C in fiask 1. Oxalyl chlonde (0.414 mL. 4.75 mmol, 
1.60 equiv) was aâded to CHzCh (20 mL) in a separate round bottom flask (flask 2) 
under Ar, and cooled to -7S°C. Dry DMSO (0.70 mL, 9.8 mmol, 3.30 equiv) was added 
to the oxalyl chloride solution (flask 2) and the mixture was stirred at -78OC for 15 
minutes. The alcohol solution was transferred slowly by cannula to flask 2 over a period 
of 45 minutes and then rinsed with CHzClz (5 mL). The resulting cloudy, white mixture 
was stirred for 1.5 hours at -7S°C. DIPEA (2.57 mL, 14.9 mmol, 5.0 equiv) was added 
and the solution stirred for 30 minutes at -78OC and 10 minutes at O°C. Ice-cold CHzClz 
(80 mL) was added and the solution was washed with ice-cold 3% N W I  (2 x 50 mL), 
saturated NaCl (1 x 50 mL), dried (MgSOa), and evaporated to dryness to yield a light 
coloured foam (0.885g) in 99% yield. 
[a]%*= - 107.1 (c =1 .SI, EtOAc); TLC (1 : 1, Et0Ac:Hex) Rr = 0.58; 'H NMR (CDC13, 
250 M H z )  6 5.37 (br d, IH, J =  8.3Hz, NH), 4.46 (d, IH, J =  8.3Hz, a-CH), 3.89 (s, 6H. 
OB0 ester C H D ) ,  2.28 (S. 3H, p-CH3) 1.39 (s, 9H, (CH3)3C), 0.79 (S. 3H, OB0 ester 
CC&); I 3 c  NMR (CDCI3, 63 MHz) 6 20 1.6 c=O), 156.6 (CONH), 107.3 (OB0 ester 
C-O) , 80.1 ((CH3)3C), 72.8 (OB0 ester CH20), 63.3 (a-CH), 30.9 (OB0 ester CCH3), - 
29.8 ($-CH3), 28.2 ((CH3),C), 14.3 (OB0 ester CcH3); IR (cast €rom CH2Clz) 2972, 
2883, 17 16, 1506, 1362, 1 167, 1045; HRMS (FAB) calculated for (M + H+) Ci&aO6 
302.1604, found 302.1593; Anai. calcd for Ci4&N06: C, 55.80; H, 7.69; N, 4.64. 
Found: C, 56.0 1 ; H, 7.96; N, 4.86. 
2A.10 l,l,l-Triacetony-l,l-dihydro-1,2-benziod0~01-3(îR)1one, 2A8.P 
Potassium bromate (19 g, O. 11 mol) was added over a 0.5 hour period to a vigorously 
stimng mixture of 2-iodobenzoic acid (21 -3 g, 0.08 mol) and 200 rnL of 0.73 M HtS04. 
During addition the temperature of the reaction was kept below 5S°C but then warmed to 
65°C and stirred for an additionai 3.5 h. The mixture was then cooled to 0°C and the 
precipitate filtered off then washed with 700 mL of water and two 30 mL portions of cold 
ethanol. The precipitate was dried under water aspirator then taken up in Ac20 (90 mL, 
0.85 mol) and AcOH (75 rnL. 1.4 mol) under NZ. The vigorously stimng mixture was 
slowly heated to 85°C over 1 h and the now clear solution stirred for 1.5 h at 85°C then 
allowed to cool to ambient temperature under N2. The solution was tightly sealed, 
wrapped in foi1 and allowed to slowly crystallized over 2 days. The crystals were 
transferred under N2 through a male-male adapter into a Schlenk tube. The white crystals 
were thoroughly washed with freshly distilled Et20 (10 x 50 mL) using positive Nz 
pressure and vacuum to assist in the filtration. The crystals were dned under N2 then 
transferred to dry amber vials and purged with N2. 
mp 125-126.S°C; 'H NMR (CDCI>,250 MHz) 6 8.69 ( br dd, lH, A m ,  8.33 (d, lH, J = 
8.SHz, ArH), 8.29 (d, lH, J =  8.5Hz, ArH), 7.90 (br dd, 1H, ArH), 2.27 (s, 3H, CfiCO), 
2.0 1 (s, 6H, 2 CH3CO). 
2-4-11 MeMgBr addition to 2.46: l-[N~ert-Butoxgcarbonyl-(1S~)-l-smin0-2- 
h ydroxypropy~]-4-methy 1-2,6,7-trioxabicycio[2.2.2 ]octane, Boc-L-Ser(Me)OBO 
ester, 2.49. 
Cnide Boc-L-Ser(a1d) OB0 ester 2-46 (0.478 g, 1.66 mrnol) was dissolved in dry EtzO (5 
mL) and CH2C12 (5 mi,) under N2. A solution of MeMgBr in Et20 (1.66 d, 4.98 mmol) 
was added quickly by syringe at -78°C and the mixture stirred vigorously. M e r  2 h the 
reaction was quenched by pouring into 25 mL of 3% =Cl. CH2C12 (80mL) was added 
and the organic Iayer was separated, washed with 3% m l  (1 x 50 rnL) and bnne (1 x 
50 rnL), dried (MgSO& and evaporated to dryness. The product was punfied by flash 
chromatography (4:1, CH2C12:EtOAc) to give 0.307 g of a light oil (6196). A 
diastereornetric ratio of 85: 15 threo:erythro was determined using 'H NMR integration of 
the threo P-CH3 at 6 1.12- 1 .O7 ppm and the erythro B-C& at 6 1.2 1 - 1.14 ppm in the 
crude product. The two diastereomers were separable by flash chromatography, the threo 
diastereomer with a RI of 0.39 and eryrhro diastereomer a Rf of 0.34. 
[a120578= - 15.4 (C = 1.01, CH2CIZ); TU3 (4: 1, CH2C12:EtOA~) Rf = 0.39: 'H NMR 
(CDCl3, 250 MHz, rhreo isomer) 6 5.06 (br d, 1 H, J = 1 O.4EIz, NH), 4.3 1 (br q, 1 H, I = 
6.4Hz7 P-CH), 3.89 (s, 6H, OB0 ester CH20), 3.63 (br d, 1H, J = 10.4Hz, a-CH), 2.88, 
(br s, 1 H, OH), 1.42 (s, 9H, (CH3)3C), 1 .O6, (d, 3H, J = 6.4H2, B-CH3), 0.77 (s, 3H, OB0 
ester CCH3); 13c NMR (CDCk, 63 Mm) 6 155.8 (CONH), 108.4 (OB0 ester - O ) ,  
79.1 ((CH3)3Q, 72.5 (OB0 ester w20), 65.6 (p-CH), 59.0 (a-CH), 30.9 (OB0 ester 
84 
I CCH3), 28.3 (a3)C), 20.1 (fLm3) 13.9 (OB0 ester IR (cast from CH2CL2) - 
3386, 2975, 1694, 1515, 1367, 1164, 1055; HRMS (FAB) cdculated for (M + 
! C 14H&06 304.176 1, found 304.1769; Anal. cdcd for Cifi25N06: C, 53.78; H, 8.33; N, 
l 
4.83. Found: C, 54.08; H, 8.66; N, 5.16. 
2.4.12 EtMgBr addition to 2.46: l-~~ert-Butoxy~~~bonyl-(1S~)-1-amin0-2- 
hydroxybutyl]-4-methyl-2,6,7-trio~8bicyc10 [2.2.2]octane, Boc-L-Ser(Et)OBO ester, 
2.50. 
Cnide Boc-L-Ser(a1d) OB0 ester 2.46 (0.101 g, 0.35 mmol) was dissolved in dry 
Et20:CH2C12 (5 mt. L : 1) under N2. A solution of EtMgBr in Et20 (0.35 mL, 1 .O5 mmol) 
was added quickly by syringe at -78°C and the mixture stimd vigorously. After 2 h the 
reaction was quenched by pouring into 5 rnL of 3% -1. CH2C12 (40 mL) was added 
and the organic layer separated, washed with 3% W C 1  (1 x 10 mL) and brine (1 x 10 
mL), dned (MgS04) then evaporated to dryness. The product was purified by flash 
chromatography (4:1, CH2C12:EtOAc) to give 0.072 g of a light oil (65%) with a 
diastereometric ratio of 84: 16 threo:erythro. 
[ a l t o ~ 8 =  -26.3 (c = 0.96, CHzC12); TU3 (4:1, CH2C12:EtOAc) Rf = 0.45; 'H NMR 
(CDC13, 250 MHz) major isomer = threo (84%), rninor = erythro (168) 6 5.30 (br d, 
0.84H, J =  10.4Hz, threoNH), 5.13 (brd,O.ldH, J =  10.4Hz, erythroNH),4.21 (brt, lH, 
J = 6.4H.2, P-CH), 3.87 (S. 6H, OB0 ester C m ) ,  3.69 (br d, lH, J = 10.4Hz, a-CH), 
85 
2-79, (br s, lH, OH), 1.60-1 -34 (m, 2H. m3CH2), 1-42 (s, 9H, (CH&C), 1.0 1, (t, 3H, J = 
7.1Hz, CH3CH2), 0.76 (s, 3H, OB0 ester CCH-); I3c NMR ((CDCls 63 MHz) 6 156.7 
(CONH), 108.1 (OB0 ester - O ) ,  79.0 ((CH&Q, 72.7 (OB0 ester cH20), 66.1 @-SEI), 
56.8 (a-CH), 46.3 (CH3-2). 30.4 (OB0 ester C a 3 ) ,  28.3 (CH3)3C), 13.9 (OB0 ester 
CCH3), 10.1 (CH3CH2); IR (cast from C&CI2) 3386, 2975, 1694, 1515, 1367, 1164, 
1055; HRMS (FAB) caiculated for (M + H+) C i 5 H a O d  3 18.3869. found 3 18-39 19; 
Anal. calcd for CisHnN06: C, 56.77; H, 8.57; N, 4.41. Found: C, 57.09; H, 8.76; N, 
4.49. 
2.4.13 VmylMgBr addition to 2.46: 1-[Njert-Butoxymbnyl-(1S3)-1-amino-2- 
hydroxybuteoyl]4-methyl-2,6,7-tri0~~1bi~yc10[2~2.2]0~tane, Boc-L-Ser(viny1)OBO 
ester, 2-51. 
Cnide Boc-L-Ser(a1d) OB0 ester 2.46 (0.097 g, 0.33 mrnol) was dissolved in dry 
Et20:CH2CI2 (5 mL, 1:l) under N2. A solution of VinylMgBr in THF (0.99 mL, 0.99 
mmol) was added quickly by syringe at -78°C and the mixture stirred vigorously. M e r  2 
h the reaction was quenched by powing into 5 mL of 3% IWKl. CH2C12 (40mL) was 
added and the organic layer was separated, washed with 3% NKCl (10 rnL) and brine 
(10 mL), dned (MgS04), and evaporated to dryness. The product was purified by flash 
chromatography (4: 1, CH2C12:EtOAc) to give 0.041 g of a light oil (40%) with a 
diastereometric ratio of 87: 13 threo:erythro. 
TLC (4: 1, CH2C12:EtOAc) Rf = 0.44; 'H NMR ( m l 3 ,  250 MHz) 6 5.79 (ddd, lH, J = 
4.9, 11.5, 16.5Hz, CHzdH), 5.30 (br d, lH, J =  16.5Hz, CM-, 5.21 (br d, lH, J = 
1 MHz, CHHSH), 5.33 (br d, 0.87H, J = 10.4Hz, threo NH), 5.10 (br d, 0.13H, J = 
10.4Hz, ewhro NH), 4614.50 (m, 1H. p-CH), 3.88 (S. 6H, OB0 ester CHIO), 3.69 (br 
d, IH, J =  10.4Hz, a C m ,  2.69, (br s, IH, OH), 1.40 (s, 9H, (CH3)3C), 0.81 (S. 3H, OB0 
ester CC&); "C NMR (CDC13, 63 MHz) 6 156.1 (ÇONH). 135.8 (CH2-, 115.1 
(CH2=CH), 108.5 (OB0 ester - O ) ,  79.1 ((CH3)3C), 72.6 (OB0 ester cH20), 67.1 ($- 
CH), 56.5 (a-CH), 30.4 (OB0 ester CCH3), 28.3 (CH&C), 13.9 (OB0 ester CCH3); - 
HRMS (FAB) calculated for (M + ClsH2- 316.3709, found 316.3819; Anal. 
calcd for C15H25N06: C, 57.13; H, 7.99; N, 4.44. Found: C, 57.34; H, 8.26; N, 4.48. 
2.4.14 PhMgBr addition to 2A6: l - [ N - t e ~ - B u t o x y ~ 1 ~ b o n y l - ( l S ~ ) - 1 - ~ 0 - 2 -  
hydioxybutenyI]4methyl-2,6,7-trioxabicyclo[2.2e2]octane, Boc-L-Ser(Ph)OBO 
ester, 2.52. 
Crude Boc-L-Ser(a1d) OB0 ester 2.46 (0.122 g, 0.42 mmol) was dissolved in dry 
Et20:CH2C12 (5 mL, 1 : 1) under N2. A solution of PhMgBr in THF (0.42 mL, 1.26 mmol) 
was added quickly by syringe at -78°C and the mixture stirred vigorously. AAer 2 h the 
reaction was quenched by pouring into 5 mL of 3% N&Cl. CH2C12 (5OmL) was added 
and the organic layer was separated, washed with 3% NH.&l(10 mL) and bnne (10 mL), 
dried (MgSOa), and evaporated to dryness. The product was purified by flash 
chromatography (4: 1, CH2C12:EtOAc) to give 0.092 g of a light yellow oil (60%) with a 
diastereometric ratio of 88: 12 threo:erythro. 
TLC (4: 1, CH2C12:EtOAc) Rf = 0.58; 'H NMR (CDC13, 250 MHz) 6 7.51-7.25 (m, SH, 
ArH), 5.69 (br d, 0.88H, J = 10.3Hz. threo NH), 5.30 (br d, 0.12H, J = 10.3Hz, erythro 
NH), 4.93-4.8 1 (m, 1 H, &CH), 3.9 1 (s, 6H, O B 0  ester CHD). 3.72 (dd, 1 H, J = 3.4, 
10.3Hz, a-CH), 1.43 (s, 9H, (CH3)Ç), 0.79 (s, 3H, OB0 ester CCH3); 13c NMR 
(-13,63 MHz)  6 1 56.8 (CONH), 136.7 (ArsC-=), 128.3, 127.7, 127.6 (&=CH), 108.1 
(OB0 ester C-O), 79.3 ((CH3)3C), 72.4 (OB0 ester GHzO), 69.1 (8-H), 57.5 (a-CH), 
30.4 (OB0 ester WH3). 28.3 ((Q13)3C), 13.9 (OB0 ester CCH3); HRMS (FAB) 
calculated for (M + H+) Cl&aNOs 366.4309, found 366.4365; Anal. calcd for 
ClgH27NOs C, 62.45; H, 7.45; N, 3.83. Found: C, 62.73; H, 7.75; N, 3.91. 
2-4-15 Deprotection of Boc-Ser(Me)OBO ester 2-49: (2S,3R)-2-amino-3- 
hydroxybutanoic acid, L-Tb, 2.53. 
Boc-Ser(Me)OBO ester 2.49 (0.210 g, 0.69 mmol) was dissolved in CH2C12 (5 rnL) to 
which TFA (1 mL) was added. The mixture was stirred for 30 min and the solvent then 
removed under reduced pressure. The mixture was nnsed with Fresh CH2CI2 then 
reduced again and repeated once more. The mixture was dissolved in MeOH:H20 (5 rnL, 
4: 1) then t mL of a 10% (wthol) Cs2C03 solution was added. The mixture was allowed 
to stir for 18 h at room temperature before k i n g  acidified to pHd with 3 N Hel. The 
solution was then Ioaded ont0 a cation exchange resin column (Bio-Rad AGa SOW-X8 
88 
100-200 mesh, hydrogen form, 1x10 cm) washed with 0.01 N H a T  Hg (5 colurnn 
lengths each) then eluted with 0.5 N W H .  The eluant was reduced in volume then 
lyophilized to dryness to give 69 mg (81%) of a white, powdery solid. Spectral data 
identical to authentic Thrlallo-Thr. 
2.4.15a HPLC Anaiysis of L-Thr 2.53. 
A solution of 2.53 (10-50 pl., of approximately lmg/mL) was mixed with borate buffer 
(0.1 mL of a 0.133 M solution. pH 10.4), O-phthalaldehyde 2.63 (40 pi, of a 5 m@nL 
solution in borate buffer) and N-isobutyryl-L-cysteine 2.64 (40 ~LL of a 20mg/mL 
solution in borate buffer). After 5 min, 25 pL of the mixture was injected ont0 a Waters 
125-A 8x100 mm p-Bondpak C l 8  Radiai-Pak cartridge colurnn (2 mumin; 1 0 %  30 
mM sodium acetate buffer, pH 6.5; linear gradient over 25 min to 60:40 buffer:MeOH; 
detection at 338 nm). Retention times were identical to those of standards prepared from 
L-Thr (21.3 min), L-allo-Thr (25.5 min), D-Thr (22.2 min), D-aiIo-Thr (26.4 min) 
showing a threcxerythm ratio of 85: 15 with 98% ee. 
2.4.16 Deprotection of Boc-SW(E~)OBO ester 2.50: (ZS,3R)-2-smino-3- 
hydmxypentanoic acid, 2.54. 
Boc-Ser(Et)OBO ester 2.50 (0.062 g, 0.16 mmol) was deprotected as descnbed in 
procedure 2.4.15 and lyophilized to give I 1 mg (5 1%) of a white powder. HPLC analysis 
performed as described in 2.4.15a indicated a threo:erythro ratio of 87:13 with 97% ee 
(threo-L-254: 33.0 min, threo-D-2.54: 34.1 min, erythro-L-2.54: 37.2 min, erythro-D- 
2.54: 38.1 min). 
TLC ( 1 : 1 : 1 : 1. Et0Ac:nBuOH:MeOH:Hfi) Rf = 0.48; 'H NMR (DzO, 250 MHz) 6 3.85 
(dt. 1H. J = 4.9, 8.2Hz, B-CH), 3.57 (d, 1H. J = 4.4Hz, a-CH). 1.57-1.32 (m, ZH, 
C H K H z ) ,  0.87 (t, 3H, J = 7.4Hz. CH3CH2); 13c NMR (&O. 63 MHz) 6 178.3 (COzH), 
75.2 @-CH), 62.2 (a-CH), 30.0 (CH3_&), 1 3.1 cH3CH2); ESI-MS (M + H+) 1 34.19. 
2.4.17 Deprotection of BoclSer(viny1)OBO ester 2.51: (2S,3R)-2-smino-3-hydroxy- 
4-pentenoic acid, 2.55. 
Boc-Ser(vinyl)OBO ester 2.51 (0.041 g, O. 13 mmol) was deprotected as described in 
procedure 2.4.15 and lyophilized to give 8 mg (40%) of a white powder. HPLC analysis 
performed as described in 2.4.15a indicated a threo:erythrû ratio of 89: 11 with 97% ee 
(threo-L-2.55: 37.2 min, threo-D-2.55: 40.1 min, erythro-L-2.55: 43.6 min, erythro-D- 
2.55: 45.2 min). 
TU3 (1 : 1: 1: 1, EtOAc:nBuOH:MeOH:HzO) Rf = 0.46; 'H NMR (DD, 250 MHz) 6 5.89 
(ddd, lH, J =  5.3, 10.9, 16.8Hz, CH2=CH), 5.39 (br d, 1H, J = 17.OHz, CHH=CH), 5.22 
(br d. IH. J =  10.6Hz, CHH-CH), 4.634.52 (m, 1H. P-CH), 3.88 (d, IH, J=4.0Hz, a- 
CH); "C NMR @ 2 0 ,  63 MHz)  6 175.3 (C02H), 136.9 (CH2=CH), 12 1.1 m2=cH)7 
73.2 (p--m, 62.0 (a--; ESI-MS (M + HC) 13 1.92. 
2.4.18 Deprotection of Boc-Ser(Ph)OBO ester 2.52: (~~R)-2-Pmino-3-hydroxy-3- 
pheny Bpmpanoic acid, 2.56. 
Boc-Ser(Ph)OBO ester 2.52 (0.073 g, 0.20 mmol) was deprotected as described in 
procedure 2.4.15 and lyophilized to give 23 mg (66%) of a white powder. HPLC analysis 
performed as described in 2.4.15a (linear gradient to 5050 30mM sodium acetate: MeOH 
over 25 min) indicated a threo:erythro ratio of 90: 10 with 98% ee (threo-L-2.56: 35.1 
min, threo-D-2.56: 38.1 min, erythro-L-2.56: 40.6 min, erythro-D-2.56: 4 1 -3 min). 
TU3 (1: 1: 1: 1, EtOAc:nBuOH:MeOH:H20) Rr = 0.61; 'H NMR 020, 250 MHz) 6 7.4 1 - 
7.29 (m, SH, ArH), 5.3 1 (d, O. IH, / = 4.0Hz, erythro p-CH), 5.25 (d, 0.9H. J = 4.OHz, 
threo p-CH), 4.08 (d, lH, J = 4.0Hz, a-CH); 13c NMR (D20, 63 MHz) 6 175.0 (C02H), 
140.9 (-=), 131.0, 129.9, 128.1 (mH), 73.9 (p-GH), 63.1 (a-CH); ESI-MS (M + 
182.01. 
2.4.19 Reduction of recovered Boc-Ser(ald)-OB0 ester 2.46 fmm section 2.4.11. 
91 
Before being purified by flash chromatography, an aliquot (0.093 mg, 0.31 mrnol) of the 
reaction mixture described in section 2.4.1 1 was dissolved C&C12 (20 mL), cooled to 
-20°C and NaB& (0.012 g, 0.3 1 mmol) then added. The mixture was allowed to warm 
to room temperature and after 2 h poured into 3% -1 (10 m . )  which was then 
extracted with C H s l 2  (3 x 10 mL). The organic fractions were pooled, extracted with 
brine (15 mL) then dned over MgS04 and evaporated to dryness. After purification by 
flash chromatography the optical rotation of Boc-Ser-OB0 ester 2-44 was determined. 
[a120na = -40.2; (c = 0.98, EtOAc). 
2.4.20 Addition of MeMgBr to Boc..Tùr(ket)OBO ester 2.47: 1-[Nfert- 
Butoxy~bonyl-(lS)-l-amin0-2-bufanol]4met~yl-2,6,7-~o~bicyclo[2~2.2]~~e, 
Boc-L-Thr(Me)-OB0 ester, 2.57. 
Cnide Boc-L-Thr(ket)-OB0 ester 2.47 (0.561g, 1.86 mmol) was dissolved in dry EtzO 
(15 mL) and CH2C12 (15 mL) under N2. A solution of MeMgBr in Et20 (1.86 mL, 5.58 
mrnol) was added quiclcly by syringe at -78°C and the mixture stirred vigorously. M e r  2 
h the reaction was quenched by pounng into 25 mL of 3% W C l .  CH2C12 (120rnL) was 
added and the organic layer was separated, washed with 3% N u l  (50 mL) and brine 
(50 mL), dried (MgS04), and evaporated to dryness. The product was purified by flash 
chromatography (4: 1, CH2Cl5:EtOAc) to yield 0.4248 (72%) of a white solid. 
mp 80-8 1 OC; [ a ~ ~ * ~ a =  -67.0 (0 1.55, EtOAc); TLC (4: 1. CH2C12:EtOAc) Rr = 0.45; 'H 
NMR (CDCl3, 2 M  MHz) 6 5.02 (br d. lH, J = 10.6Hz, NH), 3.89 (s, 6H, OB0 ester 
C m ) ,  3.71 (d, IH, J =  10.6Hz. a-CH), 3.38, (br s, lH, OH), 1.41 (s, 9H, (CH3)3C), 1.28 
(s, 3H, B-CH3), 1.15 (s, 3H, p-CH3), 0.78 (s, 3H, OB0 ester CCH3); 13c NMR (CDC13, 
63 MHz) 6 156.1 (CONH), 109.3 (OB0 ester - O ) ,  79.1 ((CH3)3Q, 72.5 (OB0 ester 
CH20), 72.3 (p-C), 59.8 (a-_CH), 30.4 (OB0 ester cCH3), 28.3 (a3)3C), 28.1 (B-c&), - 
26.6 (p-GH3), 14.3 (OB0 ester C-3); IR (neat) 3386, 2975, 17 15, 1506, 1365, 1 169, 
1049; HRMS (FAB) calcd for (M + H+) Ci5H&J06 318.1917, found 318.1929. Anal. 
calcd for C, 56.77; H, 8.57; N, 4.4 1. Found: C, 56.98; H, 8.69; N, 4.73. 
2.4.21 Addition of EtMgBr to Boc-Thr(ket)OBO ester 2.47: torf-butyl N4(lS,2R)-2- 
hydr0xy-2-metayCl-(4-metby1-2,6,7-tri0~bi~y~lo[2.2.2]~t-l-yl)bu~l]~b~te, 
Boc-L-Thr(Et)-OB0 ester, 2.58. 
Cnide Boc-L-Thr(ket)-OB0 ester 2.47 (0.3888, 1.29 rnmol) was dissolved in dry Et20 
(15 mL) and C&C12 (15 mL) under N2. A solution of EtMgBr in Et20 (1.29 rnL, 3.87 
mmol) was added quickly by syringe at -78°C and the mixture stirred vigorously. After 2 
h the reaction was quenched by pouring into 3% N W l  (25 mL). CH2C12 (100m.L) was 
added and the organic layer was separated, washed with 3% N W I  (50 mL) and brine 
(50 mL), dried (MgS04), and evaporated to dryness. The product was purified by flash 
chromatography (4:1, CH2C12:EtOAc) to yield 0.320g (75%) of a white crystalline 
product. 
mp 8748°C; [al2O5,, = -3 1.8 (c = 1 .O6, EtOAc); TLC (4: 1, CH2CI2:EtOAc) Rt = 0.55; 'H 
1 NMR (CDC13, 250 MHz) 6 5.01 (br d, lH, J = 10.3Hz, NH), 3.87 (s, 6H, OB0 ester 
CH20), 3.75 (d, 1 HT J = 10.3Hz, a-CH), 3.18, (br s, IH, OH), 1.47 (q, 2H, J = 7 SHz, 
CH3CH2), 1.41 (s, 9H, ((C&)gC), 1.23 (s, 0.98H. threo $-CH3), 1.19 (s, 0.02H, erythm 
P-CH3), 0.84 (t, 3H. J = 7.5H2, CH3CH2) 0.77 (s, 3H, OB0 ester CCH3); 13c NMR 
(Cml3,63 MHz) 6 156.1 (CONH), 109.6 (OB0 ester C-O), 79.1 ((CH3)3Q, 74.7 (B-C), 
72.3 (OB0 ester CH#), 58.3 (a-CH), 3 1.7 (CH3_CH2), 30.4 (OB0 ester mH3),  28.4 
((çH3)3C), 24.3 (&CH3), 14.3 (OB0 ester CÇH3), 8.0 (CH3CH2); IR (neat) 3380, 2975, 
1715, 1505, 1362, 1169, 1051; HRMS (FAB) calculated for (M + H') C1&&06 
332.2073, found 332.2061; Anal. cdcd for C16H29N06: C, 57.98; H, 8.85; N, 4.22. 
Found: C, 58.13; H, 9.02; N, 4-38, 
2.4.22 Deprotection of Boe-Thr(Me)OBO ester 2.57: (2S)-2-amino-3-hydroxy-3- 
methylbutanoic acid, 2.59, 
Boc-Thr(Me)OBO ester 2.57 (0.210 g, 0.66 mrnol) was dissolved in CH2C12 (10 mL) to 
which TFA (2 rnL) was added. The mixture was stirred for 30 min and the solvent then 
removed under reduced pressure. The mixture was rinsed with fresh CH2Clz then 
reduced again and repeated once more. The mixture was dissolved in Me0H:Hfi (5 mL, 
4: 1) then 1 rnL of a 10% (wthol) Cs2C03 solution was added. The mixture was allowed 
to stir for 18 h at room temperature before king directly loaded onto an anion exchange 
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resin column (Bio-Rad AGa 10x4 1 0 - 2 0  mesh, chloride fonn converted to hydroxide 
fom by prewashing with 4N NaOH then rinsed with Millipore Milli-Q Hz0 until the 
rinsings appeared neutral. larger column lengths were required to accommodate the CQ" 
generated). ZN AcOH or 1N fonnic acid was used to elute the amino acid and the eluant 
reduced in volume then lyophilized to dryness to give 45 mg (52%) of a white, powdery 
solid. Recrystallization from H20/acetone gave 19 mg (218) of colourless crystals. 
HPLC analysis perfarmed as described in 2.4.15a (linear gradient 5050 30mM sodium 
acetate: MeOH over 60 min) eluted the diastereomer formed from the L-arnino acid at 
42.5 min and the D-amino acid at 43.9 min to indicate 99% ee. 
mp 195- 198°C (dec); TLC (1 : 1 : 1 : 1, EtOAc:nBuOH:MeOH:H20) Rr = 0.48; 'H NMR 
p 2 0 ,  250 MHz) 8 3.61 (s, lH, a-CH), 1.35 (s, 3H, p-CH3), 1.1 1 (s, 3H. p-CH3); I3c 
NMR @20,63 MHz) 6 176.1 (ÇOZH), 73.6 (BQ, 63.3 (a--, 30.7 @-CH3), 26.3 (P- 
CH3); ESI-MS (M + H+) 133.93. - 
2.4.23 Deprotection of Boe-Thr(Et)OBO ester 2.58: (2S,3R)-2-amho-3lydroxy-l 
methylpentanoic acid, 2-60, 
Boc-Thr(Et)OBO ester 2.58 (0.151 g, 0.46 mrnol) was deprotected as described in 
procedure 2.4.21 and lyophilized to give 37 mg (56%) of a white powder which was 
recrystallized from H20/acetone to give 15 mg (22%) of colourless crystals. HPLC 
analysis perfonned as descnbed in 2.4.15a (iinear gradient to 80:20 30mM sodium 
acetate:MeOH over 5 min then to 60:40 over 100 min) indicated a rhreo:e~hro  ratio of 
99: 1 with 99% ee (threo-L-2.W. 73.1 min. threo-D-2.60: 77.8 min, erythro-L-2-60: 7 1 -6 
min, erythro-D-2.60: 76.3 min). 
mp 220-225°C (dec); TLC (1 : 1 : 1 : 1. EtOAc:nBuOH:MeOH:H20) Rf = 0.56; 'H NMR 
@20. 250 MHz) 6 3.5 1 (s, 1 H, CECH), 1.65- 1.53 (rn, 2H, J = 7.7Hz. CH3C&), 1 .O9 (s, 
3H, B-CH3), 0.79 (t, 3H. I = 7.7&, CH3CH2); I3c NMR (D@, 63 MHz)  8 175.1 (CO2H), 
72.6 (p-Q, 64.5 (a-CH). 34.7 (@-CH&Hz), 24.1 @-CH3), 10.0 (p-cH3CH2); ESI-MS (M 
+FI+) 147.93. 
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3.1 Introduction 
3.1.1 lsa lation and Biological Activity 
P,y-Unsaturated arnino acids, or vinylglycines, are a class of a-amino acids which 
have garnered much interest due to both their varied biological activity and as synthetic 
intermediates.' Various substituted vinylglycines have k e n  isolated from naturai sources 
and found to possess antimicrobial activity. The first isolates were of 2-methylene- 
cyclohept-(4,5 or 6)-ene- 1.3-diglycine 3.1 and p-methylene-L-norvaline 3.2 which were 
found in the mushmom Lactariris helvus in 19&I2 and 1967)~~ respectively. In 1968 two 
more a,e-unsaturated a-amino acids were isolated €rom the mushroom Bankera 
fuligineoalba, L-2-amino-3-hydroxymethyl-3-pentenoic acid 3.3 and L-2-arnino-3- 
fomyl-3-pentenoic acid 3.4. Graduaily as more and more a$-unsaturated a-amino acids 
were isolated their biological activities were detennined. For example, L-2-arnino-4- 
methoxy-tram-3-butenoic acid 3.5 was extracted from Pseudomonas aemginosa5 and is 
active as an antibiotic against both gram positive and negative bactena by inhibiting 
methionine biosynthesis? Rhizobitoxine, an antirnetabolite isolated from root nodules 
induced by Rhizodium japonicum in the soybean Glyine max, was identified as 2-amino- 
4-(2-amino-3-hydroxypropoxy)-r+ons-but-3noic acid 3.6.' Rhizobitoxine's activity 
occurs through a number of pathways, including the inhibition of the conversion of 
methionine into ethylene in plants and by irreversibly inactivating B-cystathionase, a 
pyridoxal phosphate dependent enzyme catdyzing a step in methionine biosynthesist it 
can also catdyze B- and y-replacement, p- and y-elimination and a- and p-hydrogen 
exchange in a number of arnino a ~ i d s . ~  The simplest a,B-unsahuateci a-amino acid, 2- 
amino-3-butenoic acid, also known as vinylglycine 3.7, was not isolated until 1974 when 
the Denantiorner was found in the mushn>om Rhodophylllus nidor~sus.'~ 
Most of the interest in a$-unsaturated a-amino acids is due to their ability to act 
as suicide substrates or mechanistic probes of pyridoxal phosphate (PLP) dependent 
enzymes. These enzymes are involved in cataiyzing chernical changes at the a-. P- or y- 
carbons of comrnon amino acids and are a vital link in many biosynthetic pathways. The 
concept of suicide substrates in general has been extensively reviewed" as has the 
specific use of vinylglycines with respect to PLP dependent enzymes." 
Suicide substrates, or enzyme activated inhibitors, are chernically unreactive 
substances which possess latent reactive groups that are specifically unmasked through 
the action of the target enzyme. Once generated, the reactive intermediate irreversibly 
inactivates the enzyme by covalently reacting with an active site residue. Since the 
suicide substrate must be pre-activated by the enzyme, these substrates can be designed to 
target specific classes of enzymes. The mechanism for inactivation of PLP enzymes is 
generally proposed to proceed as outiiwd in scheme 3.111G"f although a more recent 








The aldimine 3.9 initially generated is the amino acid-PLP intemediate that the 
enzyme normaily foms with amino acid substrates. However, with suicide substrates, 
once the reactive 1.4-addition site is unmasked by decarboxylation or proton abstraction, 
an irreversible addition by an active site nucleophile to give 3.11, 3.13 or 3.15 occurs. 
Some of the more recent vinylglycine related inhibitors include a-allenic-a-amino acids 
(suicide substrates of Vitamin Bs linked decarboxylase)'* and a D-vinylglycine containing 
peptide (a mechanism based inactivator of peptidylglycan a-hydroxylating 
In some pyridoxal phosphate dependent enzymes, vinylglycine anaiogs are 
important intermediates in the enzyme mechanism and lead to products instead of 
inhibition.' lb-1 lf.12.16 Vinylglycine has been used as a probe of 1 -arninocyclopropane- 1 - 
carboxylate synthase (ACC)17 and to determine the mechanism of desulfurization of L- 
cysteine by the nifS gene product in Azobacter vinlandii." 
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Vinylglycines are also useful as synthons towards more complex molecules. For 
example, vinylglycine 3.7 itself has been used in the synthesis of antitumor agents (such 
as acivicin, a-amino-3-bromo-4,s-dihydroisoxazole-5-a acid),Ig rnitomycin 
antitumor antibioticsDD, cis substituted p-lactams,l1 and a number of other amino acid 
denvatives? The vinyl amino alcohols that are obtained as intermediates in some 
spthetic routes to vinylglycines have been used in the synthesis of kainoids) galantinic 
acid,- cycloprop y 1 amino a c i d ~ , ~ ~  p l  yh ydroxy amino acidsn and 3-alkylated glu t arnic 
acids? 
3.1.2 Synthesis of Racemic Vinylglycines 
The B,yunsaturated-a-amino acids pose a synthetic challenge primarily due to the 
tendency of these compounds to isornerize to the conjugated a$-unsaturated derivatives. 
Racemic vinylglycine was first synthesized in 1974.= These authors reported that 
vinylglycine was unstable to heat. acid and base. Compleie decomposition was found 
after 50 hours at 10°C in IN HCI or after 22 hours at 100°C in 2N N-OH with 
unidentified decomposition products. When heated in water, vinylglycine was reported 
to decompose to 2-aminobutync acid. It was synthesized in 1.1% yield by a Strecker 
synthesis (Scheme 3.3, left side) from acrolein 3.16 or in 6.6% yield by bromine 
displacement from ethyl-2-bromo-3-butenoate 3.17 (Scheme 3 -3, nght path). D- 
Vinylglycine was then obtained in approximately 82% ee by resolution with baker's 
y e a d g  
Scheme 3.3 
2) cation exchange kn2 3) cation 
exchange 
Br 
3.1 6 3.7 3.17 
Racemic vinylglycine was also reportedly synthesized in 50% yield from 2- 
hydroxy-3-butenoic acid,"' however, no synthetic details were provided. In 1977, 
Baldwin et aL used the same 2-hydroxy-3-butenoic acid 3.18 to synthesize racemic 
vinylglycine in 26% overall yield (Scheme 3.4)? 
Scheme 3.4 
A better yield (48% for 3 steps) was achieved in 198 1 by f3-elimination of a silyl 
protected glycine enolate adduct 3.20 in a Petenon-type olefination (Scheme 3 S)." 
Scheme 3.5 
In 1984, a modified Strecker synthesis using TMSCN was used to prepare a 
variety of racemic P,y-unsaturated amino acids in 15-688 overall yield although 
vinylglycine itself was obtained in a low 7% yield (Scheme 3.6). It was noted that cation 
exchange column elution of vinylglycine with 1M bH&H gave a later eluting product 
identified as 2.4-diaminobutyric acid? 
Scheme 3.6 
A four step process that makes use of a [3,3] sigmatropic rearrangement of 3.21 
gives vinylglycine 3.7 in 26% overall yield (Scheme 3.7) and has potential for industrial 
application since inexpensive chernicals are used? 
Scheme 3.7 
A number of racernic f3,yunsaturated amino acids have been prepared by 
oxidative rearrangement of allylic selenides 3.22 with yields of 12-878 reported in the 
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last step (Scheme 3.8). Pmtected vinylglycine was synthesizeâ in 18% overall yield from 
methyl c r o t ~ n a t e . ~ ~ ~  
Scheme 3.8 
A three step synthesis of vinylglycine via a Neber rearrangement of a N- 
chloroirnidate 3.23 intermediate was reported in 50% overall yield.j6 The use of cheap 
and convenient reagents makes this racemic synthesis of vinylglycine attractive, 
particularly since an enzymatic resolution method is also described. 
Scheme 3.9 
3.1.3 Synthesis of Optically Active Vinylglycine 
Optically active vinylglycine was first synthesized in 1980 in 54% yield3' via a 
thennal degradation of L-methionine 3.24 and an improved methodology amenable for 
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The main byproduct of elimination was the a#-unsaturated isomer 3.27. The 
protected vinylglcine 3.26 was found to be particuiarly base sensitive as prolonged 
stimng with triethylarnine or N-methylmorpholine in organic solvent or in aqueous 0.5 N 
LiOH gave quantitative conversion to 3.27. However, vinylglycine is stable to the acid 
hydrolysis conditions required for protecting group removal(6N HCl, I hour at 100°C).' 
An equally effective method was described in 1984 by Hanessian and Sahoo in 
which L-vinylglycine was prepared fiom glutamic acid 3-28 by a decarboxylative 
elimination of N-Cbz-L-glutamic acid monomethyl ester 3.29 (Scheme 3.1 l)?' Acid 
hydrolysis gave L-vinylglycine in 49% yield from the protected glutamic acid 3.29, 
which in tum was obtained in 88% yield from Cbz-Glu. An improved version of the 
Hanessian decarboxylation/elimination procedure was reported in 1991 after the authors 
found that the synthesis often led to substantial racemization (40-90% ee) when either the 
N-Boc benzhydryl ester, N-Cbz benzyl ester or N-Cbz methyl ester was prepared." 
Enantiomerically pure N-Cbz benzyl ester could be obtained by crystallization (in 28% 
yield from N-Cbz-L-glutarnic acid). 
Two other routes to enantiomencally enriched vinylglycine were reported in 1985 
(Scheme 3.12), both proceeding through photochernical rearrangements and selenium 
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Sc hollkopf used a more general approach, reacting the valine derived bis-lac tam 
enolate 1.33 (Section 1.3.3.1) with silyl aldehydes. Elimination and hydrolysis of the 
resulting $-hydroxy adducts 3-30 generated a number of substituted vinylglycines 
(Scheme 3-13)? L-Vinylglycine itself was prepared in 32% overall yield with some 
racemization (86% ee). 
The D-mannitol derived ddehyde 3.31 of Mulzer et aP2 c m  be elaborated for 
vinylgiycine synthesis. Addition of vinyl Grignard reagent followed by a Mitsunobu 
reaction with phthdimide on the secondary chiral al1 ylic alcohol and subsequent 
oxidative cleavage of the protected di01 gives D-vinylglycine in approximately 10% yield 
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More recentiy, the same Dmannitol denved aldehyde 331 has been used to 
synthesize L-vinylglycine via imine 3.32 which was reacted with vinylmagnesium 
bromide to give amine 3.33 as one diastercorner (Scherne 3.25): Subsequent hinctional 
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As discussed earlier (Section 1.3 A.2, Scheme 1 .Z), Gamer's aldehyde 153 
racemizes completely when treated with Ph3P%eBr'/~H.U However, the aldehyde may 
be used to generate p,y-unsaturated amino acids by Wittig reactions. Garner's aldehyde 
1.53 was also successhrlly methylenylated with AIMemCH212 in 75% yield with 
>95% ee (Scheme 3.16)." The amino alcohol 3.34 was not oxidized to the amino acid 
since it was shown to proceed in low yield. 
Scheme 3.16 
CHO 7 
L-vinylglycine has been synthesized fiom L-homoserine 3.35 in 49% overall 
yield (Scheme 3.17)& and L-homoserine lactone 3.36 (Scheme 3.18)" in 72% overall 
yield with both routes involving dehydroselenoclirninations. L-Homoserine and its 
lactone are readily available in both enantiomeric forms. 
Scheme 3.17 
Scheme 3.18 
L-vinylglycine has also been synthesized using methodology previously 
developed in our laboratory. Cbz-Ser(a1d)-OB0 ester 3.37 was reacted with 
methylenetriphenyl-phosphorane to give the vinylglycine intermediate 3.m which was 
then deprotected to give vinylglycine in 5 1% yield over 3 steps albeit in 77% ee? 
Scheme 3.19 
3.1.4 Synthesis of Labelled f l  ~Unsaturated Amino Acids 
A major disadvantage of many of the methods developed for the synthesis of 
vinylglycines, especially those that rely on degradation of an amino acid, is that isotopic 
label incorporation is mcult. 
Two synthesis leading to racemic products have been described. Chang and 
Walsh1= prepared (z)-[~-~H], ( E ) - [ ~ - ~ H ]  and (~)-[3,4-~~~]vin~l~l~cine for m chanistic 
studies by catalytic hydrogenation of aikyne intermediates. S a ~ a d a ~ ~  nd CO-workers 
prepared (~) - [3 ,4 -~~z] ,  (2)-13 ,4-2~t], (E)-[~-~H] and [3 ,4,4-2~3]-vinylg~ycine via a 
stereoselective reduction of phenyl-2-(TMS)-ethynyl sulfone. 
3.2 Results and Discussion: Synthesis of Vinylglycine from Serine 
Given that the synthesis of vinylglycine 3.7 via Wittig olefination of Fmoc- 
Ser(a1d)OBO resulted in partial racernization (77% ee) and very poor yields due to Fmoc 
cleavage,' we hypothesized that the basic ylide was responsible for both the racernization 
observed and removal of the Fmoc group. Other methylenation methods were therefore 
investigated using the more robust Cbz-Ser(aid)OBO ester 3.37 in order to demonstrate 
the utility of the O B 0  ester protecting group in the synthesis of enantiomerically pure 
vinylgl ycine. 
3.2.2 Takni Reaction of Cbz-L-Ser(ald)-OB0 ester 
Nozaki et ai? in 1978 described a highly electrophilic, rnild and non-basic system 
for methylenation by the in situ generation of a metallo-carbon reagent from 
AlMeJWCH212. This reagent was previously used in the synthesis of the p-amino 
alcohol of vinylgiycine 3.34 (Scheme 3.16). 
Using the same conditions as described in Section 2.2.1, Cbz-Ser 339 was 
converted to the oxetane ester 3.4û in 78% yield and was recrystallized from 
Et0Ac:Hexanes with relative ease. BF3- Et20 cataiyzed remangement of the OB0 ester 
proceeded more rapidly than for the Boc-protected serine 2.42 to give Cbz-Ser-OB0 
ester 3.41 which could be recrystallized from Et0Ac:Hexanes in 85% yield. 
Scheme 3.19 
Cbz-Ser-OB0 ester 3.41 was oxidized to the aldehyde under Swem conditions as 
previously described (Section 2.2.1) to Ove Cbz-Ser(a1d)-OB0 3.37 in 298% ee. In situ 
generation of the Takai reagent €rom AIMefln/CH212 followed by addition of Cbz- 
Ser(a1d)-OB0 gave the desired olefin 338 in 7696 yield over two steps (Swem and 
olefination). Critical to the success of the reaction was use of freshly purified zinc5' and 
rigorous anhydrous conditions to prevent Lewis acid cataiyzed opening of the OB0 ester. 
Subsequent acid hydrolysis and ion exchange purification gave L-vinylglycine in 39% 
yield over five steps and 86% ee determined by derivatization and HPLC anaiysis as 
described in section 2.4.15a. The cause of racemization is unclear since the optical purity 
of the aldehyde 3.37 was known to be >97% ee and vinylgîycine has been shown to be 
stable to the acid hydrolysis conditions ~quired to remove the protecting groups." 
Scheme 3.20 
3.2.2 Peterson Olefination of Cbz-L-Ser(ald)-OB0 ester 
The racemization diff~culties occurring with the Takai reaction led us to consider 
other olefination techniques. At that time, a report appeared in the literature detailing the 
use of the Peterson reaction to synthesize (S)-2-amino-(2)-3,s-hexadienoic acid, an 
isolate from the beetle Leptinotarsa decemheata (Scheme 3.2 1 ).52 
Scheme 3.21 
The Peterson olefination has been widely utilized for olefin synthesis as a 
silicon analog of the Wittig or Homer-Emrnons reactions. One of the features of this 
reaction is that both E and Z olefins c m  be obtained stereospecifically from a single 
diastereomer of B-bydroxyalkylsilane by altenng the reaction conditions (acid or 
base).53vH 
The p-hydroxyalkylsilane 3.45 was generated by reaction of Cbz-Ser(a1d)-OB0 
ester 3.37 with trimethylsilylmethylenemagnesium chloride and proceeded in quantative 
yield with threo stereochernistry as previously observed (Section 2.2.5). in an effort to 
maintain the integrity of the OB0 ester and thereby allow fuxther functionalization, base 
mediated elirnination was attempted. However, those reaction conditions consistently 
failed to gïve the desired olefin regardless of base used, temperature or length of reaction, 
instead forrning the oxazolidinone 3.46 as a asult of attack of the oxyanion on the 
carbarnate of the Cbz group. Various bases investigated include KH.52 NaH," K O ~ B U , ~  
LDA, LHMDS, nBuLi and KHDMS. Methods pioneered by Chans6 to convert the 
alcohol into a better leaving group were also explored including BF3 EbO,Y 
MSCVE~~N,~" AcC~,'~ AcD/pyridine, nB~Li/Mscl,~ ACCVF;~ Acfikat. T.MSClS9 and 
AczO/cat. TMSOTf," al1 of which either resulted in no reaction or total decomposition of 
the starting material, generally as a resuit of hydrolysis of the OB0 ester. 
Scheme 3.22 
TMSCH2MgCI , 
THF, A -1 0°C 
A tram relationship for H2IH3 in the oxazolidinone was assigned on the basis of 
the 'H NMR coupling constant. The lu value of 3.8 Hz was in agreement with those 
reported for trans stereochemistry?' In retrospect, formation of the oxazolidinone 3.46 
may be explained by the requirement of the j%hydroxyalkylsilane 3.45 to adopt the syn 
conformation which is not easily achieved due to steric considerations. Oxazolidinone 
formation is a more fasile process as seen in the staggered Newman projection of the p- 
hydroxyaikylsilane 3.45 (Figure 3. l). This is in contrast to the synthesis of (S)-2-amino- 
(2)-3,s-hexadienoic acid 3.43 which does not suffer from this limitation and is driven by 
the formation of extended conjugation. 
Figure 3.1: Formation of the Oxazolidinone 3.46. 
Since base mediated elimination failed to give Cbz-vinylglycine-OBO, our 
attention tumed to the use of acid in order to form vinylglycine 3.7. This has the 
advantage that acid hydrolysis in refluxing 6N HCI simultaneously deprotects the ortho 
ester and Cbz protecting groups as discussed below. 
3.2.3 Removal of Protecting Groups 
Refuxing 6N HCI has previously been used to deprotect Cbz protected methyl" or 
isopropyl esters" of vinylglycine in good yield. When the same conditions were applied 
to both Cbz-vinylglycine-OB0 ester 3.38 and Cbz-Ser(CH2TMS)-OB0 ester 3.45 the 
free amino acid 3.7 was achieved in 76% and 74% yield respectively. 
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Since Cbz cleavage is quantitive, purification on an anion exchange column 
instead of cation exchange column ailows for the easy separation of any non-hydrolyzed 
ester. The anion exchange column also has the advantage that the base-sensitive 
vinylglycine is only briefly exposed to base dunng the period the sample is loaded ont0 
the colurnn and is not prone to racernization as previously reported in section 2.2.3.3. 
Optical purity was assessed by derivatization of the fiee amino acid with OPA 
2m63 and N-i-Bu-L-Cys 2.64 as described previously (section 2.2.4) and indicated the 
vinylglycine synthesize via Takai olefination 
olefination >95% ee (Figure 3.2). 
possessed 86% ee and via Peterson 
Figure 3m2: Assessrnent of ennntiomeric purity atGer ion exchange putif.~cation of L- 
vinylglycine obtained after deprotection of Cbz-L-Ser(CH;rTMS)OBO ester 3.45 
(left) and Cbz-L=Gly(CH=CH2)0BO ester 3.3û. Amino acid samples prepareà as 
described in Section 2.4.15a. 
3 3  Summary 
The Cbz OB0 ester protected serine aldehyde 3.42 can be used to synthesize 
vinylglycine in high yields (5 1% over three steps). Unfortunately some racemization 
occurs in the case of Takai olefination, presumably dunng the methylenaiion reaction 
since the vinylglycine is known to be stable during acid hydrolysis as indicated during the 
deprotection of the B-hydroxy silane 3.45. However, the cause of racemization is 
currentl y unknown. S imultaneous deprotection of the $-h ydroxyalky Isilane 3.45 
generates vinylglycine in 5396 overall yield and high ee (>95%) and is comparable to 
other methods used to synthesize vinylglycine. 
3.4.1 (l-Methy1cydobutyl)methy1-(~2-[(beazylo~)carbonyI~amino1~hydmxy- 
pmpmoate, Cbz-L-Ser-oxetane ester, 3.40. 
Cbz-L-Ser 3.39 (1 1.36 g, 0.047 mol) and Cs2C03 (9.19 g, 0.028 mol) were combined and 
dissolved in Hfl  (100 mL). The water was then removed in vacuo and the resulting oil 
lyophilized for 12 hours to give a white foam. To this foam was added oxetane tosylate 
2.38 (12.65 g, 0.049 mol) and Na1 (1.41 g, 9.8 rnmol) which was then taken up in DMF 
(500 m . )  and allowed to stir under Ar for 48 hows. The DMF was then removed in 
vacuo and the resulting soiid dissolved in EtOAc (600 mL) and l&O (200 mL) and 
extracteci with 10% NaHC03 (2 x 100 mL), saturated NaCl (100 mL) and dried over 
MgSOa. The solvent was removed under reduced pressure to yield a yellow oil which 
: was recrystallized from ethyl acetate and hexanes to yield colourless rod-like crystals in 
78% yield (1 1.85 g). 
mp 70-70.5 OC; [al2O0 = -8.5 (c = 1.04, EtOAc); TU3 (2:1, EtOAc:Hex), Rr = 0.34; 'H 
NMR (CDCI,, 250 MHz) 6 7.34-7.28 (br m. SH, ArH), 5.89 (d, lH, J =  7.9Hz. NH), 5-12 
(s, 2H, CbzCfiO), 4.56-4.38 (m, 6H, 3 oxetane ester C m ) ,  4.134.04 (br m, 2H, a-CH, 
p - C m ,  3.93-3.84 (br m, 1 H, p-CHH), 3.22 (t, 1H, J = 6.OHz, OH), 1.28 (s, 3H, oxetane 
ester CC&); "C NMR ( m l 3 ,  63 MHz) 6 170.6 (Cd), 156.2 (CONH), 136.1 (A-=), 
128.5, 128.1, 128.0 (-El), 79.4 (oxetane ester CH2-O), 68.9 (oxetane ester CO&H2), 
67.1 (Ar_cH20), 63.2 @--a), 56.3 ( a m ,  39.5 (oxetane ester CCH3), 20.7 (oxetane 
ester C-3); IR (cast fiom CHZC12) 3371, 3û64, 3034, 2956, 2879, 1723, 1525, 1457, 
1339, 1214, 1195, 1061; Anal. cdcd. for CI&12106N: C, 59.43; H, 6.55; N, 4.33. Found: 
C, 59.44; H, 6.61; N, 4.31. 
3.42 1-[N-(Be~loxy~nyI)-(1S)-1-amin012lethan01]4methyI-2,6,7-trioxa- 
bicyclo[2.2.2]octane, Cbz-L-Ser-OBO ester, 3.41. 
Cbz-Ser oxetane ester 3.40 (15.0 g, 46.2 mrnol) was dissolved in dry CHtC12 (450 mL) 
and cooled to O°C under Ar. BF3- Et20 (O. 1 1 mL, 0.93 mrnol) was diluted in CH2C12 (5.0 
mL) and added to the reaction flask after which the reaction was allowed to wann up to 
room temperature. After 6 hours, Et3N (1.29 rnL, 9.25 m o l )  was added and the reaction 
stirred an additional 30 minutes before king concentrated to a thick oil. The crude 
product was redissolved in EtOAc (400 mL) and washed with 3% -1 (2 x 250 d), 
10% NaHC03 (100 mi,), saturated NaCl (250 mL), dned (MgS04), and evaporated to 
M e s s .  The reaction yielded a colourless thick oil in 95% (14.2 g) yield which was 
crystallized from Et0Ac:Hexanes to give rd-like shiny crystds in 93% (13.6 g) yield. 
mp 103.5-105.0 OC; [ a l 2 O D  = -24.8 (c = 1.00, EtOAc); TU3 (3: 1 EtOAc:Hex), Rr = 0.37; 
'H NMR (CDCls, 250 MHz)  6 7.36-7.31 (m, 5H, ArH). 5.34 (br d, lH, J = 8.8Hz, NH), 
5.17-5.1 1 (m, 2H, CbzCHfl), 3.94-3.83 (m. ZH, a-CH, p-CHH), 3.9 1 (s, 6H, OB0 ester 
C H D ) ,  3.7 1-3.67 (m, lH, B-CHH), 2.60 (br s, IH, OH), 0.8 1 (S. 3H, OB0 ester CC&); 
13c NMR (-13, 62.9 MHz) 6 156.3 GONH), 136.4 (Ar=-), 128.4, 128.0, 127.9 
( ,  108.0 (OB0 ester O ) ,  72.7 (OB0 ester ÇHzO), 66.9 ( -H20) ,  6 1.9 (8- 
CH2), 55.3 (a-CH), 30.5 (OB0 ester CCH3), 14.2 (OB0 ester CCH3); IR (cast from - 
CH2Cl2) 3407,3063,3033,2948,2883,1716,1607, 1586,1527,1399,1352, 1237, 1048, 
1010 cm-'; HRMS (FAB) caiculated for (M + H?) C16HuN06: 324.1447. Found: 
324.1435; b a i .  Calcd for C16H21N06: C, 59.43; H, 6.55; N, 4.33. Found: C, 59.43; H, 
6.64; N, 4.34. 
3.43 l-[N-(Benzy10xy~ny~)-(lS)Il-aminol21o~oetbyl]4-methyl-2,6,7-tri0~8- 
bicyclo[2.2.2]0ctane, Cbz-L-Ser(dd)lOBO ester, 337. 
Cbz-Ser OB0 ester 3.41 (9.04 g, 27.86 m o l )  was dissolved in freshly distilled CH2CI2 
(80 mL) under Ar and cooled to -7g0C in flask 1. Oxaiyl chloride (3.89 mL, 44.58 mrnol, 
1.60 equiv) was added to CHzCb (120 mL) in a separate round bottom flask (flask 2) 
under Ar, and cooled to -7g°C. Dry DMSO (7.03 mL, 91.94 mrnol, 3.30 equiv) was 
added quickly (to prevent freezing in the syringe) to the oxalyl chloride solution (flask 2 
- taking care to release the evolved gas) and the mixture was stirred at -7g0C for 15 
minutes. The alcohol solution was transferred slowly by cannula to flask 2 over a period 
of 30 minutes and then rinsed with CH2C12 (50 mL). The resulting cloudy, white mixture 
was stirred for 1.5 hours at -7S°C. DPEA (24.27 mL, 0.14 mol) was added and the 
solution stirred for 30 minutes at -78OC and 10 minutes at 0°C. Ice-cold CHXl2 (250 
rnL) was added and the solution was washed with ice-cold 3% N a C l  (3 x 250 d), 
brine (250 mL) and dried over MgS04 before being evaporated to dryness. The reaction 
yielded a slightiy yellowish solid in 96% (8.68 g) yield. Recrystallization was possible 
from EtOAdhexane but the aldehyde was generally used without further purification. 
mp 139.5- 141.5 OC; [alZ0~ = -99.3 (c = 1-03, EtOAc); TU3 (3: 1 EtOAc:Hex), Rr = 0.60; 
'H NMR (CDCI392SO MHz) 6 9-69 (s, 1 HT CHO), 7.38-7.30 (III, SH, AM), 5.34 (d, IH, J 
= 9.2Hz, NH), 5.15-5.10 (m, 2H, ArCH20), 4.61 (d, lHT J =  8.9Hz, a-CH), 3.94 (s, 6H, 
OB0 ester CH@), 0.83 (S. 3H, OB0 ester CCH3); 13c NMR (CDCls, 63 MHz); 6 195.6, 
156.1 (CONH), 136.1 (A-=), 128.4, 128.1, 127.9 (m, 107.1 (OB0 ester - 
O), 72.8 (OB0 ater a20), 67.1 (Ch-m), 63.2 (aCH), 30.8 (OB0 ester CCH3), 14.2 
(OB0 ester Cm3); IR (cast fiom Cl&C12) 3353, 3063, 3033, 2947, 2884, 1723, 1599, 
1521, 1355, 1234, 1192, 1071, 1046 cm-'; HRMS (FAB) calculated for (M + H+) 
C1t&N06: 322.12906; observed : 322.12854. And. Calcd for C1&flo6: C, 59.8 1 ; H, 
5.96; N, 4.36. Found: C, 59.72; H, 6.12; N, 4.33. 
3*4*4 Takai olefination of Cbz-LSer(dd)-080 ester 3.37: 1-[N-(Benyl- 
o x y ~ 8 r b n y l ) - ( l S ) - l - a m u i 0 1 2 - p r o p e o e ] 4 - ~  
Cbz-L-Giy(-CH=CH2)-OB0 ester, 338. 
Cnide Cbz-Ser(a1d)-OB0 ester 3.37 (0.50 g, 1.56 mm01 assuming 100% yield of the 
aldehyde from the oxidation) was dissolved in dry THF (10 rnL) then added via cannula 
to a stimng mixture of purified zinc dusr" (0.918 g, 14.04 mrnol), freshly distilled 
duodomethane (0.376 g, 4.67 mmol) and trimethylalurninum (0.47 mL, 0.94 mmol, 2.OM 
in hexanes) in dry THF (10 mi,) under Ar. The mixture was stirred at room temperature 
for 4 h before cold saturated potassium tartrate (10 mL) was added. The resulting 
queous layer was extracted with EtOAc (3 x 40 mL), the organic layers were pooled and 
extracted with 3% -1 (2 x 25 mL), IO % NaHC03 (25 mL), saturated NaCl (25 mL) 
and dned over MgSQ. The solvent was removed under reduced pressure and the 
resulting slightly yellow oil purified by flash chromatography (Et0Ac:Hex 1: 1) to give a 
clear oil which was crystallized from Et2Ohexanes to give 0.35 g of 3.38 (76% yield). 
mp 73-74°C; [ a l 2 O ~  = -66.5 (c = 0.9, EtOAc); TLC (1 : 1 EtOAcHex). Rr = 0.48; ' H NMR 
(CD% 250 MHz) 6 7.34-7.25 (m. 5& ArH), 5.92 (ddd, lH, J = 5.5, 10.5, 1 7.2Hz, P- 
CH), 5.3 1-5.06 (m, 3H, NH, y-C&), 5.12 (S. 2H. CbzCW), 4.43 (br t, 1 H, J = 6.9Hz, 
a-CH), 3.89 (s, 6H, OB0 ester CHzO), 0.78 (s, 3H, OB0 ester CCH3); 13c NMR (CDC13, 
63 MHz)  6 156.0 (CONH), 136.5 (m), 133.2 (CH=CH2), 128.4, 128.0, 128.0 
(Ar=cH), 1 16.7 (CH=w2), 10S.O (OB0 ester C-O), 72.8 (OB0 ester CH20), 67.8 
(Cbz-20), 57.1 (a-GH), 30.7 (OB0 ester mH3), 14.3 (OB0 ester CcH3); IR (cast 
from CH2C12) 3371,3064, 3033, 2944,2881, 1722, 1646, 1515, 1397, 1336, 1223, 1053 
cm-'; ESI-MS (M + HC) 318.91; Anal. Calcd for Ci7H2iNOs: C, 63.94; H, 6.64; N. 4.39. 
Found: C, 64.09; H, 6.73; N, 4.36. 
JAS Grigiarà ddition of t r i m e t h y l s i l y ï m e t h y ~  chionde to Cbz-G 
Ser(ald)-OBO ester 337: 1-[N-~~10xycsrieony1)-(~1-smin012-bydn,~-3-(1,1,1- 
trimetbylsilyl)-propy1]4meth-yI-2,6,7-~o~bicyd~2~ ]octane, Cbz-LlSer- 
(CH2TMS)-OB0 ester, 3.45. 
Cnide Cbz-Ser(a1d)-OB0 ester 3.37 (0.40 g, 1.25 mm01 assuming 100% yield of the 
ddehyde from the oxidation) was dissolved in dry THF (40 mL) to which 
trimethylsilylmethylmagnesium chloride (5.0 mL, 5.0 mrnol, 1 .O M in EtzO) was added 
by syringe. The mixture was refiuxed under Ar for 6 h before 3% m C 1  (20 mL) was 
added and the mixture then extracted with EtOAc (3 x 50 mL). The organic fractions 
were pooled and then extracted with with 3% m C 1  (2 x 25 mL), 10 % NaHC03 (25 
mL), saturated NaCl (25 mL) and dried over MgS04. The solvent was removed in vacuo 
and the resulting oil purified by flash chromatography to give 0.368 g (72% yield) of a 
clear oil. 
TU3 (Et0AC:Hex) Rr = 0.58; 'H NMR (CDCb, 250 MHz) 6 7.40-7.26 (m, SH, ArH), 
5.32 (d, lH, J = 10.3Hz, NH), 5.12 (s, 2H, CbzCm),  4.31 (dd, lH, J = 4.8, 9.7Hz, B- 
CH), 3.89 (s, 6H, OBO ester CH20), 3.68 (d, 1 H, J = 10.3Hz, a-CU), 0.85 (dd, 1 H, J = 
9.6. 14.7Hz, y-CHH), 0.78 (s, 3H, OB0 ester CC&). 0.60 (dd, 1 H, J = 4.7, 14.7Hz, y- 
CHH), 0.02 (s, 9H, Si(CH3),); "C NMR (CM3I3, 63 MHz) 6 157.2 (CONH), 136.7 
(-=), 128.6, 128.5, 128.2 (=-Fi), 108.9 (OB0 ester C-O), 72.8 (OB0 ester m), 
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67.1 (Cbz-O), 60.5 (p--w, 59.1 (a--H), 30.7 (OB0 ester cm3), 21.5 ( s H 2 ) ,  14.3 
(OB0 ester CD3), -0.8 (Sim3)3); IR (cast from CH2Clâ) 3389, 3044, 3033, 2944, 
288 1, 1719, 1510, 1387, 1336, 1223, 1053,995 cm-'; And. Cdcd for Cz&13iNOsSi: C, 
58.65; H, 7.63; N, 3.42- Found: C, 58.56; H, 7.85; N, 3.2 1. 
3.4.6 Attemptd base-mediated Peterson olefination of Cbz-L-Ser(CH2TMS)-OB0 
ester, 3.45. (5~4(~methy1-~6,7-tFi0~~bicydo[22.2]~t-l-yl)-5-[(l,l,l-~e~yl- 
silyl)-methyl]-l~~~8zol81~-2~ne, 3.46. 
Cbz-L-Ser(CH2TMS)-OB0 ester 3.45 (0.210 g, 0.52 rnmol) was dissolved in dry THF (20 
mL) and rapidly transferred to a flask containing KH (0.063 g, 0.55 m o l ,  washed with 
Et20) suspendeci in THF (10 mL) at -lO°C under Ar. One how later a TLC indicated total 
conversion to 3.46. The reaction mixture was poured into Et20 (40 mL) and extracted with 
3% NH&3(10 mL), 10% NaHCa (10 mL), brine (10 rnL) and dried over MgS04. The 
solvent was then removed under reduced pressure and the result slight yellow oil purified 
by flash chromatography (1:2, Et0Ac:Hex) to give 0.139 g (89% yield) of a clear oil. 
TU3 (1 :2 EtOAc:Hex), Rc = 0.41 ; 'H NMR (CDC13, 250 MHz) 6 5.38 (s, 1 H, NH), 4.66 
(ddd, lH, J = 3.4, 6.8, 7.8- &CH), 3.85 (s, 6H, OB0 ester CHD) ,  3.30 (d, IH, J = 
3.4Hz, a-CH), 1.06 (dd, lH, J = 7.8, 14.5Hz, y-CHH), 0.95 (dd, lH, J = 6.8, 14.5Hz, y- 
C m ,  0.76 (s, 3H, OB0 ester CCHg), 0.02 (S. 9H, Si(CH&; I3c NMR (CDC13, 63 MHz) 
6 158.9 (CONH), 107.4 (OB0 ester C-O), 76.3 ( B a ,  72.7 (OB0 ester a20), 62.8 
(CbzW20). 30.8 (OB0 ester G a g ) ,  24.7 (mz), 14.1 (OB0 ester C a 3 ) ,  -1 -1 
(Si(CH3)3); Anal. Calcd for C&&NSiOs: C, 51.80; H, 7.69; N, 4.65. Found: C, 52.09; H, 
7.96; N, 4.34. 
3.4*7 Acid Hydrolysis of Cbz-L-Gly(-CH=CHt)aBO ester 3.38 with 6N HCI. (2S)- 
2-amiao-3-butenoic acid, 3-7. 
Cbz-L-Gly(-CH=CH+OBO ester 3-38 (0.230 g, 0.720 rnmol) was rnixed with 6N HCI 
(2.0 mL) and refluxed for 1 h. The solution was reduced in vacuo then cooled, 
neutralized with a sahirated solution of NaHC03 (approx. M mL) and loaded on an anion 
exchange column (Bio-Rad AG 1-X4 100-200 mesh, chloride forrn, converted to 
hydroxide fonn by prewashing with 4N NaOH). The column was rinsed with H20 (5 
column lengths) and eluted with IN AcOH, then lyopholized to give 0.0109 g (79%) of a 
colourless powder. Recrystallization (H20/acetone) gave 0.010 g (72%) of a white solid. 
Derivatisation and analysis by HPLC indicated 86% ee (conditions as described in 
Section 2.4.1 Sa) (L-viny lgl ycine 26.5 min; D-viny lglycine 28.4 min). 
mp 1 78- 1 80°C (dec); TLC (1 : 1 : 1 : 1, EtOAc:nBuOH:AcOH:H20) Rf 0.46; 'H NMR 
(Da, 250 MHz) 6 5.85 (ddd, lH, J =  7.4, 10.1, 17.4Hz, B-CH), 5-38 (d, lH, J =  17.2Hz, 
y-CHH), 5.38 (d, 1H, J = 10.4Hz, y-CHH), 4.27 (d, lH, J = 7.3Hz. a-CH); 'k NMR 
(D2O, 50.3 MHz): 6 174.7 GO2H), 132.0 (B-CH), 124.8 (y-CH2), 59.1 (a-CH); ESI-MS 
(M + He) 102.22. 
3.43 Acid Hydrolysis of Cbz-ESer(CHtTMS)IOBO Ester 3.45 witb 6N HCI. (249-2- 
amino-3-butenoie acid, 3.7. 
Cbz-L-Ser(CHzTMS)-OB0 ester 3.45 (0.140 g, 0.34 rnmol) was mked with 6N HCI 
(10.0 mL) and refluxed for 3 h. The solution was cmled extracted twice with ether (2 x 5 
mL), neutralized with a saturated solution of NaHC03 (approx. 50 mL), then loaded on 
an anion exchange column (Bio-Rad AG 1-X4 100-200 mesh, chloride form, converted 
to hydroxide form by prewashing with 4N NaOH). The column was rinsed with HzO (5 
cloumn lengths) and eluted with LN AcOH, then lyopholized to give 0.028 g (8 1%) of a 
colourless powder. Recrystallization (wlacetone) gave 0.025 g (74%) of a white solid. 
Derivatisation with O-phthaladehyde and N-isobutyryl-L-cysteine, and analysis by HPLC 
indicated 95% ee (conditions as described in 2.4.1 Sa and retention times as in 3.4.7). 
mp 177-1 80°C (dec); TLC (1 : 1 : 1 : 1, EtOAc:nBuOH:AcOH:H20) Rr 0.46. 'H NMR (DzO, 
250 MHz) 6 5.85 (ddd, lH, J = 7.4, 10.1, 17AHz, B-CH), 5.38 (d, IH, J = 17.2Hz, y- 
CHH), 5.38 (d, lH, J =  10.4&, y - C m ,  4.27 (d, IH, J =  7.3Hz. a-CH); "C NMR (D20, 
50.3 MHz): 6 174.7 (ÇOtH), 132.0 ($-CH), 124.8 (y-CH2), 59.1 (a-C-); ESI-MS (M + 
H+) 102.29. 
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Chapter Four 
4.1.1 Isolation 
y-Substituted glutamic acids have receiveci significant attention recently due to 
both their diverse biological activity and synthetic significance. Various glutamic acid 
denvatives have been isolated from natural sources, beginning with the isolation of y- 
methylglutamic acid 4.1 (Scheme 4.1) from the fem Phyllitis scolopendrium in 1955 and 
subsequenily from numerous other plants including the mushmom Mycena pura.' y- 
Ethylglutamic acid 4 3  has been found in varying concentrations in Wagatea spicuta and 
the seeds of the Caesulpinia species.' 
y-Hydroxyglutamic acid 4.4 was fmt isolated from the plant Phlox decussatd and 
later as a metabolite in the Hemerocallis species.lb Both (2S.4R) and (2S,4S)-y- 
hydroxygiutamic acid have been found to be constituenu of natural product skeletons, 
including the potent epileptogenic dysiherbaine 4.5 isolated from the marine sponge 
Dysidea herbacea4 and the sweetener, monatin 4.6 isolated from Schlerochiton 
ilicifoliud The Lthreo diastereomer of B-hydroxyglutarnic acid 4.7 was first iden ti fied 
in the natural product, antibiotic S-520, obtained from Streptomyces diustaticos in 197OO6 
This a-amino acid has been used in the synthesis of other naturai products, most 
noticeably trïcolomeric acid 4.8 and its analogs, which have insecticidal activity.' &y- 
dihydroxyglutamic acid 4.9 was isolated from the seeds of Lepidiwn sativium and leaves 
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of Rheum rhaponticum over forty years agoa and since that time has been shown to be a 
constituent of a large variety of flowenng plants, fems, mosses and mushrooms? 
Scheme 4.1 
4.7 R'=&H. R ~ ~ I - I  
4.9 R'=R- OH, R2= H 
4.10 R ' & o ~ ~ ,  R2=R3= H 
The best-known y-substituted-a-amino acid is ycarboxyglutamic acid 4.10 which 
is a component of several vitamin K dependent hemostasis proteins, including 
prothrombin. 'O The y-dicartmxylate moiety binds ca2+ ions to induce a conformational 
change in numerous hemostasis proteins providing a biofeedback route for the control of 
bleeding. First detected in 1974 this calcium binding amino acid has also been 
discovered in the conantokins, potent N-methylaspartate receptor agonist peptides 
isolated from the venom of the cone snail Conus geographus.." 
y-Aminoglutamic acid 4.11 and y-haloglutarnic acids 4.12 have not been 
identified in nature to date but the compounds are of interest therapeuticaily as will be 
discussed (vide infia). 
4.1.2 Biological Activity 
The main medicinal interest in glutamic acid derivatives is due to the fact that 
glutamic acid is the major excitatory neurotrarisrnitter in the central nervous system 
(CNS) and is thought to play a role in a number of pathological processes including 
epilepsy, pain. neurodegenerative diseases and schi~ophrenia.'~ Glutamic acid exens its 
actions at both the ionotropic and metabotropic excitatory amino acid (EAA) receptors. 
The metabotropic glutamate receptor (melu) and ionotropic glutamate receptor (iGIu) are 
disparate receptors that are further divided into subclasses of receptors. The mGlu 
receptors are a family of eight different G-protein coupled receptors: Group 1 receptors 
(mGlu 1 and 5) couple to phospholipase C, whereas both group II (mGlu 2 and 3) and 
group III (mGlu 4,6,7 and 8) are negatively coupled to adenylate cycla~e. '~ The iGlu 
receptors are associated with integral cation-specific channels and include the N-methyl- 
D-aspartate (NMDA), 2-amino-3-(3-hydroxy-5-methylisoxazol4yl)propmoic acid 
(AMPA) and kainic acid (KA) subtypes.14 
A variety of agonists and antagonists have k e n  described for both iGlu and mGlu 
receptors. most of which inherently include some type of glutamate motif. For exarnple, 
(2S,4R)-methylglutamic acid 4.2 is a potent and selective agonist of the iGlu KA 
receptor" while (2S94S)-methylglutamic acid 4.1 is an agonist of the group 1 mGlu 
receptod6 The medical interest in this class of receptors arose in the 1980's in an 
attempt to modify various biological processes andor diseases, and can be associated 
with the asymmetnc methods developed for the synthesis of various glutamate 
derivatives. 
Glutamic acid derivatives are aiso constituents of numerous natural products and 
synthetic targets. This includes both discmte incorporations of the glutamic acid motif 
within the natural product as in the case of dysiherbaine 4.5 or the potent antifolate dmg 
methotrexate 4.13 and the presence of glutamate denvatives within the composition of 
peptides, as in the lipopeptide antibiotic YM-170320 4.14 (Scheme 4.2).17 
Scheme 4.2 
4.1 4 
Derivatives of glutamic acid have been used as substrate analogs in the study of 
various enzyme mechanisms. In 1984, Weinstein et al. used both pmethyl and y- 
fluoroglutamic acid dunng a study of the stereochemistry of the vitamin K dependent 
carboxylation of small peptides." pAminoglutamate derivatives have been employed to 
probe the rnechanism of marnmalian dihydroorotase, a component of the trifunctional 
CAD (carbamoylphosphate synthetase II, aspartate transcarbamoylase and 
dihydroorotase) protein that is involved in the de novo pyrimidine nucleotide biosynthesis 
pathway." ~Difluoroglutamic acid has been designed as an alternative substrate and 
inhibitor of folate dependent enzymes.= yEthylglutamate derivatives have been utiiized 
to probe the mechanism of senne proteases in an attempt to design y-lactam analogues of 
Glutamic acid has also been used for the preparation of p-hm mimetics in order 
to introduce restrained backbones and side-chah conformations in peptide-based 
therapeutics." These conformational restrictions reduced the ability for protease 
degradation in vivo, increase bioavailabilty and generally incorporate atom efficiency. 
Glutamic acid enjoys a preferred role in the synthesis of these heterocycles because of the 
existence of an a-amino-6carboxy moiety in a five carbon arrangement which is ideally 
suited for the synthesis of pyrollidines 4.15, pyyrolizidinones 4.16 and indolizidines 4.17, 
al1 components of p-turn mimetics (Scheme 4.3). However, stereoselective methods for 
the generation of substituted glutamates for the subsequent incorporation into p-tum 
mimetics are lacking. 
Scheme 4 3  
4.1 5 4.1 6 4.1 7 
As a result of the varied biological activities discussed above, numerous 
methodologies have been developed to provide routes to these synthetic targets but none 
address ail the requirements discussed in Section 1.4. In particular, few stereoselective 
syntheses exist for the functionaiization (Scheme 4.1 where R=dkyl, allyl, acyl. 
hydroxyl. amino, halo, etc.) of the y-position of glutamate by a broad range of reagents. 
4.1.3 Synthesis of Racemic ~Substituted Glutamic Acidr 
Many of the general synthetic methods described in chapter one can be used to 
synthesize y-substituted glutamic acids. The synthetic challenge arises when attempting 
to induce stereoselectivity in the remote y-position in glutamic acid and although there 
are exceptions, these methods generally fail to give hi@ selectivity. 
4.1.3.1 Synthesis of ~Substituted Glutantic Acids: General Racemic Merhods 
Michael reactions have been used extensively to synthesize racemic y-substituted 
glutamates due to the well characterized nature of the reaction and availability of starting 
materials. The racernic synthesis of ~methylglutamic was first reported in 1952 by two 
independent groups. Done and Fowden reacted diethyl acetamidomalonate 4.18 
(R'=CO~E~) and methyl methacrylate 4.19 ( R ~ , R ~ = M ~ )  in a Michael reaction followed 
by hydrolysis and decarboxylation to give racernic ymethylglutamate in 45% overall 
y ield? In a similar reaction. Fillman and Al bertson used eth y1 acetarnidoc yanoacetic 
ester 4.18 (R'=cN) and methyl methacrylate 4.19 (R',R~=M~) followed by acid 
hydrolysis and recrystallization to give an unidentified stemisomer of y-methylglutamic 
acid in 1746 yield (Scheme 4.4)? This procedure was also used to synthesize other 
racernic yalkylsubstituted gl~tamates.~ 
A similar method was used to synthesize y-hydroxyglutarnic acid d 4  by reacting 
ethyl acetarnidocyanacetate with ethyl-a-acetoxy-f5chloropropionate. Acid hydrolysis 




R'=CN, C O ~ E ~  R~ = Me, Et, P r ,  
CH3NH, F 
FI3=Me, Et 
The 1,s-dipolar addition of ethyl cyanoformate Noxide 430, generated from 
glycine and methyl acrylate gave isoxazoline 4.21 which upon catalytic hydrogenation 
and acid hydmlysis gave erythro-(2S,4R)-)rhydroxygIutamate 4.4 in 20% overall yield 
and the threo (2R,4R) isomer in 40% yield as the lactone (Scheme 4.5)? 
Scheme 4 J 
O 
t 
MeOOC 1 Et3N.4ôh> 3 1) Hm. MeOH, HCI 
O 0. 
C02Et 2) 20% HCI, 5 h 
O OEt 
y-Aminoglutamate was synthesized by a Michael reaction between diethyl 
acetarnidomalonate 4.18 (R'=co~E~) and ethyl acetamidoacrylate 4.19 (R~=CH~CONH, 
R 3 = ~ t )  then t h e d l y  decarboxylated and hydrolyzed to give racernic y-aminoglutamate 
4.12? 
Racemic y-fluoroglutarnate has been synthesized by a variety of methods 
inciuding the Michael addition between diethyl acetamidoacrylate 4.18 (R'=CO~E~) and 
ethyl-2-fluoroacrylate 4.19 (R~=F, R3=~t)? 
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4.1.4 Synthesis of Optically Active ~Substihted Glutamic Ac* 
Synthetic methodologies designed spcificaily for the generation of glutamic acid 
derivatives center around four main concepts with varying degrees of success: glycine 
enolate equivalents. enzymatic methods, asymmetric hydrogenation and y-anion 
chemistry (including the use of pyroglutamate). Surprisingly few diastereoselective 
syntheses for psubstituted glutamic acids exist. 
4.1.4.1 Glycine Enolates 
The Ni@) glycine Schiff base enolate 1.39 of Belekon et dm (Scheme 1.3.3.1) 
was reacted in a Michael addition with methyl methacrylate to give 2: 1 mixture of 2S:4R 
4.2 and 2S:4S methylglutamic acid 4.1 in 75% yield. However, only the methyl adduct 
was teported. 
1 &Addition of Schollkopf s bis-lactim ether 1.33 (Scheme 1.3.3.1) with meth y1 
methacrylate 4.19 (lt2,It3=~e) resulted in a 1: 1 ratio of 2R:4R and 2R:4S methylglutamic 
acid to the exclusion of any of the 2s isomer.)' 
4.1.4.2 Enzymntic Methods 
Enzyrnatic methods have k e n  used to prepare asymmetric molecules due to the 
inherent nature of enzymes to differentiate between chiral centers. Both of the methods 
reported to synthesize yglutarnate denvatives have used appropriately substitutea 2- 
ketoglutaric acids as the substrate. rii 1984, Righini-Tapie and Azeraà incubated 
glutamate dehydrogenase (GDH, EC 1.4.1.2) in ammonium phosphate buffer with 
racernic methyl ketoglutarate 4.22 (R = Me) to give ymethylglutarnate A l  in 60 1 yield 
(Scheme 4.6, lefbhand side). Surprisingly, no differentiation between the two 
enantiomers of methyl ketoglutarate 4.22 (R = Me) was observecl since a 1: 1 mixture of 
2S:4R and 2R:4S rnethylglutarnic acid was isolated.fz 
In 1987, Bolte et al. reporteci the large-scale synthesis of y-hydroxy-L-glutank 
acid by the transamination of cysteine sulfinic acid and y-hydroxy-a-ketoglutarate 
cataiyzed by glutamic oxalacetic transaminase (E.C. 2-61. l)." In 1993, the sarne group 
descnbed the synthesis of methyl and ethyl y-substituted glutarnic acid and in 1999 the 
synthesis of n-propyl-y-giutamate (Scheme 4.6, cight-hand side). Al1 three alkyl 
substituents gave 4: 1 ratios of 2S:4R to 234s palkylglutamates while equal amounts of 
threo and erythro y-hydroxyglutarnate were i s ~ l a t e d . ~  
Kokuryo et al.35 used a combination of recrystalüzation and porcine kidney 
arninoacylase (EC. 3 S. 1.14) to prepare enantiomericall y pure L-erythro and L-threo-4- 
fluoroglutamic acid in poor yield from a racemic mixture of 4-fîuoroglutamate 4.12 
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4.1.4.3 Catalytic HydrogeMrion 
The fmt use of catalytic hydrogenation to synthesize y-substituted glutamic acids 
was reported in 1990 by Hon et al." TBDMS protected pyrollidinone 4.23 derived from 
L-pyroglutamic acid 4.29 was alkylated and then selenenylated/deselenylated to give 
both endo 4.25 and exo 4.26 a$-unsaturateci lactams. Catalytic hydrogenation gave the 
(2S,4S) diastereomer 4.27 as the sole product through steric approach control induced by 
the TBDMS protecting group. Deprotection evennially gave the desired y- 
benzylglutarnate 4.28 in 13% overall yield (Scheme 4.7). 
Scheme 4.7 
OTBS 2) PTSA, MeOH 
hoc 
4) Jones oxidaüori 
5) TF& CH& H 
In 1992, Young et al., while preparing isotopically labeled valines, used 2S- 
pyroglutamatic acid as the starting point of their synthesis since it "not only had the 
desired stereochemistry at C2, but the 1.3 relationship of C2 and C4 in the ring offered 
the possibility of inducing chirality at C4.''38 The t-butyl ester of pyroglutarnate 4.29 was 
converted to the enaminone 4.31 in 91% yield using Bredereck's reagent 4-30," and the 
intermediate then reduced by catalytic hydrogenation using 10% Pd-C to give the 
stereochemically pure cis4methyl derivative 4.32 (Scheme 4.8). 
This methodology was fùrther expanded to include other yralkyl groups (R=Et, 
nPr, Bn)" in an elegant 1 &addition of Grignard reagents to the vinyl amide 4.33 to give 




R = Et, nPr, Bn 
4.32 
R = Et, Wr, Bn 
A similar approach has been described to synthesize 4-substituted glutamic acids 
by using aldol reactions to introduce various substituents." The hydroxylated products 
4.35 were dehydrated to the Calkylidene pyroglutarnates 4.36 and then hydrogenated to 
give exclusively the 2S,4S stereoisomer 4.37 (Scheme 4.10). A variety of esters have 
been used as protecting groups in both this synthesis and by other groups indicating a 
bulky group is not necessary to achieve stereoselectivity in this step? 
Scheme 4.10 
C02Et CO*Et 
R=Me, Et, Ph b c  b c  
R'= H, Me. Et 
4.35 4.36 4.37 
Both the meso and 2R,4R forms of pminoglutamic acid have been synthesized 
using Garner's aldehyde 1.53 (Scheme 1.24) to  generate either an E 4.38 or Z 4.39 olefin 
which is subsequently hydrogenated to give almost exclusively one stereoisomer?' In the 
case of 4.38, a ratio of 9 5 5  for 4AO:4A1 (Scheme 4.1 1, lefi-hand side) and for 439, a 
ratio of 94:6 for 4.41:4.40 (Scheme 4.1 1, right-hand side). nreso-2,4-Diaminoglutamic 
acid 4.42 was generated in 45% overall yield fiom the aldehyde 1.53 although no overail 
yield was given for the 2R,4R derivative. 
Scheme 4.11 
1 1) CSA, MeOH. R 2) Jones ortidation 3) C M  4)10 N HCI, A 
4.1.4.4  anion Chernisîry (Including Pyroglutamic Acid) 
Various groups have tried to utilize the chiraiity of glutamic acid in an attempt to 
induce stereochemistry in addition reactions. The fmt report of the use of carôanion 
chemistry to generate 4-substituted glutamic acids was in 1980 when Robert et al. 
attempted to synthesize y-carboxyglutarnic acid in what they termed an effort to mimic 
nature? Glutarnic acid, protected as the N-trityl dibenzyl ester 4.43, was treated with 
lithium diisopropylamide (LDA) to generate the enolate. The buky trityl group was used 
to decrease the acidity of the a-proton through stenc effects and hence reduce 
racemization. The enolate was treated with benzyl chloroformate, then hydrogenated to 
give y-carôoxyglutamic acid 4.10 in 50% yield frorn the hilly protected glutamate. The 
authors reported no detectable racemization occurred at the a-carbon. 
Scheme 4.12 
Tanaka et al.' introduced the use of y-anion chemistry with pyroglutamate, using 
the chiral template to synthesize y-carboxyglutamic acid in a rnanner identical to that 
reported by Robert and CO-workers six years previously. 
Baldwin et al., in the first of a series of papers. described enolate generation and 
subsequent aldol chemistry on N-trityl-glutamic acid-ymethyl ester a-t-butyl ester 4.45 
(P=Trt, R'=?BU, R~=M~) ."  Although no mention was made conceming any 
stereochemicaî induction at the remote 'yrposition, Baldwin and co-workers noted that the 
presence of the N-trityl group appeared to prevent racemization at the a-carbon. 
Scheme 4.13 
In rapid succession, articles appeared in which stereoselective y-anion chemistry 
was investigated to derivatize both glutamic acid and pyroglutarnic acid. In 1989, Ohta et 
al."* reportecl the hydroxylation of N-Boc-L-pyroglutamate benzyl ester to give the 2S,4R 
derivative of 4 . a  *%oc, R ' S ~ B ~ ,  E = =  with complete stereoselectivity. Baldwin 
and co-workers experienced similar results when alkylating 4.47 (P=Boc, R'SO~~BU) 
with benzyl bromide, aithough both methyl iodide and bromopropane failed to alkylate?' 
Ezquerra et al. observed the same selectivity for larger ammatic substitutes but poor 
selectivities for smaller groups such as allyl and cyan~methyl.~ This methodology has 
k e n  used to synthesize 4-allyl and 4-cinnamyl derivatives for structure activity 
relationship (SAR) studies on mGlu 5 kinate receptor agonists." 
Scheme 4.14 
Rapoport et al., in the f m t  reported stereoselective synthesis of 4-substituted 
glutamic acids used the 9-(9-phenylfluorenyl)(PhFi) group for nitmgen protection 4-45 
(P=PhFl, R'=~Bu, R ~ = M ~ ) ,  which also prevents epimerization of the a-carbon due to the 
size of PhFl? Minimal selectivity, in the order of 2:l (2S94S:2S,4R) for Me1 were 
achieved and 3: 1 with propyl triflate, 4.46 (P=PhH, R'=~Bu, R ~ = M ~ ,  E = Me, nPr). 
In the same paper in which they describe the synthesis of 2S,4S y-substituted 
glutamic acid derivatives via catalytic hydrogenation (Section 4.1.4.3), Hon et al. 
describe the alkylation of pyroglutamate 4-47 (P=Boc, R'SH~OTBDMS) with benzyl 
brornide to give the 2S,4RRpyroglutamate with 15: 1 selectivity." Pyroglutarnate 4.47 
(P=TBDMS, ~ ' = C 0 a n )  was also alkylated with ethyl iodide to give the 2S94R:2S:4S 
product in a 10: 1 ratio.') 
In 1993, Hanessian and Vanasse reported the 9: 1 (2Sg4S;2S,4R) hydroxylation of 
Cbz-glutamate dimethyl ester 4-45 (P = Cbz, R'=R*=M~) with Davis' oxaziridine to give 
the y-hydroxy derivative in 70% yield? 
The 2,4-diamino derivative of glutamic acid was synthesized via azide 
displacement of a protected glutamate (4.46, P=PhFl, R'=~Bu, R ~ = M ~ ,  EQ- II) in a 3: 1 
ratio (2S94S:2S,4R) and 54% yield followed by reduction for subsequent incorporation 
into a benzodiazepine side-chain of a tripeptide." 
Johnstone et al. reported the successful y-methylation of 4.45 -2, ~ ' = t ~ u ,  
R 2 = ~ e )  in 1994 in a ratio of 2: 1 (2S94S:2S,4R) and 1 : 1 for allylation, however aldol 
reactions with benzaldehyde proceeded with high selectivities at the y-carbon since only 
two of four possible stereoisomers were formed in a 1:l ratio.' The lack of 
stereoselectivity during alkylation was attributed to the fact that the dianion of the 
protected glutamate did not adopt a chelated, cyclic structure since both faces of the 
enolate were obviously accessible whereas the benzaldehyde adduct formed a six- 
member, chelated, cyclic transition state 4.49 where al1 substituents adopt equatorial 
positions (Figure 4.1). The authors commented "the chiral center at the a-carbon appears 









Figure 4.1: Six-member chelated cyclic transition state? 
Shortly thereafter, Gu and CO-workers published the stereoselective synthesis of 
p-nitrobenzoyl N-protected 2S,4S-methylglutamate 4.46 @=PNB, R'=R*=E=M~) 
obtained by dianion chemistry and isolated as a single i s ~ r n e r . ' ~ ~  However, in contrast to 
those observations reported by Johnstone and CO-workers," Gu et al. explained their 
drarnatic results by way of a chelated dianion similar to those reported for the alkylation 
of succinimides? The use of potassium as a counter-ion reportedly negated any 
stereoselectivity, strengthening the argument of chelation controlled alkylation. Gu et al. 
also reported the synthesis of 2S,4R-methylglutamate by the alkylation of protected 
pyroglutamate 4.47 (P=Boc. R'ECH~OTBDPS) with methyl iodide to give the 
2SV4R;2S,4S derivative in a 6: 1 ratio? Hanessian and Margarita reported the allylation of 
similady protected glutamic acid 4.45 (P=Cbz, R'=R~=M~) in remarkable 
stereoselectivities of >99: 1 for 2S94S.2S,4R? However, in our hands, methylation and 
allylaîion consistently gave selectivities of 6: 1 as described later. 
4-1.4.5 Other Merhodr for the Synthesis of ySubstituted Glutamie Aci& 
Numerous methods exist for the synthesis of y-substituted glutarnic acids that do 
not fit into the categories described above. These are methods usually designed to 
synthesize a specific amino acid. 
Protected 4-hydroxy-L-proline 4.50 has been used in a synthesis of 2S94S- 
diaminoglutamate 4.11.61 Conversion of the alcohol to the mesylate was followed by SN2 
displacement with azide to give 4.51 which was then reduced and trapped as the Boc 
protected amine 4.52 (Scheme 4.15). Hydrolytic ring-opening and deprotection yieided 
2S,4S-diaminoglutamate 4.1 1 as one diastereomer in 20% overall y ield. 4- 
Fiuroglutamate 4.12 has also been synthesized using similar methods with DAST as the 
fluorinating agent.' 
Scheme 4.15 
Oppolzer's chiral sultarn (Section 1.3.3.1) has been employed in the 1,3-dipolar 
cycloaddition of nitrone 4.53 with acrylamide 4.54. After removal of the chiral synthon 
and reprotection, protected (ZS,4S)-hydrox yglutamate 4.46 (P=Cbz, R'=E~, R ~ = ~ B  u, 
E=OH) was isolatai in 52% overall yield with a diastereomeric ratio of 20:ï (Scheme 
4.1 6).62 
Scheme 4.16 
The first synthesis of p,y-dihydroxyglutamic acid 4.9 has only recentiy been 
reported." 2S73S,4S-Dihydroxyglutamic acid 4-57 was synthesized from a D-ribose 
derivative 4-55 via an aziridino-y-lactone 4.56 in a Iengthy procedure and 3% overall 
yield (15 steps) (Scheme 4.17). Phannacological studies have shown 4-57 to be an 
agonist against mGIu 1 and weak agonist of mGlu 4? 
Scheme 4.17 
The synthesis of (2S,3S94R)-dihydroxyglutamic acid 4-59 followed shortly 
thereafter using a strategy essentially opposite that used for the synthesis of the 4S 
stereoisomer." An epoxy-pyrrolidinone template 4-58 derived fiom S-pyroglutaminol 
(4.48, &OH, R'=CO~H) gave the desired product 4.59 in 50% overall yield over 7 steps. 
Scheme 4.18 
4.2 Results and Discussion: Synthesis of .)rSubstituted Glutamates 
4.2.1 Methylation of Cbz-Glu(OMe)OBO 4.69: Optimization and Detemination of 
Diastereoselectiv@ 
Since the OB0 ester protecting group had shown its usefuiness in both 
maintaining the chiral integrity of the a-carbon and acting as a directing group through 
steric constraints in various nucleophilic additions (Chapter 2), we decided to investigate 
its utility with electrophilic reactions in the context of amino acid chernistry. Aspartic 
and glutamic acid provided the ideal oppominity to explore this area since both are 
i nexpensive, readil y available and arnenable to electrophilic chernistry . Furthemore, the 
additional methylene unit in the sidechain of glutamate provides an opportunity to 
explore not only 1 ,Zinduction as with aspartate but also 1,î-induction of stereochemistry 
(aspartic acid is described in chapter five). We were also eager to develop a broadly 
applicable route with both high yields and diastereoselectivities towards the synthesis of 
y-substituted glutamates since al1 the reports in the literature describe methods that 
provide access to only a few of the potential ysubstituted glutamates. We decided to 
protect the glutamic acid sidechain as the methyl ester in order to ensure any 
stereoselectivi ty during electrophilic additions would be due to 1 -3-as ymmetric induction 
of the chiral center and not a result of a bulky y-carboxy protecting group. The a-amino 
group was protected as the Cbz group since it is typically more robust that han the Boc 
group and the use of strong base to generate the enolate prohibited the use of the Fmoc 
IFOUP* 
Regioselective esterification of glutamate 4.60 was achieved using a similar 
method to that reported earlier by our gmup.' Chlorotrimethylsilane (TMSCI) was 
added in two separate diquots to giutamic acid 4.60 stimng in dry methanol (Scheme 
4.19). Mer the removal of any residual solvent, CbzOSu was used to protect the amine 
as the Cbz carbarnate to give 4.61- Purification at this point was laborious. therefon 4.61 
was esterified using oxetane tosylate 2.38 to give the fully protected glutamate 4.65 in 
68% and 4-66 in 62% yield over three steps. The t-butyi ester 4.67 was synthesized in 
78% yield from cornrnercially availabie 4.63 and the benzyl ester d68 in 7546 yield from 
4.64. Boron trifluoride etherate mediated rearrangement of 4.654.68 to the OB0 esters 
4*69-4.72 gave crystalline products in 72%. 69%, 70% and 70% yield respectively after 
flash chromatography. Larger arnounts (15-20 mol%) of boron trifluoride etherate could 
be used to rapidly promote the rearrangement of the oxetane ester 4.65, conditions which 
caused an increase in decomposition of the OB0 ester in the senne derivative 3A1 
previously reported." This is presumably due to the lack of interaction of a hydroxyl 
sidechain with the Lewis acid. 
Lithium hexamethyldisilazane (LWMDS) was chosen as the base to generate the 
dianion since other groups have reported inconsistent results and decomposition of the 
enolate with However, carefiil control of the reaction conditions is necessary. 
Inverse addition was used to generate the dianion (based on results described in chapter 
5) and addition of electrophile were both carried out at -78'C to prevent decomposition 
of the enolate and erosion of diastereoselectivity which occurred upon warming to -30°C. 
Methyl iodide was chosen as the alkylating agent since an easily identifiable doublet 
would be formed which could be integrated by NMR methods to determine 
diastereoselectivity . 
At first, &ter generation of the enolate and addition of methyl iodide. the y- 
methylglutamate 4.73 denvative was seemingly generated in approximately 10: 1 ratio 
based upon 'H-NMR intcgration of the new methyl group at 61.15 ppm (Figure 4.2) 
although no other signals comsponding to the other diastenomer were observed. High 
field NMR analysis (2 300 MHz) was essential since examination of the methyl doublets 
on lower field instruments failed to distinguish between diastereomers (vide infra). In 
k t ,  when we repeated the synthesis of 2S,4S-Cbz-Glu(yMe)(OMe)OMe 4.46 e-Cbz, 
R'=R2=E=~e) reprted by Hanessian and MargariaM we observed (500 MHz 'H-NMR) 
diastereomecïc contamination of the crude product as a 6:1 mixture of the 2S94R2S,4R 
diastereomers. However, the 2S,4R isomer was not observed when using conditions 
identical to those by Hanessian and Margarita to analyze their product (200 MHz 'H- 
Figure 4.2: 3ûû MBz 'H-NMR of Cbz-L-GJu(pMe)(OMe)OBO ester 4.73. 
Numerous attempts at optirnization failed to alter the 10:l ratio. suggesting the 
1 existence of some other phenomena H-NMR studies in CDC13, CD&&, acetone-&, 
methanol-ci4, m-&, DMF-d7 and DMSQ& al1 showed the same ratio of methyl 
doublets. Variable temperature 'H-NMR studies in DMF-d7 failed to disprove the notion 
that the minor doublet was due to the presence of  rotamers. 
In an effort to rationalize the modest selectivity we were encountering, we 
attempted to identify the stereochemistry of methylation. Lactones have been used 
extensively to determine relative stenxichemistry and so 4-73 was reduced with 
DIBALH and the OB0 ester ring-opened with 20% acetic acid to the mhpd ester 4.83. 
then lactonized under acidic conditions @-TsOH in refluxing benzene) to give lactone 
484 (Scheme 4.20). The relative stereochemistry was initially assigned as 2&4R after 
decoupling 'H-NMR experiments showed the proton at C4 to be axial with a coupling 
constant of 10.3Hz (J4an5ax). Typical values for the ABX axial, axial proton coupling in 
lactones are S-IOHZ.~ However, the assipment of this stereochemistry was determined 
to be incorrect since a crystal structure of 4.73 was eventually obtained (Figure 4.3) and 
X-ray anaiysis indicated S,4S stereochemistry (Appendix A). Presumably, under the 
themodynarnic conditions used to lactonize 4.83, epimerization occurs at the a-carbon of 
2S,4S-4.83 to convert the dihydroxy ester to 2R,4S4m83 which then lactonizes to 2R,4S- 
4.84. An alternative mechanism involves the lactone 2S,4S4m84 racernizing to the more 
stable 2R.4S-lactone 4.84 in which both CH3 and CbzHN equatoriai? 
In an effort to irrefutably determine the diastereomenc ratio of methylation, we 
unsuccessfully attempted to epimerize the varbon of y-methylglutamate 4.73 with 
excess LiHMDS; however, excess LDA at -78OC followed by aqueous work-up 
successfully epimerized the y-carbon to give a 1: 1 mixture of the 2S94S:2S,4R y- 
methylglutamate derivative. Although the pmethyl protons had essentially identical 
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Figure 4.3: X-Ray Crystal structure of Cbz-L-Glu(yMe)(OMe)OBO ester 4.73. 
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vs. 1.40- 1.55 ppm and 2.00-2.10 ppm) and ?protons (2.36-2.50 ppm vs. 2.50-2-6 1 ppm) 
were clearly distinguishable allowing for the assignment of diastereoselectivity in the 
alkylation (Figure 4.4). It is interesting to note that 2S94R-Cbz-Glu(yMe)(OMe)OBO 
ester 4.74 does not have the corresponding minor y-methyl doublet. GC-MS studies aiso 
clearly indicated that methylation occumd stereospecifically (Figure 4.5). The two 
diastereoisomers were also separable by TLC, although 2S,4R-Cbz-Glu(y- 
Me)(OMe)OBO ester 4.74 had an identical Rf to that of the Cbz-L-Glu(0Me)OBO ester 
4.69 synthon. 
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F i  4.4: 300 MHz 'H-NMR of 2S,4R 4.74 (top) and 2S,4S 4.73 (bottom) Cbz-L- 
Figure 4.5: GCMS of 2S,4S-Cbz-L-G1u(yCH3)(OMe)OB0 ester 4-73 (top) and 
epimerized 2S,4RS-Cbz-L-Glu(yC&)(OMe)OBO ester 4.7314.74 (bottom). The 
isoeyanate (rt 16.5 min) is a result of pyroiysis of the carbamate on the columo. 
Extensive attempts to punfy the 2S,4S-Cbz-Glu(y-Me)(OMe)OBO ester 4.73 by 
both flash chromatography and HPLC failed to remove the unknown doublet at 61 .O5 
ppm. In order to dismiss the possibility that racemization had axumd at the a-carbon, 
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quenched by aqueous work-up. After acid hydrolysis in 6N HCl and ion exchange 
purification, the rotation of the resulting glutamic acid 4.60 was comparable to that of the 
starting material, indicating no racemization had occurred during esterification, amine 
protection, rearrangement to give Cbz-L-Glu(0Me)OBO ester 4.69 or after prolonged 
exposure to base. Cbz-D-Glu(0Me)OBO 4.70 was also methylated to give 2R,4R-Cbz- 
Glu(y-Me)(OMe)OBO ester 4.75 which haci an identical 'H-NMR spectra to the 2S,4S 
product 4.73 as expected, including the minor doublet at 1.05 ppm. 
To eliminate the possibility of the methyl ester regioisomer 4.85 k i n g  formed in 
the initial esterification and k i n g  carried through, Cbz-L-Glu(OB0)-OMe was 
synthesized via the ~xazolidinone~ and subsequently y-esterified to the oxetane ester 4.86 
followed by rearrangement to the OB0 ester 4.87 (Scheme 4.21). Exposure of 4.87 to 
conditions identical to those used for the methylation of 4.69 failed to produce any 
product after 6 hours as expected. 
Scheme 4.21 
1, C 5 2 C 0 3 1  CR=""" 4.m 2, =, OMF#  = oxetane ester 4.86 
48 h 
Kawahata et al. were able to dimethylate PhFbAsp(0Me)OtBu 5.11 by sequential 
treamient with KHMDS and MeLn In order to dismiss ydimethylglutarnate as a possible 
contaminant, (whose two methyl singlets might be mistaken as the rninor doublet) we 
tried to ydmethylate Ch-L-Glu(0Me)-OB0 4.69 and y-monomethylate 2S,4S-Cbz- 
162 
Glu(y-Me)(OMe)OBO ester 4.73. However, both mutes failed to give the dimeth ylated 
product 4 .a  instead giving cis 4.89 and am 4.W 2S,4S-Cbz-N-Me-Glu(y- 
Me)(OMe)OBO (Scheme 4.22) in 36% yield with remaining starting material regardless 
of base used. This is presumably due to the sterically hindered nature of the y-carbon 
once monomethylated, leading to N-methylation at the elevated temperatures (-40°C to 
0°C) required to drive the reaction. 
Scheme 4.22 
1) LiHMDS. -78% 
42) Md. 4% CbzH CbzH % 
Serendipitously, while exploring the methylation of 4.69 in non-polar solvents. 
the y-methyl derivative was found to be quite soluble in toluene. The use of a non-polar 
solvent with a broad temperature range was ideal for variable temperature NMR studies. 
Experiments over the range of 233 K (4°C) to 363 K (90°C) in toluene-da showed 
coalescence of the minor methyl doublet at 330K (57OC) indicating the existence of 
rotamers in Cbz-LGlu(y-Me)(OMe)OBO ester 4.73 (Figure 4.6). The fkee energy 
difference (AG0) was calculated to be 1.31 kcal mol" and the free-energy of activation 
(AG:) 17.3 kcal- mol", calculami From the coalescence temperature using the graphical 
method of Shanan-Atidi and Bar-Eli (Appendix B)." 
Conformational isomers have been reporteci for amidesn and carbamatesn as the 
C-N bond adopts a less stable syn conformation (Figure 4.7a) and have k e n  observed in 
aspartic acid ~ierivatives.'~ Typical values for rotation about the C-N bond are 22 kcal 
mol-' in the case of amides (N~-dirnethylfor~namide)~~ and 16 kcal mol-' for carbarnates 
(Na-dimeth ylbenz ylcarbamate). 
Figure 4.6: Variable-Temperature 5(10 M& 'B-NMR studies ia toukne-4 of Cbz- 
L-Glu(pMe)(OMe)OBO ester 4.73. 
This conformational isomerism is observed in the methyl ester 4.73, the t-butyl 
ester 4.76 and benzyl ester 4.77 derivatives and also in 2S,4S-Boc-Glu(y-Me)(OMe)- 
OB0 ester. Moreover, the stereochemistry at the parbon appears to induce this effect 
since the minor rotamer seems to be absent in the 2S,4R-Cbz-Glu(y-Me)(OMe)OBO ester 
4.74 isomer (Figure 4.4 bottom) regardless of solvent. Since anti carbarnate rotamers are 
more stable than syn rotamers, presumably the anti rotamer corresponds to the major 
doublet at 6 1.26 ppm and the syn rotamer the minor doublet at 6 1.08 ppm. Some 
intrinsic property present in ~S,~S-C~~-G~U('~LM~XOM~)(OM~)OBO ester 4.73 is therefore 
responsible for the observed rotamer. Intramolecular hydrogen bonding may stabilize the 
conformation depicted in Figure 4.7b in which both the OB0 and methyl groups are 
equatorial in the syn-2S,4S conformer whereas the syn02S,4R conformer has the methyl 
group axial, perhaps sufficiently disfavoured to explain the absence of the syn-2S,4R 
isomer in the 2S,4R-Cbz-Glu(y-Me)(OMe)OBO ester 4.14 'H-NMR spectrurn. Similar 
seven-membered hydrogen bond interactions have k e n  shown to be responsible for the 
configurational stability in sugar thioureas," N-(a-hydr~peroxyalkyl)arnides,~ and 
macrocyclic polypeptides." Corey and Lee also recently discussed the importance of 
hydrogen-bonding as an organizing element in the restriction of rotation leading to 
enantioselectivity in many rea~tions.'~ Polar pro tic solvents should disrupt the propensity 
of the 2S,4S-methyl denvative to intramolecular hydrogen bond which would be detected 
in the 'H-NMR specûum, however, the rotamer doublet is observed with solvents such as 
methanold. If this phenornenon is indeed due to intramolecular hydrogen bonding, the 
seven-member hydrogen bond must be sufficiently strong to overcome the disniptive 
nature of methanol-c4. 
Figure 4=1. (a) Anti versus Syn carbamate isomers (b) Hydrogen bonding in the Syn 
conformational wmer of Z,4S and 2S,m Cbz-L-Glu(yMe)(OMe)OBO ester 4.73 
and 4.74. 
Once the high diastereoseIectivity of addition had been established, Our attention 
tumed to optimizing alkylation (Table 4.1). Other counterions were investigated for the 
generation of the enolate. NaHMDS gave the same results as LiHMDS, however, the 
potassium enolate resulted in a 1:l mixture of 4-methylated product. This is in 
agreement with results reporteci by Gu and Hessonn (Scheme 4.13.4A6 P-PNB. R'=R~= 
=Me) where a chelated dianion mechanism was proposed and subsequently described 
by Hanessian and Schuarn (Section 4.2.10). An excess of base was also required since 2 
equivalents of LiHMDS, titrated according to the method of Love and Jonesp gave a 
lower yield of product (entry 8). Inverse addition (i.e. addition of the substrate dropwise 
to a mixture of base) was also necessary, implying that the reaction is under kinetic 
control? In order to identify whether an E or Z enolate was formed we attempted to trap 
the enolate with TMSCl as described by Humphrey et al.= and compare the chernical 
shift of the silyl ketene acetal to literature values described by Ireland and Daub? 
However, al1 trapping experiments failed and the addition of HMPA had no effect on 
either yield or diastereoselectivity. 
Table 4.1: Optimilgtion of Methyiation of Cbz-EGlu(0R)OBO estet. 
YC@R Tempb Reaction Yieldc ~ a t i o ~  













L ~ H X ~ S ~  
LiHMDSg 
a Reaction performed in THF unless otherwise noted, with 3 equivalents of base and 
inverse addition 
Temperanire dunng addition of alkylaîing agent 
Value in parenthesis denotes yield base on recovered starting material 
Detennined by 'H-NMR andlor HPLC analysis 
Two equivalents of base 
' Reaction pedormed in toluene 
Reaction performed in diethyl ether 
4.2.2 Addition of Other Alkylating Agents to Cbz-Glu(0Me)UBO 4.69. 
Confident that we had assignecl both the stereochernistry and diastereoselectivity 
of methylation, we then investigated other alkylations. Ethyl iodide, allyl bromide and 
benzyl bromide were al1 used as alkylating agents following optimized conditions 
developed with LiHMDS and M e l  In al1 cases, alkylation occurred in both good yield 
and excellent &astereoselectivïty with no observable racemization. Only one 
stereoisomer was visible within the detection limits of TLC, 'H-NMR and 1 3 ~ - ~  and 
was tentatively assigned as the isomer due to the observed results for the y-methyl 
denvative. This was contmed upon deprotection, derivatization and HPLC analysis 
(vide infra) and cornparison to literature results. The major by-product of the additions 
was unreacted Cbz-Glu(0Me)OBO ester 4.69. Care was taken to ensure diastereomeric 
e~chment  did not occur d e r  purification. 
Ethyl iodide gave the y-ethyl derivative 4.78 in 75% yield, allyl bromide the y- 
allyl denvative 4.79 in 83% yield and benzyl brornide the ybenzyl derivative 4.80 in 
76% yield. The reactivity, leaving group and bulk of the electrophile had little effect on 
the yield and selectivity. 
4.2.3 Aldol Reaction of Cbz-Glu(OMe)OBO 4.69. 
The aldol reaction of benzaldehyde with the enolate of 4.69 gave only two of the 
four possible stereoisomers of 4.91 in 71% yield and ratio of 3: 1 (determined by 'H- 
NMR and 13c-NMR) compared to the aldol reaction of 4.45 (P=Cbz, R'=~Bu, R ~ = M ~ )  in 
which a 1:1 ratio of diastereomea was reported (Scheme 4.23)? The ratio was 
determined by the integration of well resolved paaks in the 'H-NMR spectmm. The 
stereochernistry of the major diastereomer was not identifid although, based on previous 
results. presumably the 2S,U stereoisomer predominates. 
Scheme 4.22 
M'2aL O 2) 1  LiHMDS, PhCHO CbzH 
4.66 4.91 
The 2-sulfonyloxaziridine 4.92 of Davis and coworkersU has been used 
extensively to a-hydroxylate ketones and enolates due to its convenient preparation. 
However, only one account of its use to synthesize y-hydroxyglutamic acids has been 
reported giving 2S,4S-Cbz-Glu(y-OH)(OMe)OMe d46 (P=Cbz, R'=R~=M~,  E-OH) in 
70% yield as a 9: 1 mixture of inseparable diastere~mers.~ Using identical conditions as 
those optimized for the alkylation of Cbz-Glu(0Me)OBO 4.69, Davis' oxaziridine 4.92 
was added to the lithium enolate resulting in a cornplex mixture of products that were not 
isolated. However, when 3 equivalents of LNMDS was added to a stimng mixture of 
the oxaziridine 4.92 and Cbz-LGIu(0Me)OBO ester 4.69 at -78"C, three distinct 
products were isolated. The suifonamide 4.94, an adduct of the sulfonimine 4.93 and 
enolate of 4.69, the silyl ether 4.95, presumably generated through trimethylsilylation of 
the oxyanion by hexamethyldisilazane, and the desired produa 4.96 (Scheme 4.24). 
Scheme 4.24 
UHMDS, -78°C 
Davis et ai. have previously observed the formation of the sulfonamide 4.94, 
albeit in low yield? Its formation was reportedly not signifiant until the reaction was 
perforrned at r w m  temperature and both the use of KHMDS and maintaining the reaction 
at -78°C alleviated this side reaction. A variety of conditions were investigated to 
optimize y-hydroxylation. (Table 4.2) including those reported by Davis' group," in situ 
reduction of the sulfonamide 4.93 with N a B a  (entries 5 and 6)," and the use of LDA 
with varying arnounts of oxaziridine 4.92 to avoid both sulfonamide 4.94 and TMS ether 
4.95 formation (entries 7 and 8). 
Silylation of alcohols with hexarnethyldisilazane has been previously describedg6 
and the secondary nature of the silyl ether probably explains its stability during aqueous 
work-up. The TMS ether 4.95 could be quantitively converted to the desired a- 
hydroxyester 4.96 derivative with stimng in rnethanol over silica for 24 hours, conditions 
attempted due to the observation of decomposition of 4.95 to 4.96 on TLC. 
Table 4.2: Optimization of Hydroxyiatioa of CauL-Glu(0Me)OBO ester 4.69. 
Yield (%) 
Entry Condi tionsa 4.94 4.95 4.96 
1 L ï S ( 3  eq.), 4.92 (1.5 eq.) 28 46 20 
2 LiHMDS(3 eq.), 4.92 (5 eq.) 5 64 23 
3 KHMDS (3 eq.), 4.92 (1.25 eq.) 30 34 22 
4 NaHMDS (3 eq.), 4.92 (1.25 eq.) 19 39 45 
5 LHMDS(3 eq.), 4.92 (1 -5 eq.), N a B a  (20 eq.) 5 69 10 
6 LiHMDS(3 eq.), 4.92 (1.5 eq.), NaB& (20 eq.lb 6 58 9 
7 LDA (3 eq.), 4.92 (1. l eq.) 35 O 55 
8 LDA (3 eq.), 4.W (5 eq.) 12 O 79 
a Reaction performed in THF at -78°C unless otherwise noted. 
Performed at 4 ° C  
Only one stereoisomer of Cbz-Glu(y-OH)(OMe)OBO ester 4.96 could be 
detected by TLC, 'H-NMR and ' 3 ~ - ~ ~ ~  and subsequent HPLC analysis. An X-ray 
structure of 4.96 was obtained confirming the same stereochemical outcome (2S,4S) as 
observed with alkylation (Figure 4.8) and showing a strong hydrogen-bond between the 
hydrogen of the y-hydroxyl group and the double bonded oxygen in the carbarnate 
(Appendix C). The excellent diastereoselectivity observed in the electrophilic y- 
hydroxylation of Cbz-Glu(0Me)OBO ester 4.69 is in contrat to that reported by 
Hanessain and Vanasse in which a 9:1 (2S,Qs:2S94R) stereoselectivity was obsewed." 
This is pnsumably due to the higher stenc dernand of the OB0 ester protecting group 
over that of the methyl ester in the chelated transition state mode1 described in Figure 4.9 
(Section 4.2.10). 
Figure 4.8: X-Ray Crystal stnict~re of Cbz-L-Glu(~Oa)(OMe)OBO ester 4.96. 
Dihydroxylation to give Cbz-Glu(~,')"dihydroxy)(OMe)OBO esters was 
accomplished by the osmylation of both the E 4.97 and Z 4.99 isomers of Cbz-Glu(p,y- 
dehydro)(OMe)OBO ester. E-Cbz-Glu(f3,y-dehydro)(OMe)OBO ester 4.97 was 
s ynthesized from Cbz-Ser(a1d)OBO es ter 3.42 and methyl(Enphenylphosphor~ylidene) 
in good yield (78%) and with 98:2 EZ ratio (Scheme 4.25). Cbz-Ser(a1d)OBO ester 3.42 
was reacted with Ando's reagent" 4.98 to give zCbz-~lu(~,y-dehydro)(OMe)OBO ester 
4.99 as a 10:l Z:E ratio. The E-isomer could be separateci by flash chromatopphy to 
give 4.99 in 6 196 yield. 
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Initially, dihydroxylation of 4.97 and 4.99 with stoichiometric amounts of O s 0 4  in 
pyridine and reduction with refluxing methanolic sodium sulfite or sodium bisulfite gave 
a complex mixture of decomposed materials that were not i s ~ l a t e d . ~  However, N- 
methylmorpholine N-oxide catalyzed osmylationgg gave the cis-diols 4.100 and 4.101 in 
54% and 48% yield respectively. Detennining the stereochemistry of dihydroxylation 
proved to be problematic since attempts at crystallizing 4.102, its N-trityl derivative and 
bis-3,s-dinitrobenzoyl ester derivative failed to give crystals capable of X-ray analysis. 
With optical rotations reported for only two of the eight possible isomers of 
dihydroxyglutamic a~id,6~." deprotection of 4.102 and 4.103 and cornparison of opticai 
rotations held little promise for identiving the stereuchemistry of addition, especially due 
to the small amount of materiai available. Efforts are continuing in an attempt to grow 
cry stals for identification of stereochemistry b y X-ray anal y sis. Deprotection of the Cbz 
and subsequent formation of the Glactarn is a well known method which would provide 
the relative stereochemistry of the dihydroxy derivatives 4.100 and 4.101. 
The fl-hydroxyglutarnic acid derivative 4.1û4 was synthesized by Reformatsky 
reaction of 3.42 with the organozinc derivative of t-butyl bromoacetate to give a 93:7 
ratio of threo (2S,3R):erythro (2S,3S) B-hydroxyglutamic acid denvative 4.104 in 75% 
yield over huo steps (Scheme 4.26)" The addition of lithium t-butyl acetate9' failed to 
fùmish the desired product, instead giving a complex mixture of products that were not 
isolated. Ali three groups were simultaneously deprotected upon treatment with TMSI to 
give 2S,3R-j3-hydroxyglutamic acid 4.7 in 82% yield and >98% ee. 
Scheme 4.26 
Epoxidation of the a$-unsaturated ester 497 was attempted as an alternative 
means of tùctionalizing the protected glutamate but was unsuccessful. Both nucleophilic 
and non-nucleophilic conditions were explored including 10% NaHC03 and H202, 
K2C03 and tBuOOH, dimethyldioxirane @MW) and m-chloro~erox~benzoic acid 
(MCPBA) and NaHC03. Previous attempts from Our group to epoxidize Fmoc-Glu(p,y- 
dehydro)(OMe)OBO ester also reportedly failed? Presurnably the umactivity of 4.97 to 
epoxidation is due to a combination of the electron deficiency of the a$-unsaturated 
ester 4.97 and stenc factors. 
The direct electrophilic azidization of enolates has previously been described, 
pnmarily in a landmark study by Evans et al. showing that treatnient of the potassium 
enolate of chiral oxazolidinones with trisyl azide producecl the corresponding 2-azido 
derivatives in good yield and excellent selectivity (Section 1.3.2.2)." Hanessian et al. 
have investigated the azidation of 3-substinited-butyrolactones although no 
diastereoslectivities were reported." Encourageâ by the excellent selectivity we 
encountered in the y-hydroxylation of Cbz-Glu(0Me)OBO ester 4.69, we attempted the 
azidation of Cbz-Glu(0Me)OBO ester 4-49 under conditions previously reported by 
Evans et aP3 
Initially visyl azides 4-105 was added to the potassium enolate of Cbz- 
Glu(0Me)OBO ester 4.69 as described by Evans et al." with littie success. However, 
reaction of the lithium dianion gave the desired azide 4.106 although prolonged reaction 
times resulted in a decrease of product as shown in Figure 4.9. This was monitored by 
both quenching the reaction and isolating the product and by following the progress of 
the reaction by ESI-MS. A variety of conditions were investigated including counter-ion, 
temperature and lengh of reaction, however, after op timization 2S,4S-Cbz-Glu(y- 
N3)(OMe)OB0 ester 4.106 was synthesized in 54% yield with 32% recovery of starting 
rnaterial (Scherne 4.27). Only one stcreoisomer was detected by TLC. 'H-NMR and 13c- 
NMR, presumably the S,4S isomer based on earlier results. nie reasons for apparent 
decomposition of y-azide 4-106 during prolonged reaction times are unclear. Evans et 
aLg3 have reported the use of acetic acid to quench the reaction and decompose the 
diazonium sait fonned, however, the sensitivity of the OB0 ester to acidic conditions 
prectudes the use of any acid aithough the addition of potassium acetate may have the 
desired effect if 4.106 is formed according to the mechanism described by Evans et al. 
The yield is however consistent with previous attempts by other groups at generating y- 
a~idoglutamates~~ and pyroglutamates." The azide 4.106 was then reduced to the amine 
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Figure 4.9: Plot of Yîeld (%) versus T i e  (minutes) atbr quencbing of electrophilic 
aziàation of Cbz-Glu(0Me)OBO ester 4.69 with T m  Azide 4.1û5. 
The other diastereomer, 2S94RCbz-Glu(yN3)(OMe)OB0 ester 4.109 was 
synthesized by conversion of the alcohol of 2S94S-CbzGlu(y-OH)(OMe)OBO ester 4.96 
176 
to the mesylate Alûû in 80% yield and subsequent s ~ 2  displacement with N a 3  to give 
* 
the desired product 4.109 in 56% yield (Scheme 4.28). The only other product was 
unreacted starting material which was recovered. The azide 4.109 was then reduced 
under Staudinger conditions as described for 4.107. Alternatively, Mitsunobu naction of 
4.96 with HN3 also gave the desired azide 4.109. TU- analysis indicated only one 
product that was contaminated with diethylamidodicarboxylate. However, after 
reduction under Staudinger conditions, the y-arnino derivative 4.110 was isolated in 76% 
yield for the mesylate method and 5496 yield (for two steps) for the Mitsunobu method in 
ester 4.110 in hand, confirmation of the diastereoselectivity of the direct electrophilc 
azidation to give 4.1W by 'H and 13c-NM~ was possible. 
Scheme 4.28 
Electrophilic bromination was performed in order to introduce a good leaving 
group in the y-position of the Cbz-Glu(0Me)OBO ester 4.69. The lithium enolate of 
177 
Cbz-Glu(0Me)OBO ester 4.69 was added to N-bromosuccinimide (NBS) under 
conditions simüar to that reporteci by Evans et al? After generation of a deep purple 
colour, the reaction was quenched to give the protected ybromoglutamate 4.112 O(rBr) 
in 64% yield (Scheme 4.29). A number of side-reactions occurred since only 8% of Cbz- 
Glu(0Me)OBO ester 4.66 was recovered, although none of these contaminants were 
isolated. 'H-NMR integration gave a 90:10 ratio of diastereomers, the major product 
presumabiy the 2S,4S stereoisomer based on previous electrophilic additions. The 
reduced diastereoselectivity is perhaps due to displacement at the a-bromoester with a 
brornine anion to give the 2S,4R stereoisomer by an SN2 reaction. Higher 
diastereoselectivities (955) were achieved after shorter reaction times although yields 
were drastically lower (&O%), quenching the reaction after six hours was a compromise 
between diastereoselectivity and yield. 
Scheme 4.29 
4.69 X+=NBS, DAST, NFSI, 4.112 X=Br 
Selectfiuor 
Al1 attempts at synthesizing the yfluoro derivative 4.112 (X=F) failed although 
lithium, sodium and potassium enolates were feacted with a number of fluorinating 
reagents including diethylaminosulfur trifluoride (DAST), Selec$luorTU and N- 
fluorobenzene sulfonamide (NFSI) using methods previously reported for the successful 
electrophilic fluorination of enolates?' Complex mixtures of products generali y resulted 
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which were not isolated. ESI-MS and '%-NMR aoalysis of the crude reaction mixture 
indicated Cbz-Glu(0Me)OBO ester 4.69 remained although no mono- or di-fluoronated 
glutamic acid derivatives were identified. 
In order to synthesize the important glutamic acid derivative, 'y'carboxyglutamic 
acid 4.10 via electrophilic addition it was necessary to select conditions to prevent the 
competing side-reaction of O-acylation, known to occur with acyi halides or  anhydride^.^' 
Methyl cyanoformate. also known as Mander's Reagent,- was used to trap the lithium 
enolate of Cbz-Glu(0Me)OBO ester 4.69 to give the malonate derivative 4.113 in 68% 
yield (Scheme 4.30). Initial attempts to deprotect 4.113 to 'y~carboxyglutamic acid 4.10 
by first opening the OB0 ester to the rnhpd ester followed by aikaline hydrolysis of the 
esters with Cs2CQ then hydrogenation of the Cbz group failed to give any 4.10, but 
rather a complex mixture of products. 
Scheme 4.30 
4.2.8 Claisen Condensation of Cbz-Glu(OMe)OBO 4.69. 
Another classical reaction of enolates is the Claisen condensation. In particular, 
in the case of glutamates, the condensation product provides access to various substituted 
pni rn  mimetics such as the pyroliidines 4.15, pyyrolizidinow 4.16 and indolizidines 
4.17 (Scheme 4.3). Lubeil and coworkers have reported the Claisen condensation of PhFl 
glutamates 4.45 (P=PhFl. Ri=tBu, R2=Me) giving the adduct 4.114 which was 
subsequently decarboxylated 4.115 and cyclized to give indolizidinone 4.116 in good 
overall yield (Scheme 4.31).Im However, the stereoselective introduction of various 
substituents proved to be problematic, with diastereoselectivities ranging from 1 : 1 to 15: 1 
depending on substrate. base and ele~trophile.'~' 
Scheme 4.31 
A variety of conditions were examined for the Claisen condensation of Cbz-L- 
Glu(0Me)OBO ester 4.69 including various addition conditions, concentrations, counter- 
ion and temperature (Table 4.3). NaHMDS, the preferred base reported by Lubell and 
Lombart,lm failed to give any of the desired product 4.117, instead giving a complex 
mixture of products including 4.69 (Scheme 4.32). Cbz-L-Glu(0Bn)OBO ester 4.72 is 
presumably formeci by transesterification with benzyl alcohol liberated from the Cbz of 
4.69 by adventitious hydrolysis (entry 2 and 3). L,jHMI)S (entry 5) gave the desired 
Claisen condensation product 4.117 in 48% yield Decarboxylation of the f3-keto ester 
4.117 to the ketone 4.118 failed under a number of therrnodynamic conditions including 
NaOH in dioxane,lm NaCl in DMSO/H20,lm and Cs2Ca in MeOH/H20.'m The highly 
concentrateci reaction mixhue of 4.114 (1 .O M) reporteci by Lubell and Lombart was not 
necessary for the formation of 4.117. 
Scheme 4.32 
Table 4.3: Claisen condensation of 4.69 
Yield 
Time 
Enîry Base Temp.(OC) (h) [4.69](M) 4.69 4.117 4.72 
1 NaHMDs -78°C 2 0.5 95 - 
(1.5 eq) 
- 
3 -30°C+ rt 1 .O 48 - 32 18 
(3 eq) 
4 LiHMDS - 7 8 0 ~  18 0.5 18 33 - 
6 L~HMDs ooc 2 O. 1 25 3 1 - (1.5 eq) 
4.2.9 Deprotection of pSubstituted Gluturnic Acids 
Acid hydrolysis has been used extensively to deprotect y-substituted glutamic acid 
de ri vat ive^.^^'^ In our case refluxing 6N HCl gave ysubstituted glutamates in good 
yield. Reflux periods of beh~een 2-4 hours were required to fully hydrolyze the 
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dihydroxyester 262, generated after ring opeaing of the OB0 ester, although both the 
benzyl carbarnate and methyl ester were rapidly cleaved."" However, this method has 
been repocted to cause up to 3% racemization during 6 hours in refiuxing 6 N HCI.m3"'" 
Purification by cation exchange (gradient elution with 0.1N to 1N N W H )  or anion 
exchange (elution with 0.1N to IN fonnic acid or  0.1N to 0.5 HCI) typically gave the 
desired ysubstituted glutamates in 50-80% yield. Formation of the y-lactarn of 4- 
substituted glutamates during prolonged hydrolysis has been observed,'" especially in the 
case of diaminoglutamic acids (17%) 4.12 and 4.111.- y-ktonization has also k e n  
observed with 2S,4S-yhydroxyglutarnic 4.4 afier prolonged bubbling of HCl gas through 
an aqueous solution (18 h o u r ~ ) . ~ ~ ~  No cyclized product was isolated in our case, 
although ESI-MS analysis of 4.11 indicated formation of a polymenc substance although 
in insufficient yield for full characterization. Only the p-hydroxyglutamic acid derivative 
4.104 was cleaved by TMSI, based on a previously reported synthesis from our 
laboratory 7 
Crystallization of the ysubstituted glutamates proved difficult and was generally 
unsuccessful with the exception of the hydroxyglutamic acids 4.4 and 4.7. However, 
diastereornenc and enantiomenc purities, established by denvatization and HPLC 
analysis of the lyophilized powciers after ion exchange, were excellent. In most cases, the 
values reported for the diastereoselectivity of addition of various electrophiles to the 
enolate of Cbz-Glu(0Me)OBO ester 4.69 are based upon HPLC analysis of the 
denvatives after deprotection. Since a minimal amount of racemization occurs (4%) 
during h y d r o l y s i ~ , ~ ~ ~ ~ ~  these values are reported as >95:5 since one cannot distinguish 
between racemization occurring during addition of the electrophile in basic conditions 
and during acid hydrolysis. HPLC analysis conditions for al1 the y-akyl glutamates were 
identical to those describeci previously (section 2.4.lSa) and gave excellent separation. 
HPLC analysis of the diarninoglutamic acids was unsuccessful due to the partial reaction 
of both amino groups with the derivatizing agent to give two peaks for meso- 
diaminoglutamic acid 4.111 and three for 2S,4S-diarninoglutamic 4.11 acid. 
It was also difficult to obtain samples that were analytically pure by elemental 
analysis although spectroscopic techniques al1 indicated high purity. This rnight be 
caused by smdl amounts of residual salts and the fact that recrystallizations were 
generally unsuccessful. However, optical activity for ail the isolated y-substituted 
glutamic acids agreed with literahire results. 
4.2.10 Discussion of the Stereoselectivity of Electrophilic addition to the Cbz- 
Glu(0Me)OBO ester 4.69 Enolate 
The model depicted in figure 4.10 has been previously proposed to explain the 
1,3-induction occumng in the addition of various electrophiles to the enolates of 
protected glutamates.lq Gu et al. have also explained their high diastereoselectivities by 
way of a chelated dianion, similar to those reported for the alkylation of suc ci ni mi de^.^^ 
Indeed, Our results further support these models since the increased steric b u k  of the 
OB0 ester comlates well with the increase in diastereoselectivity observed as predicted 
by the model (Figure 4.10). For example, the hydroxylation of protected glutamic acid 
4-45 (P=Cbz, R'=R~=M~), where a methyl ester replaces the OB0 ester proceeds with 
9: 1 2S94S;2S,4R selectiviw compared to >95:5 in the case of Cbz-Glu(0Me)OBO ester 




Figure 4.10: Possible transition states of the lithium enolate of Cbz-GIu(0Me)OBO 
ester 4.66? 
The 1: 1 selectivity observed in the electrophilic addition of methyl iodide to the 
potassium enolate of 4.69 (Table 4.1, entry 3) also supports the chelation transition state 
depicted in figure 4.10 since larger counter-ions (i.e. K*>Na+>Li3 are known to possess 
a reduced ability to chelate? Furthemore, the ability of the Lienolate of 4.69 to chelate 
and fom a seven-membered transition state may be implied from the syn rotamer of 4.73 
depicted in figure 4.7. Resumably, if hydrogen bonding can induce the formation of a 
stable seven-membered ring, then the stronger ionic interaction between the lithium 
cation and the oxygen anion may aiso do so. 
A general method for the synthesis of a wide variety of SS,U 'substituted 
glutamates has been developed w ith diastereoselectivities generall y >95: 5 (2S94S;2S,4R). 
This methodology represents a significant step in the synthesis of y-substituted glutamic 
acids due to its hi& selectivity and flexibility since a wide variety of substituents rnay be 
incorporated. Overail yield of the fne ysubstituted glutamic acids fiom glutamic acid 
4.60 range from 15-33% over six steps. The fully protected glutamate 4.69 is 
conveniently crystalline as are a number of the y-substituted derivatives. 
The 4-alkyl substitutents are easily generated in high yield (75-846 yield) and 
excellent diastereoselectivity (>95:5) with the only contaminant starting material, whic h 
may be recovered and recycled. 
y-Hydroxyglutamic acid 4.4 is synthesized in good overaii yield (2546) and 
excellent diastereomeric purity ( ~ 9 5 : s )  and is a noteworthy improvement over cumnt 
rnethods used to synthesize this amino acid. The synthesis of the two unidentified 
dias tereomers of dihydroxyglutamic acid (4.102/4.103) represents a significan t 
improvement of current methods in both length and overdl yield. fi-Hydroxyglutamic 
acid 4.7 was synthesized in both good yield and high diastereoselectivity, comparable to 
other reported methods. Furthermore, crystalline ~S,~S-C~~-G~U(~OH)(OM~)OBO ester 
4.96 provides access to a number of other potential denvatives via functionalization of 
the hydroxyl group as illustrated in the synîhesis of the 2S,4R isomer of diaminoglutamic 
acid. 
Protected 2S,4S-azidoglutamic acid 4.106 was obtained in moderate yield (54%) 
but excellent diastereomeric purity (>95:5). Reduction and deprotection gave 2S,4S- 
diaminoglutamic acid 4.11 in eight steps and 12% overall yield from glutamic acid. 
2S,4R-Cbz-Glu(y-N3)(OMe)OB0 ester 4.109 was synthesized Ma SN2 displacement with 
azide from the corresponding 2S,4S-Cbz-Glu(yOH)(OMe)OBO ester 4%. Reduction 
and deprotection gave 2S,4R-diaminoglutamic 4.110 in 10% (nine steps) and 12% (eight 
steps) overail yield depending on the method of azide displacement. Excellent 
diastereoselectivity in the electrophilic azidation (>95:5) was also achieved and could be 
unambiguously assigned since both diastereomers were in hand. 
Both 2S.M-Cbz-Glu(y-Br)(OMe)OBO ester 4.112 and 2s-Cbz-Glu(y- 
CqMe)(OMe)-OB0 ester 4.113 were synthesized in good overall yield (33 and 3 2 4  
respectively) and good selectivity, 90: 10 for 4.112. 
The Claisen condensation product, although by no means an optimized synthesis. 
has promise in providing a synthetic route towards indolizidines with the possible 
incorporation of ysubstituted glutamic acid denvatives. 
The overall yields and diastereoselectivities of the products synthesized by our 
route are comparable, if not significantly better to most reported synthesis for y- 
substi tuted glutamates. 
Generai Procedure for Removd of Rotecting Grwpc. Cbz-GGlu(y-Me)(OMe)-OB0 
ester 4.73 (72 mg, 0.18 rnmol) was combined with doubly distilled 6N HCI (2 ml) and 
refluxed for 4 hours. The solvent was then removed in vacuo, rinsed with distilled water, 
reduced again and then lyophilized to a white powder. The white powder was disso!ved 
in a minimum of distilled water and placed on Dowex 50x8- 100 ion-exchange resin. 
The column was then rinsed with 5 column lengths of distilled water then 5 column 
lengths of 0.5 N N&OH that were collected. The solvent was removed under reduced 
pressure and lyophilized to give a white powder which was then crystallized from 
acetone:water or ethanol: water. 
4.4.1 ( Z S ) - 2 - [ @ e a z y l o x y ) ~ b o n y I ] a m i n 0 1 S = m e ~  acid, Cbz-L- 
Glu-(0Me)-OH, 4.61. 
Glutamic acid 4.60 (20.0 g, 0.136 mol) was suspended in freshly distilled MeOH (400 
mL) and cooled to 0°C whilst stimng under Ar. Chlorotrimethylsilane (15 mL, 0.1 19 
mol) was slowly added by dropping funnel and after 30 min allowed to warm to ambient 
temperature. After 2 hours the mixture was cooled to 0°C and a second aliquot of 
chlorotrimethylsilane (15 mL, 0.119 mol) slowly added. After 24 hours the solvent was 
removed in vacuo, revealing an oil which was placed under high vacuum. De-ionized 
water (200 mL) was added to the oil followed by slow addition of Na2C03 (20.23 g, 
0.163 mol) to prevent excessive frothing. Once the oil was completely in solution it was 
cooled to 0°C and N-(benzyoxycarbony1)-succinimide (33.89 g, 0.136 mol), pre- 
dissolved in 1,Qdioxane (200 mL), slowly added to the stirring mixture which was then 
allowed to warm to rwm temperature. After 24 hours, the volume was reduced to 
approximately 200 mL under vacuum, then de-ionized water ( 1 0  mL) added and the 
final pH of the mixture adjusted to 3 with 1M H a .  This was then extracted with CH2C12 
(3 x 150 mL), the organic extracts were then pooled and extracted with saturated 
NaHC03 (3 x 100 mi,). The aqueous extracts were pooled, chilled to O°C, acidified to 
pH 3 with 1M HCI then extracted with CH2C12 (4 x 100 mL). The organic extracts were 
pooled, extracted with brine (50 mL) then dried over MgSQ and the solvent removed 
under reduced pressure to yield a colourless oil which solidified upon standing and was 
used without further purification. 
TU3 (111, CHCl,:EtOAc, 1% ACOH) Rr= 0.18; 'H NMR (CDC13, 300 MHz) 6 10.72 (br 
s, lH, CO& 7.31-7.26 (m, 5H, ArH), 5.61 (d, lH, J = 7 . 5 H z ,  Nn), 5.08 (s, 2H, 
CbzCHzO), 4.60-4.42 (m. 1 H, a-CH), 3.63 (s, 3H, CO2CH3). 2.50-2.33 (m, 2H, y-CH2), 
2.30-2.16 (m, 1H, p-CHH), 2.09-1.9 1 (m, LH, p-CHH); "C NMR (CDC13, 75 MHz) 6 
176.1 C O ) ,  173.6 c=O), 156.3 (CONH), 136.1 (Cbz===), 128.6, 128.3, 128.2 
(Cbz<H=), 67.3 (CbzCH20), 53.3 (a---, 52.0 (C0&H3), 30.1 (y*), 27.3 @-CH2); 
Anal. calcd for C14H17N06: C, 56.95; H, 5.80; N, 4.74. Found: C, 57.19; H, 5.61; N, 
4.8 1. 
Same procedure as in 4.4.1. TU3 (1: 1, CHCL3:EtOAc, 1 % AcOH) Rf = 0.18; 'H NMR 
( m l 3 ,  300 MHz) 6 8.74 (br s, lH, COzH), 7.36-7.28 (m, SH, ArH), 5.52 (d, 1H, J = 
7.8Hz, NH), 5.08 (s, 2H, CbzCW), 4.46-4.36 (m, lH, a-CH), 3.63 (s, 3H, C0gH3), 
2.48-2.34 (m. 2H, y-CH2), 2.30-2.16 (m. IH, PCHH), 2.08- 1.94 (m, lH, P-CHH); "C 
NMR (-13, 75 MHz) 6 176.1 CC-), 173.6 E=O), 156.3 (CONH), 136.1 (Cbz<=), 
1 28.6, 128.3, 128.2 (Cbz<H=), 67.3 (Cbza20), 53.3 (a-CH), 52.0 (COsH3), 30.1 (y- 
C&), 27.3 (&CH2); Anal. calcd for CI.&~NO~: C, 56.95; H, 5.80; N, 4.74. Found: C, 
57.19; H, 5.62 ; N, 4.8 1. 
4.4.3 S-Methyl-l-[(3-rnethyl-3loxetanyl)methyI~-(2S)-2-(be11zyIoxy)~~~bonyI~- 
aminopentanedioate, Cbz-L-Glu(0Me) oxetane ester, 4.65. 
Cbz-L-Glu(0Me)-OH 4.61 (6.14 g, 0.0208 mol) was combined with Cs2C03 (4.06 g, 
0.0125 mol) then dissolved in de-ionized water (100 mi.) and lyophilized ovemight. To 
the resulting solid was added oxetane tosylate 2.38 (5.59 g, 0.02 18 mol) and Na1 (0.62 g, 
4.16 mrnol) and then taken up in DMF ( 3 0  mL). The mixture was allowed to stir for 48 
hours before the DMF is then removed in vacuo (0.5 mm Hg, bath temperature 50°C) and 
the resulting solid dissolved in EtOAc (300 m . )  and H20 (100 mL) and extracted with 
10% NaHC03 (2 x 50 mL), saturated NaCl (50 mL) and dried over MgS04. The solvent 
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was removed under reduced pressure and the resulting oil purified by flash 
chromatography (1: 1 Et0Ac:Hex)to give a clear oil in 78% yield (6.23 g). 
[al*'~ = + 1 A (c = 1 .O, CH2C12 ); TU: (1: 1, EtOAcHex), Rf = 0.3 1 ; 'H NMR (CDC13, 
300MHz) 8 7.35-7.28 (m, 5H, ArH), 5.41 (d, lH, J = 7.9Hz, NH), 5.07 (s, 2H, 
CbzCH20), 4.50-4.34 (m, 5H, 2 oxetane ester CH20, a-CH), 4.21 (br s, 2H, CO2%), 
3 -62 (s, 3H, C02CH3), 2.46-2.32 (m, 2H, y-CH2), 2.27-2.1 3 (m. 1 H, 8-Cm), 2.03- 1.92 
(m, lH, B-CHH), 1.29 (s, 3H, oxetane ester CH3); 13c NlMR (CDC13, 75 MHz) 8 173.1 
(Cd), 172.1 (C=O), 156.1 CONH), 136.2 (Ch<=), 128.3, 128.2, 128.1 (Cbz=CH), 
79.5 (oxetane ester CH20). 69.8 (C0&312), 67.1 ( C b z w ) ,  53.5 (a-CH), 
5 1 .9(CO&H3), 39.1 (oxetane ester CC&), 30.0 (ym2), 27.5 (&CHz), 2 1.1 (oxetane 
ester CCH3); IR (cast fiom CHC13) 3342, 2956, 2875, 1736, 1526, 1263, 12 13, 1053, 
982; Anal. calcd for C19H25N@: C, 60.15; H, 6.64; N, 3.69. Found: C, 59.88; H, 6.48; 
N, 3.71. 
4.4.4 S-Methy l - l~ [ (3 -metbyI -3~xe i tany l )methy l ] - ( ) -2 - [ lo )nyI ] -  
aminopentanediate, Cbz-D-Glu(0Me) oxetane ester, 4.66. 
Same procedure as in 4.4.3. [al% = -1.3 (c = i .O, CH2Ci2); TU: (1 : 1, EtOAc:Hex), Rr = 
0.37; 'H NMR (CDC13, 300MHz) 6 7.35-7.28 (m, 5H, ArH), 5.41 (d, lH, J = 7.9Hz, NH), 
5.07 (s, 2H, CbzCW), 4.50-4.34 (m, 5H, 2 oxetane ester C m ,  a-CH), 4.21 (bt s, 2H, 
C02CH2), 3.62 (s, 3H, C02CH3). 2.49-2.32 (m, 2H, y-CH2), 2.28-2.16 (m, 1 H, f 3 - C m ,  
2-03-1 -92 (m, 1H, B-CHH), 1.31 (s, 3H, oxetane ester CCH& ' 3 ~  NMR (CDCI1, 75 
MHz)  6 173.1 -01, 172.1 cd), 156.1 (CONH), 136.2 (Cbz<=), 128.6, 128.3, 128.2 
(CbzeH), 79.4 (oxetane ester Q120), 69.7 (C0&H2), 67.1 (Cbzc&O), 53.5 (a-. 
51.9(CO&H3), 39.1 (oxetane ester cCH3), 30.0 (ycH2), 27.5 (B-W2), 21.1 (oxetane 
ester Cw3); IR (cast fiom CHC13) 3342, 2956, 2875, 1736, 1526, 1263, 12 13, 1053, 
982; Ad. calcd for C19Hd07: C, 60.15; H, 6.64; N, 3.69. Found: C, 60.32; H, 6.78; 
N, 3.74. 
amhopentanedioate, Cbz-L-GIu(0tBu)exetane ester, 4.67. 
Same procedure as in 4.4.3. [a]"~ = - 1 1.5 (c = 1.45, EtOAc); TLC (1 : 1, EtOAcHex), Rr 
= 0.53; 'H NMR (CDC13, 300 MHz) 6 7.34-7.26 (m, 5H, ArH), 5.52 (d, lH, J = 7.9Hz, 
NH), 5.06 (s, 2H, CbzC-), 4.494.42 (m. 2H, oxetane ester C m ) ,  4.39-4.30 (m, 3H, 
oxetane CH20, a-CH), 4.20 (s, 2H, C02CH2), 2.34-2.24 (m, 2H, y-CHZ), 2.18-2.08 (m. 
1H, B - C m ,  2.00-1.86 (m, lH, B-Cm,  1.39 (s, 9H, C(CH3)3), 1.28 (s, 3H, oxetane 
ester CC&); 13c NMR (CDQ, 63 MHz) 6 172.2 Ca), 172.0 (ça), 156.1 (CPNH), 
136.2 (Cbz*), 128.6, 128.3. 128.2 (Ch===), 8 1.0 (C(CH3)3), 79.4 (oxetane ester 
CH20), 69.7 (CW2), 67.1 (CbzQ120), 53.7 (a--CH), 39.1 (oxetane ester CCH3), 3 1.5 - 
(Y-CH~), 28- 1 (CCH3)3), 27.4 (p-w2), 2 1.1 (oxetane ester CcH3); IR (cast from CH~CII) 
3336, 2969, 2875, 1728, 1539, 1456, 1258, 1153, 1053, 982; Anal. calcd for 
C~~H~LN%:C, 62.69; H, 7.41 ; N, 3.32. Found: C, 62.85; H, 7.6 1; N, 3.39. 
4A.6 5-Benzyl-l-[(3-meUiyl-J-oxetanyI)methyl])- 
pentanedioate, Cbz-L-GIu(OBn)*xetane ester, 4.68. 
Same procedure as in 4.4.3. [al2% =- 12.5 (c = 1 M, EtOAc); TU: (1 : 1, EtOAcHex), Rf 
= 0.48; 'H NMR (CDCï3, 300 MHz) 6 7.36-7.77 (m, 10H, ArH), 5.44 (d, lH, J = 7.8Hz, 
NH), 5.10-5.06 (m, 4H, CbzCH20, PhCH20), 4.47-4.32 (m, 5H, 2 oxetane ester CH20, 
a-CH), 4.20 (s, 2H, C02CH2), 2.55-2.36 (m. 2H, y-CH2), 2.30-2.1 7 (m, 1 H, P-Cm), 
2.07-1.92 (m, 1H, P - W ,  1.28 (s, 3H, oxetane ester CCH3); 13c NMR (CDC13, 75 
MHz)  8 172.5 cd), 172.0 Ca), 156.0 CONH), 136.2 (Cbz<=), 135.7 (Ph*), 
128.7, 128.6, 128.4, 128.4, 128.3, 128.2 ( C b z a = ,  Ph-=), 79.4 (oxetane ester 
C W ) ,  69.8 (CO&H2C), 67.2 ( C b z w ) ,  66.7 (C0&H2Ph), 53.5 (a-=, 39.1 - 
(oxeiane ester CCH3), 30.3 27.6 (f3-w2), 21.1 (oxetane ester CÇH& IR (cast 
ffom CH2Cl2) 3338,2962,2875, 1732, 1522, 1455, 1262, 1214, 1 176, 1053.98 1; Anal. 
calcd for CUH29N&: C, 65.92; H, 6.42; N, 3.07. Found: C, 65.65; H, 6.27; N, 3 .M. 
4.4.7 5-Methyl-(2S)-2-[(benzyloxy)cartw,nyl ]~~l-(4-me~yI-2,6,7-~o~bicycIo- 
[2.2.2]oct-1-yl)pntanmte, Cbz-L-Glu(0Me)-OB0 ester, 4.69. 
Cbz-L-Glu(QMe)-oxetane ester 4.65 (5.40 g, 14.2 rnmol) was dissolved in dry CHK12 
(225 rnL) while stimng under Ar. The mixture was cwled to 0°C then BF3. Et20 (90& 
0.64 mmol) was added by syringe. The mixture was allowed to warm to room 
temperature and stir for 6 hours after which a TLC indicated the reaction was complete. 
Et3N (0.39 mL, 2.58 mrnol) was then added and the mixture stirred an additional 30 min 
before the solvent was removed in vacuo. The resulting oïl was dissolved in EtOAc (150 
mL) and extracted with 3% -1 (2 x 25 mL), saturated NaHC03 (25 mi,), brine (25 
rnL) and dried over MgS04. The solvent was removed under reduced pressure to reveal a 
light coloured oil which was purified by flash chromatography (1: 1 Et0Ac:Hex) to give a 
clear oil in 9146 yield (4.45 g) which crystallized upon standing. The product can be 
recrystallized ftom a mixture of diethyl ether:petroleum ethers (30-60):hexanes to give 
3.54 g (65.5% yield) of white, needles. 
m.p. 50.5-51.5 OC, [a120D = -33.0 (c = 1.0, EtOAc); TLC (1: 1, EtOAc:Hex), Rr = 0.56; 'H 
NMR (Acetone-6, 300 M H z )  8 7.38-7.26 (m, SH, ArH), 5.74 (d, 1H, J =10.3Hz, NH), 
5.10 (d, lH, J =  12.7Hz, CbzCHHO), 5.03 (à, lH, J = 12.7Hz, CbzCHHO), 3.89 (s, 6H, 
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OB0 ester CH20), 3.79 (dt, lH, J = 3.9, 10.3Hi, a-CH), 3.59 (s, 3H, C02CH3), 2.38- 
2.28 (m, 2H, yCH2), 2.10-1.98 (m. IH, p - C m .  1.74-1.60(m, lH, p-CHH), 0.81 (s, 3H, 
OB0 ester CCH3); "C NMR (Acetone-4, 75 MHz) 6 173.1 (Ç=O), 156.4 (CONH), 
137.6 (Cbz<=), 128.3, 127.7, 127.6 (-a=), 108.2 (OB0 ester Ç-O), 72.3 (OB0 
ester -), 65.7 (CbzCM), 54.5 (a-CH), 50.7 (C02CH3), 30.3 (OB0 ester EH3) ,  
30.1 (y--), 25.2 (p-m2), 13.3 (OB0 ester CCH3); IR (cast fiom CHC13) 3354, 2953, 
2881, 1727, 1521, 1452,1233, 1049, 101 1; HRMS (FAB) calcd for (M + H') CIPHZy@ 
380.17093, found 380.17034; Anal. calcd for C19H&JC)7: C, 60.15; H, 6.64; N, 3.69. 
Found: C, 60.36; H, 6.62; N, 3.71. 
Same procedure as in 4.4.7. [alZ0D = +30.1 (c = 0.98, EtOAc); TU3 ( 1 : 1, EtOAc:Hex), 
Rr = 0.47; 'H NMR (Acetone-&, 300 MHz) 6 7.38-7.26 (m, 5H, ArH), 5.74 (d, lH, J 
=10-3Hz, NH), 5.07 (d, 1Hy J = 12-7H~, CbzCHHO), 5.00 (d, 1H, J = 12.7H~, 
CbzCHHO), 3.87 (s, 6H, OB0 ester C m ) ,  3.79 (dt, lH, J = 3.9, 10.3Hz, a-CH), 3.56 
(s, 3H, C02CH3), 2.35-2.27 (m, 2H, yCH2), 2.10-1.98 (m, 1 H, f3-CHH), 1.72- 1 S8 (m, 
lH, p-CHH), 0.79 (s, 3H, OB0 ester CC&); 13c NMR (Acetone-&, 75 MHz) 6 173.1 
c=O) ,  156.4 (CONH), 137.6 (Cbz<=), 128.3, 127.7, 127.6 ( C b z a = ) ,  108.2 (OB0 
ester - 0 ) .  72.4 (OB0 ester w20), 65.7 (Cbza20), 54.5 ( a m ,  50.7 ( C w 3 ) ,  30.4 
(OB0 ester cm3), 30.1 (yQI*), 25.2 (fi---), 13.2 (OB0 ester CÇH3); IR (cast from 
CHCl3) 3354,2953,288 1, 1727, 1521, 1452, 1233, 1049, 101 1 ; HRMS ('AB) calcd for 
(M + HC) C I s H ~ ~ N -  380.17O93, found 380.17038; Anal. calcd for C i~H&J@: C, 60.15; 
H, 6.64; N, 3.69. Found: C, 60.28; H, 6.76; N, 3.72. 
4-4-9 5 ~ e ~ - B u i y l - ( 2 S ) - 2 - [ ( b e l l z y I o ~ y ) c a r b o n y l ] ~  
~~~10[2rn2rn2  OC^-l-~I)pe~t~~1011te, Cbz-L-GIu(O~BU)-OBO ester, 4.71. 
Sarne procedure as in 4.4.7. m.p. 86087°C [ a l 2 O D  = -29.0 (c = 1-00, EtOAc); TLC (1: 1, 
EtOAc:Hex), Rr = 0.59; 'H NMR (Acetone-6,300 MHz)  G 7.38-7.23 (m, SH, ArH), 5.72 
(d, 1& J =  9.8Hz, NW), 5.08 (d, 1H. J =  12.7Hz, CbzCHHO), 5.03 (d, lH, J =  12.7Hz, 
CbzCWIO), 3.86 (s, 6H, OB0 ester C m ) ,  3.77 (dt, 1H. J = 3.4, 10.8Hz, a-CH), 2.26- 
2.16 (m. 2H, y-CH2), 2.06 1.92 (m, lH, f3-CHH), 1 64- 1.54 (m 1 H, f3-CHH), 1.39 (s, 9H. 
C(CH3)A 0.78 (S. 3H, OB0 ester CC&); l3c NMR (Acetone-&, 75 MHz)  6 172.1 
(c=O), 156.3 c = O ) ,  137.6 (Cbz-<=), 128.4, 127.7. 127.6 (Cbz<=), 108.3 (OB0 ester 
C-O), 79.3 (COg(CH3)3), 72.3 (OB0 ester CH20). 65.7 (Cbz-a),  54.5 (a-CH), 3 1.5 - 
(y-CHz), 30.3 (OB0 ester cCH3), 27.5 (Ca3)3), 25.2 @-CH2), 13.4 (OB0 ester CCH3); 
IR (cast from CHC13) 3361, 2974, 2934, 2880, 1727, 1520, 1456, 1367, 1 153, 1047, 
1013; HRMS (FAB) calcd for (M + HÇ) C22H32N& 422.21786, found 422.2163 1. Anal. 
caicd for C22H31N4: C, 62.69; H, 7.41; N, 3.32. Found: C, 62.50; H, 7.28; N, 3.23. 
4.4.10 S-Beazyl-(~-2-[(be~1oxy}carbonyi Jarnino-1-(4-me thyl-2,6,7-trioxabicycI0- 
[2.2.2]oct-l-yI)pentaao8~ Cbz-L-Glu(0Bn)-OB0 ester, 4.72. 
Same procedure as in 4.4.7. [al2OD = -27.2 (c = 1.6, EtOAc); TLC (1 : 1, EtOAc:Hex), Rf = 
0.55; 'H NMR (Acetone-d6, 300 MHz) 6 7.39-7.24 (m, 10H, ArH), 5.73 (d, lH, J = 
10.1 Hz, NH), 5.10-4.97 (m, 4H, CbzCH20, PhCH20), 3.87 (S. 6H, OB0 ester CH20), 
3.80 (dt, IH, J = 3.9, 10.1Hz, a-CH), 2.42-2.34 (m. ZH, y-CHz), 2.11-2.00 (m, lH, B- 
CHH), 1.74-1 -62 (m. 1 H, B-CHH), 0.78 (s, 3H, OBO ester CCH3); "C NMR (Acetone-4, 
75 MHz)  6 172.6 @O), 156.4 (CONH), 137.6 (Cbz<=), 136.8 (Ph<=), 128.4, 128.3, 
128.2, 128.1, 127.9, 127.7 (Cbz==H=, Ph=ÇH=), 108.2 (OB0 ester c-O), 72.3 (OB0 
ester CH20). 65.7 (CbzCH20), 65.5 (CO&H2Ph), 54.5 (a---, 30.3 (y-GHz), 30.1 (OB0 
ester mH3), 25.2 (B-cH2), 13.4 (OB0 ester CCH3); IR (cast from CHCl3) 3359, 2982, 
2930,2879, 1723,15 14, 1455, 1367, 1 143, 1045, 1010; HRMS (FAB) calcd for (M + H'+') 
C u H 3 m  456.20224, found 456.20102. Anal. caicd for C25H29N0,: C, 65.92; H, 6.42; 
N, 3.07. Found: C, 66.12; H, 6.54; N, 3.10. 
4m4.11 5-Methyl-(~,~-2-[(betl~gIo~)carbonyl]~&~~yl-l-(4~thyl-2,6,7- 
hiox~bicycio[2~2~]0~t-l-yl)pentan~te, Cbz-L-Giu(yMe)(OMe)-OB0 ester, 4.73. 
Cbz-L-Glu(0Me)-OB0 ester 4.69 (0 .M g, 1.12 rnmol) was dissoived in dry THF (40 
mL) then cwled to -78OC whilst stimng under Ar. In a second flask, LiHMDS (3.48 
mL, 3.48 mrnol, 1.OM in THF) was added to dry THF (10 mL) then cooled to -78OC 
whilst stirring under Ar. The Cbz-L-Glu(0Me)-OB0 ester 4.69 was then transferred 
dropwise to the second flask via cannula The mixture was allowed to stir at -78°C for 1 
hour before methyl iodide (0.28 mL, 5.60 mmol) was added by syringe. The mixture was 
allowed to stir for 4 hours at -78°C before k i n g  poured into 3% N&Cl (20 mL) and 
extracted with Et20 ( 1 0  mL). The organic layer was then extracted with 3% W C 1  (20 
rd), saturated NaHCO3 (20 mL), bnne (20 mL) and dned over MgSO*. The solvent was 
removed in vacuo to reveal a yellow oil which was fùrthcr purified by flash 
chromatography (1:l EtOAc:Hex, 0.5% Et3N) to give a clear oil in 82% yield (0.358 g). 
The product was crystailized h m  Et0Ac:Hexanes to give 0.3 16 g of white needles (72% 
yield after crystallization). 
mp 75-76OC, [UJ*~II = -25.6 (c = 1.02, CHzCl*); TLC ( 1 : 1, EtOAcHex), Rf = 0.60; 'H 
NMR (Acetone-&, 300 MHz) 6 7.43-7.26 (m. SH, AH), 5.71 ( d  1H, J = 10.2H., NH), 
5.15-5.05 (m, 2H, CbzCH20), 3.9 1-3.85 (s + rn, 7H, OB0 ester CH20, a-CH), 3.58 (s, 
3H, C02CH3). 2.50-2.38 (m. lH, yCH), 1.84 (ddd, lH, J =  5.1, 11.3, 14.OHz, P - 0 ,  
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1.73 (ddd, lH, J =  3.6, 9.3, 14.OHz, B-CHH), 1.16 (d, 3H, J =  6.7Hz, yCH3), 0.82 (s, 
3H, OB0 ester CC&); NMR (Acetone*, 75 MHz) 6 176.5 ad), 156.4 (CONH), 
137.6 (Cb-), 128.3, 127.7, 127.7 (Cbz===), 108.3 (OB0 ester - O ) ,  72.4 (OB0 
ester CHD), 65.8 (CbzCH20), 53.0 (a--H), 50.9 (CW3), 35.8 (y--, 33.3 (OB0 
ester CC&), 30.3 (B-m2), 15.9 (ym3), 13.4 (OB0 ester C w 3 ) ;  IR (cast from CHCI,) 
3330, 2958, 2877, 1714, 153 1, 1214, 1061,978,752; HRMS (FAB) calcd for (M + 
C20Hd07 394.1 8658, found 394.18465. Anal. calcd for C&N@: C, 6 1 -06; H, 6.84; 
N, 3.56. Found: C, 60.87; H, 6.84; N, 3.43. 
trio~bi~y~10[2~2.2]0~t-l-yl)pentan01ite, Cbz-L-Glu(pMe)(OMe)-OBO ester, 4.74 
Cbz-L-Glu(y-Me)(OMe)OBO ester 4.73 (0.177 g, 0.45 rnmol) was dissolved in dry THF 
(25 mL) and cooled to -78°C under Ar. LDA (9 mL, 9.00 mmol) was added by syringe 
and the mixture stirred for 1 h at -78OC before king poured into Et20 (100 mL) and 
extracted with 3 1  N W l  (25 mL), 1096NaHCO3 (25 mL), brine (25 mL) and the dried 
over MgSO4. The solvent was removed under reduced pressure to give a light yellow oil 
which was purified by flash chromatography (1: 1 Et0AC:hexanes) to give 79 mg of 4.73 
(44% yield) and 85 mg of 4.74 (46% yield). 
O F 3  
TU3 (1: 1, EtOAc:Hex), Rf = 0.55; 'H NMR (Acetone-&, 300 MHz) 6 7.38-7.22 (m, SH, 
Ar-H), 5.71 (d, lH, J =  10.3Hz. NH), 5.07 (d, lH, J =  12.7H.2, CbzCHHO), 4.98 (d, 1H, J 
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= l2JHz, CbzCHHO), 3.87-3.78 (s + rn, 7H, OB0 ester C&O, a-CH), 3.55 (s, 3H, 
co2cH3), 2.60-2.48 (m, lH, WH), 2.10-2.00 (m. 1H. 8-CHH), 1.45 (ddd, 1H, J = 3.9, 
10.7, 14.5- B - C m ,  1.16 (d, 3H, J = 7.3H.2, yCH3), 0.78 (s, 3H, OB0 ester CCH3); 
"C NMR (Acetone*, 75 MHz) 6 176.4 c=O),  156.3 GONH), 135.1 ( C b z e ) ,  128.3, 
127.6, 127.6 (Cbz-a=), 108.8 (OB0 ester - O ) ,  72.3 (OB0 ester w), 65.6 
(CbzGH20), 53.3 (a--), 50.8 (COa3), 35.7 (yCH), 33.5 (OB0 ester C a 3 ) ,  30.3 (p- 
CH3, 17.6 (y-CH3), 13.4 (OB0 ester CcH3); And. calcd for CZ&InNq: C, 61 .O6; H, - 
6.84; N, 3.56. Found: C, 61.29; H, 7.01; N, 3.66. 
4.4.13 5-Methyl-(2R,~)-2-[(be~1zylo~1y)caibonyl]~~-m~yl-1-(4me~yl-2,6,7- 
trhxa-bicyclo[2.2.2]0~t-1-yl)pentanoate, Cbz-D-Glu(yMe)(OMe)-OB0 ester, 4.75 
Sarne procedure as in 4.4.1 1. [a120D = +24.3 (c = 1.1, CH2C12); TU3 (1:1, EtOAc:Hex), 
Rf = 0.59; 'H NMR (Acetone-a, 300 MHz) 6 7.38-7.26 (m, SH, ArH), 5.71 (d, lH, J = 
9.8H.2, NH), 5.10-5 .O0 (m, SH, CbzC&O), 3.89 (s, 6H, OB0 ester Cao), 3.90-3.82 (m, 
lH, a-Cm, 3.55 (s, 3H, CO2CH,), 2.49-2.28 (m. IH, yCH), 1.88- 1.64 (m, 2H, $-Ca), 
1.10 (d, 3H, J = 6.7Hz, y-CH3). 0.78 (s, 3H. OB0 ester CCH3); 13c NMR (Acetone-6, 
75 MHz)  6 176.5 cd), 156.4 (CONH), 137.6 (Cbz=c=), 128.3, 127.7, 127.7 
( C b z q = ) ,  108.3 (OB0 ester C-O), 72.4 (OB0 ester m), 65.8 (Cbzw20), 53 .O (a- 
CH), 50.9 (COcH3), 35.9 (y-CH), 33.3 (OB0 ester CCH3), 30.3 @--), 15.8 (y-CH3), - 
13.5 (OB0 ester Cw3);IR (cast fiom CHCls) 3330, 2958, 2877, 1714, 153 1, 1214, 
1061, 978, 752; HRMS (Fm) caicd for (M + H") CZ&&Ja 394.18658, found 
394.18563. Anal. calcd for C a n N O . r :  C, 6 1.06; H, 6.84; N, 3.56. Found: C, 6 1.17; H, 
6.98; N, 3.6 1. 
4.4.14 5.ie~-Butyl-(2S,4S)-2-[(bellzyloxy)csrbonyi]amin~methyI-1-(4-metbyl- 
2,6,7-Moxa-bicyclo[2.2.2]0~t-1-yl)pentano8~ Cbz-L-GIu(yMe)(OlBu)-OB0 ester, 
4.76. 
Procedure same as in 4.4.1 1. [al% = -2 1.2 (c = 0.94, EtOAc); TLC (1 : 1, EtOAc:Hex), Rr 
= 0.56; 'H NMR (Acetone-&, 300 MHz) 6 7.37-7.25 (rn, SH, ArH), 5.67 (d, lH, I = 
10.8Hz, NH), 5.08-5.00 (m, 2H, CbzCH20), 3.87 (s, 6H, 080 ester C H f l ) ,  3.79 (ddd, 
lH, J = 3.9, 10.8, 21.OHz, a-CH), 2.36-2.26 (m. lH, y-CH), 2.23-2.16 (m, lH, B-CHH), 
1 -80- 1.60 (m, 1 H. $-CHH), 1.38 (s, 9H, C(CH3)3), 1 .O7 (d, 3H, J = 7 -3 Hz, y-CH3), 0.78 
(s, 3H, OB0 ester CC&); "C NMR (Acetone-&, 75 MHz) 6 172.0 (Ca), 156.3 
CONH), 137.6 (Cbz<=), 128.4, 127.7, 127.6 (Ch-=), 108.3 (OB0 ester - O ) ,  
78.3 (C0g(CH3)3), 72.3 (OB0 ester w), 65.7 (CbzCHZO), 54.5 (a-CH), 31.5 (y- 
CH), 30.3 (OB0 ester CCH3), 27.5 (Cw3j3), 25.2 (p-CHI), 16.0 (y-m3), 13.4 (OB0 - 
ester Cm); IR (cast fiom CHC13) 3354, 2952, 2880, 173 1, 1520, 1456, 1244, 1045, 
1016; HRMS (FAB) calcd for (M + H+) C&&IC)7 436.23352, found 436.23647. Anal. 
calcd for C&&07: C, 63.43; H, 7.64; N, 3.22. Found: C, 63.58; H, 7.87; N, 3.29. 
4.4.15 5-Beazy1-(ts9s)-2-[(betlzyloxy)carbonyI]amin~metby1-1-(4-methy1-2,6,7- 
triow~-bicycI0[2~2-2]0~t-l-yl)pentano11~ Cbz-L-Glu(pMe)(OBa)-OBO ester, 4-77. 
Procedure sarne as in 4.4.1 1. [alMo = -22.5 (c = 1.08, EtOAc); TU3 (1 : 1, EtOAcHex), Rr 
= 0.62; 'H NMR (CDQ, 3ûû MHz) 6 7.37-7.23 (m, 10H, ArH), 5.73 (ci, 1 H, J = 1 O.3Hz, 
NH), 5.00-5-11 (m, 4H, CbzCHzO, PhCHfl), 3.86-3.82 (s + m, 7H, OB0 ester C H D ,  a- 
CH'), 2.56-2.42 (m. lH, y-CH), 1.85 (ddd, lH, J=4.9, 11.2, 14.2Hz. $ - C m  1.72 (ddd, 
1H, J = 3.9, 13.7, 14.2H2, BCHH), 1.13 (d, 3H, J = 6.8Hz, ?CH3), 0.78 (s, 3H, OB0 
ester CCH3); I3c NMR (CDCS, 63 MHz)  6 175.8 @O), 156.4 (CONH), 137.6, 136.8 
(Ch+, Ph-<=), 128.5, 128.3, 128.0, 127.9, 127.7, 127.6 (Cbz<H=, Ph<H=), 108.3 
(OB0 ester - O ) ,  72.4 (OB0 ester cH20), 65.7, 65.6 (CbzçH20, PhcH20), 52.9 (a- 
CH), 35.9 (y-C-), 33.2 (OB0 ester CCH3), 30.3 (f3-CHt). 15.9 (y-CH3), 13.3 (OB0 ester - 
CC&); IR (cast fiom CHC13) 3350, 2952,2880, 1732, 1519, 1451, 1239, 1040, 1016; 
H R M S  (FAB) calcd for (M + H+) Ca3ZN& 470.2 1786, found 470.21705. And. calcd 
forC2&1N&: C, 66.51; H, 6.65; N, 2.98. Found: C, 66.70; H, 6.42; N, 3.01. 
4.4.16 S-Metby1- (2S ,4S) -2- [ (be~to~~nyI  ]amin&th JI-1-(4-methyl-2,6,7- 
a.i-onabieyclo[2.2~]OCf-l-yl)pentan~te, Cbz-L-Glu(pEt)(OMe)-OB0 ester, 4.743. 
Cbz-L-Glu(0Me)-OB0 ester 4.69 (0.325 g, 0.85 mmol) was dissolved in dry THF (30 
mL) then cooled to -78°C whüst stirring under Ar. In a second flask, L i i i D S  (2.57 
mL, 2.57 mmol, 1.OM in TEIF) was added to dry THF (5 mL) then cooled to -78°C 
whilst stimng under Ar. The Cbz-L-Glu(0Me)-OB0 ester 4.69 was then transferred 
dropwise to the second flask via cannda. The mixture was allowed to stir at -78°C for 1 
hour before ethyl iodide (0.34 mL, 4.25 mmol) was added by syringe. The mixture was 
allowed to stir for 6 hours at -78OC before being poured into 3% NH&l (20 mL) and 
extracted with Et20 (100 mL). The organic layer was then extracted with 3% W C 1  (20 
mL), saturated NaHC03 (20 mL), brine (20 mi,) and dried over MgS04. The solvent was 
removed in vacuo to reveal a yellow oil which was m e r  purified by flash 
chromatography (1: 1 Et0Ac:Hex. 0.5% E t m  to give a clear oil in 68% yield (0.234 g). 
[a120D = -25.6 (c = 1.24, EtOAc); TU3 (1: 1, EtOAc:Hex), Rf = 0.61; 'H NMFt (Acetone- 
&, 300 MHz)  6 7.42-7.24 (m, 5H, ArH), 5.63 (d, 1 H, J = 10.3i-I~. NH), S.lW.98 (m 2H, 
CbzCH20), 3.86 (s, 6H, OB0 ester C m ) ,  3.88-3.78 (m, 1H, a-CH), 3.53 (s, 3H, 
C02CH3), 2.36-2.26 (m, l& yCH). 1.82 (ddd, 1H, J = 3.6. 8.0, 14.1&, fj-CHH), 1.71 
(ddd, 1 H, J = 6.4, 1 1.3, 14.1 Hz. B-CHH), 1.64- 1.44 (m, 2H, CH2CH3). 0.79 (t, 3H. J = 
7.3&, CHZCH~), 0.78 (s, 3H, OB0 ester CCH3); I3c NMR (Acetone-a, 75 MHz) 6 
175.9 E=O), 156.3 GONH). 137.6 (Cbz===), 128.3, 127.7, 127.7 (Cbz==H=), 108.3 
(OB0 ester C-O), 72.4 (OB0 ester w20), 65.7 (Cb2m20), 53.3 (a-CH), 50.7 
(COa3) .  43.2 (y-), 3 1.6 @-CH*), 30.3 (CCH3).  24.3 a2a3), 13.4 (OB0 ester 
C m ) ,  10.8 (CHCH3); IR (cast fiom CHC13) 3359, 2962, 2879, 1730, 1517, 1457, 
1230, 1047, 1009; HRMS (FAB) calcd for (M + H+) C2iH3flQ 408.20224, found 
408.20133. Anal. calcd for C21bN07: C, 61.90; H, 7.17; N, 3.44. Found: C, 61.70; H, 
7.16; N, 3.45. 
4A. l'l 5 - M e t b y l - ( ~ , 4 S ) - 2 - [ ~ t l ~ y 1 0 x y ) c a r b o n y l ] P -  
2,6,7-trioxa-bieyei0[2~2~2 Joct-1-yI)ethyI]-pentanmte, Cbz-L-GIu(~AUyl)(OMe)-OB0 
ester, 4.79. 
Cbz-L-Glu(0Me)-OB0 ester A69 (0.232 g, 0.61 mmol) was dissolved in dry THF (30 
mL) then cooled to -78°C whilst stimng under Ar. In a second flask, LiHMDS (1.83 
mL, 1.83 mmol, 1.OM in THF) was added to dry THF (5 mL) then cooled to -78°C 
w hilst s timng under Ar. The Cbz-L-Glu(0Me)-OB0 ester 4.69 was then transferred 
dropwise to the second flask via cannula The mixture was allowed to stir at -78°C for 1 
hour before allyl brornide (0.25 mL, 3.05 mmol) was added by syringe. The mixture was 
allowed to stir for 6 hours at -78°C before king poured into 3% m l  (20 mL) and 
extracted with EtzO (100 mL). The organic layer was then extracted with 3% N w l  (20 
mL), saturated NaHC03 (20 mL), bnne (20 mL) and dried over MgS04. The solvent was 
removed in vacuo to reveal a yellow oil which was further purified by flash 
chromatography (1 : 1 EtOAc:Hex, 0.5% Et3N) to give a clear oil in 78% yield (0.199 g). 
[al2OD = -20.0 (c = 1.1, EtOAc); TLC ( 1 : 1, EtOAc:Hex), Rr = 0.56; 'H NMR (CDCls, 300 
MHz) 6 7.41-7.26 (m, SH, Am, 5.78-5.60 (m, lH, CH=CH2), 5.15-4.95 (m, 4H, 
CbzCH20, CH<&), 4.73 (d, lH, J = 10.5Hz, NH) 3.95-3.85 (m, lH, a-CH), 3.85 (s, 
6H. OB0 ester CHÎO), 3.50 (s, 3H, COzC&), 2.55-2.45 (m, 1H. y-CH), 2.36-2.25 (m, 
2& C&CH=CH*), 1.95- 1.73 (m, 2H, B-W), 0.76 (S. 3H, OB0 ester CCH3); 13c NMR 
(CDCIa, 75 MHz)  6 176.3 (C=O), 155.4 (CONH), 136.5 (Cbz*), 134.9 (CH=CH2), 
128.4, 128.1. 128.0 ( C b z a = ) ,  1 17.1 ( m a 2 ) ,  108.2 (OB0 ester Ç-O), 72.7 (OB0 
ester CH20). 66.7 (Cbz-), 53.7 (a-Q-I), 51.4 (CwH3), 42.1 (y-CH), 36.2 
CHzCH=C&), 3 1.2@-GHz), 30.5 (OB0 ester CCH3), 14.3 (OB0 ester CÇH& IR (cast 
From CHC13) 3355,2952, 2881, 1732, 1519, 1448, 1340, 1227, 1047, 1013; Anal. calcd 
for C22H29Na: C, 62.99; H, 6.97; N, 3.34. Found: C, 62.78; H, 7.15; N, 3.33. 
triow~bicyclo[2.2.2]0~t~l-yl)pe1itano8te, Cbz-L-Glu(yBn)(OMe)-OB0 ester, 4.8û. 
Cbz-L-Glu(0Me)-OB0 ester 4.69 (0.135 g, 0.36 mmol) was dissolved in dry THF (10 
mL) then cooled to -78OC whilst stirring under Ar. In a second flask, LiHMDS (1.07 
mL, 1.07 mmol, 1.OM in THF) was added to dry THF (5 rnL) then cwled to -78°C 
whilst stimng under Ar.. The Cbz-L-Glu(0Me)-OB0 ester 4.69 was then transferred 
dropwise to the second flask via cannula The mixture was allowed to stir at -78OC for 1 
204 
hotu before benzyl brornide (0.21 mt, 1.80 mrnol) was added by syringe. The mixture 
was allowed to stir for 6 hours at -78'C More king poured into 3% N&C1(20 mL) and 
extracted with Et20 (100 m.). The organic layer was then extracted with 3% N m l  (20 
mL), saturated NaHC03 (20 mL), brine (20 mL) and dried over MgS04. The solvent was 
removed in vacuo to reveal a yellow oil which was further purified by flash 
chromatography (1: 1 EtOAc:Hex, 0.5% E t m  to give a clear oil in 75% yield (0.199 g). 
[a120D = -51.3 (c = 1 .W. EtOAc); TLC (1: 1, EtOAc:Hex), Rf = 0.60; 'H NMR (Acetone- 
&, 300 MHz) 6 7.40-7.02 (m, 10H, ArH), 5.75 (d, IH, J =  10.3Hz, NH), 5.13 (d, lH, J =  
22.7Hz, CbzCHHO), 5.00 (d, lH, J =  12.7Hz, CbzCHHO), 3.97 (dt, lH, J =  3.4, 10.3Hz, 
a-CH), 3.87 (s, 6H, OB0 ester C m ) ,  3.41 (s, 3H, C02CH3), 2.97-2.89 (m, lHT y - 0 ,  
2.78-2.60 (m, 2H, PhCHz), 1.93-1.85 (m, lH, $-CHH), 1.80-1.69 (m, lH, p-CHH), 0.76 
(s, 3H, OB0 ester CC&); 13c NMR (Acetone-cl6, 75 MHz) 6 175.3 (C=O), 156.5 
CONH), 139.5, 139.5 (Cbz-sz, Ph<=), 129.0, 128.4, 128.2, 127.8, 127.8, 126.2 
( C b z a - ,  Ph-), 108.3 (OB0 ester C-O), 72.4 (OB0 ester CH20), 65.9 
(Cbz-O), 53.2 (a-CH), 50.6 (COm3), 44.6 (y-CH), 37.1 m2Ph) ,  32.3 (OB0 ester 
=HI), 30.3 (8-m), 13.3 (OB0 ester CcH3); IR (cast from CHC13) 2949. 2880, 1732, 
1516, 1455, 1220, 1048, 1012; HRMS (FAB) calcd for (M + HC) cé&132N07 470.2 1786, 
found 470.21822. Anal. calcd for CA1N07: C, 66.51; H, 6.65; N, 2.98. Found: C, 
66.60; H, 6.62; N, 3.04. 
4.4.19 B e ~ 1 z y I - N - [ ( 3 R ~ S ) - 5 - m e t b y l - 2 1 0 x o t e t r a h y d ~  4.W. 
Cbz-L-Glu(0Me)-OB0 ester 4.69 (0.077 g, 0.20 rnmol) was dissolved in THF ( IO mL) 
then cooled to -30°C whilst stimng under Ar. DIBAL-H ( 0.60 mL, 0.60 mmol) was 
then added and the mixture allowed to warm to room temperature. After 6 h a TU3 
indicated the reaction complete and so 20% AcOH (4 mL) was added and the mixture 
stirred for 30 min before saturated potassium sodium tartrate (50 mL) was added and the 
mixture stirred for 1 h. The mixture was extracted with EtOAc (3 x 100 rnL), the organic 
fractions pooled then extracted with brine (50 mL) and dried over MgS04. The solvent 
was then removed under reduced pressure and the resulting oil dned under high vacuum. 
The light yellow oil was taken-up in benzene to which p-TsOH (10 mg) was added and 
the mixture stirred ovemight at 60°C. The solvent was removed in vucuo and the 
resulting oil taken up in Et0AC:Hexanes (1:l) then passed through a silica plug to 
rernove any polar by-products to give 21 mg of crude 4.84 (40% yield). 
1 H NMR (CDCl3, 3ûûMHz) 6 7.39-7.25 (m, 5H, ArH), 5.56 (br s, 1 H, NH), 5.10 (s, 2H, 
CbzCHzO), 4.56-4.43 (m, 1 H, a-CH), 4.23 (dd, 1 H, J = 5.3, 1 1.3Hz, C02CHH), 3.97 (dd, 
1 H. J = 10.3Hz (detennined by decouphg experiments), 1 1.3Hz, C-CHH,) 2-38-2.12 
(m, 2H, CHCH3, p-CHH). 1.89-1.7 1 (m. 1 H, P-CHH), 1 .O4 (d, 3H, J = 6.4Hz, CHCH& 
4.4.2û (S)-2-[(BenzyI0xy)carbonyl]amin011-metb0xy-11o~0pentan0i~ acid, Cbz-L- 
Glu-(OH)OMe, 4.85. 
Cbz-L-Glu(0H)OH (5.00 g, 17.7 mmol) and p-toluenesulfo~c acid (0.16 g, 0.81 mmol) 
and paraformaldehyde (0.66 g) were refluxed in benzene (100 mL) in a DeamStark 
apparatus. After 6 h., the solvent was removed under reduced pressure and the residue 
suspended in EtOAc (150 mL) and extracted with H20 (2 x 50 mL). The organic layer 
was then washed twice with 10% NaHCa (2 x 50 mL) and the aqueous layers pooled 
and acidified to pH 3 with I N HCl. These were then extracted with EtOAc (3 x 50 mL) 
and the organic layers pooled, extracted with bnne (50 mL) then dried over MgSO4. The 
solvent was then removed under reduced pressure. The residue was dried under high 
vacuum then dissolved in MeOH (50 mL) and added to methanol (100 mL) to which 
sodium metal (0.81 g, 35.4 mmol) had been added. The mixture was then refluxed for 6 
h, cooled and the solvent removed in vacuo. The residue was taken-up in chloroform 
(100 mL) and extracted with 0.1 N HCl (2 x 20 mL), HzO (20 mL), brine (20 mL) then 
dried over MgS04. The solvent was removed under reduced pressure to give 4.18 g 
(8 1 % yield) of 4.85 as an oil that was used without further purification. 
TU) ( 1 : 1, CHCl3:EtOAc, 1% AcOHj Rf = 0.14; NMR (CDC13, 3ûûMHz) 6 10.4 (br s, 
IH, COOH), 7.32 (br s, 5H, ArH), 6.25 (br s, 1 H, NH), 5.10 (s, 2H, CbzCH20), 4 4  1 (m, 
1 H, a-CH), 3.70 (s, 3H, C@CH3), 2.50-2.3 1 (m, 2H, y-CH2), 2.27-2.10 (m. 1 H, f3-Cm), 
2.04-1.84 (m, 1H. B-CHH); 13c NMR (CDC13, 75 MHz) 6 178.1 (CrO), 172.8 @O), 
156.1 (CONH), 136.1 (Cbz=C=), 128.6, 128.3, 128.2 (Cbz=CH), 67.3 (Cbz--O), 53.2 
(a-CH), 52.7 (com3), 29.9 27.5 (p-a2) ;  MS es0 (M + ~3 296.12. 
Same as descnbed in 4.4.3. TLC (1:1, EtOAc:Hex), Rf = 0.35; 'H NMR (CDC13, 
300MHz) 6 7.37-7.28 (m, SH, ArH), 5.41 (d, IH, J = 8.3Hz. NH), 5.08 (s, 2H, 
CbzCH20), 4.47 (d, 2H, J = 5.9Hz, oxetane ester CHHO), 4.44-4.38 (rn, 1 H, a-CH), 4.35 
(d, 2H, J = 5.9Hz. oxetane CHHO), 4.14 (S. 2H, C02CH2), 3.73 (s, 3H, C02CH3), 2.52- 
2.38 (m, 2H, y-CHz), 2.28-2.13 (m. lH, B-CHH), 2.06 1 .go (m, 1 H, P-CIW), 1.29 (s, 3H, 
oxetane ester CH3); I3c NMR (CDClg, 75 MHz) 6 172.8 C=O), 172.3 (Ç=O), 156.0 
(_cQNH), 136.2 (Cbze=), 128.6, 128.2, 128.1 (Cbz<H), 79.6 (oxetane ester CHIO), 
69.0 (COKH2), 67.2 (CbzCW), 53.3 (a-=), 52.7 (CO&&), 39.0 (oxetane ester 
CCHd, 30.0 (%Hz), 27.7 @-GHz), 21.2 (oxetane ester Cm); ESI-MS (M + H+) - 
378.22; Anal. cdcd for CI9Ha07:  C, 60.15; H, 6.64; N, 3.69. Found: C, 60.31; H, 6.78; 
NT 3-71. 
Same as described in 4.4.7. Recrystallized fkom diethyl ethechexanes:petroleum ethers 
30-60. m.p. 75-76"C, [al2OD = M.7 (c = 0.97, CH2C12); TLC (1 : 1, EtOAc:Hex), Rr = 
0.41; 'H NMR (Acetone-&, 300 MHz) 6 7.36-7.24 (m, 5H, ArH), 6.62 (d, lH, J =  8.3H.z, 
NH), 5.04 (d, lH, J =  12.7Hz, CbzCHHO), 4.20 (dt, lH, J =  4.9, 8.3 Hz, a-CH), 3.82 (s, 
6H, OB0 ester OC&), 3.65 (s, 3H, CO2C&), 2.M1.86 (m. 2H, y-CH2), 1.84-1.64 (m, 
2H, b-CH2). 0.76 (S. 3H, OB0 ester CC&); 13c NMR (Acetone-&, 75 MHz) G 174.5 
c=0), 158.0 (CONH), 139.1 (CbzS-=), 130.2, 129.6, 129.5 ( C b z a = ) ,  1 10.2 (OB0 
ester C-O), 73.9 (OB0 ester GHzO), 67.7 (Cbz,CH20), 55.7 (a-CH), 53.2 (COcH3), 34.8 
(OB0 ester CCH3). 3 1.8 (y-GHz), 27.6 (p-cH2), 15.3 (OB0 ester Cm& IR (cast from 
CHC13) 3343, 2954, 2879, 1723, 1529, 1454, 1214, 1057, 993; Anal. calcd for 
C19H25N&: C, 60.15; H, 6.64; N, 3.69. Found: C, 60.1 1; H, 6.60; N, 3.73. 
4.423 Me~yl-(2S)-2-[[(be11zgIo~~nyI](methyl)~o 1-1-(4-methy l-2,6,7-tri- 
0~bi~y~i0[2.22]0ctt-l-y1)pe11tan~~ Cbz-N-MeL-Glu(yMe)(OMe)OBO ester 
4.89/4.90. 
Cbz-L-Glu(y-Me)(OMe)OBO ester 4.73 (61 mg, 0.15 mmol) was dissolved in dry THF 
(5 mL) and then transferred via cannula to a second flask containing LDA (0.45 mL, 0.45 
rnmol) in dry THF (3 mL) at 40°C. After one hour, Me1 (38 pL, 0.75 rnmol) was added 
and the mixture allowed to w m  to room temperature. After 4 hours, the mixture was 
poured into ether (25 mL) and extracted with 3% N W l  (10 mL), 10% NaHC03 (10 
mL), brine (10 mL) and diied over MgS04. The solvent was removed under reduced 
pressure to give a light yellow oil which was purifieci by flash chromatography (1: 1, 
Et0Ac:Hex) to give a clear oil as a mixture of cis 4.89 and tram 4.90 isomers in 54% 
yield (32 mg). 
TU3 (1: 1, EtOAc:Hex), Rf = 0.58; 'H NMR (Acetone-&, 3 0  MHz)  6 7.42-7.26 (m, SH, 
ArH), 5.09 (s, 2H, CbzCH20), 4.44 (dd, 0.53H, J = 3.4, 12.2Hz, a-CH cidtrans), 4.28 
(dd, 0.47H, J = 3.4, 12.2Hz7 a-CH cidtrans), 3.86 (s, 6H, OB0 ester C m ) ,  3.55 (s, 
1.4 1 H, C02CH3 cidtrans), 3.53 (s, 1.59H, C02CH3 cidtrans), 2.72 (s, 1.5H, N - C a ) ,  2.69 
(S. 1SH. N-CH3), 2.30-2.20 (m. lH, ')"CH), 2.11-1.98 (m, lH, B-CHH), 1.64-1.52 (m. 
lH, p-CHH), 1.08 (d, 1.59H, J =  6.8Hz, yCH3 cidttans), 1.02 (d, 1.41H, J = 6.8Hz, y- 
CH3 cidtrans), 0.76 (s, 3H, OB0 ester CC&); "C NMR (Acetone-&, 75 MHz) 6 175.9 
210 
(ça), 164.0 EONH), 143.3 (Cbz==). 128.3, 127.7, 127.6 (Cbz===), 107.7 (OB0 
ester - O ) ,  72.2 (OB0 ester m20), 65.8 (Cb2m20), 53.0 (a-), 50.9 (CO&H3), 32.8 
(y-çH), 33.1 (OB0 ester CC&), 29.3 (p-m2), 17.9, 16.3 (yw3) ,  16.2 (OB0 ester 
CCH3) - 
4.4024 Methyl-(~4[(bell~ylo~y)carbonyl]amino12-[hydn,xy(pbenyl)metbyI]4-(4- 
methyi-2,6,7-tfi0~bi~y~l0[2.2.2 10ct-l-yI)b~tanoate, Cbz-L-Glu(pOHPh)(OMe)- 
OB0 ester, 4.91. 
Cbz-L-Glu(0Me)-OB0 ester 4.69 (0.107 g, 0.28 m o l )  was dissolved in dry THF (10 
mL) then cooled to -78°C whilst stirring under Ar. h a second flask. LiHMDS (0.87 
mL, 0.87 rnmol, 1.OM in THF) was added to dry THF (5 mL) then cooled to -78°C 
whilst sturing under Ar. The Cbz-LGlu(0Me)-OB0 ester 4.69 was then transferred 
âropwise to the second fiask via cannula The mixture was allowed to stir at -78°C for 1 
hour before benzaldehyde (0.14 mL, 1.40 mrnol) was added by syringe. The mixture was 
allowed to stir for 6 hours at -78°C before king poured into 3% -1 (10 mL) and 
extracted with Et20 (50 mL). The organic layer was then extracted with 3% NH&I (15 
m. ) ,  saturated NaHC03 (1 5 mL), bnne (1 5 mL) and dried over MgSO4. The solvent was 
removed in vacuo to reveal a yellow oil which was further purified by flash 
chromatography (1 : 1 Et0Ac:Hex. 0.5% Et3N) to give a clear oil in 7 1 % yield (0.096 g). 
TLC (1:1, EtOAc:Hex), Rf = 0.38; 'H NMR (Acetone-&, 300 MHz) mixture of 3:l 
stercoisomers 6 8.06-8.00 (m. 2H. ArH), 7.65-7.57 (m. IH, ArH), 7.5 1-7-44 (m, 2H, 
Am, 7-40-7.22 (rn, 5H, ArH), 5.61 (d, 0.25H, J = 10.3&, NH), 5.51 (d, 0.75H, J = 
10.3Hz, NU), 5.10-4.98 (m, 2H, CbzCHzO), 4.77 (d, 07SH, J = 6.8Hz, GCHOH), 4.7 1 
(d, 0.25H, J = 8.3Hz, &CHOH), 3.79 (s, 4.SH. OB0 ester C H f l ) ,  3.77 (s, 1 SH, OB0 
ester C m ) ,  3.84-3.72 (m, lH, (%-CH), 3.55 (s, 0.793, C&CH3), 3.44 (s, 2.25H, 
C02CH3), 2.96 (ddd, 0.25H. J = 3.4, 8.3, 1 1.7H.z. yCH), 2.8 1 (ddd, 0.75H. J = 5.3, 6.8, 
8.3Hz, y-CH), 1.96-1.84 (m. lH, & C m ,  1.78-1.64 (m, LH, B-CHH), 0.75 (s, 2.258, 
OB0 ester CCH3), 0.73 (s, 0.75H. OB0 ester CCH3); 13c NlMR (Acetone-&, 75 MHz) 6 
174.7, 174.3 (C--O), 156.2 CONH), 143.4, 143.0 (Cb*=), 137.7. 137.4 (Ar--C-=), 
128.5, 128.4, 128.3, 128.1, 128.0, 127.9, 127.9, 127.8, 127.8, 127.6, 127.6, 127.5, 127.3, 
127.3, 127.0, 126.6 (Cbz-a=), 108.2, 108.1 (OB0 ester C-O), 74.8, 74.2 ( W H ) ,  
72.2, 72.2 (OB0 ester -2), 65.8, 65.5 (CbzCH20), 53.8, 53.7 (a-CH), 50.6, 50.4 
(CO&H3), 50.0, 49.6 (y-CH), 30.2 (OB0 ester cCH3), 29.2, 29.1 (fkm2), 13.3, 13.3 
(OB0 ester CCH3); ESI-MS (M + H?) 486.3 1; Anal. calcd for C2&IN08: C, 64.32; H, 
6.44; N, 2.88. Found: C, 64.79; H, 6.70; N, 2.97. 
4.4.25 ri.rrns-2-@henylsulIonyl)-3-phenylo~ 4.92. 
N-Benzylidenebenzenesulfonarnide (5.00 g, 2.2 mmol), saturated NaHC03 (20 rnL) and 
chloroform (30 mL) were placed in a flask and cooled to 0°C. MCPBA (4.9 g, 22 mmol) 
in chloroform (30 mL) was then slowly added by dropping funnel and the mixture stirred 
for 1 hour. The organic layer was washed with water (25 mL), 10% sodium sulfite (25 
mL), water (25 mL), bnne (25 mL) then dned over anhydrous potassium carbonate for 30 
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min. The solvent was removed under reduced pressure, ensuring the bath temperature 
remained below 40°C. to give 0.55 g of the desired product as a white solid in quantative 
yield. The white solid was washed with pentaw and either used without further 
purification or recrystalIized from Et0Ac:pentane. 
'H NMR (CDC13, 300 MHz) 6 8.05 (br d, 2H, J = 7.1Hz. ArH), 7.82-7.61 (m, 3H, ArH), 
7.55-7.35 (m, 5H, J = 10.3Hz, ArH), 5.50 (s, lH, CH); I3c C ( m l s ,  75 MHz) 8 
135.2 (Ar--C-H=), 134.7 (Ar--C-=), 131.6 (M-H=), 130.5 (Arc=) ,  129.5, 129.5, 128.9, 
128.4 (-=), 75.5 (Phh-. 
Isolated from 4.4.28. TLC (1: 1, Et0Ac:Hex). Rf = 0.37; 'H NMR (Acetone+,300 MHz) 
7.92-7.02 (m, 15H, ArH). 5.60 (d, 1H. J = 10.3H.2, glu-NH), 5.09 (d, lH, J = 12.3Hz, 
CbzCHHO), 5.03 (d, 1 H, J = 12.3H2, CbzCHHO), 4.73 (d, 1 H, J = 6.8Hz, S02NH), 4.16- 
4.10 (m, 1 H, sulfonamide CH), 3.9 1-3.8 1 (m, IH, a-CH), 3.79 (s, 6H, OB0 ester OC&). 
3.38 (S. 3H, C@CH3), 2.85-2.77 (m. lH, WH), 1.94-1.80 (m, lH, B-CHH). 1.78-1.64 
(m, lH, P-CHH), 0.75 (s, 3H, OB0 ester CCH3); 13c NMR (Acetone-&, 75 MHz)  6 
174.2 (C--0). 156.3 (CONH), 141.8 (-=), 139.6 (WC=), 137.4 (Cbz--Ç=), 131.9, 
131.8, 128.9, 128.5. 128.4, 128.1, 126.9, 126.8, 126.0 (Oz-=, x H = )  108.1 (OB0 
ester C-O). 72.3 (OB0 ester cH20), 65.9 (Cbz-), 58.6 (&Q3NH), 51.9 (a-CH), 
5 1.1 (CO-3), 49.3 (y-), 35.0 (OB0 ester c m 3 ) ,  30.2 (fW-Hz), 13.3 (OB0 ester 
CW3) 
4.437 M e t a y l - ( 2 S , ~ - 2 - [ ( b e ~ l o x y ) c a r b o n y l ] ~ b i -  
~ ~ ~ ~ 0 [ 2 * 2 * 2 ] ~ t ~ l ~ y 1 ) 4 ~ [ ( l , l ~ 1 ~ t r i m e t h y I s i l y l ~  C~Z-L-GIU(POTMS)- 
(0Me)-OB0 ester, 4.95. 
Isolated from 4.4.28. TLC (1: 1, Et0Ac:Hex). Rr = 0.76; 'H NMR (Acetone-a, 300 MHz) 
6 7.38-7.24 (m. 5H, ArH), 5.85 (d, lH, J = 10.3Hz, NH), 5.09 (d, lH, J = 12.7Hz. 
CbzCHHO), 5.01 (d, 1 H, J = l2.7Hz, CbzCHHO), 4.20 (dd, 1 H, J = 1.9, 1 1.4Hz, y-CH), 
4-10-4.00 (m, 1 H, a-CH), 3.85 (s, 6H, OB0 ester C H S ) ,  3.64 (S. 3H, C02CH3), 1.97 
(ddd, lH, J = 1.9, 10.7, 14.1H~. p-CHH), 1.74 (ddd, lH, J = 2.4, 1 1.4, 14. ~Hz ,  P-CHH), 
0.76 (s, 3H, OB0 ester CC&), 0.06 (S. 9H, (Cff&Si); I3c NMR (Acetone-d6, 75 MHz) 6 
173.8 c=O), 156.3 CONH), 137.6 ( C b e ) ,  128.4, 127.7, 127.7 (Cbz===), 108.5 
(OB0 ester C-O), 72.4 (OB0 ester w20), 68.8 (CbzQ120), 65.7 (m, 5 1.6 (a-CH), 
5 1.2 (C0&H3), 35.2 (OB0 ester CCH3). 30.3 (f3-m2), 13.5 (OB0 ester CGC3), -0.7 
(Si(CH3)& ESI-MS (M + Ht) 468.32. Anal. calcd for CnH3&I@Si : C, 56.51; H, 7.11; 
N, 3.00. Found : C, 56.71; H, 7.29; N, 3.04. 
4.438 M e t h y l - ( 2 S , 4 S ) - 2 - [ ~ ~ I o x y ) c a r b O n y l ] ~ -  
trioxa-bicyc1o[2.2.2]oct1-yl)pentan~~ Cbz-L-Glu(îi)H)(OMe)-OBO, 4.96. 
n-Butyllithium (0.72 mL, 1 .O8 mrnol) was slowly added to diisopropylamine (0.165 mL, 
1.18 mmol) in dry THF (5 mL) at 0°C under Ar. After 30 minutes the mixture was 
transferred via cannula to a second flask containing Cbz-L-Giu(0Me)OBO 4-69 (0.135 g, 
0.36 mmol) and (it)-~ranr-2-(phenylsuifonyl)-3-phenyloxaW 4.92 (0.47 g, 1.80 
mmol) in dry THF (10 mL) at -78°C under Ar. After 3 h the mixture was poured into 
ether (50 mL) and extracted with 3% NH&1 (2 x 10 mL), 10% NaHC03 (10 mL), brine 
(10 rnL) and dried over MgSQ. The resulting light y e l i ~ ~  oil was purified by flash 
chromatography (1: 1 Et0Ac:Hex) to yield O. 1 lg (79% yield) of a clear oil which could 
be crystailized from Et0Ac:hexanes to give 95 mg (68 % yield) of clear needles. 
m.p. 103-104°C; [alZoD = -29.3 (c = 1 .O 1, CWl2); TLC (1 : 1, EtOAc:Hex), Rr = 0.17; 'H 
NMR (Acetone-&, 300 MHz) 6 7.36-7.25 (m, SH, ArH), 5.89 (d, 1H, J = 1 O.OHz, NH), 
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5.10-5.00 (m, 2H, CbzCH20), 4.244.04 (m. 3H, W H ,  a-, OH) 3.86 (S. 6H, OB0 
ester CH20). 3-64 (S. 3H, C&CH3), 1.92 (ddd, 1 H, J = 2.9, 1 1.3, 14.2 Hz. p-CHH), 1.75 
(ddd, 1H, J = 2.9, 11.7, 14.2Hz. $-CHH), 0.79 (s, 3& OB0 ester CCH3); 13c NMR 
(Acetone-&, 75 MHz)  6 174.6 @O), 156.6 CONH). 137.6 (Cbz<=), 128.3, 127.7, 
127.7 (Cbz<H=), 108.4 (OB0 ester C-O), 72.4 (OB0 ester m2O), 67.4 (y-CH), 65.8 
(C~ZÇH~O), 5 1 9 (a-GW, 5 1 -2 (Co&&), 35.1 (OB0 ester cCH3), 30.3 (B-w2), 13.4 
(OB0 ester CGH3); IR (cast from CHC13) 3370, 2953, 288 1, 1730, 1523, 1234, 1049, 
1012; MS (EST) (M + H+) 396.22. Anal. calcd for Ci9H&T08: C, 57.72; H, 6.37; N, 3.54. 
Found: Cl 57.90; H, 6.35; N, 3.65. 
4.4.29 Me~l-(E5s)-2-[(be112yioxy)carbo11y1~smin011-(4methy1-2,6,7-trio~bi- 
cycîo[2.2.2]-oct-l-yl)-3-b~ten0~1t~ Cbz-GGlu(E-B,~ehydro)(OMe)OBO ester 4.97. 
Cbz-Ser(a1d)OBO ester 3.42 (0.5 17 g, 1.6 1 rnmol) and methyl(tripheny1phosphor- 
any1idene)acetate (0.646 g, 1.93 mmol) were combined then dissolved in dry CH2C12 (25 
mL) and stirred under Ar. Afier 1.5 h, the solvent was removed under reduced pressure 
and then purified by flash chromatography (1 : 1, Et0Ac:Hexanes) to give the desired 
product in 86% yield (1.62 g) which was recrystallized from diethyl 
ethenhexanes:petroleum ethers 3 0 a 0  to give 1.46g (74% yie1d)of white needles. 
0 y O C H 3  
mp. 1 16- 1 165°C; [al2'D = -2 1 .O (c = 0.95, CH2C12); TLC (1 : 1, EtOAcHex). Rr = 0.5 1 ; 
'H NMR (Acetone*, 300 MH2) 6 7.38-7.24 (m. 5H, ArH), 6.94 (dd, lH, J = 4.9, 
15.7)Iz, CH=CIfC02CH3), 6.30 (6, lH, J =  9.3HZ, NH), 5.96 (dd, lH, J =  1.5, 15.7H2, 
CH=CHC02CH3), 5.07 (s, SH, CbzCH20), 4.49 (ddd, IH, J = 1.5, 4.9, 9.3Hz, a-CH), 
3.89 (s, 6H, OB0 ester CH20), 3.66 (s, 3H, CaCH3), 0.80 (s, 3H, OB0 ester CCH3); 
13c NMR (Acetone+. 75 MHz) 6 165.4 ) 155.3 CONH), 142.5 
cH=CHC02CH3), 137.4 (Cbz<=), 128.4, 127.9, 127.9 (Ch-=), 108.1 (OB0 ester 
C-O), 72.5 (OB0 ester - 20 ) ,  65.9 (Cbzm20), 5 1.8 (a-CH), 50.7 (COLCHs), 30.5 - 
(OB0 ester ÇCHs), 13.5 (OB0 ester Cm& HRMS (FAB) calcd for (M + HC) 
C2fH2.JU@ 378.14746, found 378.1343 1. Anal. cafcd for C 19HuN207: C, 60.47; H, 6.14; 
N, 3.71. Found: C, 60.24; H, 6.16; N, 3.71. 
4.4.M Methyl Dipbenylphospbonmcetate, 4.98." 
Triphenyl phosphite (4.65 g, 15.0 rnrnol) and methyl iodide (0.76 mL, 15.0 rnmol) were 
combined and refiuxed for 24 h. After cooling, ethanol(20 mL) was added to the thick 
oil and stirred to homogeneity then distilled to remove ethanol and ethyl iodide. The 
temperature was then raised until phenol stopped crystailizing in the distillation 
apparatus. The dark oil was then cooled to room temperature and diluted with Et20 (80 
mL) and extracted with 1 N NaOH (2 x 20 mL) then dried over MgS04. The solvent was 
removed under reduced-pressure to give a brown coloured oil. The oil was then dissolved 
in dry THF (20 mL) and combined with methyl chloroformate (1.16 mL, 15.0 rnmol) and 
cooled to -78°C then transferred to a flask containing LiHMDS (34.5 mL, 34.5 mmol) at 
-78°C. After stining at -78°C for 1 hour the mixture was quenched with 3% NH&I and 
extracted with EtOAc (2 x 20 mL). The organic extracts were combined and washed 
with water (2 x 20 mi,), brine (20 rnL) the dried over MgS04 and then concentrated to a 
pale yellow residue which was purified by flash chromatography ( 5 1  to 3:l 
hexanes:EtOAc) to give 4.98 (3.22 g, 67% yield) as a clear oil. 
1 H NMR (CDC13, 300 MHz) 6 7.37-7.3 1 (m, 4H, ArH), 7.25-7.17 (m, 6H, A@, 3 -77 (s, 
3H, C02CH3), 3.28 (d, 2H, J = 22H~,  CH2C02). 
4.4.31 Methyï-(Z,~-2-[~~1zyïoxy)carbnyï]amin01 1-@-me thyl-2,6,7-t rioxabi- 
cycio[2.2.2]6et-l-yl)-3-butenaate, Cbz-L-G!u(Z-f&flehydro)(OMe)OBO ester 4.99. 
Sodium hydride (0.220 g, 4.56 rnmol) was suspended in dry THF (20 mL) to which 
methyl diphenylphosphonoacetate 4.98 (1.32 g, 4.32 mrnol) pre-dissolved in THF (25 
mL) was added. M e r  30 min. the mixture was cooled to -78°C and Cbz-Ser(a1d)OBO 
ester 3.42 (1.55 g, 4.8 mmol) dissolved in dry THF (15 mL) added by syringe. After 2 h 
the mixture was quenched with 3% W C 1  and extracted with EtOAc (2 x 50 mL). 
NaB& (OSg) was then taken-up in Hz0 (30 mL) then added to the vigourously stimng 
EtOAc extracts to reduce any remaining 3.42. After 10 min. the organic layer was 
separated and washed with 10% NaHC03 (2 x 15 mL), brine (15 rnL) then dried over 
MgS04 and concentrated to a white residue which was purified by flash chromatography 
(3:2 Et0Ac:hexanes) to give 4.99 (1.10 g, 61% yield) as an oil which could be 
recry stallized fiom Et0Ac:hexanes to give white, dense crystals. 
mp. 128-130°C; [a120D = 48.8 (c = 1.03, EtOAc); TLC (1 : 1, EtOAc:Hex), Rf = 0.5 1 ; 'H 
NMR (Acetone-&, 300 MHz) 6 7.38-7.20 (m, SH, MW), 6.04 (dd, 1 H, J = 9.8, 1 1.4Hz, 
CH=CHC02CH3), 5.86 (4 1 H, J = 1 1.4Hz, CH=CHC02CH3), 5.74 (br dd, 1 H, J = 9.4, 
9.8Hz, NH), 5.00 (s, 2H, CbzCH20), 3.86 (S. 6H, OB0 ester CH20), 3.66 (s + m, 4H, a- 
CH, C02CH3), 0.79 (s, 3H, OB0 ester CCH3); I3c NMR (Acetone-&, 75 MHz) 6 165.4 
(Ca), 156.3 (CONH), 142.5 cH=CHCaCHs), 137.5 (Cb2<=), 128.4, 127.9, 127.9 
( C b z a = ) ,  108.1 (OB0 ester C-O), 72.5 (OB0 ester m20), 65.9 (Cbz-O), 5 1 -8 (a- 




Cbz-L-Glu(E-f3,ydehydro)(OMe)OBO 4.97 (0.426, 1.13 mmol) and N-methylmorph- 
oline N-oxide (0.139 g, 1.19 mmol) were combined and dissolved in acetone: water (4: 1, 
15 mL) to whkh OsOs (15 mg, 0.05 mmol) was added. After the mixture had stirred for 
48 hours at rmm temperature the solvent was reduced in vacuo, dissolved in methanol 
(20 mL), reduced again then dissolved in a minimum of methanol to which an equal 
amount of Et0Ac:Hex (2: 1) was added and then flash chromatographed to give 0.264 g 
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(57% yield) of the âesired produa which was recrystallized h m  Et0Ac:hexanes to give 
0.20 g (44% yield) of small dense white crystals. 
mp. 121-122.S°C; [ U ] ~ D  = -38.3 (c = 1 .O7, CH2Cu; TU3 (2: 1, Et0Ac:Hex). Rf = 0.2 1 ; 
1 H NMR (Acetone-&, 300 MHz) 6 7.40-7.26 (m, 5H, A&), 6.09 (d, 1 Hl J = 9.6Hz. NH), 
5.06 (S. 2H, CbzCH20), 4.47 (m, 1 H, WH), 4.20 (m, 1 H, P C H ) ,  4.12 (dd, 1 H, J = 7 -3, 
10.3Hz, a-CH) 3.97-3.93 (s + m, 7H. OB0 ester CHD, $-OH), 3.86 (d, lH, J = 7.9Hz. y- 
ON), 3.70 (s, 3H, C&CH3), 0.84 (S. 3H, OB0 ester CCH3); I3c NMR (Acetone-&. 75 
MHz)  6 173.3 C C ) ,  156.3 (CONH), 137.5 (Cbz<=), 128.3, 127.7, 127.7 (Cbz=ÇH=), 
108.3 (OB0 ester c-O), 72.3 (OB0 ester m20), 71.7 (yCH), 70.0 @-CH), 65.8 
(Cbz-), 56.8 (a-CH), 51.4 (Co&&), 30.4 (OB0 ester mH3) ,  13.3 (OB0 ester 
CCH3); IR (cast fiom CHzC12) 3429,2955,2883, 173 1, 1520, 123 1,  1046, 1013; ESI-MS 
(M + HC) 412.15; Anal. calcd for Ci9H&Q: C, 55.47; H, 6.12; N, 3.04. Found: C, 
55.64; H, 6.26; N, 3.09. 
Cbz-L-Glu(Z-B,y-dehydro)(OMe)OBO 499 (0.150 g, 0.40 rnmol) and N-methylrnorph- 
oline (0.049 g, 0.42 rnmol) were combined and dissolved in acetone:water (4: 1 , s  mL) to 
which Os04 (1 grain) was added. After the mixture had stined for 48 hours at room 
temperature the solvent was reduced in vacuo, dissolved in methanol (20 mL), reduced 
again then dissolved in a minimum of methanol to which an equal amount of Et0Ac:Hex 
(2: 1) was added and then flash chromatographed to give 0.074 g (45% yield) of 4.101 as 
a light coloured oïl. 
[al2'o = +4.4 (c = 0.9, CH5Cl2); TLC (2: 1, EtOAc:Hex), Rr = 0.21; 'H NMR (Acetone-Q, 
300 MHz) 6 7.40-7.26 (m, 5H, ArH), 6.09 (d, IH, J = 10.3Hz. NH), 5.07 (s, 2H, 
CbzCH20), 4.66 (br d, lH, J =  7.3Hz, yrCH), 4.16 (dd, IH, J = 9.8, 10.3Hz, a-CH), 3.91 
(s, 6H, OB0 ester C H B ) ,  3.83 (dd, lH, J = 7.3, 9.8Hz, p-CH) 3.66 (s, 3H, C02CH3), 
0.80 (s, 3H, OB0 ester CC&); I3c NMR (Acetone-4, 75 MHz) 6 172.8 C=O), 156.7 
(CONH), 137.4 (Cbz*), 128.4, 127.8, 127.8 (Cbz=CJI=), 108.6 (OB0 ester - O ) ,  
72.4 (OB0 ester cH20), 71.5 (PSH), 70.8 (y=, 66.1 (CbzÇ&O), 53.8 (a-CH), 50.9 
(COS&), 30.4 (OB0 ester CCH3), 13.2 (OB0 ester CcH3); IR (cast from CHzClz) 
3447,2953,2883, 1734, 1717, 1521, 1228, 1048; ESI-MS (M + 412.15; Anal. cdcd 
for ClgHsNQ: C, 55.47; H, 6.12; N, 3.04. Found: C, 55.69; H, 6.24; N, 3.06. 
4.434 Reformatsky addition to Cbz-L-Ser(dd)-OBO ester 3.42: te*butyl(lS,2R)-l- 
[(benzyloxy)carbon y1]amino12-hydn,xy-1-(~metbyI-2,6,7-nio~bi~ycl0[2~2.2]0~t-l- 
yl)butanaate, Cbz-L-GIu(p-O~(OtBu)OBO ester, 4.104. 
Purified zinc powder (O.Mg, 2.88 mmol) and iodine (1 small crystal) were dissolved in 
dry THF (10 rnL) then refluxed for 20 min before a solution of Cbz-Ser(a1d)OBO ester 
3-42 (0.153g, 0.48 m o l )  and t-butylbromoacetate (0.35 rnL, 2.40 mmol) in THF (5 mL) 
was quickly added to the refiuxing solution. After 30 min the zinc was filtered off and 
the filtrate poured into cold 3% N W I  (50 mL) then extracted with Et20 (3 x 50 mL). 
The organic layers were combined and extracted with 10% NaHC03 (15 mL), brine (15 
mL) and dried over MgS04. The solvent was removed in vacuo and the resulting oil 
purified by flash chromatography to give 0.157 g of 4.104 (75% yield over 2 steps) as a 
pale oil. 
[a l2 'D = -7.3 (c = 0.9, CH2C12); TU3 (1: 1, EtOAc:Hex), Rf = 0.32; 'H NMR (Acetone-a, 
300 MHz) 6 7.40-7.24 (m, SH, ArH), 5.78 (d, lH, J = 10.3Hz, NH), 5.10 (d, IH, J = 
12.7Hz, CbzCHHO), 5.03 (d, 1H, J = 12.7Hz, CbzCHHO), 4.51-4.44 (m, lH, $-CH), 
3.86 (s, 6H, OB0 ester CH20), 3.79 (dd, 1 H, J = 2.0, 1 O.3H.z. a-CH), 2.3 1-2.24 (m, 2H, 
Y-C&), 1 -39 (s, 9 8  (CH3)3C), 0.80 (s, 3H. OB0 ester CCH3); I3c NMR (Acetone-&, 75 
MHz) 6 170.1 (çEO), 156.4 KONH), 137.5 (Cbz<=), 128.4, 127.7, 127.6 (CbZ<H=), 
108.4 (OB0 ester GO), 79.5 ((CH3)3C), 72.3 (OB0 ester -Hz), 66.3 @--QI), 66.0 
(CbzQI20), 57.4 ( a m ,  39.8 (yCJS2), 30.4 (OB0 ester CCH3), 28.5 (a3)C) 13.7 
(OB0 ester Cm3); IR (cast h m  C&C12) 35 15, 3452, 2973, 2934, 288 1, 1726, 15 13, 
1366, 1279, 1225, 1 153, 1047; ESI-MS (M + H+) 438.21; Anal. calcd for C22H3iN08: C, 
60.40; H, 7.14; N, 3.20. Found: C, 60.63; H, 7.34; N, 3.26. 
4.4.35 1 - [ ( 2 , 4 , 6 - T r i i S o p r o p y I p h e n y I ) S U E f o n y l ] ~  Trisy1 azide, 
4.105. 
2,4,6-Tnisopropylbenzenesulfonyl chloride (3.94 g, 13.0 m o l )  was added to a stimng 
mixture of NaN3 (2.53 g, 39.0 mrnol) in Hz0 (20 mL). Acetone (40 rnL) was 
immediately added and the solution stirred for 5 hours. The mixture was then extracted 
with Et20 (3 x 50 mL), the organic layers pooled and then extracted with H20 (30 mL), 
brine (30 mL) and then dried over Na2S04. The solvent was removed in vacuo to reveal 
a crearn coloured oïl which crystallized on standing to give 3.40 g (85% yield) of 4.105 
which was used without further purification. 
'H NMR (Acetone-&, 300 MHz) 7.43 (S. 2H, Adf), 4.06 (septet, 2H. J = 6.8Hz, 
(CH3)2CH), 3.03 (septet, 1 H, J = 7.1 Hz, (CH3)2CH), 1-29 (d, 1 2H, J = 6.8Hz. (Ca)2CH), 
1.26 (d, 6H, J = 7.1Hz, (cH3)2CH); 13c NMR (Acetoned, 75 MHz)  6 155.7 (A-=) 
15 1.2 (Ar--C-=), 132.3 (Ar-iJ=), 124.8 (Ar=C-Hz), 34.5 ((CH3),CH), 30.2 ((CH3)sH), 
24.4 ((CH3)2CH), 23.2 ((CH3)2CH). 
4.4.36 1-[(~,4S)-~[(Be11zylo~)carbonyl]amin01l-(metboxyCIVbOny 1)-3-(4-methyl- 
2,6,7-trioxabicyc10[2.2.2 ]oct-l-yl)pmpy1]-1~tri~dien-%iurll, Cbz-L-G1u(pN3)- 
(0Me)-OB0 ester, 4.106. 
Cbz-L-Glu(0Me)-OB0 ester 4.69 (0.600 g, 1.58 mmol) was dissolved in dry THF (5 
mL) then cooled to -78°C whilst stimng under Ar. In a second flask, LiHMDS (4.74 
mL, 4.74 mrnol, 1.OM in THF) was added to dry THF (15 mL) then cooled to -78°C 
whilst stimng under Ar. The Cbz-L-Glu(0Me)-OB0 ester 4.69 was then transferred 
dropwise to the second flask via cannula. The mixture was allowed to stir at -78°C for 1 
hour before trisyl azide 4.105 (0.825 g, 3.16 mmol) was added, predissolved in dry THF 
(10 d), by syringe. The mixtwe was allowed to stir for 6 hours at -78°C before being 
poured into 3% W C 1  (20 mL) and extnrted with Et20 (100 mi,). The organic layer 
was then extracted with 3% m l  (20 mL), saturated NaHC03 (20 mL), brine (20 rnL) 
and dried over MgS04. The solvent was rpmoved in vacuo to reveal a yellow oil which 
was further purified by flash chromatography (1 : 1 EtOAc:Hex, 0.5% Et&) to give a 
clear oil in 54% yield (0.08 1 g). 
TLC (l:l, EtOAc:Hex), Ur = 0.40; 'H NMR (CDC13, 300 MHz) 6 7.38-7.26 (m, SH, 
Am, 5.12-5.02 (m. 2H, CbzC&O), 4.92 (d, IH, J =  10.1Hz, NH), 4.08 (dt, lH, J =  2.9, 
10.1 Hz, a-CH), 3.96 (dd, lH, J =  3.7, 10.7 Hz, Y-CH), 3.85 (s, 6H, OB0 ester C&0), 
3.71 (s, 3H, C o r n 3 ) ,  2.08 (ddd, 1& J =  2.9, 10.9, 14.5Hz. PCHH), 1.85 (ddd, 1H. J = 
224 
3.7, 10.7, 14.5Hz. BCHH), 0.76 (S. 3H, OB0 ester CCH3); I3c NMR (CDCls, 75 MHz) 6 
171.1 (Cd), 156.4 (CONH), 136.3 (C~Z-%=), 128.5, 128.2, 128.1 (C~Z-a=), 108.0 
(OB0 ester C-O), 72.7 (OB0 ester 0CH2), 67.0 (CbzD20), 59.3 (y-, 52.6 (a--CH), 
52.1 (CO=), 32.2 (OB0 ester CCH3), 30.5 (fbW2), 14.2 (OB0 ester CcH3); IR (cast 
from CHC13) 3432,2954,2883,2121, 1727,1515,1227, 1048,1016,909; ESI-MS (M + 
H+) 421.03. Anal. calcd for Ci9H*4@: C, 54.28; H, 5.75; N, 13.33. Found: C, 54.48; 
H, 5.98; N, 13.36. 
4.4.37 Metbyl-(2S,AS)4-amin0-2-[(be~10xy)~bonyI]smin011-(4-methyI-2,6,7- 
trioxabicycIo-[2.2.2]oct-1-y1)butanoate, Cbz-L-GIu(~NH2)(OMe)-O80 ester, 4.107. 
Cbz-L-Glu(y-N3)(0Me)-OB0 ester 4.106 (0.032 g, 0.07 rnmol) was combined with PPh3 
(24 mg, 0.09 mmol) and dissolved in dry THF (50 mL) then stirred at ambient 
temperature for 24 hours. Distilled water (15 pi) was then aàded and the mixture 
refluxed for 3 hours. The solvent was then removed under reduced pressure to give a 
white solid which was purified by flash chromatography to give the desired product in 
76% yield (21 mg). 
TU= (9: 1, Et0Ac:MeOH:O.S % m H ) .  Rf = 0.60; 'H NMR (Acetone-&, 300 MHz) 6 
7.36-7.21 (m, 5H, ArH), 5.78 (d, lH, J = 10.4Hz, NH), 5.06 (d, IH, J = 12.7Hz, 
CbzCHHO), 4.96 (d, 1 H, J = 12.7Hz, CbzCHHO), 4.1 1 (ôr d d  1 H, J = 3.4. 10.7Hz, y- 
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CH), 3.85 (s, 6H, OB0 ester CH20), 3.68 (ddâ, lH, J =  2.9, 10.4, 12.2Hz, a-CH), 3.57 
(s, 3H, C02CH3), 2.86 (br s, 2H, y-NH2), 2.24 (ddd, IH, J = 2.4, 10.7, 1 3.7H2, p-CHH), 
1.88 (ddd, lH, J = 3.4, 12.2, 13.7Hz, p-CHH), 0.76 (S. 3H, OB0 ester CCH3); I 3 c  NMR 
(Acetone-4, 75 MHz) 6 172.0 156.1 (ÇONH), 137.7 (a-=), 128.4, 127.7, 
127.7 (Cbz===), 108.5 (OB0 ester C-O), 72.3 (OB0 ester CJ120), 65.6 (CbzW20), 
59.5 (y-cm, 5 1.8 (a-CH), 5 1.1 (COD3), 33.0 (OB0 ester ÇCH3), 30.3 (B-w2), 1 3.4 
(OB0 ester CQi3); IR (cast fkom CHC13) 3374, 2949, 2880, 1730, 15 16, 1224, 1046, 
101 1; ESI-MS (M + H+) 394.90. Anal. caicd for Ci9Hz&J2@: C, 57.86; H, 6.64; N, 7.10. 
Found: C, 58.08; H, 6.75; N, 7.12. 
4-4-38 Metbyl-(2S,4S)-2-[(be11zyloxy)carbnyl ]am 
w t h y I - 2 , 6 , 7 - t r i o x a b i c y c 1 0 [ 2 ~ 2 . 2 ~ 0 ~ t - l - y ~  Cbz-L-Glu(~OMs)(OMe)OBO 
ester, 4.108. 
Cbz-L-Glu(y-OH)(OMe)OBO ester 4.% was dissolved in dry CHzC12 (5 mL) then cooled 
to 0°C. Et3N (57 pL, 0.42 rnmol) was then added followed by mesyl chloride (16 pL, 
0.21 rnmol). The mixture was allow to stir for 12 h before the solvent was removed in 
vacuo der which the desired product could be purifieci by flash chromatography to give 
4.108 in 80% yield (76 mg). However, the mesylate was generally displaced by azide 
without isolation. 
TLC (1:1, EtOAc:Hex), Rc = 0.35; 'H NMR (Acetone*, 300 MHz) 6 7.38-7.24 (m, SH, 
ArH), 6.22 (d, lH, J =  10.3Hz, NH), 5.10 (d, lH, J =  12.7Hz, CbzCHHO), 5.03 (d, 1H, J 
= 12.7Hz, CbzCHHO), 4.83 (dd, lH, J = 2.9, 11.7Hz, yCH), 3.96 (ddd, IH, J = 2.4, 
10.3, 11.7Hz, a-CH), 3.88 (s, 6H, OB0 ester O-), 3.71 (s, 3H, C02CH3), 2.19 (ddd, 
1H. J = 2.9. 11.7, lS.lH., BCHH), 1.89 (ddd, lH, J = 2.4, 11.7, lS.lHi, B-CHH), 0.76 
(s, 3H, OB0 ester CCH3); I3c NMR (CDC13, 75 MHz) 6 170.0 (T=O), 157.1 (CONH), 
137.7 (Cbz<=), 128.5, 128.1, 128.1 (Cbz<H=), 108.3 (OB0 ester - O ) ,  75.4 (y-CH) 
72.7 (OB0 ester CH@) 66.4 (CbzCH20), 52.4 (a-CH), 5 1.8 (C0sH3), 38.4 (S0&H3), 




(0Me)lOBO ester, 4.169. 
By displacement of the mesylate 4.lW. Cbz-LGlu(yOMs)(OMe)OBO ester 4.108 
(0.076 g, 0.16 mmol) was dissolved in dry DMF (5 mL) to which NaN3 (2 1 mg, 0.32 
mrnol) was added and the mixture stirred for 48 h. The solvent was reduced in vacuo and 
the purified by flash cluomatography to give 37 mg (56% yield) of 4.109. 
By Mitsunobu reaction. Cbz-L-Glu(y-OH)(OMe)OBO ester A% (0.100 g, 0.25 -01) 
and Ph3P (0.098 g, 0.38 mmol) were combined and dissolved in dry THF (5 mL) and 
stirred at O°C under Ar. DEAD (60 pL, 0.38 rnmol) was added dropwise followed by 
(0.97 mL, 0.75 rnmol). The reaction was allowed to warm to room temperature and 
stir for 18 h before a TLC indicated the reaction complete. The solvent was removed 
under reduced pressure with NaOH trapping the residual HN3. The oily residue could be 
purified by flash chromatography (1:l Et0Ac:hexanes) to give pure 4.109 (26 mg, 26% 
yield) with the remainder contarninated with diethyl amidodicarboxylate. 
TLC (1: 1, EtOAc:Hex), Rf = 0.52; 'H NMR (Acetone-a, 300 MHz) 6 7.38-7.23 (m, SH, 
A M ,  5.88 (d, 1 H, J = 9.7Hz, NH), 5.08 (d, 1 H, CbzCHHO), 5.00 (d, 1 H, CbzCHHO), 
4.18 (br dd, lH, J =  6.3, 6.9Hz, NH), 3.97 (ddd, lH, J =  4.4,9.3, 9.7Hz, a-CH), 3.87 (s, 
6H, OB0 ester CH20), 3.69 (S. 3H, C@CH3), 2.08 (ddd, lH, 3 = 4.4, 6.9, 14.1Hz, B- 
C m ) ,  1 -80 (ddd, lH, J = 6.3, 9.3, 14.1 Hz, p-CHH), 0.76 (s, 3H, OBO ester CC&); 13c 
NMR (Acetone-&. 75 MHz) 6 170.8 (Cd), 156.3 (CONH), 137.8 (Cbz<=), 128.6, 
128.0, 127.9 (Cbz-=), 108.5 (OB0 ester - O ) ,  72.7 (OB0 ester O=), 66.1 
(CbzW201, 59.9 ()-i), 52.5 (a--a, 52.3 (Corn3). 32.2 (p<HI),  30.7 (OB0 ester 
CC&), 13.6 (OB0 ester CcH3); IR (cast from CHQ)  3432. 2954, 2883, 2121, 1727, 
1515, 1227, 1048, 1016,909; ESI-MS (M + H+) 421.12. Anal. calcd for C19H&4@: C, 
54.28; H, 5.75; N, 13.33. Found: C, 54-41; H, 5.93; N, 13.39. 
4-4-40 Methyl-(tr,4R)4amin01%[~llzylo~)carbonyl]amin01l-(&methy1-2,6,7- 
Mo~bicyc10-[2~22]oet-i-yl)pentanmte, Cbz-L-Glu(yN&)(OMe)-OB0 ester, 4-110. 
As described in 4.4.36. TLC (9: 1, Et0Ac:MeOH:O.S 95 NI&OH), Rf = 0.57; 'H NMR 
(Acetone-&, 300 MHz)  6 7.39-7.28 (m, SH, ArH), 6.85 (d. 1 H, J = 8.9Hz, NH), 5.07 (s, 
2H, CbzCHzO), 4.22 (m, lH, yCH), 3.86 (s, 6H, OB0 ester CH20), 3.68-3.55 (m + s, 
4H, a-CH, C02CH3), 2.82 (br s, 2H, yN&), 2.54-2.46 (m. lH, p - 0 ,  2.30-2.22 (m, 
lH, P-CHH). 0.79 (s, 3& OB0 ester CC&); 13c NMR (Acetonc-a, 75 MHz) 6 171 -8 
@O), 156.0 (CONH), 137.5 (Cbz<=), 128.4, 127.7, 127.7 ( C b e H = ) ,  108.4 (OB0 
ester O ) ,  72.2 (OB0 ester -), 65.3 (CbzCH20), 59.9 (?CH), 51.7 (a-CH), 51.1 
(COL&), 33 .O (OB0 ester cCH3), 29.9 (p--a), 13.4 (OB0 ester CcH3); ESI-MS (M 
+ HC) 394.89. Anal. cdcd for C I 9 H a 2 @  : C, 57.86; H, 6.64; N, 7.10. Found : C, 58.16; 
H, 6.81; N, 7.21. 
4.4-41 Metbyl-(2S,4S)-2-[(be~~oxy)carbonyl Jamind-bmmoll-(4-methyi-2,6,7-tri- 
oxabicyc10[2.2~2]0~t-l-yl)pentan~te, Cbz-GGlu(pBr)(OMe)-OB0 ester, 4-112- 
Cbz-L-Glu(0Me)-OB0 ester 4.69 (0.179 g, 0.47 mmol) was dissolved in dry THF (10 
rnL) then cooleci to -78OC whilst stirring under Ar. In a second flask, LiHMDS (1.42 
mL, 1.42 mmol, 1.OM in THF) was added to dry THF (15 mL) then cooled to -7S°C 
whilst stimng under Ar. The Cbz-LGlu(0Me)-OB0 ester 4.69 was then transferred 
dropwise to the second flask via cannuia. The mixture was allowed to stir at -78°C for 1 
hour. N-bromosuccinimide (0.092 g, 0.52 mmol) was suspended in THF (10 mL) in a 
third fiask and cooled to -78'C. The enolate was then added quickly by cannula to give a 
deep purple coloured mixture which was then stimd for approximately 6 houn at -78OC 
before k ing  poured into Et20 (70 mL) and extracted with 3% N W I  (20 mL), 10% 
sodium sulfite (20 mL), saturated NaHC03 (20 mL), bine (20 mL) and dried over 
MgSOd. The solvent was removed in vacm to reveal a light yellow oil which was further 
purified by flash chromatography (1: 1 Et0Ac:Hex) to give a clear oil in 64% yield (O. 137 
8)- 
[u]"D = +21.2 (c = 3.00, CH2C12); TLC (1: 1, EtOAc:Hex), Rf = 0.50; 'H NMR (Acetone- 
Q, 300 MHz) 6 7.34-7.28 (m, SH, ArH), 5.09-5.04 (m, 2H, CbzCH20), 4.79 (d, 1 H, J = 
10.3&, NH), 4.29 (dd, lH, J = 6.1, 8.5H~,  p o ,  4.10 (dt, lH, J = 3.5, 10.3H.z. CECH), 
3.85 (s, 6H, OB0 ester C m ) ,  3.66 (s, 3H, C02CH3), 2.41 (ddd, lH, J = 3.6, 8.6, 
lS.OHz, B-CHH), 2.18 (ddd, lH7 J = 3.6, 6.1, lS.OHz, 8-CHH), 0.77 (S. 3H, OB0 ester 
13 CC&); C NMR (Acetone& 75 MHz) 6 170.8 @O), 156.4 (TONH), 136.3 
230 
(Cbz=@), 128.5, 128.2, 128.1 (a-=), 107.9 (OB0 ester GO), 72.7 (OB0 ester 
C W ) ,  67.0 (Cbzm20), 53.4 ( a m ,  52.8 (CO&H3), 42.3 (y-I), 35.6 (OB0 ester - 
CC&), 30.6 (B--2), 14.2 (OB0 ester Cm3);  ESI-MS (M + H+) 457.89, 459.90. Anal. - 
calcd for Cl9H2&N@: C, 49-79; H, 5.28; N, 3.06. Found: C, 50.12; H, 5.48; N, 3.10. 
4.4=42 D i m e t h y l - 2 - [ ( ~ - 2 - [ ( b e ~ I o x y ) c a t . b o n y l ] ~ b i -  
cycio[2.2.2 ]O&-1-yl)ethyi]mdonate, Cbz-L-GIu(y COOMe)(OMe)-OBO, 4.1 13. 
Cbz-L-Glu(0Me)-OB0 ester 4.69 (0.140 g, 0.37 mmol) was dissolved in a flask in dry 
THF (5 mL) and then transferred via cannula to a second flask containing LiHMDS (1.1 I 
mL, 1.1 1 mmol) in THF (5 mL) at -78°C under Ar. Mer 1 hour, methyl cyanoformate 
(35 pL, 0.44 mmol) was added by syringe. After 2 hours the reaction mixture was 
poured into Et20 (80 rnL) and extracted with 3% N&CI (20 mL), saturated NaHC03 (20 
mL), brine (20 mL) and dned over MgS04. The solvent was removed in vacuo to reveal 
a light oil which was M e r  purifed by flash chromatography (1:l EtOAc:Hex, 0.5% 
Et3N) to give a clear oil in 68% yield (0.1 10 g). 
[al2'~ = -24.4 (C = 1.2, CH2C12); TLC (l:l, EtOAcHex), Rr = 0.46; 'H NMR (Acetone- 
dg, 300 MHz)  8 7.40-7.27 (m, 5H, Atm, 5.78 (d, lH, J = 10.2Hz, NH), 5.10 (d, 1H. J = 
12.6Hz, CbzCHIfO), 5.00 (d, LH, J = 12.6Hz, CbzCHHO), 3.92-3.86 (s + m, 7H, OB0 
ester CH20, a-CH), 3.65 (s, 3H, C&CH3), 3.63 (s, 3H, C02CH3), 3.50 (dd, 1 H, J = 5.6, 
9.6Iiz, yCH) 2.36 (ddd, IH, J = 3.8.9.6, 14.3Hz. BCHH),  1.94 (ddà, 1H. J = 5.6, 11.3, 
14.3Hz, P-CHH), 0.81 (s, 3H, OB0 ester CC&); 13c NMR (Acetone& 75 MHz) 6 
169.8 (Cd), 169.1 Co*), 156.3 CONH). 137.5 (a-=), 128.3, 127.7, 127.7 
( C b z g = ) ,  108.1 (OB0 ester - O ) .  724 (OB0 ester m20), 65.8 (CbzcH20) 53.2 (a- 
-, 51.9 (CO&&), 51.8 (CO&&), 48.2 (y-, 30.3 (OB0 ester cCH3), 28.3 @-  
CH2), 13.3 (OB0 ester cCH3); IR (cast fiom CHCl3) 2954, 2881, 1734, 1522, 1438, - 
1241, 1047, 1014; HRMS @AB) calcd for (M + H') CZ~Ha09 438.17639, found 
438.17564. Anal. calcd for C ~ I H ~ ~ N ~  : C, 57.66; H, 6.22; N, 3.37. Found : C, 57.83; H, 
6.29; N, 3.37. 
a4a43 Metbyl-(2S)-2-[(be~loxy~bonyl]LIIIljllOd-[(2S)-2-[(be11zyIoxy)~8fbonyl]- 
amino-2-(4-methyl-2,6,7-tii0~abicyclo[2.2.2 Je 
b i ~ ~ ~ i 0 [ 2 ~ 2 ~ 2 ] ~ t - l - y 1 ) ~ 5 ~ ~ 0 s e p t ~ ~ ~  Cbz-L-GIu(Cbz-L-Glu@eto)OBO ester)- 
(0Me)-OB0 ester 4.117, 
Cbz-L-Glu(0Me)OBO ester 4.69 (0.1 10 g, 0.29 rnmol) was dissolved in dry THF (2 rnL) 
and cooled to -30°C under Ar. LiHMDS (0.43 mL, 0.43 mmol) was then added by 
syringe. After 12 h at -30°C the mixture was poured into Etfi (25 mL) and extracted 
with 3 4  NH&l (5 mL), 109 NaHC03 (5 mL), brine (5 mL) then dried overMgSO4. 
The solvent was removed under reduced pressure to reveal a light yellow oil which was 
purified by flash chromatography to give 4.117 in 48% yield (51 mg) as a mixture of 
approximately 1 : 1 6R,S-diastereomers. 
TU3 ( 1 : 1, EtOAc:Hex), Rf = 0.17; 'H NMR (Acetone-&, 300 MHz) 6 7.43-7.25 (rn, 1 OH, 
ArH), 5.75-5.68 (br m, 2H, 2 NH), 5.08-5.02 (m, 4H, 2 Cb2CH20), 3.94-3.86 (s + m, 
13H, OB0 ester C m ,  COCHC02CH3), 3.78-3.64 (m, 2H, 2 a - C H ) ,  3.62 (s, 1.65H, 
C02CH3), 3.60 (s, 1.35H. COZCH~), 2.67-2.60 (m, 2H, C W O ) ,  2.43-2.36 (m lH, p- 
CHHCH), 2.34-2.26 (m. lH, f%CHHCH), 1.92- 1-78 (m. l H, p-CHHCHZ), l -92- 1.78 (m, 
IH, B-CMCHI), 0.80 (s, 6H, 2 OB0 ester CCH3); I3c NMR (Acetone-6, 125 MHz) 6 
204.7, 204.2 g=O), 170.2, 169.8 G==), 156.8, 156.8, 156.6, 156.6 CONH), 137.9, 
137.9, 137.8, 137.7 (Cbz<=), 128.7, 128.7, 128.2, 128.1 128.0, 128.0, 127.9 
( C b z a = ) ,  108.5, 108.5, 108.4 (OB0 ester - O ) ,  72.6, 72.6 (OB0 ester q H 2 ) ,  66.3, 
66.2, 66.1, 66.0 (Cbzm20), 55.4, 54.7, (a-CH), 54.7, 53.6 (C-02CH3), 52.0, 5 1.9 
(COCHd, 39.4, 38.5 (CHzCO), 30.6, 30.6 (OB0 ester CC&), 28.7. 28.5 (B-W2CH), 
24.2, 24.1 (p-CH2C&), 13.7, 13.6, 13.6 (OB0 ester CsH3); ESI-MS (M + IF) 727.27; 
Anal. calcd for C37)146N2013 : C, 6 1.15; H, 6.38; N, 3.85. Found : C, 6 1.42; H, 6.72; N, 
3.99. 
4-4-44 (ZS,4s)-2-Amin014-metbylpentanedioic acià, (2S,AS)-Methylglutamic acid, 
4.1. 
H2 ; 
See General Procedure for Removal of Roteding Groups. 
[al2OD = +34.0 (c = 0.71, 6 N HCI), (lit? [a120D =+34.7 (c = 0.79, 6 N HCI)); 'H NMR 
(&O, 300 MHz) 6 3.84-3.76 (m, IH, a-CH), 2.70-2-6 1 (m. lH, y€@, 2.12-2.0 1 (m. lH, 
$-CHH), 1.93- 1.84 (m, 1 H, $-CHH), 1.12 (t, 3H. J = 6.8 Hz, fl-CH3); I3c NMR (w, 75 
MHz)  6 183.5 175.0 CC), 55.0 (a---, 39.1 ($--a2), 36.6 (y-, 19.6 (y- 
CH3); ESI-MS (M + 16 1.9 1. Anal. cdcd for C&XlzNO4Cl: C, 36.47; H, 6.12; N, 7.09. - 
Found: C, 36.72; H, 6.32; N, 7.19. 
4*4*45 (2S,4S)-2-Amin0-4~tby1pentrnedioic acid, (2S,4S)-EthylglutPmic acid, 4.3* 
See General Procedure for Removal of Protecting Groups. 
[al2Oo = +23.0 (c = 0.78,6N HCl) (lit? [a120D = +28.4 (c = 1.OY6N HCl)); TU3 (1 : 1 : 1 : 1, 
EtOAc:HsO:nBuOH:AcOH), Rr = 0.75; 'H NMR (DS, 300 MHz) S 4.08-3.84 (m, IH, a- 
cm, 2.62-2.44 (m, lH, y-CH), 2.12-2.00 (m, lH, P-CHH). 1.98-1.85 (m. lH, p - C m  
1 S8- 1.45 (m, 2H, CH-i), 0.77 (t, 3H, J = 7.3Hz. CH2CH3); 13c NMR (&O. 75 MHz) 
6 183.8 Cs), 175.1 @O), 54.0 (a-CH). 47.5 (y-), 33.7 ($-CH2), 25.4 =CH3), 
10.9 (CH&&); ESI-MS (M + H+) 176.30. Anal. calcd for CiHl&T04CI :C, 39.73; H, 
6.67; N, 6.62. Found: C, 40.1 1; H, 6.99; N, 6.75. 
4-4-46 (2S,4S)-2-My14aminopentanedioic ad& (2S,4S)-AU y1ghatamic acid, 4.81. 
See General Procedure for Removal of Protecting Groups using 1N HCl. 
[alZ0D = +36.7 (c = 0.65, 6N HCl); 'H NMR @20, 300 MHz) 6 5.72-5.56 (rn, lH, 
CH=CHz), 5.05-4.96 (m, 2H, CH=CH2), 4.07-3.95 (m, 1 H, a-CH), 2.74-2.63 (m, 2H, B- 
C m ,  y-CH) 2.55-2.44 (rn, lH, &CHH), 2.14- 1.88 (m, 2H, CN2~=CH2);  I3c N ' R  
@*O, 75 M m )  8 182.8 (C=O), 173.5 c=O), 133.2 (CH=CH2), 1 19.1 (CH--CHâ), 54.1 
(a-CH), 4 1 .O (y-CH), 35.4 (p-Hz), 3 1 .O m2CH=CH2); ESI-MS (M + H+) 1 87.85. Anal. 
calcd for CsH14N04Cl: C, 42.96; H, 6.3 1 ; N, 6.26. Found: C, 43.29; H, 6.64; N, 6.35. 
4.4-47 (ZS,4S)-2-Amin&-be1lzy1pentanedioic acid, (2S,4S)-Benzy1giutamic acid, 
4-82. 
See General Procedure for Removd of Protecting Groups. 
[ a l 2 O D  = +24A (c = 0.55.6N HCl); 'H NMR p20, 300 MHz) 6 7.28-7.10 (m, SH, Arw, 
3.85 (dd, 1 H, J = 5.2,g.O Hz, a-CH), 2.98-2.80 (rn, 3H, y-CH, Arc&), 2.05 (ddd, 1 H, J 
= 5.2, 9.8, 14.2 HZ, $-CHH) 1.93 (ddd, l& J = 4.0, 9.0, 14.2 Hz, f3-CI-W); 13c NMR 
(DzO, 75 MHz) 6 178.1 cd), 171.7 @O). 137.9 (-=), 129.1, 128.8, 126.8 
(m-H=), 51.4 (a-ÇH), 43.5 (yQ-I), 38.1 (Ar-Hz), 3 1.5 (DBm2); ESI-MS (M + H+) 
238.3; Anal. calcd for Cl2H1&O4Cl: C, 52.66; H, 5.89; N, 5.12. Found: C, 52.90; H, 
6.02; N, 5-14. 
4.4.48 (2S,4S)-2-~d-hydn,xypentanedioic acià, (2S,4S)-Hydroxy6lutPmieouc acid, 
See General Procedure for Removal of Rotecting Groups. 
[a]*OD = +60.3 (c = 0.9,6N HCI ) (iit." [al2'D = +61 (c = 1,5N HCI); 'H NMR (&O, 300 
MHz) 6 4.03 (dd. lH, J = 4.4, 7.8 Hz. YCH), 3.73 (dd, lH, J =  3.4.7.9 Hz, a-CH), 2.14- 
2.00 (m, W, fbCH2); 13c NMR (D20. 75 MHz)  6 182.6 ad)), 178.7 (C=O), 69.9 (y- 
CH), 51.8 (a-CH), 39.5 ($--); ESI-MS (M + H+') 163.87. Anal. calcd for CsH&iOsCI: - 
C, 30.09; H, 5.05; N, 7.02. Found: C, 30.4 1 ; H, 5.35; N, 7.24. 
4.4.49 (~~R)-2-amin013-hydroxypentsnedioic acid, 4.7. 
Cbz-L-Glu@-OH)(OtBu)OBO ester 4.104 (0.098 g, 0.22 rnrnol) was stirred in fresh 
TMSI (500 pL, 3.5 mmol) at 75°C for 24 h. After cooling, Et20 (3 mL) was slowly 
added followed by the dropwise addition of OSN NaOH (5 mL). The organic layer was 
carefully removed by pipette and washed with 0.5N NaOH (2 x 3 mL). The aqueous 
fractions were combined, washed with Et20 (2 x 5 mL) then acidified to pH<3 with 2N 
HCI. The sample was purified by cation exchange as describeci in section 2.4.15 to give 
0.029 g (82%) of the monoammonium sait which was recrystallized from EtO- to 
give 0.020 g (54%) of the monoamrnonium sdt. Derivatization and HPLC analysis as 
described in section 2.4.15a showed a 93:7 ratio of ihreo:erythto L-p-hydroxyglutamic 
acid with 99% ee (retention times: threo-10.7 (22.1 min), threo-D-4.7 (22.9 min), 
erythro-L-4.7 (26.9 min), eryfhro-D-4.7 (33.1 min). 
mp 202-2ûS°C (dec); (lit." mp 205-206OC (dec)), (lit6 mp 193°C (dec)); 'H NMR ( 3 0  
MHz, D20) 6 4.204.42 (m, 1 H, p-CH), 3.9 1 (d, 0.07H. J = 3.4Hz, erythro a-CH), 3.73 
(ci, 0.93H, J =  3.4Hz, threo a-CH), 2.62 (dd, IH, J =  4.7, 15.4Hz, vCHH), 2.47 (dd, IH, 
J =  8.7. 15.4&, y-CHH), ESI-MS (M + H+) 164.22. 
4.4.50 (2S,As)-2,4iiiaminopentanedioic acid, (ZS,4S)-Arninogîutamic acid, 4.1 1. 
See General Procedure for Removal of Rotecting Groups. 
[al2', = +36.3 (c = 0.4, 6N HCI); (litO6' [al2OD = +45.4 (C = 1 ,  1N HCl); 'H NMR (D20, 
300 MHz) 6 3 .!JO (t, 2H, J = 6.7 Hz, B-CH*), 2.26 (t, 2H, J = 6.7 Hz. a-CH, y-CH); 13c 
NMR (&O, 75 MHz) 6 176.0 (Cd), 55.9 (u-CH, p-CH), 34.3 (p-cH2); ESI-MS 163.2 1. 
Anal. calcd for C5Hi2N&)&l2: C, 25.55; H, 5.15; N, 1 1.92. Found : C, 25.83; H, 5.42; N, 
12.15. 
4.451 (2R,4S)-2,~0pentanedioic acià, (2S,4R)-Aminoglutamic aciâ, 4.111 
See General Procedure for Removai of Protecting Groups. 
[al2OD = O (C = 0.55, 6N HCI); (lit? [a120D = O (c = 5.83, H20); 'H NMR (&O, 300 
MHz)  6 3.99 (t, 2H, J = 6.9 Hz, aCH, WH), 2.46-2.31 (m, IH, b - C m ,  2.12-1.99 (m, 
lH, f3-CHH); "C NMR (&O, 75 MHz) 6 172.0 CC) , 53.9, 5 1 .1  (a--, y-CH), 30.3 
P-GH2) ; ESI-MS (M + HC) 163.27. Anal. caicd for CsHi2N204Clz: C, 25.55; H, 5.15; N, 
11.92. Found: C, 25.83; H, 5.42; N, 12.15. 
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Chapter Five 
Stereoselective Synthesis of f3-Substituted Aspartic Acids 
5.1 Introduction 
5.1.1 Isolation 
The biologicai activity and synthetic importance of p-substituted aspartic acids 
has led to considerable interest in their properties and synthesis. These aspartic acid 
derivatives have been isolated from a wide variety of sources including plants, bacteria 
and humans. p-Methylaspartic acid 5.1 has been isolated fiom C l ~ s ~ d i u r n  
tetanomorphum and as a by-product of glutamic acid degradation in humans-l P-Methyl 
aspartic acid has also been identifid as a constituent of numerous biological molecules 
including aspartocin,l amphomycin: gIumamycin4 and the cyclic peptides nodularin,' 
microcystin-LR,6 cyanogenosin -LA and -RR7 and motuporin: Various B- 
alkylaspartates have been used in the spthesis of numerous biologically active molecules 
including derivatives of the dipeptide antibiotic alahopcin 5.2: the p-lactam antibiotic 
thienarnycin 5.3" and the anti-glaucoma agent pilocarpin SA" to name a few (Scheme 
5.1). 
B-Hydroxyaspartic acid 5.5 was first reported as a natural product in the 
extracellular materiai of ~zobacter cultures12 and has been isolated from numerous plant 
seeds and extracts,' Streptomyces cultures,13 rat liver extracts" and human urine." The 
diastereomers of p-hydroxyaspartic acid are aiso key intemediates in the Krebs cycle in 
some micr~organisms.~~ This amino acid has been found as a constituent of several blood 
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clotting cascade proteins" and as a constituent of the peptide antibiotic lysobactin.'' L- 
erythro-p-Hydroxyaspartic acid has been used in the synthesis of p-lactam antibioti~s.'~ 
&Amino aspartic acid 5.6 is less cornmon and has been isolated from 
Streptomyces rirnosus cultures. It has been used to construct the core constituent of 
lactarn 5.7 of the streptothricin class of antibioticsm and stmctudly similar bioth2' n ie  
well-known metalcomplexing propertiesa of diaminoacids have resulted in the 
investigation of various diamino derivatives in the anti-tumor drug cis-platin? 
Although not naturally occurring, 5-fluoroaspartic acid has been used as an 
intermediate in the synthesis of 5-fiuoro~racil.~ 
Scheme 5.1 
Unlike glutamate (Chapter 4), aspartate has no direct role in humans other than a 
constituent of factor X in h~rnans."~ However, derivatized aspartic acids have been used 
as probes inio the mechanistic action of various enzymes and cofactoa. The 
stereochemistry of coenzyme BI2 isomerization has been investigated in the conversion 
of p-methylaspartate 5.1 to glutamate.= Molecular biology techniques have been used to 
replaced aspartic acid with threo- or eryfhro-$-methylaspartic acid in the active site of 
the enzymes dihydrofolate reductase," asparagine synthetase Bn and HIV-1 proteaseg in 
order to elucidate the mechanism of action of these enzymes. 
Erythro-p-hydroxyaspartate 5.5 has k e n  used as an inhibitor and CO-crystallized 
with aspartate aminotransferase? 
5.1.3 Synthesis of &%bstituted Aspartic Acids 
Most of the generai synthetic methods described in chapter one can be used to 
synthesize B-substihited aspartic acids. These include Scholkopf s bis-lactim ether 
1.33,m Williams' oxazinones l.M3' and various expoxide based methods (vide in fru). 
However, as described previously, the synthetic challenge arises whilst attempting to 
stereospecificaily introduce f3-substituents by 1,2-induction. Although there are 
exceptions most of the general methods for the synthesis of a-amino acids fail in this 
regard and therefore specific methodologies have been developed for B-substituted 
aspartic acids. 
5.1.3.1 Synthesis of PSubstituted Aspurtic Acids: General Rucemic Methods 
P-Methylaspartic acid 5.1 was first prepared in 1941 by Dakin who condensed 
ethyl a-bromopropionate with diethyl benzamidomalonate (Scheme 5.2)?2 Subsequent 
racemic syntheses have also been described using diethyl a~etarnidomalonate~~ and ethyl 
a~etamidocyanoafetate.~ Fractionai crystallization and ionexchange chromatography 
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nireo- and eryrhro-p-hydroxy aspartic acid 5.5 were prepared by Komguth and 
Sallach in 1960 by the condensation of glyoxylic acid with copper glycinate; the two 
isomea were then separated by ionexchange chromatography." Liwschitz et al. 
reported the synthesis of threo- and erythro-DL-B-hydroxyaspartic acid by the 
benzylamination and subsequent hydrogenolysis of cis- and trms-2,3epoxysuccinic acid 
5.7 (Scheme 5.3).j5 A variation of this methodology was later applied to the chiral 
s ynthesis of erythro-L-f3-hydrox yaspartic acid using chiral (-)-~ans-epox y succinic acid 
S.7.36 eryzhro-DL-fbHydroxyaspartic acid has also been synthesized from fumaric acid 
via the arnrnonolysis of chloromalic acid inter~nediate.~' 
Scheme 53 
H02C 
Co BnNH2D 1 )  ion exchange BnH 2) Ha, Pd/C HO& 
Racemic p-aminoaspartate 5.6 and varbus other B-substituted aspartic acids have 
been synthesized using ethyl2-acetoxyglycinate 5.8 as a cationic synthon (Scheme 5.4).'' 
The sarne group later synthesized racernic p-fluoroaspartic acid 5.9 &er diazotization of 
5.6 in the presence of neat HE3' 
Scheme 5.4 
5.1.4 Synthesis of Optically Active PSubstituted Aspartic Acids 
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(including the use of $-lactarns) methods which will be discussed in detail. Numerous 
R=COMe, CN 
AcH C02Et 
other specific syntheses of desired p-aspartic acid denvatives exist and will be explored 
briefl y. 
5.1.4.1 Enzymatic Methods 
fbMethylaspartic acid has k e n  isolated €rom extracts of Clostrr'diurn 
tetanomorphum produced by the enzyme 3-methylaspartate ammonia lyase (EC 4.3.1.2) 
which catalyzes the a,p-elirnination of arnmonia h m  2S,3S-3-methylaspartic acid to 
give mesaconic acid. First isolated in 196û.m the enzyme has k e n  used in a retro- 
physiological reaction with various substituted fùmaric acid derivatives 5.10 and 
armnonia to give p-substituted aspartic acids (Scheme 5.3." Yields were generall y in the 
5û-6ûI  range although reactions times were described as fast to very slow. The same 
group has ais0 added various substituted amines to 5.10 although yields were typically 
less than SOS? Monne et al. have perfonned similar experiments with p- 
methylaspartase in expanding the functionalities that may be incorporated? 





Aspartate aminotransferase (EC 2.6.1.1) has also been used for the synthesis of 
both threo- and erythro-L-B-hydroxyaspartic acid From dihydroxyfumarate and cysteine 
sulfinate? It was necessary to separate the diastereomea by ion exchange 
chromatography giving 72% of the etyfhro derivative and 26% of threo-L-P- 
hydroxyaspartic acid. 
5.1.4.2 PAnion Chemistry (including &Lactans) 
The obvious, and indeed most popular, method for the stereoselective synthesis of 
p-substituted aspartic acids is to utilize the inherent chirality of aspartic acid for 1,2- 
aymrnetric induction reactions. This is most easily accomplished through the p-anion of 
aspartic acid. 
Seebach et al. first reported the stereoselective alkylation of aspartic acid 
denvatives in 198 1 ? Di-t-butyl-N-formyl-itspartate 5.11 (P=CHO, R'=R~=~BU) was 
doubly deprotonated with lithium diethylamide then alkylated with a variety of 
electrophiles to give a mixture of a- and p-substituted aspartic acid denvatives in a ratio 
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of 2:7 respectively, both of which were diastereomerically and enantiomerically pure 
(Scheme 5.6). The predorninant B-methyl product was identified as the anti or îS,3 R-3- 
methylaspartic acid 5.12 @Me). 
Scheme 5.6 
5.1 1 5.1 2 
Baldwin, in an attempt to overcome the a-deprotonation experienced by Seebach 
replaced the N-formyl protecting group of aspartic acid with Cbz." However, although 
no a-addition products were detected, diastereoselectivi ties of 3: 1 to 5: 1 were obtained in 
the reaction of 5.11 (P=Cbz, R'=~Bu, R ~ = M ~ )  with benzyl and allylbrornide. When 
methyl iodide was used, a mixture of N-methyl and B-methyl products was isolated. The 
stereochemistry of the addition product was not reported. 
Rapoport and coworkers successfully addressed the problems associated with N- 
and a-alkylation by protecting the amine in 5.11 as the PhFi (P=PhFï, R ~ = ~ B U , M ~ ,  
R'=M~)? As discussed in chapter four, this protecting group insulates the a-center and 
prevents removal of the a-proton. However, generation of the $-enolate and subsequent 
addition of various electrophiles rrsulted in poor diastereoselectivities, ranging from 3:2 
(syn:anh> for the p-methyl denvative to 5:l (~yZ:tmh3 for the p-isopropyl derivative. In 
the case of more bulky substitutents, aikyl triflates were used as electrophiles. Careful 
control of the addition conditions, including type and amount of base and alkylation 
reagent resulted in an increase in selectivity to 18:l (syn:anh> for the addition of ethyl 
triflate." Rapoport was able to further augment the diastereoselectivity to 30:l by 
increasing the steric bulk on the amine, protecting it as the P W n  derivative 5.11 
(P=PhFl, Bn, R'=~Bu, R ~ = M ~ ) . * ~  
Baldwin and coworkers approached the moderate stereoselectivity previously 
reported by his group through the use of azetidinone 5.13 (Scheme 5.7)? Stereospecific 
"antz" allylation was achieved in >95% in 95% yield. The substituted azetidinone 5.14 
was opened with O-benzylhydroxylamine to give the 2S,3R derivative en route to the 
synthesis of alahopcin 5.2? Hanessian et al. used the same methodology to synthesize p- 
methylaspartate 5.1 by hydrolyzing 5.14 @=Me) with 6N HCl? 
Scheme 5.7 
L-AS, - - 
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The 3-bromo analog of Williams and CO-worker's oxazinone 1.34 was condensed 
with a dibenzyl maionate derivative towards the synthesis of B-carboxyaspartate (Section 
1.3.3.2):' Hydrogenolysis gave B-carboxyaspartic acid in 30% overall yield with >98% 
ee. 
The first report of the general addition of heteroatoms at the B-position of 
aspartate was by Sardina et al. in 1992? Using Rapport's PhFl protected aspartic acid 
derivative 5.11 (P=PhFi, R'=~Bu,M~, R ~ = M ~ ) ,  the enolate was quenched with solid 
MoOPH to give the p-hydroxyaspartate derivative 5.12 (P=PhFl, R'=~Bu,M~, R*=M~, 
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MH). Changing the reaction conditions and base altered the stereoselectivity from 
1 : 1 1 anti:syn (2S,3R:2S,3S) to 20: 1 antisyn (2S,3R:2S,3S). The same conditions were 
used to synthesize the p-azide 5.11 @=Pm, ~ ' = t ~ u , M e ,  R ~ = M ~ )  using trisyl azide 4.105 
and di-r-butylazodicarboxylate (DTBAD). Trisyl azide consistently gave a 1 : 1 mixture of 
fkpimers whereas the use of DTBAD to trap the enolate generated by LiHMDS in 
HMPA gave a 30: 1 ratio of anti:syn (2S,3R:2S,3S).Y 
Hanessian's group used similar methodology in reacting 5.11 (P=Ts, R'=R~=ZBU) 
with Davis* oxaziridine 4.92 to give the $-hydroxyaspartate derivative 5.12 (P=Ts, 
R'=R~=ZBU, &OH) in 45: 1 anti:syn (2S,3R:2S,3S), al though this methodology suffers 
from the relatively harsh conditions required for removal of the sulfonamide N-protecting 
group." Hanessian et al. also reported the allylation of various protected derivatives of 
5.11 (P=Cbz, R'=M~, TMSE, R ~ = M ~ ,  TMSE) in generally greater than 9 5 5  
(îS,3 R:2S,3S) diastereoselectivity? 
Chamberlin and coworken used the synthon 5.11 (P=PhFl, Bn, R'=~Bu, R'=M~) 
to generate both p-akyI diastereomers as a hinction of enolate geometry? The 
potassium enolate gave selectivities of 1:10 syn:anti (2R93S:2R,3R) whereas lithium 
enolates gave ratios of 23:l syn:anti (2Rq3S:2R,3R) in the addition of methyl iodide. 
Chelation and non-chelation controlled addition models were used to describe the 
observed results. 
Parr et al. reported in 1999 the first concise study of the numerous factors 
influencing 1.2-asyrnmetnc induction in dianionic fùnctionalization of L-aspartic acid 
dies ter^.'^ This study was based upon earlier findings in which the enolate of 5.11 
(P=Cbz, R'=ZBU, R ~ = M ~ )  was methylated in poor diastereoselectivity while allylation 
occumd in high dia~tereoselectivity?~ The various factors influencing alkylation of 5.11 
(P=Cbz, R'=~Bu, R ~ = M ~ )  that were studied included temperature, solvent, various 
additives, concentration, ester protecting group, base and electrophile. The observed 
preference for anti alkylation in most of the previously descnbed syntheses by other 
O 
groups was rationalized by chelation of the lithium counter-ion in a (2)-lithium ester 
enolate (discussed in more detail in section 5.2.5). 
5.1.4.3 Other Methods for the Synthesis of flSubstiirued Aspartic Acidr 
Many methods exist for the synthesis of specific B-substituted aspartic acids that 
do not fit into the categories described above. 
(RB)-(+)-Tamate 5.15 was used to synthesize Lerythro-p-hydroxyaspartate 
(2S,3R) by selective protection and formation of triflate 5.16 which was then displaced 
with aide and reduced with H2S to give amine 5.17.M Subsequent 
deprotection/reprotection gave the desired product in 15% overall yield (Scheme 5.8). In 
1990, Wagner et al. reported a modification of the tartrate method described above, 
which although gave lower yields the authors reported was more amenable to scale-upO6' 
The key step was a copper-mediated regioselective saponification of 5.17 and subsequent 
protection of the amine. 
Scheme 5.8 
Garner's aldehyde 1.53 was also used to synthesize Lthreo-p-hydroxyaspartate 
(2S,3S) via an acetylenic intermediate which was oxidized to benzyl ester 5.18." The 
acetonide was then hydrolyzed to alcohol 5.19 that was oxidized to give the desired 
product in 12% overall yield (Scheme 5.9). 
Scheme 5.9 
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Garner's aldehyde 1.53 has also been used in an asymrnetric [2+2] cycloaddition 
in a five step synthesis of protected 2R,3R-$-hydroxyaspartate (Scheme 5.10).63 The 
sarne group also reported a short synthesis of a variety of (2R,3R)-B-alkylated aspartates 
via P-Iactam 5.22 in high diastereoselectivity and good 
Scheme 5.10 
Boc XO - y - 
OHC 
yield (Scheme 5.1 1 )? 
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Ph. Bn 
P-Methylaspartate has k e n  synthesized fiom N-phthaloylglutamic anhydride 5.22 
via a six-member nickelacycle 5.23 to give aspartate amides in a 3:l mixture 
(2S,3S:2S93R) in 55% overall yield (Scheme 5.12).66 
Scheme 5.12 
A variety of p-heteroatom aspartate derivatives were synthesized from the 
dicarboxylate azindine 5.24 to give ZR,3S-S-substituted aspartates in both excellent 
diastereoselecüvity and enantioselectivity and generally high yields (Scheme 5.13)." 
Scheme 5.13 
NU = Ci, 1, N3. Bris, CF3CO0, 
CH8, CH3CO0 
Rotected ~-aminoaspartate Sm6 was synthesized by the oxidative dimenzation of 
glycinate Sm25 in the presence of iodine to give threo derivative S.%? This was then 
deprotected and reprotected to give protected B-aminoaspartate in excellent 
diastereoselectivity, enantioselectivity and yield (Scheme 5.14). 
Scheme 5.14 
A variety of B-alkylated aspartate denvatives were synthesized from protected 4- 
ketoproline 5.27.' Bredereck's reagent 430 gave an enaminone which when reacted 
with a Grignard reagent gave enone 538 that was cataiytically hydrogenated to give only 
the cis-isomer 5.29 (Scheme 5.15). Baeyer-Villiger oxidation gave 530 and after 
hydrolysis protected p-alkylaspartic acid denvatives were isolated in good yield as single 
diastereomers. Direct alkylations on the enolate of 5.30 were also attempted, however, 
diastereoselectivities ranged fkom 1 : 1 to 4: 1 of the transxis isomers. 
Scheme 5-15 
5.2 Results and Discussion 
5.2.1 Methylation of Cbz-Asp(0Me)OBO ester 5.38: Optirnizution and Detemination 
of Diastereoselectivity 
While examining the 1,3-asymmetric induction of the addition of various 
electrophiles to glutamic acid (chapter four) we concurrently investigated the 1,2- 
induction in aspartic acid 5.31- Regioselective esterification of 5.31 was achieved under 
similar conditions to those described in chapter four.@ TMSCl was added in two separate 
aliquots to aspartic acid 5.31 stimng in fieshly distilled methanol and after 18 hours the 
solvent was evaporated to give a white solid of the monomethyl ester (Scheme 5.16). N- 
Protection of the crude product as the Cbz denvative was accomplished with CbzOSu to 
give 5.32. Purification was difficult and so the a-carboxylate was esterified with oxetane 
tosylate 2.38 to give the hilly protected aspartic acid derivative 5.35 in 66% overall yield 
for three steps. Commercially available y-t-butyl ester 5.33 and y-benzyl ester 5.34 were 
esterified under identical conditions to give 5.36 and 537 in 998 and 97% yields 
respectively, after cotumn chromatography. Al1 three oxetane esters 5.35-5.37 could be 
stored for prolongeci periods at rwm temperatun without loss of optical activity. Boron 
trifluoride etherate mediated remangement of the oxetane esters 5.35-5.37 gave the onho 
esters 5.38-5.40 which were recrystallized from Et0AC:hexanes in 91%, 68% and 78% 
yields respective1 y. 
At first, both LLHMDS and LDA were used as bases in the generation of enolates. 
although the use of LDA was later abandoned due to inconsistent results. Baldwin et 
al!& and Seebach et al? also observed increased substrate decomposition and 
racemization with LDA. Three equivalents of base were used, titrated according to the 
method of Love and Jones,"' since the use of two equivalents resulted in a significant 
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amount of unreacted starting material. Methyl iodide was chosen as the initial alkylating 
agent since the easily identifiable doublet could be integrated by NMR methods to 
determine diastereoselectivity. 
Scheme 5.16 
1) TMSCI. MeOH. 18 h , 
2) CbzOSu, Na2C03 
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CHd39 m CbzH 1) 6N HCI, A 
2) Et3N 2) E+, -78°C a* 
5.38 R=Me 5.41 R=E=Me (2S,3S) 5.47 €=Me 
5.39 R = ~ u  5.42 R=E=Mû (2S.3R) 5.48 E4Iyl 
5.40 R=Bn 5.43 h e u .  €=Me 5.49 E=Bn 
5.U R=Bn, €=Me 
5.45 R=Me, Edutyl 
5.48 R=Me, E=Bn 
Addition of LiHMDS to 538 at -30°C and quenching with methyl iodide 
disappointingly gave a I : 1 ratio of fbmethylaspartate 5.41 diastereomers, based upon 'H 
NMR integration of the new methyl doublet at 6 1.12 ppm (major) and 1 .O8 ppm (minor) 
and the a- and B-protons. Al1 attempts to increase the diastereoselectivity failed until the 
order of addition was altered. Inverse addition of 538 to base at -30°C followed by the 
addition of methyl iodide gave a 3:l ratio of diastereomers (Table 5.1, entries 1-3). 
Cooling to -78°C resulted in an increase of diastereoselectivity to 10: 1 in 8 1 k yield after 
8 hours (entry 5). However, although a number of other conditions were investigated 
including the use of other countenons, additives (HMPA and LiCl) and alternative p- 
ester protecting groups (?Bu 543, Bn 5.44), no further increase in diastereoselectivity was 
achieveà. The major contaminant was remaining stvting material (resulting in a reaction 
yield of 92% based on starting material) and the reaction failed to go to completion even 
with prolonged reaction times. Raising the temperature &ove the reaction to completion 
at the expense of diastereoselectivity. 
Table 5.1: OptimizPtioa of Methylstion of Cbz-Asp(0R)OBO ester 538-5.4. 
&c@R Temp YieldC ~ a t i o ~  
Entry R B asea ("0 (w 2S,3S:2S,3R 















a Reaction performed in THF (unless othewise noted) with 3 eq. of base and inverse 
addition. 
Temperature during addition of alkylating agent. 
C Value in parenthesis denotes yield based on recovered s t d n g  material. 
Determined by 'H-NMR. 
Two eq. of base 
' THF/Hexanes ( 1 : 1) 
in an attempt to rationalize the modest di astereoselec tivi tie ere 
encountering, we tried to identw the stereochemistry of methylation. Although attempts 
to crystallize 5.41 failed, conversion to the N-tri@ derivative 5.50 (Scheme 5.17) 
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provided crystals of sufficient quality for X-ray analysis which assigned the 
stereochemistry of addition as 2S,3S (Figure 5.1). Crystallization also removed the minor 
diastereomer to give optically pure 2S,3S-5.50 in 73% yield. Subsequent deprotection of 
the purified 2S,3S-p-methylaspartate denvative 5.41 with refiuxing 6N HCI (vide infia) 
gave p-methylaspartate 5.47 in 68% yield after purification by cation exchange, 
confirming the stereochemical assignment by comparïson of optical rotation to literature 
values. 
Scheme 5.17 
Figure 5.1: X-Ray Crystal s t ~ c h u e  ofTr-GAsp(B-Me)(OMe)OBO ester 5.50. 
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In order to confimi the 'H-NMR assignments, the B-carbon of 5.41 was 
epimerized with excess LDA to give a 1:l mixture of the 2$3S:2S,3R 8-methyl 
derivatives 5.41 and 5.42 respectively (Figure 5.2) that were separable after labourious 
flash chromatography. The 2S,3S diastereomer had a lower Rf than 2S,3R-5.41. 
Although the a- and fl-protons of 5.41 and 5.42 were distinguishable at 300 MHz. higher 
fields (500 MHz) were necessary to clearly differentiate between the 3s and 3R p-methyl 
protons in order to assign diastereoselectivities for addition. ' H-NMR in solven ts other 
than acetone-4 did not particularly influence the chemicai shifts of the resolved peaks 
except that a rotamer becarne apparent in toluene-de. 
Figure 5.2 30 MHz 'LI-NMR of ZSJS 5.41 (top) pnd S , 3 R  Sm42 (bottom) Cbz-L- 
Asp(p-Me)(OMe)OBO ester. 
5.2.2 Addition of Other AIkylation Agents to Cbz-Asp(0Me)OBO 5.38. 
Having optimized the methylation of 5.41, out attention turned to investigating 
the addition of other akylating reagents. AUyl bromide was added to the enolate of 5-38 
under the optimized conditions determined for 5.41. Allylation to give 5-45 occurred 
with a 4: 1 diastereoselectivity, determined by 'H-NMR cornparison of the B-protons, and 
in a yield of 68% after 12 hours (Scheme 5.16). The diastereomers were readily 
separated by flash chromatography and the starting material could be recovered. The 
main diastereorner had a lower Rf than the rninor isomer, which corresponds with the 
observation for 5.41. As with 5.41 the reaction failed to go to completion even after 
prolonged reaction times and the addition of HMPA. The yield based on recovered 
starting material was 88%. Deprotection of the separated diastereomers in refluxing 6N 
HCI gave both 2s-diastereomers of 5-48 in approximately 35% yield after purification by 
cation exchange. 
Benzyl bromide was used to benzylate 5.38 to give 5.46 in 3: 1 diastereoselectivity 
and 6 1% yield. Diastereomenc ratios were detennined by 'H-NMR integration of the p- 
protons. The main contaminant was starting material although the reaction was 
maintained at -78°C for 16 hours. The yield, based on recovered starting material, was 
88% and the reaction could be driven to completion with warming although 
diastereoselectivity decreased to 1.5: 1. Both diastereomers were easily separated by flash 
chromatography and subsequently deprotected in refluxing 6N HCl to give both 2S- 
diastereomers of 5.49 in approximately 55% yield. 
Presumably, addition of dlyl bromide and benzyl bromide to 538 occurs with the 
same stereochemistry as 5-41, the stereochemistry of the addition products thereby 
tentatively assigned as 2S,3S. 
5.2.3 Addition of Heteroatom to Cbz-Asp(0Me)OBO 5.38. 
In an effort to expand the methodology to incorporate a variety of heteroatoms in 
the p-position of 5.38, the enolate of 5.38 was reacted with various heteroatornic 
electrophilic reagents. 
Davis' 2-sulfonyloxaziridine 4.92 has been used previously to hydroxylate 
aspartic acid derivatives giving P-hydroxyaspartate derivative 5.12 (P=Ts, R'=R'=~Bu, 
E S H )  in 45: 1 anti:syn (2S,3R:2S93S). Using conditions previously optimized for the 
hydroxylation of Cbz-Glu(0Me)OBO ester 4.69 (Section 4.2.4), LDA (3 eq.) was added 
to a mixture of Cbz-Asp(0Me)OBO ester 5.38 and Davis' oxaziridine 4.92 (5 eq.) in 
THF at -78°C to give Cbz-Asp(f%OH)(OMe)OBO ester 5.51 in 5 1 % yield and 3: 1 ratio 
of inseparable diastereomers after 18 h at -78°C (Scheme 5.18). The predominant 
stereoisomer was tentatively assigned as 2S,3S-Cbz-Asp(B-OH)(OMe)OBO 5.51 based 
on the stereochernical assignment of 5.41. Contaminants in the optimized synthesis of 
5.51 included remaining starting material 5.38 (15%) and the sulfonarnide 5.52 (26%), 
probably in significant quantities due to the prolonged reaction time as compared to 4.96 
(Section 4.2.4). Deprotection of 5.51 with refluxing ZN HCl gave fil-hydroxyaspartate 5.5 
in 62% yield after purification by cation exchange as a mixture of diastereomers. 
Scheme 5-18 
We also investigated azidation of the enolate of 5 3 .  The addition of trisyl azide 
4.105 to the enolate of 5-38 consistently gave the p-azide 5.53 with poor 
diastereoselectivity since a mixture of approximately 1:l inseparable epimers was 
obtained under al1 the conditions examined (LiHMDS with or without HMPA. 
LiHMDSlnBuLi, NaHMDS and KHMDS) (Scheme 5.19). The azide 5.53 was also 
generated in poor yield (15-288) even after wanning to rwm temperature after 16 hours 
at -78°C and 12 hours at 4°C. Previous reports for the synthesis of 5.12 (P=PhFi, 
R'=~Bu,M~, I t 2 = ~ e ,  E=N3) stated the importance of shon reaction times (4 min.). 
However, the formation of 5.53 was not detected by ESI-MS after 5 and 10 minute 
periods. The diastereomen of 5.53 were reduced to the amine 5-54 in 67% yield, in an 
unsuccessful attempt to facilitate isolation of both diastereomers. Hycirolysis of 5.54 
gave the p-aminoaspartate 5-6 as a mixture of diastereomers in 32% yield. 
Scheme 5.19 
5.2.4 Deprotection and HPLC A ~ l y s i s  of&substituted Aspurtic AcidF 
Acid hydrolysis has been used extensively to deprotect B-substituted aspartic acid 
derivativeS. 17b.495 1.67 The diastereomers of ~~alkylaspartic acids 5.41, 5.45 and 5.46 and 
the diastereomeric mixtures of 5.51 and 5.54 were refluxed in 6N HCl for a p e n d  of 2 4  
hours. The prolonged hydrolysis conditions were necessary to fùlly hydrolyze the 
dihydroxyester 2.62, generated after ring opening of the OB0 ester. The Bsubstituted 
aspartic acids were purified by cation exchange (gradient elution with 0.1 N to 1 .O N 
W O H )  in yields of 32-68%. 
Crystallization of the fbsubstituted aspartic acids was unsuccessful with the 
exception of both 2S,3S- and 2S,3R-methyl aspartate 5.1. However, diastereomeric 
purîties established after lyophilization of the purified p-substituted aspartates and 
subsequent derivatization followed by HPLC analysis agreed well with ratios deterrnined 
by 'H-NMR. In general, HPLC analysis of the derivatized p-alkyl aspartic acids 
occurred with good separation. The diastereomers of B-hydroxyaspartic acid 5 5  proved 
to be difficult to separate with significant overlap of the 2S,3S and 2S,3R derivatives by 
HPLC, regardless of conditions. Separation of the diaminoaspartic acid diastereomers 
5.6 by HPLC was unsuccessful, presumably due to the formation of multiple denvatives 
of the O-phthaialdehyde 2.64/N-i-Bu-L-Cys 2.65 product. 
The optical rotation of 2S,3S-p-methylaspartate was comparable to literature 
values. Optical rotations for 2S,3S-p-allylaspartate SR% and 2S,3S-P-benzyl-aspartate 
S A 9  have not been reported in the literature. The optical rotations for threo- and erythro- 
L-P-hydroxaspartic acid 5.5 are very small and cannot be used reliably to ascertain 
optical purityaJ' Al1 the B-substituted aspartic acids were easily identifiable by ESI-MS. 
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5.2.5 Discussion of the Stereochistry of Addtion to Cbz-Asp(0Me)OBO 5.38. 
The majority of stereoselective electrophilic additions to aspartic acid derivatives 
5.11 occur with predorninantly 2S,3R stereochemistry. Numerous models have been 
proposed and in general employ a lithium chelation based model to explain the observed 
~tereochemistry.~" However, the factors responsible for this selectivity, or lack thereof, 
are complex and include numerous variables such as type of ester, electrophile reactivity, 
base used, enolate geometry etc.- In fact, opposite stereoselectivity of addition has 
been observed for sirnilar aspartate systerns (Le. P=CbzS6 vs. P=PhFla in 5.12 gives 
opposite stereochemistry) to those as described above. The only reports in which 2S,3S 
stereochemistry was observed (Rap~port,~ Chamberlinna) both used KHMDS in 
formation of the enolate. Furthemore, Chamberlin and CO-workers were able to inven 
stereochernistry to 2S,3R by use of a Li enolate, and aflerward identified the (E)- 
potassium enolate and (2)-lithium enolate by trapping studies and subsequently proposed 
the model depicted in figure 5.3 to explain their observations. 
Epotassium enolate 2-lithium enolate to 
to give 2S,3S stereochemistry give 2S,3R stereochemistry 
Figure 5.3: Chamberlin's proposed enolate modeIs.SIa 
In our system, the diastereoselective alkylations of the Li-enolate of 5.38 gave 
predominantly 2S,3S stereochernistry. Ireland et al. have reported that LiHMDS/THF 
systems produce (B-lithium ester enoiates? Trapping experiments with the enolate of 
Cbz-Asp(0Me)OBO 5.38 failed to provide any insight to the enolate k i n g  formed, and 
therefore the lithium enolate cannot be assurneci to be the E-enolate, especially with the 
observation that the addition of HMPA has no effect on stereoselectivity or yield and 
Chamberlin's observations. 
Adapting previously proposed models for chelation in which the (E)-lithium 
enolate of 5.38 chelates to the Cbz protected nitrogen, the predicted stereochemistry is 
2S,3R which is inconsistent with the obsewed results. However, if the (a-lithium 
enolate chelates in a 7-member ring with an oxygen in the OB0 ester, the system is 
locked in a conformation in which alkylation of the enolate gives 2S,3S stereochemistry 
in the product (Figure 5.4a). Additionally. the Li bonded to nitrogen cannot chelate to the 
ester enolate since this would also give the incorrect stereochemistry. However, the N-Li 
bond may also chelate to an oxygen in the O B 0  ester to give a 5-membered ring (Figure 
5.4a) This model is an adaptation of that proposed by Seebach and Wasmuth.JS 
Fredriksen and Dalen have shown that polyether ligands complex with Li+ and Na', in 
some cases in slightly more stable complexes with Li+ which may explain the small 
increase in selectivity when LiHMDS is used over NaHMDS and KHMDS. 
Conversely, in a non-chelation controlled model, if the (2)-lithium enolate is 
considered it becornes apparent that the oM+ group cannot form a cyclic chelate because 
of its (2)-geometry and as such adopts a hydrogen-in-plane conformation (Figure 4b) that 
is attacked opposite the O B 0  group which is buikier than the Cbz group (Le. from the re 
face) to give rise to the B,3S  stereoisomer. The mcdel in figure 5.4b is similar to that 
proposed by Chamberlin and co-workers who used bulkier N-protection (5.12 
P=Phn,Bn, R'=R~=M~) which may explain the increased stereoselectivity observed in 
their system."' 
The size of the pester protecting group has no effect on stereoselectivity, and as 
both models (Figure 5.4) indicate, have little effect on the direction of attack on the 
enolate. However, the size of the incoming electrophile alters the stereoseiectivty in 
addition from 10: 1 (2S93S:2S,3R) in the case of methyl iodide to 1 : 1 with trisyl azide. 
The reason for this are currentiy unclear although two possible explanations exist. If the 
enolate is particularly sterically constrained, the enolate intermediate may have to adopt 
some other higher energy transition state in order to react with the electrophile~' hence 
the increased reaction times. Altematively. the longer reaction times may result in 
epimerization of the B-carbon by the excess base present, although entries 5 and 6 in 
Table 5.1 suggest otherwise. 
Seebach has described the complexity of enolate structures and the dramatic 
effect these have on organic reactions.'* The observation that the addition of base to 
substrate ai -78°C and subsequent trapping with an electrophile results in 1: 1 selectivity 
in the case of 5.38 versus inverse addition which gives 10:l selectivity with methyl 
iodide may be a result of various aggregates in solution. 
Figure 5.4: A) Chdation controlled mode1 of (E)-lithium enolate of 5.38. B) Non- 
chelation d e l  d t h  (2)-lithium enolate of 538. 
Unexpectedly, the 13-addition to glutamates described in chapter four occurs in 
higher selectivity than in the case of 12-addition to  aspartate derivatives. Of 
significance, the extra methylene unit in glutamate 4.69 allows rotation of the (2)-enolate 
described in figure 4.10 into a position in which it may chelate with the N-Li bond. As 
such, both the (E)- and (%nolate may adopt the same transition state to give high 
selectivity in which the geometry of the enolate is imlevant. 
The synthesis of threo-L-b-substituted aspartic acids has been described, with 
selectivities ranging frorn as high as 10:l to 1:l  and in overall yields of 5-281 in six 
steps. 
The aspartate 5 3  was synthesized in good overall yield and its crystalline nature 
made its use as a synthon particularly convenient The stereoselectivity of methylation of 
Cbz-Asp(0Me)OBO 5.38 occurred in a 10: 1 ratio and is comparable to the best reported 
proceduren' for the synthesis of 2S,3S-methylaspartate, but is preferable in terms of atom 
efficiency. Inverse addition of the substrate to base at -78°C is necessary for high 
selectivity. Disappointingly a rapid decrease in stereoselectivity occurs with bulkier 
reagents, from 4: 1 with aiiyl bromide to 1: 1 selectivity with trisyl azide, the reasons for 
which are still unclear. 
Deprotection in refluxing 6N HCl and cation exchange gave the $-substituted 
aspartic acids in 32-68% yield. 
5.4.1 (2S)-2-[(Be~loxy)carbony1]amin&methoxy~xobutanoic acià, Cbz-L- 
Asp-(0Me)-OH, 5.32. 
Aspartic acid 5.31 (10.0 g, 0.075 mol) was suspended in freshly distilled MeOH (250 
. - mL) and cooled to 0°C whilst stirring under Ar. Chlorotrimethylsilane (1  1.8 rnL, 0.094 
mol) was slowly added by dropping funne1 and after 30 min allowed to warm to ambient 
temperature. After 2 hours the mixture was cooled to 0°C and a second aliquot of 
c hlorotrimethy lsilane (1 1.8 mL, 0.094 mol) slowly added. After 24 hours the solven t was 
removed in vucuo, revealing an oil which was placed under high vacuum. De-ionized 
water (150 mL) was added to the oil followed by slow addition of Na2C03 (10.23 g, 
0.083 mol) to prevent excessive frothing. Once the oil was completely in solution it was 
cooled to 0°C and N-(benzyoxycarbony1)-succinimide (18.7 g, 0.075 mol), pre-dissolved 
in 1,4-dioxane (150 mL), slowly added to the stimng mixture which was then allowed to 
warm to rmm temperature. After 24 hours, the volume was reduced to approximately 
200 mL under vacuum, then de-ionized water (100 mL) added and the final pH of the 
mixture adjusted to 3 with 1M KI. This was then extracted with CH2C12 (3 x 150 mL), 
the organic extracts were then pooled and extracted with saturated NaHC03 (3 x 100 
mL). The aqueous extracts were pooled, chilled to 0°C. acidified to pH 3 with IM HCl 
then extracted with CH2C12 (4 x 100 mL). The organic extracts were pooled, extracted 
with brine (50 mL) then dned over MgS04 and the solvent removed under reduced 
pressure to yield a colourless oil which was used without further purification. 
TU3 (1: 1, CHC13:EtOAc, 1 % AcOH) Rr= 0.18; 'H NMR (CDC13, 250 MHz) 6 10.07 ( br 
s, 1H. C02H), 7.38-7.26 (m, SH, ArH). 5.86 (d, lH, J = 8.SHz, NH), 5.12 (s, 2H, 
CbzCH-O), 4.694.6 1 (m 1 & a-CH). 3.69 (s, 3H, C02CH3), 3.05 (dd, 1 H, J = 4.4, 
17.4Hz, p-CHH), 2.87 (dd, LE?, J =  4.6, 17.4&, p-CHH); 13c N M R  ( m l 3 ,  63 MHz)  6 
175.9 (C--O), 173.7 @O), 156.0 CONH), 136.3 (OZ<=), 128.5, 128.3, 128.2 
(Cbz<H=), 67.2 (CbzÇHzO), 54.1 (a-CH), 52.1 (COSHd, 3 1.3 @-CHI); ESI-MS (M 
+ H') 281.9. 
5.4.2 QMethyl 1-[(3-rnethyl-J-oxe~yl)methyl] (tS)-2-[(be~loxy)cmbnyl]- 
aminobutanediate, Cbz-L-Asp(0Me) oxetane ester, 535. 
Cbz-L-Asp(0Me)-OH 5.32 (5.63 g, 0.022 mol) was combined with Cs2C03 (4.30 g, 
0.013 mol) then dissolved in de-ionized water (100 mL) and lyophilized ovemight. To 
the resulting solid was added oxetane tosylate 2.3 (5.92 g, 0.023 mol) and Na1 (0.66 g, 
4.40 mmol) and then taken up in DMF (300 mL). The mixture was allowed to stir for 48 
hours before the DMF is then removed in vacuo (0.5 mm Hg, bath temperature 50°C) and 
the resulting solid dissolved in EtOAc (300 mL) and H20 (100 mL) and extracted with 
10% NaHC03 (2 x 50 mL), saturated NaCl (50 mL) and dried over MgS04. The solvent 
was removed under reduced pressure and the resulting oil purified by flash 
chromatography (1 : 1 Et0Ac:Hex) to give a clear oil in 66% yield fiom 5.31 (5.34 g). 
TLC (1: 1, Et0Ac:Hex). Rf = 0.39; 'H NMR (CDCI,, 2SOMHz) 6 7.48-7.25 ( m  5HT ArH), 
5.82 .(d, lH, J = 8.2H.2, NH), 5.12 (s, 2H, CbzCM) ,  4.74-4.60 (m, IH, a-CH), 4.53- 
4.12 (m, 6H, 2 oxetane ester CH20, C02CH2), 3.67 (s, 3H, CC)2CH3), 3.05 (dd, 1 H, J = 
4.3, 1 7.2HzT p-CHH), 2.86 (dd, IH, J = 4.5, 17.2Hz, p-CHH), 1-29 (s, 3H, oxetane ester 
CH,); 13c NMR (-13, 63 MHz) 6 170.5 (CS), 170.3 @O), 155.3 (CONH), 135.9 
(Cbz<=), 129.3, 127.6, 127.3 (Cbz=CH), 77.9 (oxetane ester _CH20), 73.6 (COKH2), 
66.1 (CbzCHzO), 5 1 -8 (a-CH), 5 1.1 (COm3), 38.4 (oxetane ester CCH3), 35.4 (p-Hz) ,  
20.7 (oxetane ester CC&); FT-IR (cast from CDCI3) 3341, 2958, 2876, 1730, 152 1, 
1439, 1372, 1338, 1215, 1048; ESI-MS (M + El+) 365.95; Anal. calcd for CiaHuNw: C, 
59.17; H, 6.34; NT 3.83. Found: C, 59.38; H, 6.58; N, 3.81. 
aminobutanediate, Cbz-L-Asp(0tBu) oxetane ester, 5.36. 
Sarne procedure as in section 5.4.2 using Cbz-L-Asp(0tBu)OH H20 5.33 to give 1 1.8 1 
g (98.9% yield) of 5.36. TU3 (1: 1, EtOAc:Hex), Rf = 0.51; 'H NMR ( m l 3 ,  250 MHz) 6 
7.38-7.26 (m, SH, ArH), 5.78 (d, lH, J = 8.7Hz, NH), 5.09 (s, 2H, CbzC&O), 4.624.55 
(m, 1 H, a-CH), 4.50-4.16 (m, 6H, 2 oxetane ester CH20, C02CH2), 2.93 (dd, 1 H, J = 4.6, 
17.1&, P-CHH), 2.74 (dd, lH, , J=4.4, 17.1&, B-CHH), 1.39 (S. 9H, C(CH3),), 1.28 (s, 
3H. oxetane ester CCH3); 13c NMR (CDC13, 63 MHz) 6 170.9 @O), 169.9 G=O), 
156.0 (ÇONH), 1 36.2 (Cbz*), 128.5, 128.1, 128.0 (Cb~-q=), 8 1.9 (C(CH3)3), 79.3 
(oxetane ester cH20), 69.7 (CO&&), 67.0 (Cbzw20), 50.6 (a-CH), 39.1 (oxetane 
ester cc&), 37.6 (p--2), 28.0 (Cm3I3), 20.9 (oxetane ester Cm3); Anal. calcd for 
GlH29N07: C, 61.90; H, 7.17; N, 3.44. Found: C, 62.19; H, 7.31; N, 3.49. 
Pminobutaneàioa& Cbz-L-Asp(0Bn) oxetane ester, 5.37. 
Sarne procedure as in section 5.4.2 to give 5.98 g (96.8%) of 5.37. TLC (1: 1, 
EtOAc:Hex), Rr = 0.47; 'H NMR (ml3, 250 MHz) 6 7.44-7.20 (m, IOH, ArH), 5.87 (d, 
1 H, J = 8.8Hz, NH), 5.12-5.07 (m. 4H, CbzCW, PhCHfi), 4.74-4.62 (m, 1 H, a-CH), 
4.454.06 (m. 6H, 2 oxetane ester CH#, C02CH2), 3.09 (dd, 1 H, J = 4.5 , 17.1 Hz, P- 
CHH), 2.92 (dd, IH, J = 4.6 , 17.1Hz, fbCHH), 1.28 (s, 3H, oxetane ester CH3); "C 
NMR (CD(&, 63 MHz)  S 170.5 K=O), 170.4 w), 155.8 (CONH), 136.0 (Cbz=C=), 
135.2 (Ph-<=), 129.7, 128.4, 128.4, 128.3, 128.4, 128.0 (Cbz<H=, Ph$&), 79.1 
(oxetane ester Ç W ) ,  69.6 (CO&H2C), 67.0 (CbzcH20), 66.7 (CO&H2Ph), 50.4 (a- 
CH), 38.9 (oxetane ester CC&), 36.5 (B-GHz), 20.8 (oxetane ester CcH3); Anal. catcd 
for C24H27N@: C, 65.30; H, 6.16; N, 3.17. Found: C, 65.65; H, 6.32; N, 3.24. 
5.4.5 ~Methyl-(2S)-2-[(be~loxy~ny1]amin011-(&metbyI-2,6,7-tri0~8bicycIo- 
[2e2e2]~t-l-yl)pmpm~~ Cbz-L-Asp(0Me)OBO ester, 5.3û. 
Cbz-L-Asp(0Me)-oxetane ester 5.35 (10.97 g, 30.0 mmol) was dissolved in dry CH2C12 
(400 mL) while stimng under Ar. The mixture was cmled to 0°C then BF3 - Et20 (0.38 
mL, 3.0 rnrnol) was added by syringe. The mixture was allowed to warm to rwm 
temperature and stir for 4 hours after which a TLC indicated the reaction was complete. 
Et3N (0.84 mL, 6.0 mmol) was then added and the mixture stirred an additional 30 min 
before the solvent was removed in vocuo. The resulting oil was dissolved in EtOAc (600 
m . )  and extracted with 3% m C 1  (2 x 100 mL), saturated NaHC03 (100 mL), brine 
(100 mL) and dried over MgS04. The solvent was removed under reduced pressure to 
reveal a light coloured oil w hich was purifileci by flash chromatograph y ( 1 : 1 Et0Ac:Hex) 
to give a clear oil which recrystallized from Et0Ac:Hexanes to give 7.45 g (68%) of long 
white crystals. 
NMR (Cm13, 250 MHz) 6 7.39-7.26 (m, 5H, AM), 5.2 1-5.02 (m, 3H, NH, CbzC&), 
4.33 (ddd, lH, J = 5.3, 7.9, 13.OHz, a-CH), 3.85 (s, 6H, OB0 ester C m ) ,  3.61 (s, 3H, 
C02CH3). 2.68 (dd, 1H7 J =  5.3, 15.lHz, PCHH), 2.42 (dd, lH, J =  7.8, lS.lHz, B-CW 
0.77 (s, 3H, OB0 ester CCH3); 13c C ( m l 3 ,  63 MHz) 6 171.4 CS), 155.9 
(CONH), 136.6 (Cbz<=), 128.3, 128.0, 127.9 ( C b z g = ) ,  107.9 (OB0 ester - O ) ,  
72.2 (OB0 ester CH20), 66.7 (Cbzm20), 52.2 (a-_CH), 5 1.6 (C02CH3). 35.6 (OB0 
ester COI3), 30.6 (p-cH2), 14.1 (OB0 ester CDS); IR (cast from CHC13) 3362, 2953, 
2882,1734, 1520,1456, 1399, 1352, 1293,2133,1052; HRMS (FAB) calcd for (M + H+) 
C 1 8 H 2 m  366.15527, found 366.15538; And. cdcd for Cl&I*&: C, 59.17; H, 6.34; 
N, 3.83. Found: C, 59.33; H, 6.58; N, 3.87. 
5.4.6 44 e r t - B u t y E ( 2 S } - 2 - [ ( b e l l ~ y l o x y ) c a r b o n y l ] ~  
bicyclo[2.2.2]oct-1-yl)butanoate, Cbz-L-Asp(0tBu)OBO ester, 5.39. 
Sarne procedure as in section 5.4.5 to give 7.35 g (68.196) of 5.39. m.p. 77-78°C; [alZoD 
= -4.8 (c = 1.36, CH2C12); TLC (1:1, EtOAc:Hex), Rf = 0.45; 'H NMR (CDC13, 250 
MHz) 8 7.32-7.22 (m. SH, ArH), 5.97 (d, 1 H, J = 8.8Hz, NH), 5.06 (s, 2H, CbzCH?), 
4.594.51 (dt, lH, J =  4.8,8.8Hz, a-CH), 3.81 (s, 6H, O B 0  ester C m ) ,  2.87 (dd, lH, J 
= 4.8, 17.1H2, P-CHH), 2.72 (dd, lH, J = 4.8, 17.1Hz. p-CHH), 1.36 (s, 9H, (CH3)3C), 
0.77 (S. 3H, OB0 ester CC&); "C NMR ( m l 3 ,  63 MHz) 6 170.1 (C=O), 156.1 
(CONH), 135.9 (Cbz*), 128.3, 128.0, 127.9 (Cbz=QI=), 107.9 (OB0 ester C-O), 
8 1.9 ((CH3)1C), 72.4 (OB0 ester w), 66.9 (CbzCH20), 50.5 (a-CH), 40.5 (OB0 ester 
CCH3), 37.4 (B-CH2), 16.5 (OB0 ester Cc&); And. calcd for C Z I H ~ ~ N ~ :  C, 61.90; H, 
7.17; N, 3.44. Found: C, 62.23; H, 7.39; N, 3.96. 
Same procedure as in section 5.4.5 to give 7.35 g (68.1%) of SAO. [alZoD = - 16.0 (c = 
1 .O, CHzC12); TU3 (1 : 1, EtOAc:Hex), Rf = 0.49; 'H NMR (CDC13, 250 MHz) S 7.42- 
7-24 (m, 10H, ArH), 5.18 (d, IH, J = IOSHz, NH), 5.15-5.04 (m, 4H, CbzC&O, 
PhCH20), 4.36 (ddd IH, / = 5.4, 7.4, 13.2Hz, a-CH), 3.81 (s, 6H, OB0 ester 0CH2) ,  
2.71 (dd, lH, J =  5.4, lS.OHz, & C a ,  2.48 (dd, lH, J =  7.4, 1S.OHz. B-CHH), 0.74 (s, 
3H, OB0 ester CC&); "C NMR (Acetone-&, 75 MHz) 6 171.1 (C=O), 156.0 (CONH). 
136.6, 136.0 (Cbz-<==, Ph<=), 128.7, 128.7, 128.5, 128.4, 128.3, 128.1 (Cbz<H=, 
Ph<H=), 108.0 (OB0 ester c-O), 72.8 (OB0 ester -Hz), 66.9. 66.4 (CbzcH20, 
COKH2Ph), 52.3 (a-CH), 36.1 (OB0 ester cCH3), 30.7 (&CH2), 14.3 (OB0 ester 
CC&); HRMS (FAB) calcd for (M + H') C24H2fl07 442.18658, found 442.18221. Anal. 
calcd for C2&27NO7: C, 65.30; H, 6.16; N, 3.17. Found: C, 66.57; H, 6.43; N, 3.23. 
54.8 M e t n y i - ( 2 S ~ ~ - 2 - [ ( b e l l z y l o x y ) c a r b o n y l ] ~ -  
bioxsbicycio[2.2~2]0~t-1-yt)pmp8~10(1~ Cbz-L-Asp(&Me)(OMe)OBO ester, 541. 
Cbz-Asp(0Me)OBO ester 5.38 (0.240 g, 0.66 mmol) was dissolved in dry THF (5 mL) 
then added via cannula to a flask containing LiHMDS (1.98 mL, 1.98 mmol) in THF (5 
rnL) at -78°C under Ar. After 1 h, methyl iodide (0.168 mL, 3.30 mmol) was added and 
the mixture stirred for 8 h at -78°C. The mixture was poured into 3% %Cl (5 mL) and 
extracted with EtzO (3 x 25 d), the organic fiactions pooled and extracted with 10% 
NaHCO3 (10 mL), brine (10 mL), dried over MgS04 and the solvent removed under 
reduced pressure to reveal a light yellow oil which was purified by flash chromatography 
to give 0.202 g (8 1 % yield) of a clear oil. 
ra120D = -37.1 (C = 1.52, CH2Ch); TLC (1: 1, EtOAc:Hex), R~ = 0.48; 'H NMR (Acetone- 
d6, 300 MHz) 4 7.38-7.24 (m, 5 K  A m ,  5.84 (ci, lH, J = lO.lHz, NH), 5.10 (d, lH, J = 
12-6H~9 CbzCHHO), 5.03 (d, I H, J = 12-6HzV CbzCHHO), 4-29 (dd, lH, J = 7.3, 10.1 HZ, 
a-CH), 3.87 (s, 6H, OB0 ester C&O), 3.57 (s, 3H, C02CH3), 2.78 (dt, IH, J = 7.3, 
7.4W, p-CH), 1 .O8 (d, 3H, J = 7.3Hz. B-C&), 0.8 1 (s, 3H, OB0 ester CCH3); I3c NMR 
(-13, 75 MHz)  6 174.9 @-O), 156.7 CONH), 136.6, (Cbz<=), 128.3, 127.9, 127.7 
(Cbz<H=) 108.1 (OB0 ester s-O),  72.6 (OB0 ester w20), 66.8 (CbzCH20), 56.1 (a- 
CH), 5 l .6 (COS&), 40.0 (P-CH), 30.5 (OB0 ester CCH3). 14.1 (OB0 ester CCH3). 
12.7 (8-CH3); FT-IR (cast from CDCl3) 2994,2879, 173 1, 15 15, 1225, 1049; ESI-MS (M 
+ H+) 379.95; Anal. calcd for CigH25N&: C, 60.15; H, 6.64; N. 3.69. Found: C, 60.33; 
H, 6.89; N, 3.75. 
5.4.9 M e t h y l - ( ~ ~ R ) - 2 - [ ( b e n z y 1 0 x y ) c a r b o n y l ] ~  
trioxabicyclo[2.2.2]0~t-1-yl)propanoate, Cbz-L-Asp(p-Me)(OMe)OBO ester, 5-42. 
Cbz-Asp(p-Me)(OMe)OBO ester 5.41 (0.200 g, 0.53 mmol) was dissolveci in THF (IO 
mL) and cooled to -78°C while stimng under Ar. LDA (7.0 mL, 10.5 mmol) was added 
and the mixture stirred for 1 h before being poured into Et20 (50 mL) and extracted with 
3% NHKI (10 mL), 10% NaHC03 (10 mL), bine (10 mi,) and dried over MgS04. The 
solvent was removed in vacuo and the resulting oil purified by flash chromatography to 
give 0.052 g of 5.41 (26% yield) and 0.046 g of 5.42 (23% yield). 
TU3 (1 : 1, EtOAc:Hex), Rf = O S  1 ; 'H NMR (Acetone-&, 300 MHz) 6 7.40-7.28 (m. SH, 
Am, 5.88 (d, 1H. J = 10.4Hz, Nn), 5.1 1 (d, lH, J =  12.6Hz. CbzCHHO), 5.07 (d, 1H, J 
= l2.6H.2, CbzCHHO), 3.94 (dd, lH, J = 3.8, 10.4Hz, a-CH), 3.86 (s, 6H, OB0 ester 
CH20), 3.58 (S. 3H, C02CH3), 2.91 (ddd, lH, I r  3.6.6.9, 10.7&, p-CH), 1.12 (d, 3H, J 
= 7.3Hz, f3-CH3), 0.80 (S. 3H. OB0 ester CC&); "C NMR (Acetone-&, 75 MHz) 6 
174.6 (C=O), 156.4 (CONH), 136.6, (Cbz<=), 128.3, 127.7, 127.7 ( C b z a = )  108.0 
(OB0 ester C-O), 72.3 (OB0 ester GHzO), 66.8 (Cbz-O), 57.2 (a-CH), 50.8 
(COgH3), 38.2 (p-CH), 30.5 (OB0 ester CC%), 14.5 (OB0 ester CÇH3), 13.3 (p-CH3). 
5.4.10 t e ~ - B u t y l - ( 2 S ~ S ) - 2 - [ ( b e 1 1 z y l o x y ~ b o n y l ~  
trioxabicyclo[2.2.2]oct-i-yl)pmpanoate, Cbz-L-Asp(p-Me)(tBu)OBO ester, 5.43. 
Same procedure as in section 5.4.8 to give 0.184 g (74%) of 5.43. 
TU3 (1: 1, EtOAc:Hex), Rr = 0.48; 'H NMR (CDC13, 250 MHz) 6 7.39-7.24 (m. SH, 
ArH), 5.7 1 (d, 1 H, J = 1 0.2Hz7 NH), 5.10-5.03 (m, 2H, CbzCH20), 4.19 (m, 1 H, a-CH), 
3.83 (s, 6H, OB0 ester CH20), 2.78 (m. 1H. P-CH), 1.38 (s, 9H, (CH3)3C), 1.07 (d, 3H, J 
= 7.1 Hz, B-CH3), 0.79 (s, 3H, OB0 ester CCH3); 13c NMR (CDC13. 63 MHz) 6 175.5 
c=O), 156.6 (CONH), 136.3, (Cbz-<-=)), 128.3, 127.9, 127.7 (Cbz-a=)  108.3 (OB0 
ester C-O). 8 1.8 ((CH3)3Q, 72.4 (OB0 ester m20), 66.7 ( C b z w ) ,  55.6 (a-Cil), 39.8 
(B-GCH), 30.5 (OB0 ester mH3), 14.3 (OB0 ester CcH3). 12.9 (B-m3); ESI-MS (M + 
H+) 421.98; Anal. calcd for CZH3iNQ: C, 62.69; H, 7.31; N, 3.32. Found: C, 62.99; H, 
7.56; N, 3-41. 
5.4.11 B e a z y l - ( ~ ~ S ) - 2 - [ ( b e ~ 1 z y l o x y ) ~ b o n y l ~  
trioxabicyc10[2.2.2]0~t-l-yl)prop8~08te, Cbz-L-Asp(bMe)(OMe)OBO ester, 5.44. 
Same procedure as in section 5.4.8 to give 0.127 g (7 1 %) of 5-44. 
TU3 (1:1, EtOAc:Hex), Rf = 0.54; 'H NMR ( m l J ,  250 MHz) 6 7.45-7.23 (m, 10H, 
ArH), 5.94 (d, 1 H, J = 10.2H2, NH), 5.22-5.03 (m, 4H, CbzCH20, PhCH20). 4.36 (dd, 
1 H, J = 7.3, 10.1 Hz. a-CH). 3.86 (s, 6H, OB0 ester CH@), 2.87-2.73 (m, 1& p-CH), 
1.1 5 (d, 3H, J = 7.3H.z. p-CH3), 0.80 (s, 3H, OB0 ester CCH3); "C NMR (CDCls, 63 
M H z )  6 175.3 c=O), 156.4 (CONH), 136.3, 136.1 (Cbz<=, Ph<=), 128.7, 128.7, 
128.5, 128.4, 127.9, 127.7 (Cbz-CH=, -Hz), 108.1 (OB0 ester w), 72.3 (OB0 
ester GH20). 66.7. 66.3 (CbzcH20, e 2 0 ) ,  52.4 (a-CH), 39.0 @--W. 3 1.1 (OB0 
ester cCH3), 14.1 (OB0 ester CC313), 12.8 ( B a 3 ) ;  ESI-MS (M + H'+) 456.30; Anal. 
calcd for C25H29N07: C, 65.92; H, 6.42; N, 3 .O7. Found: C, 66.24; H, 6.64; N, 3.14. 
5m4m12 Methyl-(3s)-2-[(a- 1 -[(bellzylo~)~bonyI]~no11-(4-metby1-2,6,7- 
trioxabicy~io[2~2.2]0~t-1-y1)methyl]-3-pentenoate, Cbz-L-Asp($-AUyl)(OMe)OBO 
ester 5.45, 
Same procedure as in section 5.4.8 using allyl bromide to give 0.1 12 g (68%) of 5.45 as a 
4: 1 mixture of diastereomers that were separated by flash chromatography (1: 1, 
2S,3S-5.45. TU3 (1:1, EtOAc:Hex), Rr = 0.52; 'H NMR (CDC13, 250 MHz)  6 7.41-7.27 
(m, 5H. ArH), 5.92 (d, lH, J = 10.3Hz, NH), 5.78-5.64 (m. lH, CH2=CH), 5.1 1 (s, 2H, 
CbzCH20). 5.05-4.97 (m, 2H, CH2-, 4.24 (dd lH, J =  8.8, 10.4Hz, a-CH), 3.86 (S. 
6H. OB0 ester CH20), 3.58 (s, 3H, CO5CH3), 2.74 (ddd. 1 H, J = 4.0, 8 -7, 1 1.3Hz, P- 
CH), 2.3 1-2.21 (m, 2H, CH2CHXH2), 0.80 (S. 3& OB0 ester CC&); I3c NMR (CDC13, 
63 MHz)  6 175.9 cd), 156.0 EONH), 136.3 (Cbz<=), 134.1 (CH243), 128.4, 
127.9, 127.7 (Cbz=C-H=), 1 17.1 108.2 (OB0 ester w), 72.2 (OB0 ester 
CH20), 66.7 (Cbzm20), 52.8 ( a - ,  5 1.3 (CO&&), 41.5 @-CH), 36.0 - 
C&CH=CH2), 30.8 (OB0 ester cCH3), 14.0 (OB0 ester CcH3); ESI-MS (M + Jil?) 
45-96; And. caicd for C21H27N@: C, 62.21; H, 6.7 1; N, 3.45. Found: C, 62.44; H, 7-01 ;
N, 3.53. 
2S,3R-5.45. TLC (1: 1, Et0Ac:Hex). Rf = 0.56; 'H NMR (CDCls, 250 MHz) 6 7.41-7.27 
(m, 5H, ArH), 5.87 (d, lH, J = 9.8Hz, NH), 5.85-5.74 (m, lHT CH2=CH), 5.09 (s, 2H, 
CbzCHzO), 5.004.88 (m, 2H, CH2=CH), 4.00 (dd, 1 H, J = 3.2, 10.4Hz, a-CH), 3.86 (s, 
6H, OB0 ester CH20), 3.56 (s, 3H, C02CH3), 2.91 (ddd, lH, J = 3.2,6.8, 8.3Hz, P-CH), 
2.46-2.39 (m, 2H, CH2CH=CH2), 0.80 (s, 3H, OB0 ester CCH3). 
5.4.13 Methyl-(2S~S)4-be~I-2-[(be~loxy)~bony1]amin012-(4-methyI-2,6,7- 
t1i0~abic~~I0[2.2~2]0~t-l-~I)pmpan08te, Cbz-L-Asp(p-Bn)(OMe)OBO ester, 5.46. 
Same procedure as in section 5.4.8 using bmzyl brornide to give O. IO2 g (6 1%) of 5.46 as 
a 3: 1 mixture of diastereomers that were separated by flash chromatography (1: 1, 
EtOAc: Hex). 
2S.3S-5.46. TU3 (1:1, EtOAc:Hex), Rr = 0.54: 'H NMR (Acetone-&, 3 0  MHz) 6 7.41- 
7.21 (m, 10H, AH), 5.79 (d, lH, J = lO.lHz, NW), 5.1 1 (s, 2H, CbzCH20), 4.24-4.1 1 (m, 
lH, a-CH), 3.84 (s, 6H, OB0 ester CH20), 3.59 (s, 3H, C02CH3), 2.76-2.49 (m. 3H, p- 
CH, PhCHfl), 0.79 (s, 3H, OB0 ester CCH3); NMR (Acetone-a, 75 MHz) 6 175.3 
(C=O), 155.6 (CONH), 136.1 (Cbz===), 128.3, 127.9, 127.7 ( C b z a = ) ,  108.1 (OB0 
ester C-O), 72.3 (OB0 ester m20), 66.7 (Cbzm20), 53.1 (a-CH), 51 .O (CO&H3), 43.5 
@-CH), 36.9 (Ph-z), 3 1.8 (OB0 ester cCH3), 13.8 (OB0 ester CcH3); ESI-MS (M + 
456.27; Anal. calcd for C2sHzsN@: C, 65.92; H, 6.42; N, 3.07. Found: C, 66.27; H, 
6.77; N, 3.13. 
2S,3R-5.46. TU= (1 : 1, EtOAc:Hex), Rr = 0.58; 'H NMR (Acetone-&, 3 0  MHz) 6 7.4 1 - 
7.26 (m, 10H, ArH), 5.61 (d, lH, J = lO.lHz, NH), 5.1 1-5.02 (rn, 2H, CbzCH20), 4.20- 
4.07 (m, IH, a-CH), 3.86 (s, 6H, OB0 ester C H S ) ,  3.56 (s, 3H, C02CH3), 2.67-2.4 1 (m, 
3H, p-CH, PhCH@), 0.79 (s, 3H, OB0 ester CC&); I3c NMR (Acetone-Q, 75 MHz) 6 
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175.1 CC-O), 155.8 (CONH), 136.1 (Cbz===), 128.1, 127.8, 127.7 (a%=), 108.2 
(OB0 ester c-O), 72.3 (OB0 ester azO), 66.6 (Cbzm20), 53.7 (a-CH), 51.9 
(corn,), 43.3 (Ba), 36.1 (Ph-), 3 1.0 (OB0 ester CCH3), 13.3 (OB0 ester CcH3); 
ESI-MS (M + H?) 456.22; Anal. calcd for Caz9N@: C, 65.92; H, 6.42; N, 3.07. 
Found: C, 66.27; H, 6.77; N, 3.13. 
5.4.14 (S29-2-Amia013-metbylbutanedioic acid, Asp(p-Me)OE, 5.47. 
Cbz-Asp(fbMe)(OMe)OBO ester 5.41 (O. 189 g, 0.49 mmol) was taken-up in doubl y 
distilled 6N HCI (5 rnL) and refluxed for 4 hours. The solvent was removed under 
reduced pressure, rinsed with distilled water, reduced again and lyophilized to give 0.048 
g of a white powder (68% yield). The white powder was dissolved in a minimum of 
water and placed on Dowex 50x8- 100 ion-exchange min. The column was nnsed with 
5 colurnn lengths of water then ehted with 0.5 N W O H .  The fractions were collected 
and combined then reduced in vocuo, lyophilized to give a white powder which was then 
crystallized from acetone:water to give 0.02 1 g of clear crystals. 
3" 
2S,3S-5.47: mp 270-274 (dec.); [a]20t, = +12.8 (c = 0.5, 1N HCl), (lit.s9 [alZoD = +i3.6 (c 
= 0.46, 1N HCl); 'H NMR @*O, 300 MHz) 6 3.97 (d, 1 H, / = 3.6Hz, a-CH), 3.15 (dq, 
IH, J = 3.6,7.4Hz, p-CH), 1.18 (d, 3H, J = 7.5Hz. bCH3);  13c NMR OZO, 75 MHz) 6 
177.2 c=O), 172.9 (CsO), 55.5 (W-I), 39.1 (B-CH), 1 1.6 ($-w3); ESI-MS 147.89. 
2S,3R-5.47: mp 220-232 (dec.); [a]% = -3.2 (c = 2.4, iM HCi), (lit? [al2',-, = +5.6 (c = 
3.1, HzO); 'H NMR (D20, 3ûO MHz) 6 4.00 (d, lH, J = 4.3H.z. a-CH). 3.20 (dq, 1 H, J = 
4-39 7 .4b .  B-CH). 1.29 (d, 3& J 7.5Hz9 p-CH3); 13c NMR @*O, 75 MHz) 6 176-6 
G O ) ,  171.2 G O ) ,  56.5 (a-CH), 39.6 ($-CH), 12.5 (p-CJ-33); ESI-MS 147.91. 
54-15 (~~S)-3-AUyl-2-nminobutanedioic acid, Asp(p-aüyl)OH, 5.48 
Same procedure as in section 5.4.14 to give 0.02 1 g (34%) of 5 4 .  
1 H-NMR @ 2 0 .  300 MHz) 6 5.93-5.8 1 (m. 1 H, CH2=CH), 5.32-5.15 (m, 2H, CH2=CH). 
4.2 1-4.01 (m, lH, a-CH), 3.1 1-2-68 (m. 3H, p-CH, CHKH=CH2); 13c (DrO, 75 
MHz)  6 176.7 c=O), 173.3 (C=O). 132.1 (CH2<H), 117.0 cH2=CH), 54.5 (a-CH), 
39.9 @-CH), 29.9 (CH2CH=CH2); ESI-MS 173.87. 
5.4-16 (2S$S)-2-amin013-be1lzy1butanedioic acid, Asp(B-Bn)OH, 5.49. 
'H-NMR @20, 300 MHz) 6 7.26-7.03 (m. 5H, ArH), 4.194.07 (m, lH, a-CH), 3.1 1- 
2.99 (m. lH, P-CH), 2.78-2.56 (m, 2H. PhcH2); 13c NMR @20, 75 MHz)  G 176.3 
54.17 Methyl-(2S~S)-3-metbyl~(4-wthyl-2,6,7-tno~bi~yc10[2~2~2]~t-l-y1)-2- 
(trityiamino)propan08te, Tr-L-Asp@-Me)(OMe)OBO ester, 5.50. 
Cbz-Asp(f3-Me)(OMe)OBO ester 5-41 (0.360 g, 0.95 mmol) was dissolved in 
Et0Ac:EtOH (1 : 1, 40 mL) to which Pd/C (0.5 g, Depssa type E 1 O1 NUW) was added. 
The mixture was then evacuated and purged with H2 which was repeated twice. The 
mixture was stirred for 12 h before k ing  filtered through celite and the filtrate reduced in 
vacuo to reveal a yellow oil. Dry CH2CI2 (10 mL) and DlPEA (0.26 rnL, 1.88 rnmol) 
was added followed by trityl chloride (0.262 g, 0.95 mmol). The mixture was dlowed to 
stir for 6 h before king poured into Et20 (100 mL) and extracted with 3% -1 (3 x 20 
mL), 10 % N e 0 3  (20 mL). brine (20 mL) then dried over MgS04. The solvent was 
removed under reduced pressure to reveal a white foam which was recrystallized from 
Et20:Hex to give 0.332 g (73%) of small cube shaped crystais. 
1 H-NMR (CDCla, 250 MHz) 6 7.53-7.18 (m, 1SH. ArH), 3.82-3.61 (m, 6H. OB0 ester 
C m ) ,  3.55 (dd, lH, J = 3.5, 10.5Hz, a-CH), 3.25 (s, 3H, C@CH3), 2.94 (d, lH, J = 
10.5Hz, NH), 2.69 (dq, lH, J = 3.5, 7.1H~, BCH) ,  1.24 (d, 3H. J =  7.1Hz, &CH3), 0.77 
(s, 3H, OB0 ester CCH3); EST-MS 487.97. 
5.4.18 Me#yl-(2S)-2-[(betlzyloxy)carbonyl]amin01~hyd~0xy-2-(4-methyI-2,6,7- 
triowbicycIo[2.2.2]0~t-1-yI)propan08te, Cbz-L-Asp(B-OH)(OMe)OBO ester, 5.51. 
n-Butyllithium (0.78 mL, 1 .O8 rnmol) was slowly added to diisopropylarnine (0.163 mL, 
1.17 mmol) in dry THF (5 mL) at 0°C under Ar. After 30 min the mixture was 
transferred via cannula to a second flask containing Cbz-Asp(0Me)OBO ester 53% 
(0.130 g, 0.36 mmol) and Davis' oxaziridine 4.92 (0.470 g, 1.80 mmol) in dry THF (5 
mL) at -78°C under Ar. The mixhue was stirred for 18 h at -78°C then poured into 3% 
NHXl (5 mL) and extracted with Et20 (3 x 25 d), the organic fractions pooled and 
extracted with 10% NaHC03 (10 mL), brine (10 mL), dried over MgS04 and the solvent 
removed under reduced pressure to reveal a light yellow oil which was purified by flash 
chromatography to give 0.069 g (51%) of 5.51 as a 3:l mixture of inseparable 
diastereomers. 
[al2'D = -18.1 (c = 0.95, CH2Cl2); TLC (1 : 1, EtOAc:Hex), Rr = 0.23; 'H NMR (Acetone- 
4, 300 MHz) 6 7.38-7.22 (m, 5H, ArH), 5.88 (d, lH, J =  10.1Hz, NH), 5.1 1 (d, 1H, J = 
12.7Hz, CbzCHHO), 5.02 (ci, lH, J = 12.7Hz. CbzCHHO), 4.294.08 (m, 2H, a-CH, $- 
CH}, 3.83 (s, 6H, OB0 ester CHD), 3.59 (s, 3H, CO-), 0.80 (s, 3H, OB0 ester 
13 CCH3); C NMR (Acetone-4, 75 MHz) 6 174.1 @O), 156.4 (CONH), 136.2, 
(Cbz-<=), 128.0, 127.7, 127.7 ( C b z q = ) ,  108.1 (OB0 ester w), 72.3 (OB0 ester 
CH20), 66.1 (CbzmzO), 58.9, 58.5 (a<H, B-I), 5 1.1 (CO&&), 30.7 (OB0 ester - 
CCH3). 13.9 (OB0 ester C-3); ESI-MS (M + H+) 381.97; Anal. caicd for Ci&ïzNOs: - 
C, 56.69; H, 6.08; N, 3.67. Found: C, 56.99; H, 6.37; N, 3.75. 
TLC (1 : 1, EtOAc:Hex), Rr = 0.73; 'H NMR (Acetone*, 30Q MHz) 6 7.87-7.1 1 (m, 15H, 
ArH), 5.74 (d, 1 H, J = 10.2H2, glu-NH), 5.1 1 (s, 2H, CbzCH20), 4.6 1 (d, 1 H, J = 7.2Hz, 
SO2NH), 4.20-4.01 (m, 2H, a-CH, sulfonarnide-CH), 3.81 (s, 6H, OB0 ester CfiO), 
3.42 (s, 3H, CwH3) ,  2.90-2.79 (m. IH, B-CH). 0.84 (s, 3H. OB0 ester CC&); I3c 
NMR (Acetone-6, 75 MHz) 6 174.5 CC), 156.0 (CONH), 140.9 (A-=), 139.6 
(M-=), 136.9, (Cbz<=), 132.0, 131.9, 128.9, 128.9, 128.5, 128.3, 127.9, 127.7, 126.9 
(Cbz<H=, Ar=-H=), 108.1 (OB0 ester GO), 72.6 (OB0 ester CH20), 65.8 
(CbzGH20), 58.9 (m-), 52.1 (COIçH3), 5 1.5 (a--), 49.0 (B-CH), 30.5 (OB0 
ester CCH3), 13.7 (OB0 ester CcH3); ESI-MS (M + K") 6 1 1 -40. 
5-430 (2S)-2-Amin013-hydn,xgbutanedioic acid, Asp(p-OWH, 5.5- 
Same procedure as in section 5.4.14 to give 0.029 g (62%) of 53. 
"XCO*" H2 C02H 
2S,3S-5.5: [a120~ = 4 . 4  (c = 1.5, 1N HCl), (lit." = +1.3 (c = 3.12, 1N HCI); 'H 
NMR (D20.300 MHz)  6 4.89 (d. 1 H, J = 3.6Hz, p-CH) 3.82 (d, 1 H, J = 3.6Hz, a-CH); 
13c NMR (&O, 75 MHz)  6 178.2 -1, 173.7 cd), 69.3 (p-CH), 61.5 (a-CH); ESI- 
MS 149.91. 
5-4-21 1 - [ ( 2 S ) - 2 - [ ( B e 1 1 ~ y l o x y ) ~ b o ~ y 1 ] s m i n 0 1 1 - ( r n e ~ y l -  
2,6,7-trioxabicyclo[2.2.2 Joct-l-yl)ethyl]-l,2-~azadien-2-ium, Cbz-L-Asp(p- 
N3)(OMe)OBO ester, 5-53, 
Cbz-Asp(0Me)OBO ester 5-38 (0.370 g, 1.01 mmol) was dissolved in dry THF (3 rnL) 
then added by cannula to a Bask containing LiHMDS ( 3.03 rnL, 3.03 mmol) in dry T H .  
(5 mL) at -78°C under Ar. After 1 h. trisyl azide 4.105 (0.624 g, 2.02 mmol) dissolved 
in dry THF (3 mL) was slowly added by syringe. M e r  18 h at -78"C, the mixture was 
allowed to warm to room temperature then poured into Et20 (50 mL) and extracted with 
3% NHKl (2 x 20 mL), 10% NaHCO3 (?O mL), brine (20 mL) and dried over MgS04 
and the solvent removed under reduced pressure to give a bright yelIow oil which was 
purified by flash chromatography to give 5.53 in 28% yield (0.1 14 g). 
TU3 ( 1 : 1, EtOAc:Hex), Rr = 0.40; 'H NMR (Acetone-&, 300 MHz) 6 7.37-7.22 (m, SH, 
ArH), 5.44 (d, lH, J = 10.2H2, NH), 5.07 (m, 2H, CbzCH20), 4.19 (dd, lH, J = 3.7, 
10.2Hz, $-CH), 3.95-3.79 (s + m, 7H, OB0 ester C H D ,  &CH), 3.67 (S. 3H, C02CH3), 
0.80 (s, 3H, OB0 ester CC&); 13c NMR (Acetone-d6, 75 MHz) 6 172.3 Ca), 156.6 
(CONH), 136.4, (Cbz=C=), 128.2, 127.9, 127.6 (Ch-=), 108.1 (OB0 ester C-O), 
72.3 (OB0 ester _&O), 66.8 (CbzCHzO), 59.9 @-CH), 52.1 (CO&H3), 52.2 (a-CH), 
30.4 (OB0 ester CCH3), 14- 1 (OB0 ester Ca& F M R  (cast fiom CH2C12) 3432, 2962, 
2884,2122, 1729, 1515, 1048; ESI-MS (M + 406.91; Anal. caicd for C18H22N4@: C, 
53.20; H, 5.46; N, 13.79. Found: C, 53.54; H, 5.85; N, 13.85. 
5.4.22 Methyl-(~)-3-aminol21[(bellzyloxy)carbonyl]amin012-(4-methyl-2,6,7- 
trioxabicyclo[2.2.2]0~t-1-yl)pmpanoate, Cbz-L-Asp(B-NH2)(OMe)OB0 ester, 5.54. 
Cbz-L-Asp(P-N3)(OMe)OB0 ester 5.53 (0.1 14 g, 0.28 mrnol) was combined with PhsP 
(0.088 g, 0.33 mrnol) and dissolved in dry THF (5 rnL) then stirred at room temperature 
for 24 hours. Distilled water (20 pL) was then added and the mixture refluxed for 3 
hours. The solvent was removed under reduced pressure to give a white solid that was 
purified by flash chromatography (9: 1, EtOAcMeOH 0.5% W O H )  to give 5.54 in 67% 
yield (0.07 1 g). 
TLC (9: 1, Et0Ac:MeOH 0.5% N'&OH); 'H NMR (Acetone-&, 300 MHz) 6 7.37-7.24 
(m, 5H, ArH), 5.64 (d, lH, J =  lO.lHz, NH), 5.1 1 (m. 2H, CbzC&O), 4.21-3.75 (m + s, 
8H, a-CH, B-CH, O B 0  ester CH&)), 3.69 (s, 3H, CO2CH3), 0.83 (s, 3H, OB0 ester 
CC&); "C NMR (Acetone-6, 75 MHz) 6 172.3 cd), 156.1 (CONH), 137.4, 
(Cbz=C=), 128.3, 127.9, 127.7 (Ch-=), 108.4 (OB0 ester C-O), 72.3 (OB0 ester 
CHtO), 65.8 (Cbz_CD), 59.8 (B-H) ,  52.3 (a-CH), 51.2 ( C o r n 3 ) ,  32.4 (OB0 ester - 
CCH3), 13.6 (OB0 ester CC&); ESI-MS (M + H+) 380.94; And. calcd for Cl&&@: - 
C, 56.84; H, 6.36; N, 7.36. Found: C, 57.13; H, 6.85; N, 7.42. 
5.4.23 (2S)-2,34i~obutanedioie acid, Asp(p-NHz)OH, 5.6. 
Same procedure as in section 5.4.14 to give 0.029 g (62%) of 5.5. 
1 H NMR m20, 300 MHz) 6 4.09,4.00, 3.75, 3.69 (d, IH, J = 3.4Hz, 8-CH, a-CH); I3c 
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Chapter Si 
Solid Phase Synthesis of PHydroxg-PSubstituted-a-Amino Acids 
6.1 Introduction 
Traditionally, the goal of 
cornpounds in as pure a form as 
meclicinal chemists has been to produce single 
possible for subniission to biological testing and 
evaluation as drug candidates. This methodical approach to the development of new drug 
entities is tedious, expensive and unavoidably time-consuming. 
A combination of necessity as the mother of invention and econornic factors 
thereby directed the development of a new method for the rapid synthesis and screening 
of compounds, evolving into the field of combinatorial chemistry. In essence, 
combinatorial chemistry involves both the synthesis and screening of large groups of 
compounds known as Iibrarïes. These techniques have revolutionized the pharmaceutical 
industry and are gradually expanding to other fields of the physical sciences. In fact, this 
method has been used to produce or optimize lead compounds in many different research 
areas and has progressed from its early strategy in generating random librarïes into a 
powerful design approach for developing and optimizing potential candidates.' 
The primary goal of combinatorial chemistry is the generation of compounds with 
a broad stmcturai diversity, the synthesis of which should occur in a precise manner in 
order to facilitate screening. Solid-phase organic synthesis, which has many sirnilarities 
to solid-phase peptide techniques, therefore uses well-defined organic reactions to 
rninimize side-reactions on the solid phase. As such, the purity of the final product after 
cleavage off the resin is of paramount importance. 
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One of the challenges of soiid-phase organic chemistry (SPOQ is the monitoring 
of reactions on the solid phase. Classical meihods, such as TLC, are obviously 
incompatible with resin-bound synthons, and as such a number of specialized techniques 
have been devel~ped.~ These include single-bead IT-IR and magic angle spinning NMR 
(MAS-NMR) as well as a number of pulse programs that take advantage of the difference 
in relaxation rates between the resin and the "epitope" of interest. However, rather than 
provide a detailed review of the field of combinatorial chemistry and al1 of its 
peculiarities, a few key points of particula. relevance to the solid phase synthesis of 
unusual a-amino acids will be discussed. Readers are directed to the following excellent 
references by Wilson and C~arnik,~ Dolle4 and BaldinoS for fùrther reading. 
In order to exploit the benefits of solid-phase organic chemistry (SPOC), solution 
phase organic reactions should be shown to possess the same characteristics on the soïid- 
phase. Having described the synthesis of various B-hydroxy-a-amino acids in some 
detail: we attempted to transfer the synthetic methodology ont0 the solid-phase as 
described in this chapter. 
6.1.1 Solid-Phase Synthesis of a-Amino Acids 
Considering that solid-phase organic chemistry was bom from the synthesis of 
peptides on the solid phase first reported by Memfield,' remarkably few syntheses of 
unusual a-amino acids on the solid phase have been reported, especially since the 
therapeutic value of amino acid based h g s  is well d~cumented.~ a-Amino acids are 
also useful intermediate chiral building blocks and have been used toward the synthesis 
of  peptide^,^ small rnolecule combinatorial librariesI0 and as components in condensation 
reactions such as the Ugi condensation." Furthemore, the inherent hinctionality of a- 
amino acids provides a convenient handle for additional derivatizati~n.'~ 
O'Donnell et al." f m t  reported the synthesis of unnatural a-amino acids on the 
solid phase with the goal of synthesizing unnatural peptides and a number of other groups 
- have expanded on O'Donnell's chernistry. A resin-bound Schiff base 6.1. generated with 
the non-ionic base 2-te=-butylimino-2-dieth ylamino- l,3-dimethylperhydro- l,3,2- 
diazaphos-phonne (BEMP), was alkylated with either alkyl halide~'~.".'~ or 
organoborane~'~ to give the resin-bound products 6.2 in 5 1-99% yield and high purity 
(>75%) (Scheme 6.1). Enantiomenc excesses range from 6499% ee depending on the 
alkyl group but generally increasing with size. The peptide couid then be extended 
through peptide coupling. The same authors extended the Schiff base method towards the 
synthesis of a,a-disubstituted-arnino acids by starting with various amino acids and 
alkylating with benzyl, allyl or Znaphthylmethyl bromide.17 
Miyabe and CO-workers took a similar approach to unnatural a-amino acids, using 
alkyl radicals to alkylate polyrner-supported glyoxylic oxime ethers." 
Scheme 6.1 
BEMP O H 
1) H C m F  
or 
R 4) TFA R O 
6.1 
2) R-9-BEN 6.2 
P=Merrifield, Wang R=Et, d u ,  Bu, cyhex, Ph, Bn 
O'Donnell has also used the same Schiff base methodology in the synthesis of 
racemic glutamic acid derivatives via Michael reactions. The Schiff base of 6.1 was 
condensed with the Michael acceptor to give the min-bound glutamic acid derivatives 
6.3 in 61-88% yield and purities of 70-95% (Scheme 6.2).19 This methodology was later 
expanded by using chiral phase transfer cataiysts to synthesize simple glutarnic acid 
Scheme 6.2 
BEMP 
6.1 1 ) H C W F  , 
4) TFA 
z z z 
6.3 
R ' , R ~ ~ R ~ = C O & ~ ~ ,  Me, Ph 
Z=C02Me, CN, S02Ph 
The recognized therapeutic properties of dehydroamino acids 6.62' and their 
incorporation in peptide libraries have k e n  addressed by the DBU catalyzed elimination 
of the sulfone 6.5 generated by oxidation of the derivatized cysteine 6.4 attached to the 
resin via the sidechain (Scheme 6.3). The dehydro-peptides 6.6 were generated in 3 1- 
86% yield over 4 steps and generally >!XI% purity. Cycloadditions have also been 
perfomed on the solid-phase on Fmoc-dehydroalanine generated through a sirnilar 
oxidation/elimination strategy in which cysteine is attached to the resin via the a- 
Scheme 6 3  
Fll=Boc. Cbz, Cbz-Phe, 1-Nap 
# = O M ~ ,  OBn, NHBn. PheOEt 
Dehydroamino acids have also been used as intermediates towards the solid-phase 
synthesis of a-amino acids? Radical additions to resin-band dehydroamino acids 6.7 
provided various racemic a-amino acids 6.8 in both hi& yield and punty (Scheme 6.4). 
Scheme 6.4 
Polyrner supported a-imino acetates 6.9 have been used to synthesize a-amino 
libraries via a Mannich-type reaction with various silyl nucleophiles to afford resin- 
bound y-0x0-a-amino acids 6.10 (Scheme 6.5)? Cleavage off the resin gave the desired 
products in 69-94% yield and high purity although no comrnents were made regarding 
enantioselectivity in the Mannich-type reaction. 
Scheme 6.5 
H SdOTih Nu, o%~l  11NaOMe 
CH2ClflffiN 2) ~cvdioxane- 
NAr NHAr NHAr 
3-Substituted prolines 6.14 have been synthesized diasterroselectively by amino- 
zinc-enolate cyclization chemistry (Scheme 6.6).= Esterification with the oxy anion gave 
6.11 which was cyclized to give the cyclic organozinc derivative 6.12. Iodonolyzation 
gave 6.13 which could be further derivatized via nucleophilic substitution then cleaved 
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off the resin under classical conditions and N-debenzylated to give the 3-substituted 
prolines 6.14. However, no comrnents were made regarding the final yield or purity of 
6.14 after cleavage off the min. 
Scheme 6.6 






"^O 6.1 1 O %  lb 
6.1 2 
Nu=PhSH, tryptamine, pN&phenol 
Various nucleophiles have been added to pyroglutamate 6.15 attached to Wang 
resin to give glutamate derivatives 6.16 which were cleaved off the resin with TFA 
(Scheme 6.7)." The use of a catalyst (KCN) was required with most of the reactions 
occumng in good yield and high purity. 
Scheme 6.7 
O 




Pyroglutarnate was reduced into the pyrollidinone dcohol that was then attached 
to Ellman's resin-bound tetrahydropyran (THP) to give the N-tosyl lactarn 6.17.= 
Treatment with various nucleophiles opened the lactarn to give resin-bound derivatives 
6.18 which after cleavage off the resin gave N-tosyl amines in both high yield and punty. 
Scheme 6.8 
Nu=RMgBr, RNH2, 
P=Wang 6.1 7 ROH 6.18 X,Y= H,OH,C4 
Functionalized fused bicyclic amino acids 6.21/6.22 have been synthesized by an 
intramolecular Pauson-Khand cyclization (Scheme 6.9)? The position of various 
functional groups within the hexahydro-1H-[2]pyrïndinone construct is determined by the 
order of addition of various alkenes and alkynes in the intermediate 6.20. Good overall 




1) (PPh&PdCk, Cul, 
Ar 
6.21 R= C--C, R 1 = e C  
2) w O ) e .  NMO. 
NHFmoc 
6.19 6.2û 
-Wang R1= C - C , ~ C  
a= Ckc, CCC 
H 
The distinct lack of solid-phase methods for the synthesis of unusual a-amino 
acids prompted us to investigate our previously described senne aldehyde methodology 
for incorporation ont0 the solid-phase. We herein describe the stereoselective synthesis 
of P-hydroxy- and B-disubstituted-p-hydroxy-a-arnino acids on solid supports. 
6.2 Results and Discussion. 
The solution-phase synthesis of $-hydroxy- and p-disubstituted-P-hydroxy-a- 
amino acids via a senne aldehyde equivalent has been described in detail in chapter two. 
Incorporating the phydroxy functionality on a-arnino acids on the solid phase provides 
an opportunity to further hinctionalize the amino acid and extend peptide chahs off the 
sidechain of the newly synthesized solid-supported f3-hydroxy-a-amino acid (Figure 6.1). 
Consequently, a number of both cyclic and linear peptides incorporating a modified & 
hydroxy moiety may be envisioned. The well characterized nature of the reaction, having 
been performed with a variety of solvents, protecting groups, temperatures and nucleo- 
philes prompted us to transfer the senne and threonine methodology ont0 the solid-phase. 
,Oyamino aàd 
&,NH 
Figure 6.1 : Possible Fune tionalhtion of Solid-Supported p-Hydroxy -a-Amino 
Acids. 
6.2.1 Synthesis of R e s i n - B o d  BHydroxy - fiSubstituted- a-Amino Acids . - 
We siudied two common polymers, Wang resin and TentaGe1 PHB' resin, on 
which to perfonn the sequence of nations described in detail in chapter two. Wang 
resin is generally the resin of choice for SPOC due to its excellent swelling 
characteristics, straightforward cleavage of substrates off the resin and low price. 
TentaGe1 PHBa resin incorporates a polyethylene glycol (PEG) spacer, and as such 
possess sweIIing charactenstics and reaction kinetics more typical of solution-phase 
chemistry." We choose the Cbz-equivalent linker introduced by Hauske and D o e O  to 
attach the a-amino group since manipulation of the a-carboxylate into the OB0 ester 
was necessary to prevent racemization during Grignard reaction on the serine aldehyde. 
The serina1 equivalent was incorporateci ont0 the resin as the OB0 ester since 
prelirninary studies indicated BF3e Et20 mediated remangement on the resin to be 
problematic. Cbz-Thr-OB0 ester 6.25 was synthesized in 92% yield over two steps, in 
an identical manner to that described for Cbz-Ser-OB0 ester 3.41 (Scheme 6.10). The 
Cbz protecting group was easily removed from both 6.25 and 3.41 by hydrogenolysis to 
give the free amino O B 0  esters 6.26 and 6.27 in quantitative yield. Of note is the fact 
that both 6.26 and 6.27 were stored at room temperature for over three years without lost 





Nal, DMF 6.24 6.25 
In order to attach the amino acids 6.26 and 6.27 ont0 the min  via their N-tennini, 
conversion of the methylene hydroxyi moiety in both Wang (0.74 mrnoVg loading) and 
TentaGel PHBQ (0.30 mmoVg loading) resins into a carbarnate linker was necessary. The 
resins were activated as either the imidazolide carbarnate 630 using N N -  
carbonyIdiimidazo1e 628 in THF or the p-nitrophenol carbonate 6.31 using p- 
nitrophenolchloroformate 6.29 and N-methyl morpholine 0 in CH2C12 (Scheme 
6.1 1 ). Loading was monitored by elemental analysis for nitrogen and was generally 
quantitative for both carbonyldiimidazole 6.28 and p-nitrophenoichloroformate 6.29 (see 
Appendix E for calculation) on both Wang and TentaGel PHBa resin. The imidazolide 





The arnino acid denvatives 6.26 and 6.27 were coupled to the resin in the 
presence of N.0-bis(trimethysi1yl)acetarnide (BSA) and DMAP to give the resin-bound 
amino acid OB0 esters 6.32 and 6.33. After 36 h, the remaining reactants were 
thoroughly washed off the resin with DMF and CH2Q till the rinsing was clear. 
Loading was determined by either elemental analysis or in the case of 6.31, the rinsings 
combined, reduced in volume then assayed using spectrophotometric techniques for p- 
nitrophenol content. Substitution generally occurred in ~ 9 5 %  yield but varied from batch 
to batch. The resin was then capped by rinsing with copious amounts of methanol, rinsed 
with Et20 then dried under vacuum. 
The progress of reactions could be monitored by a number of techniques specially 
developed for SPOC. FT-IR is particularly useful due to changes in functional groups. 
For exarnple, 6.31 to 6.32 is charactenzed by a 1761 cm-' to 1720 cm" shifi. MAS-NMR 
was used when pronounced changes occurred in the 'H NMR, such as the appearance of 
the OB0 ester CH2-O in 6.32 using a 2D TOCSY.)' spin-echon or presaturation pulse 
experimen t (Figure 6.2).33 
Oxidation to the aldehyde 6.34 and ketone 6.35 was more difficult than in 
solution phase for a number of reasons. Swern oxidation required transfer of the alcohol 
into a -78°C mixture of the generated chiorosulfonium salt which proved to be difficult 
since the alcohol was bound to the resin. TentaGe1 PHBa resin was particularly 
troublesome due to its "sticky" nature (a consequence of the PEG spacer) in cornparison 
to Wang resin. However, after numerous different experimental setups, the arrangements 
depicted in figure 6-3 were found to be most convenient: (a) for additions of resin 400 
mg and (b) for >500 mg. 




Figure 6.3: Experimental setup for Swern Oxidation. (a) Requires a I h g  of the RBF 
to trander the resh into the mixauP (b) resin is added to the mixture m d  any 
remaiaing beads washed into solution. 
The optirnized conditions for oxidation were determined by observing the 
appearance of the aldehyde peak for 6.34 or the methyl ketone for 6.35 in the MAS 'H 
NMR (Figure 6.2). The requirement of high purity in the find product necessitated 
quantitative conversion to the ddehyde 6.34lketone 6.35 to prevent contamination with 
remaining serine or threonine. Large excesses of reagents for the Swern oxidation were 
required, (16-50 eq.) since performing the reaction on a scale comparable to that in 
solution phase (1.6-5 eq.) failed to give any oxidation product. Eight hours at -78°C was 
required for complete conversion to the aldehyde 6.34ketone 6.35 (Scheme 6.12). Other 
methods of oxidation were also investigated including the Doering oxidation 
(py~SOf lMS0) ,~  Dess-Martin oxidation with 2.48:5 and TPAP (tetrapropyl 
ammonium pemthenate)/NMe6 with littie success. 
Scheme 6.12 
Grignard addition to aldehyde 6.34 and ketone 6.35 was performed using 
essentially identical conditions as those reported in chapter two. Prolonged reaction 
times and a twenty-fold excess of Grignard reagent was required. The appearance of the 
desired resin-bound B-hydroxy-a-amino acids 636-6.44 was monitored using MAS 'H 
NMR to follow the disappearance of the aidehyde peak 6.34 at 6 9.67 ppm and the 
methyl ketone 6.35 at 6 2.30 ppm (Scheme 6.12). MAS I3c NMR was used to follow 
6.37 and 6.43, labeled by ' 3 ~ ~ 3 ~ g ~  (Figure 6.4). The use of EtzO in the reaction 
mixture was also minimized since it caused significant shnnkage of the resin, particularly 
TentaGel PHB? M e r  approximately 6 h, acetone was added and the solvents were 
removed under anhydrous conditions. The m i n  was then washed with dry CH2C12 and 
Et20. 
Figure 6.4: MAS 13c-N..~ (500 MHz) using spin-echo program of 6.37 
( E ~ e n t a ~ e l ~  PHB resin). 
Cleavage of 6.36-6.45 off the resin was accomplished with TFA and subsequent 
hydrolysis of the rnhpd ester 2.62 with CszCOs gave the FrPe p-hydroxy-a-amino acids 
6.46-6.55 (Scheme 6.13). The free amino acids cleaved off Wang resin generaily showed 
punties of ~ 9 0 %  as indicated by 'H NMR and HPLC analysis and were observable by 
ESI-MS with the exception of 655 which was not isolated. Unfortunately, the amino 
acids cleavage off TentaGel PHBa resin were contarninated with up to 30% PEG from 
the spacer on the resin. Lower concentrations of TFA decreased the amount of PEG 
contamination but prolonged reaction times were required for complete cleavage off the 
resin. Cation exchange chromaiography was necessary for the removal of contaminating 
PEG and cleavage saits and is describe in section 2.4.15. No significant difference in 
yield or purity exists between Wang and TentaGel PHBa resin as indicated in table 6.1. 
Scheme 6.13 
R 
1) 1 :1 TFA:CH2CI2 
2) Cs2C03, MeOH 
3) cation exchange - H2 R1koH C02H 
Overall yields of the B-hydroxy-a-amino acids after purification ranged from 19- 
418 on Wang or TentaGe1 PHBa resin. Derivatization and HPLC analysis (as described 
in section 2.4.15a) indicated a slight reduction in the diastereoselectivity of addition when 
compared to Grignard addition in the solution phase to Boc, Cbz and Fmoc protected 
Ser(aid)-OB0 ester 2.46, 3.42 and 2.37 respective1 y (Table 6.1 ).6 The optimized solvent 
conditions for the addition of Grignard reagents described in chapter two is a 1 : 1 mixture 
of Et20:CH2CI2. However. as previously described, the swelling problems associated 
with the use of Et20 meant it was oniy added to the reaction mixture during addition of 
the Grignard reagent. Of note. is the observation in chapter two that the use CH2C12 as 
the reaction solvent results in an erosion of diastereoselectivity. 
HPLC analysis also indicated a significant amount of racemization (15- 188) was 
occumng. Two likely sources are during Swern oxidation or after addition of the 
Grignard reagent. Racemization has been show to occur during the Swem oxidation," 
Table 6.1: Addition of R ' M ~ B ~  to 6.34 iad 6.35. 
Entry Resin R R ' Product (%)' threo:erythro (mb 
6.46 30 80:20 18 Me 

















" After purification by cation exchange chromatography. 
Determined by derivatization and HPLC analysis. 
' Not isolated. 
but is typically dependent on individual systems and cannot be predicted. The prolonged 
exposure to base under conditions required to drive the oxidation to completion might be 
responsible for causing racemization. On the other hand, enolization is frequently 
encountered during Grignard reactions" and would cause racemization if occumng with 
6.34 and 6.35. Aithough the Grignard reaction time on the solid phase is longer than in 
solution, enolization was previously dismissed as a source of racernization for Boc and 
Fmoc protected Ser(ald)-OB0 esters 2.46 and 2*47 as described in chapter two. 
Reducing the reaction time during Swem oxidation resulted in significant deterioration of 
purity, a result of incomplete oxidation since HPLC andysis indicated serine or threonine 
contamination after cleavage off the resin. 
The stereochemistry of addition is identical to that observed in solution phase 
chemistry, confirmed by the cornparison of HPLC prducts derived after cleavage off the 
resin to those reported previously6 and in chapter two. HPLC analysis generaily showed 
ail four diastereomers although the very minor erythro-D-isomer was usually dificult to 
identify. MAS "C NMR of 6.37 also clearly showed two stereoisomers (Figure 6.2). 
f3-Dialkyl-8-hydroxy-a-amino acid 655 was not isolated and is consistent with 
the reported instability of this class of compounds.19 
63 S u m m  
Attachrnent of Ser-OB0 ester and Thr-OB0 ester ont0 the solid phase via a 
carbarnate linker allowed for the oxidation and subsequent Grignard addition of various 
nucleophiles towards the synthesis of p-substituted-B-hydroxy-a-amino acids. Moderate 
diastereoselectivity for Grignard addition was observed to give predominantly the threo 
isomer. Good overall yields (19-41 %) were achieved over six steps after purification by 
cation exchange 
The synthesis of p-hydroxy-a-amino acids on the solid phase has been shown to 
possess similar characteristics 
occurrence of racemization. 
To our knowledge, this 
arnino acids on the solid phase. 
as solution phase chemistry, albeit with an increased 
0 
represents the fmt report of P-substituted-p-hydroxy-a- 
6.4 Experimental 
Wang (1.04 mmoVg to 0.74 mmoVg) and TentaGel PHB@ (0.33 mmoVg to 0.29 
mrnoVg) resin were purchased €rom Advanceci ChemTech or Novabiochem. Al1 NMR 
spectra were acquired using a BRiker AMX-500 NMR. Approximately 1-2 mg of resin 
was placed in a 4 mm MAS zirconia rotor with Kel-F cap and a spherical insert (diameter 
2.6 mm). Sarnples were spun at the magic angle at a rate of 4 kHz and were run in 
C W l 2  and referenced interndly to residual CH2C12. 
6.4.1 (3-Methyl-3-oxetanyl)methyl (~JR)-2-[(beazyIoxy)carbonyl]amin0-3- 
hydroxybutanoate, Cbz-Thr oxetane ester, 6.24. 
Cbz-L-Thr 6.23 (5.06 g, 0.02 mol) and Cs2C03 (3.91 g, 0.012 mol) were combined and 
dissolved in &O (100 r d ) .  The water was then nmoved in vacuo and the resulting oil 
lyophilized for 12 hours to give a white foam. To this foam was added oxetane tosylate 
2.38 (5.38 g, 0.021 mol) and Na1 (0.6 g, 4.0 rnmol) which was then taken up in DMF 
(200 mL) and allowed to stir under Ar for 48 hours. The DMF was then removed in 
vacuo and the resulting solid dissolved in EtOAc (300 mL) and Hfl  (100 rnL) and 
extracted with 10% NaHC03 (2 x 50 mL), saturated NaCl (50 mL) and dried over 
MgS04. The solvent was removed under reduced pressure to yield a yellow oil which 
was recrystailized from ethyl acetate to give long, clear crystals in 96.8% yiefd (6.80 g). 
mp 49-5 I0C; [al2'o = - i 8.2 (c = 1.12, EtOAc); TLC (3: 1 EtOAc: hexane), Rr = 0.46; ' H 
NMR (-13, 250 MHz) 6 7.32-7.36 (m, SH, ArH), 5.66 (d, lH, J = 8.9 Hz, NH), 5.14 
(S. 2H, CbzCHzO), 4.57-4.40 (m, 7H, 3 oxetane ester C&O, B-CH), 4.13 (d, lH, J = 
1 1.2Hz, a-CH), 2.82 (br d, IH, J = 4.9Hz. OH), 1.28 (s, 3H, oxetane ester CCH3), 1-26 
(d, 3H. J = 8.Om, pCH3); I3c NMR (CDC13, 63 MHz) 8 171.2 c = O ) ,  156.7 (C=O), 
136.0 (Cbz<=), 128.5, 128.2, 128.0 (Cbz-, 79.4 (oxetane ester w z O ) ,  68.8 (P- 
CH), 67.9 (COSHz), 67.1 (Cbzmfl), 59.5 (a-CH), 39.6 (oxetane ester CC&), 20.7 - 
(oxetane ester CC&), 19.9 @-CH3); Anal. calcd for Ci7HuNO6: C, 60.52; H, 6.87; N, 
4.15. Found : C, 60.42; H, 7.04; N, 4.18. 
6.4.2 Benzyl-N-[(~~R)-3-hydmxy-1-(4-methyl-2,6,7-tri0~abi~y~l0[2~2~2 Joct-1-y1)- 
propyl]carbamate, Cbz-L-Thr-OB0 ester, 6.25. 
Cbz-Thr oxetane ester 6.24 ( 15.0 g, 46.2 mmol) was dissolved in dry CHzClz (450 mL) 
and cooled to O°C under Ar. BF3. EtzO (0.29 mL, 2.3 1 mrnol) was diluted in CH2C12 (5.0 
rnL) and added to the reaction flask. The reaction was allowed to warm up to room 
temperature and was checked by TLC. After 6 hours, Et3N (1.29 mL, 9.25 mrnol) was 
added and the reaction was stirred for an additionai 30 minutes before king concentrated 
to a thick oil. The crude product was redissoIved in EtOAc (400 mL) and washed with 
3% N&cl (2 x 250 mL), saturated NaCl (250 mL), dried (MgSQ), and evaporated to 
dryness. The reaction yielded a colourless thick oil in 95% (14.2 g) yield. The clear 
colourless oil was crystailized from EtOAc to give rod-like shiny crystals in 93% (13.6 g)  
yield. 
- mp 117.0-1 18.0°C; [ a 1 2 0 D  = -12.1 (c = 1.06, EtOAc ); TU: (39 EtOAc:hexane), Rf = 
0.40; 'H NMR (CDC13) 6 7.27-7.38 (m, SH, ArH), 5.33 (d, lH, J = 10.3Hz, NH), 5.07- 
5.20 (m, 2H, CbzCHD), 4.36 (m, i& p-CH), 3.93 (s, 6H, OB0 ester C H D ) ,  3 -75 (m. 
1 H, a-CH), 2.88 (br s, 1 H, OH), 1.12 (d, 3H, J = 6.4Hz, 8-CH3), 0.82 (s, 3H, OB0 ester 
13 CC&); C NMR (-13) 6 156.9 (Cd), 136.5 (Cbz<=), 128.4, 127.9, 127.9 
(CbzGH), 108.7 (OB0 ester C-O), 72.7 (OB0 esterCHzO), 66.8 (CbzazO), 65.1 (p- 
CH), 57.9 (a--m, 30.6 (OB0 ester CCH3), 18.9 @-CH3), 14.3 (OB0 ester CcH3); - 
Anal. calcd for C17HUN06: C, 60.52; H, 6.87; N, 4.15. Found: C, 60.29; H, 6.82; N, 
3.94. 
14=3 ( 2 S ) - 2 - A m I n o - 1 - ( 2 , 6 , 7 - t r i o x a b i c y c I o [ 2 ~ ,  Ser-OB0 ester, 
6.26. 
Cbz-Ser-OB0 3.41 (5.0 g, 15.3 mmol) was dissolved in Et0Ac:EtOH (1 : 1, 100 mL) to 
which PdlC (2 g) was added. The mixture was evacuated, purged with Hz, evacuated 
once more then purged with H2 and allowed to stir ovemight. The solution was filtered 
through Celite and the filtrate reduced in vacuo to reveal 2.87 g (99% yield) of a slight 
yellow solid. 
NMR @MSO-&, 250 MHz) 6 3.80 (s, 6H, OB0 ester C m ) ,  3.51 (dd, lH, J = 3.4, 
10.7Hz, p-CHH), 3.12 (dd, lH, J =  8.7, 10.5Hz. 8 - C m ,  2.66 (dd, lH, J = 3.4,8.6Hz, a- 
CH), 0.72 (s, 3H, OB0 ester CCH3); "C NMR @MSO-&, 63 MHz) 6 108.2 (OB0 ester 
324 
C-O), 7 1.9 (OB0 ester GHzO), 61.7 (B--H), 57.9 (a---, 29.9 (OB0 ester s H 3 ) ,  13.9 
(OB0 ester CCH3); ESI-MS (M + H') 189.93; Anal. calcd for CsHia04: C, 50.78; H, 
I 
7.99; N, 7.40. Found: C, 50.99; H, 8.23; N, 7.47. 
6.4.4 (2S~R)-2-Amin011-(2,6,7-tri0~8bicycïo[2.2.2]~t-1-y1)prop~-3~1, Thr-OB0 
ester, 6.27. 
Cbz-Thr-OB0 ester 6.25 (6.1 1 g, 18.1 1 mmol) was dissolved in Et0Ac:EtOH (1 : 1, 100 
mL) to which Pd/C (2 g) was added. The mixture was evacuated, purged with Hz, 
evacuated once more then purged with H2 and ailowed to stir ovemight. The solution 
was filtered through Celite and the filtrate reduced in vacuo to reveal 3.63 g (99% yield) 
of a yellow oil that solidified upon standing. 
[al2'o = -5.8 (c = 1.09, EtOH); TU: (9: 1 Et0Ac:MeOH) Rf= 0.34; NMR (DMSO-&, 
250 MHz) 6 4.12 (m, 1& P-CH), 3.81 (S. 6H. OB0 ester C H G ) ,  2.59 (d, lH, J = 8.4Hz, 
a-CH), 1.22 (d, 3H, J = 6.7Hz. B-CH3), 0.79 (s, 3H, OB0 ester CCH3); 13c NMR 
@MSO-Q, 63 MHz) 6 1 08.1 (OB0 ester Ç-O), 7 1.9 (OB0 ester CH20), 64.7 @-CH). 
58.9 (a-CH), 29.9 (OB0 ester WH3). 18.3 (B-m3), 13.9 (OB0 ester CCH3); ESI-MS 
(M + H+) 203.84; Anal. caicd for C9HiïN04: C, 53.19; H, 8.43; N, 6.89. Found: C. 
6.4.5 Wan&TenîaGel pHBB resin imidazolide, 6 3 .  
N,N'-Carbony1diimidau,ie 6.28 (0.60 g, 3.7 mmd) was combined with Wang resin 
(1.0 g, 0.74 mmo1,0.74 mmollg) then taken up in dry THF (10 mL). Aner 4 h, the 
mixture was poured into a sintered giass h e l  and the sdvent removed under 
vacuum. The resin was washed Pltematively with TEIF (5 x 25 mL) and CH2Cl2 (5 x 
25 mL) then with EtzO (2 x 25 mL) and dried under high vacuum. 
IR ( D r )  1755 cm-'. Anal. calcd for N, 0.94% corresponds to 98% substitution. 
604.6 WanflentaGeI pHBe resin p-nitrophen01 carbonate, 6.31. 
p-Nitrophenolchloroformate 6.29 (1.3 1 g, 6.5 mmol) was added to a stimng mixture of 
Wang resin (1.75 g, 1.3 mmol, 0.74 mmoVg) in N-methyl morpholine (1.43 mL, 13.0 
mmol) and dry CHg12 (30 m.) whilst under Ar at 0°C. The mixture was allowed to 
reach ambient temperature and after 12 h the resin was filtered off and washed with 
CHzClz (5 x 50 mL), Et20 (2 x 50 mL) and dried under high vacuum. 
IR (KBr) 1761 cm-'. And. calcd for N, 0.92% corresponds to 99% substitution. 
6.4.6 WanflentaGel PBB' rosis Ser-OB0 carbamate, 6.32. 
Ser-OB0 6.26 (0.600 g, 3.17 mmol) and DMAP (O. 15 g, 1.26 mmol) were dissolved in 
N-methyl pyrrolidinone (5 mL) and N,O-bis(trimethylsily1)acetamide (0.94 mL, 3.8 
mmol) to which Wang p-nitrophenol carbonate resin 6.31 (1.00 g, 0.63 mmoWg) was 
added. The mixture was stirred for 24 h before the resin was filtered off and the resin 
rinsed, altemating with dry DMF (5 x 20 mL) and dry CH2C12 (5 x 20 mL) before king 
rinsed with Et20 (2 x 20 rnL) and dried under high vacuum. 
IR (KBr) 1 742 cm" ; MAS 'H NMR (Spin-Echo-6û ms): 6 3.9 1 (OB0 ester C H D ) ,  0.7 1 
(OB0 ester CH3). 
6.4=1 WanglFentaGd PEB' min Thr-OB0 carbamate, 633. 
Thr-OB0 6.27 (0.3û4 g, 1.50 mmol) and DMAP (0.074 g, 0.6 mmol) were dissolved in 
N-methyl pyrrolidinone (5 rnL) and N,O-bis(trimethylsily1)acetarnide (0.47 rnL, 1 -9 
mmol) to which Wang p-nitrophenol carbonate resin a31 (0.478 g, 0.63 mmollg) was 
added. The mixture was stirred for 24 h before the resin was filtered off and the resin 
rinsed, aitemating with dry DMF (5 x 20 mL) and dry CH2C12 (5 x 20 mL) before king 
rinsed with Et20 (2 x 20 mL) and dried under high vacuum. 
IR (KBr) 1742 cm"; MAS 'H NMR (Spin-Echo-60 ms): 6 3.88 (OB0 ester CH20), 0.70 
(OB0 ester CH3). 
64.8 WanflentaGel pHBa min Ser(aid)-OB0 carbrunate, 6.34. 
Oxalyl chlonde (0.233 mL, 2.72 mmol) was added to dry CH2C12 (20 mL) in a 50 mL 2- 
neck RBF and stimd under Ar at -78OC. DMSO (0.385 mL, 5.44 rnmol) was quickly 
added and the mixture stllred an additionai 15 min. The 2-neck 50 mL RBF was tilted 
(see figure 6.la) to add the Wang Ser-OB0 carbarnate 6.33 (0.200 g, 0.14 mmol, 0.68 
mrnovg) to the stirring mixture at -78OC. After 8 h at -78°C. DIPEA (1.41 mL. 8.2 
mmol) was added and the mixture stirred an additional 2 h while warming to room 
temperature. The solvent was removed under anhydrous conditions and copiously nnsed 
with dry CH2C12, Et20 (2 x 25 d) then dried under high vacuum. 
MAS 'H NlMR (Spin-Echo-6û ms): 6 9.71 (CHO), 3.91 (OB0 ester CH20). 0.80 (OB0 
ester CH3). 
6.4.9 Wang/TentaGe1 pHBa resin Thr(ket)-OB0 carbarnate, 6-35. 
Oxalyl chloride (0.293 mL, 3.36 rnmol) was added to dry C H S l 2  (20 rnL) in a 50 mL 2- 
neck RBF and stirred under Ar at -78OC. DMSO (0.491 mL, 6.93 mmol) was quickly 
added and the mixture stirred an additional 15 min. The 2-neck 50 rnL RBF was tilted 
(see figure 6. la) to add the Wang Thr-OB0 carbamate 6.34 (0.320 g, 0.21 mmol, 0.64 
mrnoUg) to the stirring mixture at -78°C. After 8 h at -78°C. DPEA (1.82 mL, 10.5 
mmol) was added and the mixture stirred an additional 2 h while warrning to room 
temperature. The solvent was 
with dry CH2C12, EtzO (2 x 25 
removed under anhydrous conditions and copiously rinsed 
mL) then dried under high vacuum. 
- 
MAS 'H NMR (Spin-Echd ms): 8 3.87 (OB0 ester CHD) ,  2.34 (CH3CO), 0.73 (OB0 
ester CH3). 
6.4.10 Generrl method for the addition of Grignard v e n t s  to WanglFentaGel 
PHB' resin 6.34 or 6.35. 
- Wang Ser(a1d)-OB0 ester resin 6.34 (O. 18 g, 0.12 mmol, 0.62 mmoUg) was suspended in 
CH2Ch (5 mL) and cooled to -78OC. Methylmagnesium bromide (0.3 mL, 0.9 rnmol) 
was then added by syringe and the mixture stirred for 6 h. Acetone (1 rnL) was then 
added and the mixture stirred for 30 min before the resin was filtered off and rinsed with 
CH2C12 (5 x 25 mL), DMF (5 x 25 mL), CH2CIz (5 x 25 mL), Et20 (2 x 25 rnL) then 
dried under high vacuum. 
MAS 'H NlMR (Spin-Echo-60 ms): 6 3.82 (OB0 ester CH20), 0.73 (OB0 ester CH3). 
MAS I3c NMR (Spin-&ho-6û ms) (I3c labeled 6.3'7) 19.1 (p-CH3). 
6.4.11 General method for the cleavage of 6.36 off Wang min, (2&3R)-2-amin0-3- 
hydroxybutanoic acid, 6.46. 
Wang Thr-OB0 ester 6.36 (0.15 g, 0.1 rnmol, 0.62 mmovg) was stirred in TFACHzC12 
(1: 1, 3 rnL) for 30 min before the resin was filtered off and the filtrate reduced under a 
gentle Stream of N2. The light brown residue was dissolved in CH2C12 (2 mL) and 
reduced again before Cs2C03:MeOH (10% wt/vol, 2 m.) was added and the mixture 
stirred for 18 hours. The mixture was acidified with SN HCl and purified as described in 
section 2.4.15 then lyophilized to give 4 mg (30% overaii yield) of 6.45 as a white 
powder. Spectral data identicai to authentic Thr. HPLC conditions as in section 2.4.1 Sa 
with retention times for L-Thr 6.45 (2 1.4 min), L-allo-Thr (25.5 min), D-Thr (22.5 min). 
64.12 (~,3R)-2-amin0-3-hydroxypentanoic a id, 6.4û. 
Same procedure as in 6.4.1 1 - Spectral data identicai to that in 2.4.16. 
6.4.13 (~,3R)-2-amino-3-hydroxy-3-phenylpmpmoic a id, 6.49. 
Same procedure as in 6.4.1 1. Spectral data identicai to that in 2.4.18. 
6.4.14 (2S$R)-2-amino-3-hydroxy~phenylbutanoic acid, 6.50. 
Same procedure as in 6.4.1 1. 
TU3 (1 : 1 : 1 : 1, EtOAc:nBuOH:MeOH:H20) Rf = 0.73; 'H NMR (&O, 250 MHz)  major 
threo isomer 6 7.35-7.19 (m. SH, ArH), 4.25-4.08 (m. lH, p-CH), 3.64 (d, lH, J =  4.8Hz, 
a-CH), 3.00-2.71 (m, ZH, BnCHd; "C NMR (W, 63 MHz) G 174.9 WH), 140.2 
(Ar-=), 131.0, 129.5, 128.0 (m-H), 73.1 (J3-EH), 62.7 (aSH), 41.0 (BncH2); ESI- 
MS (M + H+) 195.98. HPLC (threo-L-650: 66.1 min. threo-D-6.50: 67.3 min, eryrhro- 
L-6.50: 7 1 .O Mn, erythro-D-6.50: 75.3 min) 
6.4.15 (2S,3R)-2-amino-3-hydroxy-4-pentenoic a id, 6.51. 
Same procedure as in 6.4.1 1. Spectral data identical to that in 2.4.17. 
6.4.16 (zs)-2-Pmmo-3-hydroruy-3-meth ~Ibutanoic acid, 6.52. 
Same procedure as in 6.4.1 1. Spectral data identical to that in 2.4.22. 
6.4.17 (~~R)-2-amino-3-hydroxy-3-methylpentanoic acid, 6.54. 
Sarne procedure as in 6.4.1 1. Spectral data identicai to that in 2.4.23. 
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Chapter Seven 
Conclusions and Suggestions for Future Research 
7.1 Conclusions 
Synthesis of the Boc serinal OB0 ester synthon occurs in moderate yield and is 
isolated as an oïl. The Grignard addition to the Boc serinal OB0 ester derivative, in the 
synthesis of f3-hydroxy-~-unino acids, occurred in both high yield and good 
stereoselectivity. Although the selectivity of addition was not as high as the Fmoc and 
Cbz derivatives, the Boc protected p-hydroxy-a-amino acids have the advantage of a 
more facile deprotection with TFA to the mhpd ester before hydrolysis to the free P- 
hydroxy-a-amino acids. 
The synthesis of vinylglycine in excellent enantiomenc excess was accomplished 
by the acid hydrolysis of the j3-siland Peterson olefination intermediate. The fully 
protected vinylglycine derivative was synthesized in 86% ee via Takai olefination, 
compared to 8 1% ee via the Wittig reaction previously described by this group.' 
A varïety of y-substituted glutarnic acid derivatives were synthesized in both 
excellent stereoselectivity (2S,4S) and overall yield from a Cbz glutamate OB0 ester 
synthon. The enolate of the glutamate synthon is amenable to alkylation, acylation, Aldol 
and Claisen reactions and the electrophilic addition of various heteroatoms. The 
protected y-hydroxyglutamate derivative was dvated as the triphenylphosphine 
derivative and could be displaced by the addition of a nucleuphile in good yield and 
stereoselectivity. This methodology represents a sipificant contribution to the synthesis 
of these important derivatives due to the excellent diastereoselectivity, good yields, 
variety of electrophiles chat may be incorporated and ease of synthesis of the synthon. 
p-Substituted aspartic acid derivatives were synthesized in varying yields and 
diastereoselectivities, depending on the nature of the electrophile. The stereoselectivity 
of the addition was the more unusual 2S,3S-stereoisomer and the diastereoselectivity in 
the synthesis of p-methylaspartate is comparable to the best current procedure. However, 
the methodology described here is preferable in terms of atom efficiency. 
Disappointingly, the addition of various other electrophiles occurred with lower 
diastereoselectivty than other reported methods. Various models have been described in 
an attempt to explain the previously unreportcd stereoselectivity observed with the 
lithium enolate of the Cbz/OBO aspartate derivative. 
To our knowledge, the synthesis of 8-hydroxy-a-amino acids on the solid phase 
described herein is the first report of the synthesis of this class of a-amino acids on the 
solid phase. Although not enantiomerically pure, the functionality contained within the 
P-hydroxy-a-arnino acids makes them a particularly attractive target for synthesis on the 
solid phase due to the potential for derivitization. 
7.2 Suggestions for Future Research 
Current syntheses of the vinylglycine derivatives described in this thesis result in 
some racemization at the a-carbon. Eliminating this source of racemization is necessary 
in order to use the OB0 vinylglycine denvatives as intennediates in various syntheses. 
However, the protected vinylglycine denvative should be investigated in various [2+2] 
cycloaddition reactions towards various constrained a-amino acids. 
The success in the optirnized synthesis of allryl and hydroxy glutamic acid 
derivatives provides the opportunity to expand the methodology into other aspects of 
glutamic acid chemistry. However, the synthesis of the filly protected glutamate 
derivative 4.69, although cumntly optirnized, would be advantageous if column 
purification could be avoided. The crystalline derivative is stable making it particularly 
amenable for use as a generai synthon. 
Confirmation of the model predicting the stereochernistry of addition of various 
electrophiles with glutamic acid could be achieved by di-N-protection. The N-Li bond, 
thus removeci, could no longer participate in chelation, which is cntical in the proposed 
model in section 4.2.10. Replacing the OB0 ester protecting group with the AB0 ester 
protecting group as described by Wipf et aL2 and thus increasing the sue of the directing 
group may have a beneficiai effet on stereoselectivity. 
The successful synthesis of 2S,4R-arninogluiamic acid via the nucleophilic 
addition of azide illustrates the synthetic utility of the activated hydtonyl derivative of 
glutamic acid. Numerous other nucleophilic additions may be envisioned, providing 
access to 2S,4R derivatives of glutamic acid and hence complementarity to the synthesis 
of 2S94S substituted glutamates described in ihis thesis. The y-bromoglutamate derivative 
should also be investigated as a y-cationic glutamate denvative. 
Preliminary results indicate the Claisen condensation described in section 4.2.8 to 
be partieularly prornising. Current methods for the synthesis of substituted indolizidines 
in a stereoselective manner are severely lacking. Decarboxylation of the glutamate dimer 
4.117 to the ketone 4.118 would provide the opportunity for 1,3-stereochemical induction 
in 4.118. This may allow for the stereoselective introduction of various substituents into 
the glutamate dimer. It may also be possible to introduce psubstituted glutamate 
derivatives (such as 4.73) into pre-generated mixtures of the enolate of 4.69. ensuring the 
high stereochemistry is pre-instaiied. 
1,4-Additions to E and Z dehydroglutarnic acids would provide access to B- 
substituted glutarnic acids, of immense interest in the synthesis of kainic acid analogues 
which possess potent neuroexcitatory activity? Cumnt synthetic methods used in the 
synthesis of these denvatives suffer from a lack of generality in the incorporation of 
various substituents andfor poor stereoselectivity. 1,2-S tereoinduction has been used 
with great success in a number of Michael additions and the proximity of the OB0 ester 
may ensure hi& stereoselectivity in these reactions (Scheme 7.1). 
Scheme 7.1 
C02Me 
Epoxidation of the dehydroglutamic acids, although unsuccess€ul under 
conditions reported in this thesis, warrants further investigation due to its synthetic utility. 
Nucleophilic ring-opening reactions to give p-substitu ted-ph ydrox y-glutamic acids are 
of interest not only as potential iGlu and mGlu agonists/antagonists but also as 
intermediates in natural product syntheses due to their highly functionalized nature. 
As a naturai extension of the high 19-induction of addition to protected glutarnic 
acid denvatives, investigation of the potential 1,4-induction of L-a-aminoadipic acid 
should be explored. Various analogs of L-a-arninoadipic acid have been incorporated in 
the synthesis of penicillin analogs,' iGlu and mGlu agonists/antagonists5 and 
metailoprotease inhibitors? 
The synthesis of 2S93S-aspartic acid derivatives and the role of the numerous 
factors invotved in the stereochemical outcome of addition of electrophiles requires 
additional investigation. The use of more reactive electrophiks has been shown to 
increase diastereoselectivi~ and needs to be examined. Furthemore, the effect of larger 
N-protecting groups on stereoselectivity, and the corresponding effect of the observations 
on the proposed models should be investigated. 
The O B 0  ester has been implicated in both directing nucleophilic attack and 
chelation. Investigating the role of the oxygens of the OB0 ester in chelation could be 
accomplished by using a bicyclo[2.2.2]octane derivative. The derivative could be 
synthesized as outlined in Scheme 7.2 although the separation of the enantiomers might 
prove challenging. Synthesis of 7.1' and 7.2' have been previously reported as has the 
tramesterification to 7.5.1° 
Scheme 7.2 
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X-Ray Crystallographic Data for Compound 4.73 
Table 1, C r y a t r l  data and .tructuse refincment for g1907: 





Unit ce11 dimensions 
Volume, Z 
D e n r i t y  (calculatad) 
Absorption coefficient 
r (ooo) 
Csyatal . o i z e  
8 range for data collectio~ 
Limfting iadices 
Reflections collected 
1 adependcnt ref lectiona 
Completeneas to B = 30 .OoO 
Absorption correction 
Max. and m i n .  transmission 
Raf inenmat mmthod 
Data / re8trainta / parameter8 
G o o & e . . - o f - f i t  on F 2 
Final R indice8 [X>2a (1) 1 
R indices (al1 data) 
E a c t i K l ~ t i 0 ~  coefficieat 









a = 5.4681(6)  À alpha = 90 
b = 18.8646 (15) ji beta - 90° 
O 






0-20 X 0.20 x 0.14 
2.09 to 30.00~ 





0.9794 and 0.9717 
Pull-matrix 1ea.t-square8 on P 
2 
3361 / O / 269 
1.616 
RI r 0.0390, wR2 - 0.0609 
R1 r O.OSllo wR2 r 0.0616 
O -019s (4) 
0.212 and -0.183 &O' 
a m  one third of the trace of the orthogonalizad U tensor. 
ij 
Tabla 3. Bond langths [Al and amglrs COI for 91907. 
Symmetry transformations used to generate equivalent atoms: 
2 3 Tabla 4.  Aniiotsopic dirplacrnieat puameterr [A x 10 ] for g1907, 
TL ~ i r o t r o p i c  dimplrc.uiit factor ~ o a e n t  akei tha formt 
Table 5. Eyârogen coordinatas ( x lo4)  rnd isotropie 
- -  - 2 3 . - 
diuplrcë&nt parameteru ($ i 10 ) for g1907: * - .. 
- .  
Cakulation of Free-Energy Difference and Free- Energy of Activation for 
Compound 4.73 
Calculation of Free Energy Dinerence (m 
AG = 1.3 14 kcal mol" 
where PA= Population of A 
PB = Population of B 
R = 1.987 cal K-' mol-' 
T= 295 K 
Calculation of Free Energy of Activation (AGSc) 
where: 
X Tc = temperature of coalescence 
AG 4-57 Tc 
2d l -AP)  
+ log- 
& "1 6v = shift between the lines at very 
slow exchange 
X = 2n6n 
2.6389 r= correlation time - extrapolated 
AG *A= 4.57(330) 
2R( 1 - 0.808) + log - 89 from a plot of 6i.r vs. dP (Figure 1) 
AG 17.38 kcal mol-' 
AGta=4.57 Tc X 
241+AP)  
+ log - 
Si, Tc 1 
AG ta= 4.57(330) 
2.6389 
2n( 1 + 1.808) + log- 89 
AG 17.22 kcal mol" 
X-Ray Crystallographic Data for Compound 4.96 






Cryn ta1 sys tem 
Spacc group 
Unit ce11 dimensions 










Completeqcem to 0 = 35.01~ 
Absorption correction 
Max, and mfn. t c a a s ~ i s s i o n  
R e  f inemen t mc thod 
Data / restraints / parainetaro 
Gooâaes8-of-fit OP ? 2 
Final I indice. 1 1  >2u (1) 1 
R indices (al1 data) 
Extinction coefficient 
Largest diff. peak and hole 
Orthorhombic 
P212121 
r = 6.0244( '3)  alpha = 90° 
b r 13,7314 (8) A bcta = DO* 
c = 23.1172(13) A gamma 90 O 
0.983 and 0.961 
Full-xaattix least-squares on F 2 
0.325 and -0.296 40' 
4 
T a b l e  2. Atolaic coordinrtes C x 10 1 and equivalent irotropic 
2 - 3 
displacement parameteri [A x 10 1 .for .g1955xa. u (aq) is def ined - ' 
a m  orne th~rd of the traice of the orthogonalized u tensor. 
ij 
. Tabla 3. Bond lenpths [ i l  and rng2ei [O1 €O+ g1955ri. 
. . 
. . 
Symrnetry transformations used to geaerate equivalent atoms: 
2 3 . T a b l e  4. Animotropic displacement paranietara CA x 30 1 for g1955xmi. 
. ~ h e '  anis~tropi~ displacemat: factor uponent t&e8 the fori :  

X-Ray Crystallographic Data for Compound 5.50 
T a b l e  1. C r y m t a l  data and mtructure zefinement for 91902. 






Crys ta1 sya tem 
space group 
Unit ceIl dimensions 
Volume. z 




9 range for data collection 
Limi ting indices 
Reflections collectcd 
Independent reflections 
Completcaaas te 8 r 2 9 . 0 0 ~  
Refinememt method 
Data / reatraints / parameter* 
~0oQ888-of-fit OP P 2 
F i n a l  R fodicem [1>2o (1) 1 
R indicas (al1 data) 
Extinction c o e f f i c i e n t  
Largast d i f f .  p e a k  and hole 




T a b l a  2.  Atomic coordinates 1 x 10 1 axad equivalent isotropie 
.3 displac&nt paraiet;rs -x 10 . l  for g1902. 0(&) is d e f i  nad- 1 
as one third of the trace of the orthogonalized- 
~ i b l e  3 .  ~ o n d  l e g t h a  [A] and angle. l01 for 91902. 
- .  
2 3 ? able 4 .  Aniiotsopic dfmplaceaent puametare [A x 10 1 for g1902. 
. - 2 2 .r 
-21 (ha 1 UzI + ... + 2hka b 1)12 1 
Tabla 5 .  Sydrogen coordinates { x 104) and iaotxopic 
Calcdation to Determine Resin Loading 
Theoretical Substitution (S(&,): 
for substitution of Wang pnitrophenol resin 6.31 with Ser-OB0 6.26. 
WtQl = weight gained by resin in g 
Wt(ddl = g/mol added to resin 
Wq,) = total new weight of resin in g 
S(r) = starting substitution mmoVg 
